data_1ji8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ji8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.242 0.544 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -65.15 87.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 94.3 m -96.32 148.46 34.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -75.99 150.45 93.92 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.45 -0.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -161.87 157.66 29.46 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 21.0 pt-20 -110.64 160.81 16.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 75.9 m-85 -154.6 169.78 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.235 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.37 137.95 53.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.079 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' ASP . 10.9 t -141.35 121.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.461 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 41.38 74.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.33 -0.856 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.46 62.85 2.33 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -157.69 159.93 37.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.088 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -121.9 117.11 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 t -113.46 120.36 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -101.86 141.03 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD21 ' C ' ' A' ' 22' ' ' CYS . 6.9 mt -122.38 120.3 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.38 -169.71 2.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.4 tt0 -50.75 147.52 4.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER 64.32 20.91 12.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.423 ' C ' HD21 ' A' ' 18' ' ' LEU . 76.9 m 51.88 54.69 10.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.96 139.68 32.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.421 ' HE2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -68.31 115.4 7.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 110.185 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -116.9 34.38 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -157.71 68.67 4.01 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.21 -0.62 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.968 1.51 . . . . 0.0 110.439 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.86 -25.86 40.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.12 26.9 9.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 110.334 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -75.64 141.3 42.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -155.29 -167.41 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.219 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.54 -33.65 66.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.195 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 24.0 mmtt -71.52 -37.62 71.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.421 HG13 ' HE2' ' A' ' 24' ' ' MET . 14.2 t -70.18 -51.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.131 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.53 81.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -67.2 -26.97 66.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CE2' ' OE1' ' A' ' 41' ' ' GLU . 49.9 t90 -66.93 -60.79 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.35 -39.0 75.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.81 71.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 3.6 ttm180 -76.86 -34.72 57.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 110.128 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' OE1' ' CE2' ' A' ' 37' ' ' TRP . 4.0 mt-10 -77.29 -26.64 52.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.01 -66.07 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.681 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.76 -31.9 40.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 101.96 -4.8 52.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.84 120.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -1.156 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -89.56 -26.42 20.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.09 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -135.53 103.55 5.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 0.0 110.146 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 52' ' ' HIS . 15.5 mmm -48.13 119.02 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -71.58 -169.15 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -84.75 -20.76 30.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 3.7 mp0 -77.0 -45.05 28.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.413 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 24.8 m170 -54.76 -52.7 61.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 5.3 m95 -67.41 -27.77 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.269 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -61.63 -65.8 0.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.15 -0.969 . . . . 0.0 109.966 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.84 -43.36 94.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.884 . . . . 0.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 52' ' ' HIS . 35.1 t -56.45 -29.37 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.863 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 14.4 mttt -75.29 -48.96 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.134 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.5 ' CE1' HG11 ' A' ' 75' ' ' VAL . 30.0 t80 -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -38.12 82.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -28.55 65.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.85 -42.39 40.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.325 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -66.89 -26.86 67.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -71.93 -2.69 18.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.254 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.19 11.94 36.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.248 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.53 -46.66 3.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.069 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -129.89 -34.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.26 56.01 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -139.95 -167.17 2.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -1.118 . . . . 0.0 110.255 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.55 93.46 3.54 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.6 Cg_endo -72.74 173.95 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.985 1.518 . . . . 0.0 110.45 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.6 Cg_endo -73.07 -160.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.978 1.515 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 72' ' ' ILE . 3.4 tp -111.87 2.8 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.281 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -24.87 25.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtt -87.57 -30.37 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 58' ' ' TYR . 47.5 t -65.46 -29.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.2 m -62.34 -31.86 72.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -26.91 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.04 52.86 1.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 110.025 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.7 m -159.41 -74.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 49.77 0.4 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.0 147.56 33.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -1.193 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -98.96 131.67 44.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.924 . . . . 0.0 110.221 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -62.63 -32.32 73.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -64.54 -56.55 13.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.079 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -50.53 67.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.89 -34.98 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.987 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -61.76 -49.44 76.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.996 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 5.4 tp60 -66.18 -24.11 66.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mt -79.29 -29.51 42.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 110.09 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 16.6 m-85 -116.79 167.36 10.79 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.879 . . . . 0.0 110.042 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 92' ' ' SER . 51.3 Cg_endo -78.05 70.83 6.93 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.053 1.554 . . . . 0.0 110.622 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 91' ' ' PRO . 11.3 t 40.42 68.93 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.537 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.81 66.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.98 -12.5 23.79 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.01 1.531 . . . . 0.0 110.435 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 110.313 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 34.2 p80 -62.39 -24.62 67.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.77 -63.58 4.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' CYS . . . -48.96 -66.17 0.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.177 . . . . 0.0 110.418 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.416 ' C ' ' O ' ' A' ' 98' ' ' ALA . 8.7 t -41.92 -46.75 4.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.8 mtpt -52.52 -54.88 26.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 t -62.44 -25.95 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.965 . . . . 0.0 110.411 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.06 -32.95 69.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.07 46.63 1.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.182 -1.187 . . . . 0.0 110.221 179.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.566 HG22 ' CE2' ' A' ' 9' ' ' TYR . 5.2 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.314 0.578 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 28.5 m -104.81 154.84 38.3 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 49.7 Cg_endo -76.11 152.45 96.48 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.605 -2.248 . . . . 0.0 110.467 -0.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.85 138.92 5.07 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.03 121.74 41.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.139 . . . . 0.0 110.239 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.566 ' CE2' HG22 ' A' ' 3' ' ' VAL . 35.8 m-85 -130.32 158.61 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.101 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 18.9 mt-30 -110.4 156.31 20.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.17 -0.956 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 14' ' ' LYS . 76.1 t -129.22 105.97 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.4 38.26 24.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.12 24.09 23.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 11.1 mmtt -115.28 175.0 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -131.71 135.66 47.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.226 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' LYS . 17.3 t -140.76 121.64 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 0.0 110.163 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 HD11 ' ND2' ' A' ' 26' ' ' ASN . 21.1 mt -99.66 108.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 53.5 mt -89.64 118.85 29.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 1.1 t0 -71.53 -172.71 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -50.22 -28.22 7.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -116.79 51.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 63.1 m 42.92 32.56 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.3 157.44 26.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -98.99 101.62 13.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.31 17.51 8.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.238 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.468 ' ND2' HD11 ' A' ' 17' ' ' ILE . 1.6 m-20 -148.48 78.22 9.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.01 -7.33 20.51 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.015 1.534 . . . . 0.0 110.475 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.72 -12.61 61.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 12.1 t70 -116.43 33.9 5.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.153 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -92.75 151.01 20.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.37 -171.65 2.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -69.65 -56.21 7.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.272 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -57.33 -39.3 75.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.882 . . . . 0.0 110.27 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.68 -51.74 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.38 -50.72 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 110.385 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -58.34 -41.59 84.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.4 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -55.55 -48.93 73.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.439 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -51.13 69.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.444 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.0 -39.31 55.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 110.519 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.8 -67.1 0.53 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.938 . . . . 0.0 110.445 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -42.58 -26.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.559 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' ARG . 2.4 mp -83.85 -79.49 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.379 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.68 -79.28 0.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.18 38.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.34 115.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -1.148 . . . . 0.0 110.233 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -56.88 -45.14 82.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.878 . . . . 0.0 110.358 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.0 122.09 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.451 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 45.3 mmm -45.78 118.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.7 p -65.1 178.13 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -69.85 -23.75 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -35.05 57.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.552 ' CE1' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -62.57 -50.0 73.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.534 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m95 -66.26 -35.44 80.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.372 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -61.28 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.316 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -52.71 61.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 110.401 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.2 t -55.88 -28.76 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.487 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 ttmt -76.29 -38.27 56.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 110.389 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.25 -42.95 92.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -39.12 90.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.953 . . . . 0.0 110.283 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -36.92 67.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 43.6 tt0 -58.29 -44.95 88.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.33 -31.67 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.284 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -67.81 -12.09 59.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 10.9 mt-10 -78.51 -47.64 16.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.23 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -53.03 4.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -78.9 -75.41 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.245 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.96 17.13 11.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.2 m -115.48 146.37 41.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -1.163 . . . . 0.0 110.205 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.5 99.82 26.77 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.942 . . . . 0.0 110.164 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.8 Cg_endo -73.19 173.55 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.1 Cg_endo -72.92 -160.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.4 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 tp -123.9 54.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -141.58 -44.06 0.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.8 mmm -74.84 -21.01 59.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.8 t -72.28 -32.32 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 m -44.33 -32.47 1.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -56.33 -51.45 68.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -65.6 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 p -68.91 -70.69 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.201 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.13 11.15 32.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.18 170.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -1.166 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -95.64 141.95 28.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.219 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 tp -69.2 -29.12 67.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 2.2 tt0 -61.16 -55.66 29.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.227 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -56.27 14.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.462 ' CG2' ' HG3' ' A' ' 94' ' ' PRO . 36.6 mt -56.17 -26.91 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.74 -58.4 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -34.48 70.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.552 HD23 ' CE1' ' A' ' 52' ' ' HIS . 21.3 mt -65.67 -51.66 57.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 110.134 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.521 ' CE1' ' HA3' ' A' ' 97' ' ' GLY . 1.5 t80 -128.64 128.57 23.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 110.048 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.4 Cg_endo -73.14 156.2 51.64 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.898 1.473 . . . . 0.0 110.417 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 49.4 m 56.81 31.37 19.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 62.19 147.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 96' ' ' HIS . 45.7 Cg_endo -72.9 -92.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.889 1.468 . . . . 0.0 110.304 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 49.6 -89.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.169 -0.957 . . . . 0.0 110.358 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 94' ' ' PRO . 8.1 m-70 -68.05 -44.85 75.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' A' ' 90' ' ' PHE . . . -64.66 -41.77 97.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.74 -48.97 74.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -1.131 . . . . 0.0 110.335 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 100' ' ' LYS . 34.5 m -64.24 -55.39 21.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 99' ' ' CYS . 5.9 tttt -42.41 -49.9 5.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.27 -37.96 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.59 -8.58 55.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.5 48.02 77.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.211 -1.17 . . . . 0.0 110.197 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.346 0.593 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.89 151.71 1.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.064 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 6.0 p -125.35 161.88 47.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 49.3 Cg_endo -75.08 145.26 83.33 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.54 -2.275 . . . . 0.0 110.474 -0.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.61 152.56 18.01 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 51.4 mt-10 -103.68 141.9 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 110.381 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 77.7 m-85 -152.53 150.21 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -104.17 125.02 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 67.0 t -105.8 118.82 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.297 -0.877 . . . . 0.0 110.113 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 19.6 m-20 55.69 -89.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -141.41 50.6 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 158.91 44.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -1.144 . . . . 0.0 110.164 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -104.6 115.57 30.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.31 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.12 129.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 2.7 mp -115.59 116.58 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.308 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.443 HD21 ' HA ' ' A' ' 22' ' ' CYS . 10.8 mt -95.14 110.54 22.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.996 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 23' ' ' PHE . 6.9 t70 -75.42 -161.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.274 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -64.31 137.31 57.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.1 t70 66.49 30.41 8.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 8.5 m 55.75 50.5 14.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . 1.6 m-30 -94.87 109.37 21.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.44 ' HG3' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -52.61 106.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.26 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' OE1' ' CB ' ' A' ' 19' ' ' ASP . 1.5 tp60 -108.86 35.88 3.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.231 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.464 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.8 p-10 -151.74 68.25 7.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 -7.51 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.003 1.528 . . . . 0.0 110.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -79.29 -46.65 17.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -84.61 -4.68 59.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.124 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.522 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 20.9 t90 -57.2 153.55 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -165.65 -160.06 0.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.544 ' OE2' ' CZ2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -74.39 -56.48 4.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.308 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -40.21 76.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -64.4 -49.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 0.0 110.293 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.42 -48.86 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.214 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.28 -57.67 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 92.3 t90 -49.23 -32.41 10.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -67.6 -61.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.216 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.0 -47.22 33.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.942 . . . . 0.0 110.21 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.405 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -65.3 -32.53 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.88 -33.36 75.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 0.0 110.152 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.459 HD23 ' HE3' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -91.39 -73.54 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.234 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.43 -76.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 40' ' ' ARG . . . 142.65 69.13 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.87 114.11 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -1.15 . . . . 0.0 110.247 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -46.34 -29.47 1.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.298 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.78 130.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.324 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 21.5 mtp -44.0 128.1 5.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.234 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -89.12 178.7 6.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -43.94 76.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.43 -39.19 89.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.501 ' CE1' ' HB3' ' A' ' 89' ' ' LEU . 6.8 m170 -65.08 -64.49 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CZ2' ' SD ' ' A' ' 48' ' ' MET . 2.0 m95 -46.73 -38.03 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.115 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -57.56 12.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.48 -54.49 21.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.98 -33.86 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -68.04 -61.67 1.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -37.01 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -69.6 -48.18 60.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.296 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 59' ' ' LEU . 8.4 tpt180 -42.8 -38.55 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.306 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.17 -54.24 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.354 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.72 -43.88 58.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.377 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.407 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 2.2 t90 -63.81 -47.44 80.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.02 7.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.3 m -82.15 -47.35 12.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.0 -35.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.407 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 103.62 56.39 0.77 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.48 HG21 ' N ' ' A' ' 69' ' ' CYS . 31.5 m -128.61 157.5 41.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -1.148 . . . . 0.0 110.218 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.48 ' N ' HG21 ' A' ' 68' ' ' THR . 21.4 t -120.94 86.99 42.62 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 110.092 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.44 167.77 26.11 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.059 1.557 . . . . 0.0 110.416 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.4 -90.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.961 1.506 . . . . 0.0 110.43 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -175.51 74.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.88 -63.78 1.14 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.154 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -64.9 -11.63 40.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.417 ' O ' ' OG1' ' A' ' 79' ' ' THR . 58.3 t -69.83 -45.53 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 m -64.01 -40.53 96.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.201 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.47 -29.79 17.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.289 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -102.88 -71.0 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.512 ' HB ' ' CD1' ' A' ' 81' ' ' PHE . 61.6 p -49.68 -52.59 29.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.81 30.25 6.88 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.512 ' CD1' ' HB ' ' A' ' 79' ' ' THR . 10.4 m-85 -99.66 120.43 39.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.16 147.54 52.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.53 -28.27 59.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.07 -44.8 87.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -53.38 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.209 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 9.1 mt -53.02 -30.16 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 90' ' ' PHE . 1.5 m-85 -77.14 -36.26 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.283 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -44.89 91.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 3.4 mt -78.92 -53.64 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.296 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 87' ' ' TYR . 1.1 m-85 -88.94 165.06 28.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.19 -179.29 4.57 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.068 1.562 . . . . 0.0 110.46 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.16 86.17 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' ' CD2' ' A' ' 96' ' ' HIS . . . 135.65 80.03 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.69 -0.02 8.81 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.497 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -79.56 -53.61 6.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 93' ' ' GLY . 23.3 p80 -77.2 -23.41 51.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.472 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -78.18 -71.8 1.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.91 -36.95 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -1.138 . . . . 0.0 110.405 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -71.28 -51.5 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.397 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -47.82 -44.11 28.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.326 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' ALA . 39.2 t -69.12 -55.32 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 101' ' ' VAL . . . -44.01 -35.45 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 0.0 110.162 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.74 63.28 1.77 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.258 -1.143 . . . . 0.0 110.299 -179.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.243 0.544 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -81.5 83.43 6.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.361 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.45 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 36.5 m -82.49 154.47 68.78 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.511 ' HD3' ' CG ' ' A' ' 20' ' ' GLU . 50.3 Cg_endo -75.62 164.88 87.05 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.58 -0.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.21 160.85 28.05 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -104.34 152.08 22.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.192 . . . . 0.0 110.328 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -152.66 144.81 23.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -100.17 132.22 45.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.968 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 22.9 t -129.75 109.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.59 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 64.45 28.13 13.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.476 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.5 7.39 82.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 3.5 mttt -98.99 171.1 8.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -1.206 . . . . 0.0 110.087 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.32 123.73 49.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 110.282 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.42 138.18 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.7 mt -120.65 100.0 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.24 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.1 mt -74.49 118.39 17.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.232 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.74 -172.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.323 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.511 ' CG ' ' HD3' ' A' ' 6' ' ' PRO . 1.5 tt0 -62.01 -13.47 26.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 110.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -118.58 43.28 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.0 m 43.25 34.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.339 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -103.07 115.78 31.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 110.128 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' PHE . 1.3 ttt -41.88 137.67 1.7 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.921 . . . . 0.0 110.338 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 17.24 21.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.154 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -124.22 67.3 44.94 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.227 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.5 -6.63 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.054 1.555 . . . . 0.0 110.463 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -32.97 56.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 1.3 m-20 -97.41 -81.86 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.459 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 52.2 t90 59.47 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.6 178.44 7.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HG2' ' CZ2' ' A' ' 53' ' ' TRP . 1.8 tm-20 -65.64 -64.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -29.43 2.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.35 -62.54 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.326 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.59 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.56 -35.87 82.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -0.948 . . . . 0.0 110.421 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.442 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.448 HD22 HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -66.37 -55.99 13.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.98 -31.55 60.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.456 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -74.45 -36.53 63.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.108 -0.995 . . . . 0.0 110.392 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.5 -26.99 61.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.448 HD11 HD22 ' A' ' 38' ' ' LEU . 6.9 mp -81.18 -42.79 20.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.447 ' OE1' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -110.24 -83.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 38.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.2 88.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -1.148 . . . . 0.0 110.281 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -45.41 -30.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.52 130.89 10.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 mmt -57.87 130.32 45.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 52' ' ' HIS . 10.0 t -86.55 160.02 19.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.204 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.75 -40.45 79.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.455 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HB2' HG21 ' A' ' 49' ' ' THR . 38.2 mt-10 -57.89 -37.0 73.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.437 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.463 ' HB2' HG22 ' A' ' 49' ' ' THR . 3.2 m170 -63.6 -64.43 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.285 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.474 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 5.0 m95 -54.8 -26.6 35.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 110.505 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -67.17 -67.31 0.46 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.96 -45.89 61.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.26 -48.21 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 110.168 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -54.83 -44.94 74.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.189 -0.945 . . . . 0.0 110.112 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.83 -58.04 9.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.471 ' CD1' ' HB3' ' A' ' 98' ' ' ALA . 6.3 mt -51.64 -33.44 33.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.354 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.34 -56.15 19.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.364 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.44 -37.33 7.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.472 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -36.89 70.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -70.36 -3.45 17.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.157 -0.965 . . . . 0.0 110.421 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.02 -25.6 10.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.4 m -88.4 -69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.9 -45.66 7.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.969 . . . . 0.0 110.123 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.97 68.68 1.26 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.501 HG21 ' N ' ' A' ' 69' ' ' CYS . 53.9 m -151.0 161.11 43.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -1.169 . . . . 0.0 110.326 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.501 ' N ' HG21 ' A' ' 68' ' ' THR . 1.6 m -110.79 84.33 4.13 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.53 172.05 16.51 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.1 1.579 . . . . 0.0 110.468 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.94 -161.95 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.001 1.527 . . . . 0.0 110.478 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.52 6.37 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.195 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -36.04 66.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -18.15 47.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -74.1 -46.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 110.195 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 5.6 m -62.01 -26.84 68.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -63.61 -28.49 69.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.57 -78.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.144 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 p -53.82 -27.73 31.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.982 . . . . 0.0 110.207 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 77.91 4.33 85.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.04 135.43 56.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -1.192 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.95 140.22 58.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.446 HD23 ' CD2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -63.71 -29.91 71.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.216 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -52.23 66.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.104 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -37.84 17.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 30.5 mt -73.32 -34.74 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.34 -0.85 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -61.53 -32.82 72.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -83.27 -48.42 10.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 110.184 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.444 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 57.2 mt -57.72 -28.68 64.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 87' ' ' TYR . 11.2 m-85 -129.01 168.03 17.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.026 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -173.54 1.27 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.93 1.49 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.28 94.75 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.39 76.65 0.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.474 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.2 Cg_endo -73.21 -9.01 22.85 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 110.444 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.5 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -46.52 -31.09 2.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.81 -61.89 5.48 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . . . -44.7 -56.42 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.1 m -47.6 -51.2 22.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 12.2 ttmt -53.25 -40.96 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.56 -52.06 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.56 -25.5 68.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.168 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.73 63.79 0.63 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.215 -1.167 . . . . 0.0 110.152 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.446 HG12 ' OE2' ' A' ' 41' ' ' GLU . 34.6 m . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.24 0.543 . . . . 0.0 110.176 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.19 152.31 19.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.424 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 m -115.11 144.86 32.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.75 167.51 80.06 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.246 -0.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -178.98 142.22 5.24 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 6.3 tt0 -99.33 159.51 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -1.138 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 2.8 m-85 -161.43 166.79 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.199 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -112.01 124.84 53.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 110.256 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.509 HG21 ' CD2' ' A' ' 37' ' ' TRP . 35.3 t -99.14 98.24 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' VAL . 18.6 t70 43.2 73.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.75 56.23 25.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 170.81 20.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -1.145 . . . . 0.0 110.287 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -123.39 123.08 39.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.47 124.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.13 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 17' ' ' ILE . 1.1 tt -105.76 145.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 26.0 mt -112.08 112.7 24.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.407 ' OD1' ' HG3' ' A' ' 25' ' ' GLN . 19.9 m-20 -58.77 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.825 . . . . 0.0 110.229 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.23 -28.32 69.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 22' ' ' CYS . 8.3 m-20 -106.99 44.26 1.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' A' ' 21' ' ' ASP . 60.0 m 42.49 31.58 0.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.252 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -86.78 142.65 27.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.5 ttm -78.16 125.0 28.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HG3' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -95.34 0.33 53.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.34 68.53 14.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.96 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.99 -18.9 23.77 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.051 1.553 . . . . 0.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -66.11 -14.04 61.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.204 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.5 m-20 -113.39 6.64 17.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 51.7 t90 -46.32 158.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.547 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 1.2 m-20 178.4 -177.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.887 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -62.62 -45.05 94.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 110.163 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -26.78 68.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.169 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.2 -60.68 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.422 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.58 -29.51 51.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.394 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 2.8 mt-10 -75.81 -59.76 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.339 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.509 ' CD2' HG21 ' A' ' 11' ' ' VAL . 81.5 t90 -49.53 -35.57 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.378 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -51.23 20.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.304 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -55.71 -28.63 56.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -60.2 2.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.455 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.446 ' OE2' HG12 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -53.5 -26.86 22.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.81 -73.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.422 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.39 -52.69 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 24.71 1.57 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 39' ' ' ALA . 3.9 mt -73.11 84.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -1.194 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -44.07 -29.79 0.66 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.45 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -150.37 111.51 4.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.451 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 23.1 mmm -48.92 155.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.08 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.475 HG23 ' ND1' ' A' ' 52' ' ' HIS . 5.2 t -106.94 -177.3 3.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.89 . . . . 0.0 110.282 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.56 -35.34 60.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.929 . . . . 0.0 110.226 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -40.61 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.284 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.495 ' CE1' HD22 ' A' ' 89' ' ' LEU . 5.6 m170 -62.43 -55.79 24.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 110.328 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.486 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.5 m95 -61.28 -26.92 68.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -67.09 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.93 . . . . 0.0 110.38 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.513 HD13 ' CE2' ' A' ' 81' ' ' PHE . 0.4 OUTLIER -54.36 -43.04 70.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 52' ' ' HIS . 25.0 t -52.98 -57.56 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.154 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -46.16 63.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.13 -43.52 70.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.69 -40.49 95.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -60.54 -28.67 68.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.97 -51.68 63.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -71.19 -26.99 63.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 65.8 t90 -80.9 -6.3 58.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 65' ' ' THR . 9.5 tt0 -77.4 -50.65 12.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 64' ' ' GLU . 18.7 m -44.71 -39.96 5.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.19 -58.61 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 131.07 43.19 0.19 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -105.1 113.91 27.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -1.156 . . . . 0.0 110.193 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.8 t -53.77 108.1 1.03 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.198 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 68' ' ' THR . 45.8 Cg_endo -73.06 169.61 21.81 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.9 1.474 . . . . 0.0 110.371 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.87 -162.49 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.003 1.528 . . . . 0.0 110.434 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 72' ' ' ILE . 8.8 tp -125.87 -0.75 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -91.0 -11.49 38.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.44 -30.01 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 110.405 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.92 -29.89 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.448 ' HA ' ' HB2' ' A' ' 81' ' ' PHE . 14.1 t -77.0 -36.2 56.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' N ' ' CG2' ' A' ' 76' ' ' THR . 0.1 OUTLIER -65.87 -29.33 69.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.56 0.04 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.276 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' GLY . 66.2 p -135.38 22.76 3.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' THR . . . 43.58 26.79 0.74 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.513 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -68.26 -163.94 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -1.135 . . . . 0.0 110.155 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.1 t -154.4 137.42 15.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 110.176 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 15.1 tp -50.42 -34.43 24.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.215 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.55 -35.1 70.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.64 -46.6 89.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 110.41 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 34.9 mt -76.87 -31.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -67.05 -32.18 73.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.289 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -86.68 -39.68 15.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -0.978 . . . . 0.0 110.273 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.495 HD22 ' CE1' ' A' ' 52' ' ' HIS . 19.8 mt -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 110.169 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.445 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 4.2 m-85 -109.11 171.28 4.59 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.6 Cg_endo -74.28 -61.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.091 1.574 . . . . 0.0 110.637 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.42 107.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.15 -0.969 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.24 75.43 0.93 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.506 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.0 Cg_endo -72.33 -16.77 27.78 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.047 1.551 . . . . 0.0 110.431 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -69.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.357 -0.839 . . . . 0.0 110.148 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -77.07 -8.0 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.18 -81.43 0.44 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.1 -32.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -1.078 . . . . 0.0 110.418 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -62.95 1.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -50.96 -51.28 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.131 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -48.76 -57.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -53.76 -34.48 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.09 -63.61 0.42 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.27 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.445 HG12 ' CE2' ' A' ' 9' ' ' TYR . 6.4 t . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.233 0.539 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.41 -156.73 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 4.9 p -175.14 162.57 2.31 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 48.6 Cg_endo -74.72 153.67 99.28 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.611 0.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.34 167.26 40.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 5.9 mt-10 -120.58 148.57 43.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -1.194 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 97.2 m-85 -156.37 143.81 19.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -113.47 140.82 47.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 17.6 t -109.44 99.68 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 12.4 t70 55.32 -89.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -122.71 42.42 1.63 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 169.03 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -1.178 . . . . 0.0 110.205 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -127.34 138.15 52.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 110.281 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.0 128.69 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.066 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 25' ' ' GLN . 66.7 mt -116.15 102.59 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.428 ' CD2' ' C ' ' A' ' 22' ' ' CYS . 2.8 mt -87.14 132.17 33.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' GLU . 3.2 m-20 -117.44 -170.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.03 148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.576 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.6 t0 66.76 18.32 10.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.438 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 4.3 m 51.05 45.72 27.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 1.5 m-85 -86.35 126.56 34.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 110.235 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.435 ' HG3' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -42.88 -36.06 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.242 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.473 ' CB ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 53.58 19.89 1.92 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.156 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.425 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -151.16 59.87 3.57 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.157 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.33 -30.33 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.031 1.543 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.43 73.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 0.0 110.26 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.21 30.15 2.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.453 ' CD2' ' N ' ' A' ' 31' ' ' ASP . 60.4 t90 -82.57 160.62 22.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.453 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -167.56 -169.21 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.192 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 18.7 mt-10 -71.32 -58.4 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -33.69 72.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.357 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.05 -57.57 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.99 66.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.0 110.406 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -54.6 41.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.461 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 76.7 t90 -59.19 -28.89 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.189 -0.944 . . . . 0.0 110.432 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -70.98 -41.42 71.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.447 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.74 -26.91 60.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.95 . . . . 0.0 110.591 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -75.9 -40.27 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.571 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -77.15 -33.81 56.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.687 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.3 mp -80.74 -68.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.105 -0.997 . . . . 0.0 110.572 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -79.59 -72.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 110.413 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.84 39.59 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 46' ' ' GLN . 11.3 mt -103.33 107.71 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' ILE . 14.0 mt-30 -43.28 -37.77 2.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -156.64 140.61 16.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.329 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -52.87 100.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 110.133 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -52.62 162.17 0.61 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 110.276 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.53 -27.62 4.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.95 -39.62 55.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.594 ' CE1' ' CD2' ' A' ' 89' ' ' LEU . 5.2 m80 -61.59 -41.03 96.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.527 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 1.4 m95 -74.09 -36.06 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.247 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -58.88 -45.64 89.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.554 HD11 ' CD2' ' A' ' 81' ' ' PHE . 5.9 mp -72.76 -58.27 3.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 74.9 t -47.14 -30.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -76.45 -51.48 11.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.56 ' CE2' HG13 ' A' ' 75' ' ' VAL . 38.5 t80 -52.47 -48.34 65.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.6 -43.58 76.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 21.8 ttp180 -50.32 -39.8 46.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 110.426 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.16 -55.2 19.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -27.0 66.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.476 ' CD1' ' HB1' ' A' ' 104' ' ' ALA . 59.6 t90 -70.08 -21.62 63.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.284 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 -17.63 59.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.19 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.3 m -75.74 -70.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.336 -0.853 . . . . 0.0 110.156 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -125.31 30.63 5.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 43.9 80.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -178.07 5.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -1.117 . . . . 0.0 110.176 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 t -140.1 92.95 9.4 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.229 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.43 157.88 52.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.079 1.568 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.68 -159.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.045 1.55 . . . . 0.0 110.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.8 tt -125.25 46.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.86 -82.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -16.16 40.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.56 HG13 ' CE2' ' A' ' 58' ' ' TYR . 79.0 t -70.33 -40.85 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.148 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -54.12 -38.84 65.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -69.02 -34.1 74.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.142 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.79 -0.24 37.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.57 -77.55 0.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.348 -0.845 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.89 22.56 3.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.554 ' CD2' HD11 ' A' ' 55' ' ' LEU . 36.0 m-85 -81.64 102.98 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -1.144 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.44 127.89 6.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.297 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -47.84 -36.65 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.166 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.09 -49.74 72.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.034 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -50.83 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 36.4 mm -50.29 -39.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -37.18 80.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.59 -31.35 72.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.594 ' CD2' ' CE1' ' A' ' 52' ' ' HIS . 12.5 mt -76.72 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -94.07 147.91 34.26 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 92' ' ' SER . 46.6 Cg_endo -73.98 84.13 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.03 1.542 . . . . 0.0 110.407 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 91' ' ' PRO . 38.6 m 43.5 70.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.52 62.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.0 Cg_endo -73.63 -0.41 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.033 1.543 . . . . 0.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -98.97 -63.35 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.901 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.01 -14.24 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.277 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -77.06 -77.26 0.8 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.54 -37.15 1.56 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.32 -50.84 62.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.374 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.9 tptt -53.41 -48.57 68.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.293 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.24 -27.55 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.65 -19.8 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.39 63.15 1.66 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB1' ' CD1' ' A' ' 63' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.207 -1.172 . . . . 0.0 110.161 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG2' ' HG3' ' A' ' 41' ' ' GLU . 57.4 t . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.232 0.539 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' N ' HG11 ' A' ' 3' ' ' VAL . 1.2 mtmm -109.07 147.31 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.5 m -142.89 159.43 56.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.968 . . . . 0.0 110.369 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.87 154.43 98.49 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.492 -0.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.06 142.62 7.79 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.05 128.05 45.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.262 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -131.63 161.94 31.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 110.213 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -104.94 142.33 34.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.117 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 53.9 t -127.8 96.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 11' ' ' VAL . 10.3 t70 41.98 85.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 110.311 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.48 65.46 2.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -168.32 161.43 12.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -1.181 . . . . 0.0 110.144 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' C ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.32 126.36 42.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.392 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 15' ' ' LYS . 69.7 t -131.32 122.31 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 110.044 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.57 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.412 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 22' ' ' CYS . 16.2 mt -69.8 123.06 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.056 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.446 ' OD2' ' HG3' ' A' ' 25' ' ' GLN . 9.9 m-20 -99.66 -157.92 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.8 mm-40 -45.57 132.31 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 13.3 t70 62.32 30.55 17.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.022 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 74.5 m 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.46 95.28 9.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.4 ptm -54.21 149.98 9.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 1.7 mt-30 -127.04 40.56 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -126.05 72.47 70.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.028 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.0 -19.47 30.19 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.125 1.592 . . . . 0.0 110.574 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.68 -0.65 55.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -128.25 34.01 4.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.285 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -85.86 149.77 25.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -173.08 1.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -65.64 -39.19 91.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 110.209 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -68.31 -27.17 66.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.0 110.386 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 21.8 t -76.16 -55.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.01 74.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.473 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 3.3 tt0 -70.47 -57.43 4.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 110.419 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -56.77 -31.39 64.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -69.03 -63.27 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.346 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.5 -27.97 28.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -76.05 -34.74 59.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.459 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 1.9 tp10 -74.81 -28.58 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD12 HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -82.45 -76.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -80.23 -76.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.55 46.74 0.02 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.78 102.05 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -1.148 . . . . 0.0 110.148 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -42.52 97.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -136.32 115.48 12.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.9 mmm -56.83 125.22 21.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -72.9 165.45 24.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.204 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.02 -32.19 71.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -44.69 65.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -50.67 -54.46 22.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.194 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.507 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 1.8 m95 -62.5 -30.7 71.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.293 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -64.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD12 ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -51.63 -41.92 61.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.7 t -57.46 -41.59 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.944 . . . . 0.0 110.106 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.28 -56.92 8.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -47.97 -34.47 9.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.14 -49.26 52.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.085 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -52.01 52.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 110.084 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -40.46 72.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.089 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -62.64 -29.88 70.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.141 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.522 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 77.5 t90 -74.74 -31.17 61.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.69 -42.05 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.2 m -58.6 -40.64 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.47 -57.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.912 . . . . 0.0 110.066 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 119.18 83.48 0.85 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -155.6 171.8 19.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -1.164 . . . . 0.0 110.25 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.99 75.07 21.21 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 161.37 43.06 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.992 1.522 . . . . 0.0 110.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.59 -174.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.994 1.523 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 72' ' ' ILE . 3.6 tp -87.43 49.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 76' ' ' THR . 0.2 OUTLIER -97.74 -60.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.049 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ttm -73.93 -24.01 59.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.082 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' O ' ' OG1' ' A' ' 79' ' ' THR . 13.6 t -67.07 -37.94 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 72' ' ' ILE . 6.1 p -65.16 -26.76 68.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -28.98 70.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.36 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.35 48.13 1.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.234 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 43.9 m -154.69 -49.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.106 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.36 -15.04 60.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.532 ' CE2' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -54.17 98.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 110.16 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -70.16 148.59 48.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.233 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.52 -27.77 67.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -48.04 65.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -40.64 79.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.19 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.42 -27.83 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 110.113 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 -43.14 75.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.172 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -54.12 10.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.133 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.87 -29.51 68.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.71 96.13 4.8 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 110.141 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.5 Cg_endo -72.87 88.43 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 12.9 t 176.47 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.96 141.55 5.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.48 -10.21 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.991 1.522 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -89.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.853 . . . . 0.0 110.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 21.5 m170 -77.14 -10.89 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.92 . . . . 0.0 110.215 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -79.21 -83.88 0.62 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.86 -34.76 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.291 -1.123 . . . . 0.0 110.341 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 100' ' ' LYS . 8.5 t -70.44 -64.46 0.89 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 26.6 tttm -43.18 -31.61 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.301 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.64 -52.31 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.212 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.14 -27.4 45.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.14 46.53 5.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.279 -1.13 . . . . 0.0 110.148 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 41' ' ' GLU . 48.3 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.282 0.563 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.64 143.19 58.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.877 . . . . 0.0 110.223 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 18.6 m -138.8 149.42 61.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -76.05 164.71 87.22 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.705 -2.206 . . . . 0.0 110.567 -0.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.48 156.66 25.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.01 154.54 18.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -1.123 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -147.59 147.21 29.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.34 117.56 34.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 39.5 t -112.12 102.88 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 110.401 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.9 m-20 55.24 -101.73 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.443 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.82 51.31 0.82 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 143.55 21.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -1.136 . . . . 0.0 110.102 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.87 123.87 43.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.99 140.55 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.326 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -124.61 100.66 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 110.183 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.14 121.74 24.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.136 -0.977 . . . . 0.0 110.32 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -141.45 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.7 tt0 -66.09 133.51 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.508 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.4 t70 66.82 34.79 5.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 21' ' ' ASP . 60.5 m 44.05 42.71 5.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.508 ' CD2' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -86.85 144.19 27.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.143 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.76 112.61 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 110.248 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -105.85 31.1 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -152.32 65.86 6.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.54 -14.03 24.91 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.045 1.55 . . . . 0.0 110.399 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.99 -33.82 39.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 9.9 m-20 -103.42 -85.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.129 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.464 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 33.5 t90 58.98 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 110.297 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -163.5 179.43 7.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.69 -55.59 10.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.287 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -36.36 71.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.91 -61.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.97 -45.74 21.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.09 -45.41 87.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.0 t90 -58.13 -51.87 67.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.983 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -54.39 -40.87 68.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.245 -0.909 . . . . 0.0 110.506 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.92 69.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.921 . . . . 0.0 110.564 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.442 ' CD ' ' OE2' ' A' ' 41' ' ' GLU . 1.3 tmm_? -73.66 -45.22 53.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 110.562 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HB3' HG22 ' A' ' 3' ' ' VAL . 2.0 mp0 -66.81 -33.9 76.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -68.13 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.348 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.89 -64.48 1.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.4 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.36 117.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -1.19 . . . . 0.0 110.26 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -74.69 -33.16 62.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.74 144.17 43.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.6 mmm -85.95 129.78 34.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.288 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 52' ' ' HIS . 3.5 t -73.69 170.77 14.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.18 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 3.8 mt-10 -67.89 -23.43 65.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.49 -40.06 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.898 . . . . 0.0 110.339 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.465 ' HB2' HG22 ' A' ' 49' ' ' THR . 2.5 m170 -59.84 -59.67 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -58.68 -30.24 67.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.243 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -63.79 -65.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.908 . . . . 0.0 110.215 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.01 -29.03 63.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 52' ' ' HIS . 48.2 t -65.52 -39.82 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.73 -31.5 57.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.5 -49.33 71.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.04 -31.35 71.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.039 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -27.6 63.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.0 -45.81 90.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.298 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.5 -29.91 61.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -66.02 -44.3 85.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -44.13 83.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -64.19 -67.76 0.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.24 -63.34 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.33 44.13 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 p -139.39 -158.63 0.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -1.105 . . . . 0.0 110.187 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 m -139.41 101.87 7.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 110.192 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.87 172.27 16.21 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.107 1.582 . . . . 0.0 110.364 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 -164.96 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.066 1.561 . . . . 0.0 110.368 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.448 HD11 ' HG2' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -116.12 44.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.81 -66.79 0.9 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.7 mtp -60.04 -14.77 18.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.53 -58.21 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -28.18 69.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -28.12 69.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -106.68 -65.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.8 p -56.97 -35.09 68.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.7 79.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' HB3' HD12 ' A' ' 86' ' ' ILE . 4.2 m-85 -75.04 122.88 24.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -1.137 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.453 ' CB ' ' HE2' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -53.67 136.26 39.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.01 -35.45 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.94 -36.03 77.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HE2' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -58.4 -53.1 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 110.174 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 81' ' ' PHE . 79.9 mt -65.9 -38.68 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.18 -37.57 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 109.946 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -48.2 25.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.6 mt -65.27 -11.72 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -173.08 104.89 0.32 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.31 -25.6 18.36 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.056 1.556 . . . . 0.0 110.381 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.7 m -75.92 0.52 18.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.27 147.78 5.81 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 46.9 Cg_endo -73.09 -10.39 24.41 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.035 1.545 . . . . 0.0 110.346 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.22 -84.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.348 -0.845 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -76.72 -18.08 58.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.53 -67.1 1.73 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 94' ' ' PRO . . . -44.59 -38.09 4.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.124 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.88 -44.32 70.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -41.65 70.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.84 -37.24 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.5 70.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.72 50.19 1.85 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.251 -1.147 . . . . 0.0 110.252 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.193 0.52 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -63.19 104.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.8 m -94.5 142.76 25.23 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.32 144.94 82.14 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.38 -0.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.94 165.11 30.6 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 144.59 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -1.111 . . . . 0.0 110.146 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -146.23 171.41 14.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.2 mt-30 -133.45 122.57 23.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.206 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 3.9 t -99.83 109.37 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.041 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 46.6 t0 56.33 -88.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.244 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.64 48.01 0.99 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 2.8 mttm -149.14 151.69 34.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -1.15 . . . . 0.0 110.257 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -112.53 111.28 22.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.56 140.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.7 107.87 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' CD2' ' C ' ' A' ' 22' ' ' CYS . 13.2 mt -83.65 124.59 30.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 3.1 t70 -66.39 -170.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -38.23 69.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.33 39.79 1.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.489 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 67.4 m 44.85 39.63 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.55 151.15 22.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 132.82 34.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.31 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -108.26 -8.66 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -139.66 60.49 16.28 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.15 -1.73 11.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.03 1.542 . . . . 0.0 110.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -31.28 62.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -106.09 36.54 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.244 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -61.19 144.04 54.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.181 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.14 175.59 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.49 -39.24 90.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.239 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 16.4 mttt -67.02 -31.79 72.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.49 -58.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.98 -46.75 68.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.256 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.26 -33.12 74.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 33.7 t90 -61.72 -48.44 80.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.45 -38.88 85.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.411 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.69 81.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.396 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.456 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 2.0 ttt-85 -71.63 -51.65 22.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.336 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.12 -26.84 65.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.427 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.5 mp -87.56 -72.08 0.54 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -42.7 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.384 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 118.12 21.11 4.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.433 ' N ' ' HA ' ' A' ' 40' ' ' ARG . 19.6 mt -79.63 105.6 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -1.108 . . . . 0.0 110.188 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -46.94 72.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' MET . 11.5 tptp -118.71 109.45 16.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' LYS . 4.6 tpt -42.8 150.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.271 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 52' ' ' HIS . 30.7 p -84.75 174.18 10.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.26 -40.87 64.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 110.302 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' CB ' HD11 ' A' ' 89' ' ' LEU . 67.2 mm-40 -68.61 -33.7 74.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -55.42 -49.67 71.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.491 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.2 m95 -71.23 -26.93 63.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -62.54 -58.44 7.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD22 HG12 ' A' ' 86' ' ' ILE . 5.1 tp -68.42 -50.48 52.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.369 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 52' ' ' HIS . 95.5 t -52.44 -33.61 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -51.78 13.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.236 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.545 ' CZ ' HG21 ' A' ' 79' ' ' THR . 52.4 t80 -53.62 -31.53 47.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -44.78 63.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.164 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -49.13 -35.62 16.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.17 -51.75 68.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -41.88 98.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.428 ' O ' ' CD2' ' A' ' 63' ' ' TRP . 15.8 t90 -68.83 -12.51 61.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.221 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -14.27 35.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.244 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 96.2 m -97.82 -46.37 5.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.913 . . . . 0.0 110.145 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -124.94 -8.86 7.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 63' ' ' TRP . . . 65.83 45.44 88.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.19 147.57 40.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -117.32 103.13 51.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.28 152.69 50.34 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.971 1.511 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.87 -90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 0.0 110.346 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.469 ' CG1' ' CD1' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -169.42 57.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -135.56 -68.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.028 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.7 ttm -67.84 -14.36 62.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.043 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' OG1' ' A' ' 79' ' ' THR . 93.8 t -70.56 -42.68 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.882 . . . . 0.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 81' ' ' PHE . 0.4 OUTLIER -68.09 -27.11 66.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.088 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -72.14 -33.5 67.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.826 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.23 -63.64 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.545 HG21 ' CZ ' ' A' ' 58' ' ' TYR . 46.9 p -60.6 -42.34 96.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.13 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.52 59.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.413 ' O ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -51.66 149.72 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -1.19 . . . . 0.0 110.179 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -71.96 143.11 49.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.469 ' CD1' ' CG1' ' A' ' 72' ' ' ILE . 29.0 tp -73.32 -29.28 62.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -31.42 69.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.264 -0.898 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.473 ' HE2' ' NE2' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -65.3 -62.13 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.465 HG12 HD22 ' A' ' 55' ' ' LEU . 2.5 mp -51.26 -45.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.355 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 92' ' ' SER . 1.5 t80 -60.53 -33.73 73.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.473 ' NE2' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.71 -24.86 53.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.488 HD21 ' CG ' ' A' ' 52' ' ' HIS . 9.4 mt -76.13 -50.7 13.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.81 162.5 22.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 92' ' ' SER . 48.0 Cg_endo -74.92 76.7 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.115 1.587 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.486 ' HA ' ' CE1' ' A' ' 87' ' ' TYR . 0.8 OUTLIER 41.61 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.14 70.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.401 ' CB ' HD12 ' A' ' 72' ' ' ILE . 46.7 Cg_endo -72.99 -21.27 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.003 1.528 . . . . 0.0 110.432 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.54 -81.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.226 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -66.34 -16.09 63.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.76 -70.84 1.2 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.35 -42.34 61.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -1.161 . . . . 0.0 110.165 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.51 -48.41 81.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.22 -37.21 69.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.101 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.438 HG13 HG11 ' A' ' 56' ' ' VAL . 50.6 t -72.19 -31.96 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.13 -50.94 64.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.865 . . . . 0.0 110.213 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.03 43.41 1.78 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.224 -1.162 . . . . 0.0 110.079 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.1 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.192 0.52 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 109.58 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.436 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 26.0 p -102.18 157.36 33.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 47.7 Cg_endo -75.48 147.28 88.14 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.504 -0.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.03 174.86 46.88 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.72 144.38 44.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 0.0 110.148 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.09 165.94 26.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -116.26 137.94 51.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 77.7 t -133.84 118.64 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t0 46.34 52.33 10.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.304 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.98 39.61 97.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.0 tttt -131.02 166.92 19.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -1.172 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 103.34 9.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.8 t -99.03 130.95 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.139 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.73 115.96 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.185 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.433 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.3 t0 -59.55 -172.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 6' ' ' PRO . 3.6 mt-10 -64.25 -23.21 67.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.827 . . . . 0.0 110.298 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -108.26 35.17 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.261 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m 52.42 42.96 31.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.263 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -111.49 111.08 21.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 110.263 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -45.12 144.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.256 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.36 13.46 15.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.193 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -145.79 59.71 5.91 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.141 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.78 -8.14 21.9 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 0.0 110.517 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -27.4 65.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' TRP . 5.9 m-20 -92.82 -74.36 0.52 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 29' ' ' ASP . 68.9 t90 56.92 162.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.86 176.19 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.29 -51.22 39.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -32.96 74.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.73 -55.79 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.542 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . . . -53.79 -47.3 70.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.53 -26.88 66.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -68.73 -54.49 15.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.291 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -36.9 84.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.62 -37.26 86.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.465 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.09 -28.67 54.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.372 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 7.3 mm-40 -76.95 -27.6 54.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.96 . . . . 0.0 110.378 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.53 -21.43 17.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.283 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HB3' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -127.29 -36.68 2.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.933 . . . . 0.0 110.324 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 96.96 21.93 19.32 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.407 HG21 ' HA ' ' A' ' 48' ' ' MET . 34.8 mt -59.03 97.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -1.161 . . . . 0.0 110.23 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.11 -43.77 51.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 109.984 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -136.32 115.09 12.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.449 ' HE2' ' HB3' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -42.55 137.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.208 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -81.07 139.38 35.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 -24.8 7.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 110.229 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -75.98 -45.55 34.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 48' ' ' MET . 22.6 m170 -51.8 -55.57 19.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.542 ' CH2' ' HB2' ' A' ' 35' ' ' ALA . 16.7 m95 -55.87 -29.24 59.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -52.9 48.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -37.12 85.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 52' ' ' HIS . 11.9 t -64.63 -38.19 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -54.29 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.424 ' CE1' HG11 ' A' ' 75' ' ' VAL . 17.2 t80 -51.84 -41.11 61.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.225 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -34.87 77.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.234 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -60.44 -30.14 69.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.93 -45.94 72.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.276 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -37.87 89.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 67' ' ' GLY . 48.9 t90 -64.03 -48.15 77.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.233 -0.917 . . . . 0.0 110.193 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.03 -12.74 60.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.7 m -91.23 -22.33 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.97 -43.79 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' TRP . . . 103.07 43.03 1.97 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.8 t -154.3 158.89 40.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 110.25 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.0 116.6 66.11 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 45.9 Cg_endo -72.71 174.28 12.03 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.832 1.438 . . . . 0.0 110.425 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 45.5 Cg_endo -72.1 -159.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.947 1.499 . . . . 0.0 110.46 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.9 tp -118.02 -1.4 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.375 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -90.19 -44.67 9.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -23.74 63.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.424 HG11 ' CE1' ' A' ' 58' ' ' TYR . 97.5 t -71.48 -41.93 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 110.317 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 80' ' ' GLY . 6.8 m -62.24 -45.4 93.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -45.34 -47.67 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.372 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.66 -32.35 70.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 p -103.84 -74.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 76' ' ' THR . . . 128.85 -12.23 6.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.8 m-30 -43.24 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -1.164 . . . . 0.0 110.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 80' ' ' GLY . 34.3 t -42.82 131.74 4.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.847 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tp -51.61 -37.65 51.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -40.55 72.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -64.11 -54.96 25.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 110.1 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.5 mt -51.64 -32.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 110.083 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -74.99 -35.86 62.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.105 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.22 62.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.28 -19.91 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.43 109.05 9.49 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -39.69 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.982 1.517 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -44.86 66.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 110.257 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.86 153.53 9.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -74.06 -162.41 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.96 1.505 . . . . 0.0 110.508 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 57.02 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 110.511 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' PRO . 36.3 m170 -66.6 -44.37 82.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.411 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -62.65 -66.93 2.31 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.67 -56.75 2.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -1.148 . . . . 0.0 110.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -50.44 -62.25 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -41.99 -49.61 4.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.216 -0.928 . . . . 0.0 110.526 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.26 -50.21 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.44 -19.23 65.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 70.03 1.36 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.239 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 4' ' ' LYS . 4.9 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.269 0.557 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' N ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.07 171.0 15.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.277 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.446 ' SG ' HD13 ' A' ' 18' ' ' LEU . 14.5 m -121.41 155.93 58.53 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.6 Cg_endo -76.19 158.01 97.87 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.545 -2.273 . . . . 0.0 110.403 -0.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.84 151.27 15.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.84 143.56 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -1.123 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -150.78 158.39 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.62 132.11 54.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 110.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.569 ' CG2' ' CD2' ' A' ' 37' ' ' TRP . 98.9 t -116.56 104.98 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 24.8 t0 55.14 -90.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -132.5 52.56 0.82 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.522 ' CD ' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -153.15 152.51 31.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -1.144 . . . . 0.0 110.224 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.32 133.34 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -132.41 111.19 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 0.0 110.158 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 17' ' ' ILE . 11.5 tt -107.55 96.66 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 76.4 mt -61.65 122.94 16.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -152.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -37.4 87.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 22' ' ' CYS . 2.5 t0 -108.37 51.38 0.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 93.0 m 43.32 27.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.12 138.76 45.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.1 mtp -79.79 110.99 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.214 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.15 18.85 11.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.502 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 16.2 p-10 -135.12 52.34 7.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.5 Cg_endo -72.94 -22.64 19.53 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.999 1.526 . . . . 0.0 110.427 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -60.08 -18.0 43.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -127.2 36.92 4.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.897 . . . . 0.0 110.13 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.8 t90 -73.44 139.46 45.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.188 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.91 174.7 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 33' ' ' LYS . 25.4 pt-20 -66.42 -42.11 88.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 1.9 ttmm -67.85 -47.51 68.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.522 ' CG2' ' CD ' ' A' ' 14' ' ' LYS . 42.8 t -56.0 -54.41 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.8 -36.52 70.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.033 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.74 -44.73 93.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.569 ' CD2' ' CG2' ' A' ' 11' ' ' VAL . 38.0 t90 -64.64 -38.43 90.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.184 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -58.16 -51.68 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.29 -27.24 66.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -64.43 -49.03 73.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' OE1' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.17 -28.19 53.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.413 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.9 mm? -84.34 -3.72 58.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.364 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.3 -46.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 122.51 12.72 4.99 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.437 ' O ' HG21 ' A' ' 45' ' ' ILE . 9.6 mt -76.16 79.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.14 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -50.21 60.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.263 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 131.31 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 71.4 mmm -74.38 121.01 20.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.43 -157.17 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -92.86 -27.86 16.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.188 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -48.38 35.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.613 ' CE1' ' CD2' ' A' ' 89' ' ' LEU . 23.2 m80 -51.25 -46.5 62.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.267 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.474 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.9 m95 -72.15 -31.27 65.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -64.01 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.19 -43.43 98.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.911 . . . . 0.0 110.265 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 52' ' ' HIS . 37.4 t -60.32 -27.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.257 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 tttt -76.64 -53.89 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -53.1 60.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.53 -51.31 60.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.92 -41.82 46.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 70' ' ' PRO . 4.9 t80 -65.74 -35.11 79.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.903 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.43 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 36.0 t90 -66.42 -22.24 66.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.76 -10.64 59.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -81.31 -49.13 11.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -152.0 -38.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.98 88.48 0.95 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.77 -178.5 7.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 0.0 110.238 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.46 84.87 15.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.496 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 45.0 Cg_endo -72.44 125.92 11.13 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.395 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.57 91.54 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.897 1.472 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 8.4 mm 48.56 -132.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 109.917 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 8.3 mttt 57.81 -97.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.052 -1.03 . . . . 0.0 110.36 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.55 -23.91 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.03 -1.044 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 72' ' ' ILE . 22.2 t -69.6 -47.18 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 110.301 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 73' ' ' LYS . 1.1 p -63.97 -34.86 78.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -43.99 -32.94 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 0.0 110.149 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.92 48.02 2.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.4 m -153.75 -70.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.54 87.35 1.92 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.16 104.55 2.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -1.131 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.4 143.3 40.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 tp -60.56 -26.87 67.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -41.48 74.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.45 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -65.84 -58.04 6.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.396 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.487 ' CG2' ' HG3' ' A' ' 94' ' ' PRO . 54.6 mt -46.29 -49.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 110.224 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -59.37 -41.39 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.17 -24.75 67.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.613 ' CD2' ' CE1' ' A' ' 52' ' ' HIS . 4.5 mt -79.48 -62.33 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 110.259 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.456 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 11.3 m-85 -85.08 170.81 12.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.123 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 42.5 Cg_endo -74.54 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.117 1.588 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.87 56.52 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.044 -1.035 . . . . 0.0 110.033 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.52 143.07 1.4 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HG3' ' CG2' ' A' ' 86' ' ' ILE . 45.5 Cg_endo -72.96 -90.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.954 1.502 . . . . 0.0 110.447 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . 53.91 -93.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 97' ' ' GLY . 8.7 m170 -69.63 -57.39 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 96' ' ' HIS . . . -43.65 -59.1 3.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -47.48 -48.65 26.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.125 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 99.7 m -53.78 -62.54 1.59 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 99' ' ' CYS . 15.0 mttp -44.16 -45.87 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 54.4 t -53.76 -55.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.344 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.15 -22.74 66.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 104' ' ' ALA . . . 114.07 -46.65 1.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.354 -1.086 . . . . 0.0 110.276 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 41' ' ' GLU . 5.7 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.169 0.509 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 63.33 114.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.397 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 79.2 m -137.14 151.71 72.32 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 50.6 Cg_endo -78.62 162.91 87.29 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.316 -0.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.11 45.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 16.5 mt-10 -106.07 170.65 7.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.035 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 1.2 m-85 -169.52 171.21 7.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 110.344 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -132.6 137.97 47.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' A' ' 37' ' ' TRP . 75.8 t -117.71 106.88 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 51.18 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.96 60.06 0.68 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -161.44 164.26 29.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -1.132 . . . . 0.0 110.246 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.98 147.85 26.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 110.208 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.7 t -140.28 135.81 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 17' ' ' ILE . 4.5 mp -127.33 100.24 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 43.0 mt -73.36 131.78 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 5.1 t0 -83.85 -146.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 110.385 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.4 -48.54 69.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.343 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -98.67 39.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.95 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 55.7 m 56.56 31.99 20.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.377 -0.827 . . . . 0.0 110.026 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.94 155.09 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -98.61 113.66 25.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.26 16.03 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.98 64.74 71.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.63 -15.85 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.969 1.51 . . . . 0.0 110.357 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -15.96 62.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -116.53 12.89 15.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.324 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -63.77 147.87 50.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -0.898 . . . . 0.0 110.215 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.27 -154.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.11 -33.3 61.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -72.19 -39.87 68.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.274 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 41.2 t -72.9 -36.93 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.425 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.46 42.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.381 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.76 -46.62 89.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 110.427 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.569 ' CE2' HG21 ' A' ' 11' ' ' VAL . 77.6 t90 -60.25 -54.63 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.509 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.94 -41.11 58.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.598 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.06 85.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.562 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -35.58 74.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HB3' ' CG2' ' A' ' 3' ' ' VAL . 2.9 mm-40 -77.1 -30.05 55.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 110.383 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -75.98 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.919 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.3 -61.26 1.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.07 42.52 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.5 mt -78.88 99.86 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -1.117 . . . . 0.0 110.214 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.59 -28.97 67.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -144.07 118.46 9.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.145 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.427 ' HG3' ' NE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -48.76 142.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.268 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.443 ' OG1' ' ND1' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -93.19 147.4 22.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.882 . . . . 0.0 110.301 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 16.2 pt-20 -57.53 -36.85 72.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mm-40 -66.87 -34.62 78.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.443 ' ND1' ' OG1' ' A' ' 49' ' ' THR . 19.0 m80 -69.09 -53.34 20.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 110.204 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.427 ' NE1' ' HG3' ' A' ' 48' ' ' MET . 5.0 m95 -58.28 -27.96 64.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -56.81 5.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -39.42 65.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.056 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -69.46 -32.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.13 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -49.78 69.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -65.9 -37.25 85.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.86 75.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 110.314 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 38.1 ttm-85 -60.08 -28.93 68.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 110.33 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 1.8 tt0 -56.77 -60.84 2.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -69.55 -26.57 64.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 110.198 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 60' ' ' ARG . 32.5 t90 -65.94 -20.16 66.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 110.338 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.96 -0.46 47.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -108.34 -60.52 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.933 . . . . 0.0 110.306 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' GLY . 4.8 m-85 -107.17 7.65 29.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' PHE . . . 45.91 69.83 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.23 147.31 25.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.7 t -116.19 83.71 13.04 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.62 169.85 21.36 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.953 1.502 . . . . 0.0 110.355 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.02 -160.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.012 1.533 . . . . 0.0 110.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 94' ' ' PRO . 25.1 mm -102.75 40.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.78 -58.82 1.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.256 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mmt -61.76 -28.85 69.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' OG1' ' A' ' 79' ' ' THR . 6.8 t -71.43 -38.07 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -27.03 68.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.87 -29.92 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.68 46.63 2.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.255 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 24.5 m -148.29 -50.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.243 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.68 1.16 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.35 143.93 51.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -1.171 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 130.59 54.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.9 -34.24 62.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 19.8 tt0 -58.01 -55.23 37.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' CE ' HD12 ' A' ' 89' ' ' LEU . 1.3 tptm -51.97 -52.16 52.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.3 mt -54.94 -31.04 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.086 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -67.88 -51.16 51.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.222 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.57 68.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' CE ' ' A' ' 85' ' ' LYS . 13.8 mt -73.32 -66.73 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.244 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 102.29 51.17 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.07 94.76 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.918 1.483 . . . . 0.0 110.442 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 177.7 -37.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.21 131.85 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 46.9 Cg_endo -73.37 -162.89 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.937 1.493 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 94' ' ' PRO . . . 56.08 -90.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.3 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 57.1 m-70 -59.43 -33.85 71.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -69.62 -67.15 2.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.62 -52.3 4.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -46.91 81.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.79 -36.73 48.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 t -74.43 -36.24 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.61 -21.69 61.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.94 72.33 0.95 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.192 -1.181 . . . . 0.0 110.195 -179.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.282 0.563 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -128.92 157.78 40.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 21.7 m -116.63 146.41 37.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 48.9 Cg_endo -75.5 174.21 53.98 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.357 -0.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' ILE . . . -176.34 173.03 46.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.532 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -150.82 138.35 19.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -1.115 . . . . 0.0 110.041 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 51.6 m-85 -145.22 171.31 14.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -104.47 111.56 24.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 91.6 t -118.86 107.79 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.263 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 11.0 t0 66.06 64.73 0.53 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 44.7 32.12 2.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.3 mttp -129.03 165.0 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.145 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -122.14 113.43 19.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 93.1 t -111.08 145.72 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.101 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.5 tt -137.53 109.61 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 110.223 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 56.4 mt -78.25 134.64 37.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 4.6 t0 -67.11 -167.97 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -17.92 65.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.26 38.14 3.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 53.1 m 47.68 39.09 9.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.1 155.55 16.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.455 ' HE1' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -90.24 90.68 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.418 ' NE2' HG12 ' A' ' 17' ' ' ILE . 9.5 pt20 -83.62 -4.21 58.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' HE1' ' A' ' 24' ' ' MET . 1.8 t30 -121.39 62.74 12.6 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.86 -16.27 26.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.015 1.534 . . . . 0.0 110.396 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.436 ' OE2' ' HA ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -64.22 -25.06 67.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.69 0.37 30.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.533 ' CZ2' ' HB3' ' A' ' 35' ' ' ALA . 42.7 t90 -46.38 148.19 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -168.45 2.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 4.9 tt0 -74.93 -55.35 5.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -30.87 71.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 110.203 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.01 -50.04 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.533 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . . . -59.89 -50.83 72.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.62 -57.73 11.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 110.281 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 59.1 t90 -47.78 -36.85 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.64 -57.1 8.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.266 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.38 -28.49 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.306 -0.871 . . . . 0.0 110.189 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -62.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.892 . . . . 0.0 110.219 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -48.97 -37.0 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.318 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -75.33 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.315 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.4 -76.8 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.68 38.65 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mt -79.73 104.4 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 110.034 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -78.8 -19.09 52.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.334 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -151.61 96.46 2.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.459 ' HE1' ' HB3' ' A' ' 52' ' ' HIS . 70.8 mmm -52.06 103.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.039 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.567 ' CG2' ' ND1' ' A' ' 52' ' ' HIS . 2.3 t -55.99 160.34 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.87 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -52.61 -36.63 56.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -0.936 . . . . 0.0 110.281 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -35.29 79.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.311 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.567 ' ND1' ' CG2' ' A' ' 49' ' ' THR . 22.4 m170 -65.16 -60.53 2.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.943 . . . . 0.0 110.541 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.564 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 5.4 m95 -57.02 -34.22 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.733 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -62.91 -60.1 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.163 -0.961 . . . . 0.0 110.464 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD12 ' CD2' ' A' ' 81' ' ' PHE . 1.9 tp -52.3 -39.16 60.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.6 -30.88 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.185 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -49.8 64.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.11 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.495 ' CD2' HG22 ' A' ' 79' ' ' THR . 0.7 OUTLIER -66.86 -34.35 77.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -66.13 -49.46 67.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -43.75 -46.18 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.95 -32.1 63.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.218 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.453 ' CG ' ' O ' ' A' ' 63' ' ' TRP . 78.7 t90 -81.63 8.75 9.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -113.36 -17.59 12.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.69 -46.02 3.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.082 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.79 -50.91 9.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.08 25.12 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 t -167.03 168.06 14.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -1.153 . . . . 0.0 110.109 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 23.5 p -114.01 104.72 54.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 172.02 16.41 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.015 1.534 . . . . 0.0 110.433 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.87 -169.83 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mm -97.54 63.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -107.26 -63.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 mtm -74.77 -19.36 60.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.74 -29.99 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.231 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.436 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 84.0 m -59.32 -36.72 76.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.04 -28.19 54.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 -76.12 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.495 HG22 ' CD2' ' A' ' 58' ' ' TYR . 66.5 p -67.3 -51.16 56.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.279 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 106.75 9.07 31.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CD2' HD12 ' A' ' 55' ' ' LEU . 3.0 m-85 -66.96 108.21 2.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -1.156 . . . . 0.0 110.142 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.07 139.38 47.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.419 HD22 ' CE1' ' A' ' 87' ' ' TYR . 1.4 tp -60.16 -27.86 67.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -49.32 72.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.154 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -51.52 -55.25 20.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 110.12 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.408 HG12 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mt -54.82 -39.19 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.17 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.419 ' CE1' HD22 ' A' ' 83' ' ' LEU . 3.1 m-85 -60.26 -36.84 78.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -75.31 -27.37 59.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 0.0 110.194 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -92.48 -5.36 52.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.43 99.61 2.09 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.199 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.25 -17.53 24.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.996 1.524 . . . . 0.0 110.459 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.9 m -67.47 -29.89 69.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.85 147.71 8.48 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.12 -1.79 11.08 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.051 1.553 . . . . 0.0 110.48 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.453 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . -79.65 -86.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 110.239 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -73.85 -5.42 40.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.363 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -65.23 -94.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.69 -27.26 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 56.0 m -65.63 -79.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -43.04 -40.25 3.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 110.289 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.91 -48.72 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 110.247 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -65.39 -49.64 68.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.61 54.38 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.228 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.122 0.487 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.33 107.92 3.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 26.3 p -88.13 158.73 49.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 110.098 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.45 145.05 82.3 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.667 -2.222 . . . . 0.0 110.476 -0.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.08 174.93 46.91 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 125.96 54.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 110.123 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -129.99 156.18 44.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -113.29 134.78 54.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 99.0 t -116.3 94.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.483 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' GLY . 1.1 m-20 48.29 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.542 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.0 59.52 3.31 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 1.3 mttt -166.6 153.2 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -1.138 . . . . 0.0 110.109 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -116.73 145.84 43.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 110.279 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.412 HG23 ' HE3' ' A' ' 24' ' ' MET . 38.7 t -141.99 138.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 17' ' ' ILE . 50.8 mt -117.36 96.85 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.367 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 5' ' ' CYS . 16.4 mt -75.02 121.91 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.43 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -69.84 -171.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -62.47 -16.89 57.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.29 36.72 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.61 29.07 3.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.231 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -84.57 141.14 30.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.215 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.412 ' HE3' HG23 ' A' ' 16' ' ' VAL . 2.5 ttt -89.46 115.06 26.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -92.7 22.89 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -133.2 67.06 76.62 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.321 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.07 -13.7 26.09 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.027 1.54 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -78.17 -10.81 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.192 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' TRP . 21.6 t70 -110.93 -5.12 14.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.455 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 12.0 t90 -44.0 143.15 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.188 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 18.6 m-20 -159.93 -163.43 1.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -74.52 -58.76 3.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -65.41 -31.03 71.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.188 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.5 t -66.99 -53.02 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.08 -53.83 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 2.7 tt0 -52.33 -36.23 52.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -70.08 -38.13 75.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.245 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -51.54 66.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.495 ' CB ' HD12 ' A' ' 45' ' ' ILE . . . -68.65 -26.53 65.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.468 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.7 -44.61 73.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.503 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.405 ' OE1' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -77.31 -36.93 53.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.144 -0.972 . . . . 0.0 110.797 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -58.56 2.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.677 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -16.63 55.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.472 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 85.48 14.64 67.88 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.495 HD12 ' CB ' ' A' ' 39' ' ' ALA . 8.0 mt -67.23 101.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -70.48 -13.87 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.235 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -168.32 120.21 0.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.481 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 31.5 mmm -67.74 131.68 46.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.29 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.0 p -78.68 -167.16 1.02 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.99 -52.61 7.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' A' ' 51' ' ' GLU . 9.5 mm-40 -56.61 -30.63 63.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.124 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.431 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -57.54 -61.05 2.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.193 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 3.7 m95 -57.21 -33.7 67.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 4.2 tmtm? -58.2 -57.14 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.198 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tp -56.9 -50.88 71.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.198 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -54.14 -29.04 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 54' ' ' LYS . 9.5 mmtt -73.44 -53.79 9.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 110.261 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 62' ' ' TYR . 3.1 t80 -51.3 -41.28 60.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 110.342 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -49.53 77.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.306 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.98 -60.34 4.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -27.01 4.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.29 -0.881 . . . . 0.0 110.361 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.8 -37.66 58.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.425 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 41.9 t90 -65.05 -22.22 66.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.314 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.19 -59.06 5.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.211 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -75.89 -58.52 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.247 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -65.3 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 110.209 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.23 18.94 3.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.8 t -141.22 174.22 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.148 . . . . 0.0 110.135 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 t -124.69 84.69 57.51 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.443 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.2 Cg_endo -73.17 173.73 13.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.981 1.516 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.7 Cg_endo -73.09 160.44 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.002 1.528 . . . . 0.0 110.313 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.1 tt -79.03 -7.06 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.145 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -55.1 -62.81 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -63.74 -27.08 68.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.071 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.84 -34.22 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -54.8 -27.65 43.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -65.04 -39.4 93.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -70.05 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.113 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 p -46.8 -39.09 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.91 8.7 84.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -55.4 171.82 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.8 m -113.94 147.23 38.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.326 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HA ' HD11 ' A' ' 86' ' ' ILE . 13.0 tp -60.44 -27.9 67.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 110.268 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -63.67 -59.95 3.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.272 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 83' ' ' LEU . 3.5 mt -47.01 -33.04 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.377 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -36.32 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.923 . . . . 0.0 110.378 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.63 -24.36 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.37 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.22 -49.99 6.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -98.43 167.22 11.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.217 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.68 -89.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.998 1.525 . . . . 0.0 110.505 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.7 t -104.68 85.77 2.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 61.3 139.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.436 ' HG3' HG21 ' A' ' 86' ' ' ILE . 46.4 Cg_endo -73.05 -90.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.061 1.558 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 97' ' ' GLY . . . 62.28 -132.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 8.2 p-80 -42.28 -25.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.0 110.582 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.515 ' N ' ' CD2' ' A' ' 96' ' ' HIS . . . -66.63 -74.56 0.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.17 -48.1 4.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -1.107 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.4 t -57.01 -44.09 82.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.468 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -60.64 -58.22 9.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.373 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.0 t -46.76 -41.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.29 59.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.52 52.23 3.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.308 0.575 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 133.68 55.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.157 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 62.3 m -103.09 150.38 37.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.4 Cg_endo -76.36 165.6 84.88 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.612 -2.245 . . . . 0.0 110.412 -0.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 154.91 20.26 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.33 152.56 27.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -1.144 . . . . 0.0 110.168 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -149.15 157.06 43.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.404 ' C ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 tp60 -110.55 145.01 38.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.243 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 10' ' ' GLN . 22.7 t -148.79 110.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.023 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t0 58.51 -143.85 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.951 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.42 50.44 2.99 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.0 146.36 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.243 . . . . 0.0 110.319 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.98 143.18 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.098 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 17' ' ' ILE . 85.0 t -127.79 162.31 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.351 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.472 ' N ' HG13 ' A' ' 16' ' ' VAL . 8.7 tt -148.96 164.37 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' N ' HG12 ' A' ' 17' ' ' ILE . 16.6 mt -136.43 115.78 12.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.908 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -57.74 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.47 -20.71 66.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.32 38.85 2.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.5 m 48.46 42.57 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -96.52 145.13 25.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.44 ' SD ' HD13 ' A' ' 38' ' ' LEU . 2.1 mtp -82.81 105.43 13.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.33 19.42 13.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -129.51 71.81 82.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.69 -30.5 11.7 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.139 1.6 . . . . 0.0 110.418 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.09 -16.9 64.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.83 35.68 3.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -90.85 153.59 20.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.84 -168.08 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 2.5 mt-10 -72.12 -57.06 4.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.198 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.77 -29.99 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.34 -57.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . . . -55.44 -38.74 69.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.309 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -52.23 63.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ2' ' OE2' ' A' ' 41' ' ' GLU . 57.9 t90 -56.87 -33.13 66.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' A' ' 24' ' ' MET . 4.8 tt -69.57 -42.9 73.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.55 -31.43 72.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -74.63 -44.07 52.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.444 ' OE2' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -62.97 -36.93 85.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.865 . . . . 0.0 110.145 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 42' ' ' LEU . 6.3 mp -83.46 -67.75 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 45' ' ' ILE . 4.3 tt0 -80.44 -66.38 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.61 -13.9 2.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.401 ' CD1' ' OE1' ' A' ' 43' ' ' GLU . 33.7 mt -44.19 134.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -106.77 3.85 26.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.212 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -161.03 91.29 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -44.95 123.85 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 t -73.83 158.42 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.257 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -34.47 55.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.24 -43.34 92.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.497 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -58.25 -56.66 19.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.224 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CZ2' ' SD ' ' A' ' 48' ' ' MET . 6.6 m95 -59.29 -27.31 65.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -67.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.61 -32.44 58.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.152 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 101' ' ' VAL . 29.0 t -68.72 -33.53 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.47 -42.43 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 110.136 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -44.42 94.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.15 -50.99 71.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 110.236 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -49.17 -50.05 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.381 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.78 -38.97 61.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.58 74.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -52.86 -46.52 67.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.16 -35.48 80.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.334 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.2 m -64.66 -33.99 77.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -142.11 -69.18 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.27 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.62 79.11 0.38 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 t -162.7 159.88 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -1.185 . . . . 0.0 110.18 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.6 t -112.6 82.52 4.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.42 160.25 44.99 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.15 -89.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.095 1.576 . . . . 0.0 110.454 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -172.14 42.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -64.83 1.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.15 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -40.22 95.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' OG1' ' A' ' 79' ' ' THR . 20.8 t -52.63 -37.17 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m -66.19 -33.58 76.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -74.17 -33.1 63.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.59 -35.39 62.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -107.44 -78.44 0.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.22 38.42 0.23 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -91.99 128.9 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 84' ' ' GLU . 72.4 m -77.83 134.68 37.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.898 . . . . 0.0 110.238 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 82' ' ' SER . 1.3 tp -42.8 -26.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -60.73 -53.3 59.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.34 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -47.92 79.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.64 -30.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -72.35 -48.08 44.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -38.5 80.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.497 HD22 ' CE1' ' A' ' 52' ' ' HIS . 8.1 mt -68.36 -65.58 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.084 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.479 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.1 m-85 -82.25 173.7 7.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.3 Cg_endo -73.65 -88.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.984 1.518 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -155.86 80.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.56 82.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.07 -17.63 24.66 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.932 1.49 . . . . 0.0 110.432 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.77 -88.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -76.81 -2.26 32.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.18 -70.41 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.81 -36.53 37.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.188 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.2 m -70.26 -52.74 20.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -33.25 36.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 110.173 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.407 HG13 HG22 ' A' ' 56' ' ' VAL . 25.1 t -73.62 -45.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.092 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -21.63 66.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.74 53.9 3.41 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.205 -1.174 . . . . 0.0 110.135 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 9' ' ' TYR . 7.0 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.275 0.559 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.45 148.0 52.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.411 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.4 m -102.84 141.11 21.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.36 159.21 97.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 -2.153 . . . . 0.0 110.314 -0.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.77 136.34 3.01 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.444 ' OE2' ' CG1' ' A' ' 17' ' ' ILE . 12.4 tt0 -101.24 142.53 32.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -1.104 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.414 ' CE2' HG12 ' A' ' 3' ' ' VAL . 25.5 m-85 -150.68 148.49 28.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -101.77 143.95 31.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.065 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 43.7 t -120.37 94.87 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 110.448 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.41 63.68 2.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.52 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.53 14.48 79.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 11' ' ' VAL . 16.1 mmtt -102.82 169.96 8.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -1.205 . . . . 0.0 110.162 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.53 108.57 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.495 HG11 ' CB ' ' A' ' 24' ' ' MET . 55.2 t -116.73 145.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.26 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.444 ' CG1' ' OE2' ' A' ' 8' ' ' GLU . 3.6 mt -134.51 97.47 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.79 110.15 6.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.273 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -68.46 -141.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.77 -2.71 58.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.872 . . . . 0.0 110.145 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.42 38.01 4.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.3 m 47.9 49.14 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -119.69 116.19 25.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.495 ' CB ' HG11 ' A' ' 16' ' ' VAL . 1.8 ptp -51.83 -21.75 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.63 29.81 5.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.62 75.97 36.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 110.175 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.84 -21.46 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.007 1.53 . . . . 0.0 110.408 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -38.34 73.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.74 -2.77 57.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -61.93 125.6 24.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -0.969 . . . . 0.0 110.277 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.3 -162.9 1.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -72.14 -62.43 1.44 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.965 . . . . 0.0 110.284 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -48.29 -49.28 34.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.31 -52.1 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.236 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.77 -36.19 35.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 110.301 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 46.2 mt-10 -72.85 -36.61 67.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -60.49 -48.13 83.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.397 -0.815 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 42' ' ' LEU . 8.1 mt -67.36 -51.21 54.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 110.32 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.75 -29.17 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -77.07 -60.82 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.95 -35.35 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 42' ' ' LEU . 6.0 mp -80.16 -66.53 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -89.81 -47.62 7.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 119.47 13.69 6.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.2 mt -54.8 92.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -1.158 . . . . 0.0 110.173 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 44' ' ' GLY . 3.5 mp0 -57.48 -35.79 70.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.216 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 146.1 46.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.496 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -85.07 134.74 34.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.325 -0.859 . . . . 0.0 110.208 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -93.36 -179.13 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.42 -21.7 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -77.05 -36.25 56.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -71.09 -54.8 9.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.504 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 3.0 m95 -57.67 -33.22 68.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -67.33 -59.09 3.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.142 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.56 -35.77 31.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.89 -40.37 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -63.04 -35.44 80.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.2 -36.85 61.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.247 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.2 -29.43 68.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -59.64 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -44.85 -45.94 10.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.247 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -44.79 96.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.283 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 21.4 t90 -67.88 -14.5 63.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.329 -0.857 . . . . 0.0 110.287 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.17 -49.83 8.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.302 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.95 -49.09 16.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.65 -72.46 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.16 89.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.04 174.86 14.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -1.177 . . . . 0.0 110.014 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -153.58 57.52 1.95 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 69' ' ' CYS . 46.3 Cg_endo -73.02 171.79 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.975 1.513 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.68 171.7 16.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.098 1.578 . . . . 0.0 110.498 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 3.5 tp -68.08 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -178.54 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 109.98 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -27.18 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.048 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 t -77.04 -27.52 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -54.95 -38.82 68.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -36.97 16.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 78' ' ' GLU . 13.5 mm-40 -87.98 -32.64 18.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.28 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -97.2 -74.91 0.56 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.01 36.88 1.09 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -92.64 88.31 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.188 -1.183 . . . . 0.0 110.228 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.4 m -49.29 136.07 16.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.44 HD13 ' CG2' ' A' ' 72' ' ' ILE . 1.2 mp -44.16 -31.92 1.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.282 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.22 -53.8 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.249 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -48.55 81.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.2 mt -53.37 -29.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.912 . . . . 0.0 110.151 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -77.02 -45.22 27.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.12 -33.56 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 110.267 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.91 -63.89 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.26 106.48 45.54 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.86 -38.13 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.973 1.512 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -49.3 -28.81 5.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.271 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.43 151.59 18.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 45.7 Cg_endo -73.41 -170.33 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.017 1.535 . . . . 0.0 110.445 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . 66.85 -84.34 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.339 -0.851 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -74.24 -34.05 63.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.03 -1.044 . . . . 0.0 110.379 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.2 -58.64 5.01 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.93 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -1.161 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 5.4 t -61.18 -51.06 70.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -48.82 -50.09 36.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.15 -35.65 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.423 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.64 69.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.71 36.24 29.79 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.281 -1.129 . . . . 0.0 110.177 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 18' ' ' LEU . 48.3 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.214 0.531 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 mttt 53.7 96.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.446 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 61.5 m -97.11 157.83 34.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.8 Cg_endo -75.5 170.8 70.85 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.387 -0.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -177.02 150.66 10.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -106.43 137.26 44.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -1.095 . . . . 0.0 110.301 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -134.66 170.64 15.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 140.65 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.272 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 39.5 t -122.98 99.13 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.0 110.036 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 10.0 t0 55.89 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -130.91 62.83 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.32 157.17 17.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -114.88 133.91 55.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.93 124.9 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.14 97.98 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' CD1' HG11 ' A' ' 3' ' ' VAL . 20.5 mt -67.48 108.54 2.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 18' ' ' LEU . 34.3 t0 -49.62 -179.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.819 . . . . 0.0 110.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -62.58 -15.81 53.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.915 . . . . 0.0 110.223 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 1.5 m-20 -117.07 41.99 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.0 m 48.2 49.91 16.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -109.65 161.45 15.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.428 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -89.73 108.85 19.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.233 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.82 4.57 28.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.505 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 4.3 m-20 -131.62 51.97 8.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.1 Cg_endo -72.56 -13.52 27.44 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.032 1.543 . . . . 0.0 110.474 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -37.65 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' TRP . 0.9 OUTLIER -95.78 -70.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 110.213 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.577 ' CD2' ' N ' ' A' ' 31' ' ' ASP . 37.2 t90 55.78 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.155 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.577 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -172.86 -172.93 0.91 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.87 -41.33 68.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -70.06 -32.43 70.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.9 t -70.04 -51.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.62 44.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.07 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -39.84 70.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.46 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 83.3 t90 -64.57 -31.79 73.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.877 . . . . 0.0 110.184 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.79 -44.18 67.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.352 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.36 67.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -76.76 -36.04 57.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 37' ' ' TRP . 3.2 mm-40 -77.18 -27.02 53.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.554 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.2 -62.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.551 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.04 -78.12 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.99 51.48 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.88 107.8 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -1.105 . . . . 0.0 110.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -42.73 -43.36 3.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.311 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 143.11 28.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.29 125.33 22.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.0 p -70.76 160.84 31.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.226 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.08 -27.34 32.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.6 -41.4 62.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 110.394 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -61.83 -48.81 78.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.438 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.504 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.0 m95 -65.82 -31.94 73.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.41 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 1.4 tttt -64.57 -66.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -49.98 67.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.477 ' CG1' HG13 ' A' ' 101' ' ' VAL . 34.3 t -55.33 -31.41 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.33 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -70.29 -46.64 63.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.211 -0.93 . . . . 0.0 110.192 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -60.2 -34.72 74.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.378 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -43.3 86.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.0 110.453 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -55.81 27.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.436 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.06 -27.38 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.947 . . . . 0.0 110.347 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.576 ' CG ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -76.8 -42.32 41.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.569 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 19.2 t90 -58.18 -20.31 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.304 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.54 -42.14 30.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.31 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -60.26 3.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -116.99 -33.78 4.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 63' ' ' TRP . . . 93.01 71.59 1.17 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.3 t -166.09 -175.15 3.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.211 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.0 m -102.3 106.01 46.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.576 ' HG3' ' CG ' ' A' ' 62' ' ' TYR . 45.8 Cg_endo -72.94 144.92 39.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.052 1.553 . . . . 0.0 110.459 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 -178.28 3.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.091 1.574 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.8 62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -130.89 -50.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 74' ' ' MET . 0.9 OUTLIER -67.23 -37.75 84.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.282 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' ' OG1' ' A' ' 79' ' ' THR . 57.1 t -65.59 -55.76 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.0 m -52.87 -26.84 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.17 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.92 -41.46 24.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.98 32.7 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.351 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 46.2 m -123.77 -22.33 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.13 78.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CG ' HG21 ' A' ' 79' ' ' THR . 3.3 m-85 -96.55 172.68 7.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.144 . . . . 0.0 110.121 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.6 148.92 34.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.65 -27.59 64.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 110.222 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.56 -52.2 64.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -33.21 68.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 94' ' ' PRO . 50.4 mt -73.67 -29.01 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 110.073 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -35.76 66.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -40.8 50.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -39.44 79.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 110.242 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 116.14 32.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.067 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.76 -7.82 20.61 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.579 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 92' ' ' SER . 1.3 t -104.11 21.3 16.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 59.06 161.04 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -73.09 -16.68 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.977 1.514 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 94' ' ' PRO . . . -45.57 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -77.2 -2.91 36.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 110.209 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.55 -91.96 0.16 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -43.1 -34.31 1.04 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.396 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.16 -62.37 1.66 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.02 -38.01 48.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.285 -0.884 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.477 HG13 ' CG1' ' A' ' 56' ' ' VAL . 52.6 t -58.97 -59.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.938 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.64 -7.07 45.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 110.305 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.79 79.45 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 110.201 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.41 ' CG1' HD13 ' A' ' 18' ' ' LEU . 56.6 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.259 0.552 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -96.14 109.32 21.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.512 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 31.6 p -108.94 152.09 42.22 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.219 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 49.1 Cg_endo -75.57 161.59 94.13 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.644 -2.232 . . . . 0.0 110.548 -0.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.02 47.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -104.66 121.69 44.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.163 . . . . 0.0 110.364 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -137.09 155.44 49.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -117.31 145.62 43.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.26 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 42.4 t -125.66 125.83 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.86 -91.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -137.98 59.44 0.61 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.16 170.34 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 110.225 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.02 136.21 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 24' ' ' MET . 56.0 t -137.67 144.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mt -112.29 105.85 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 6' ' ' PRO . 11.8 mt -62.64 129.61 41.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.429 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.9 t0 -84.5 -160.43 0.47 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.45 -13.05 60.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -107.59 26.27 10.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.512 ' HA ' ' CB ' ' A' ' 5' ' ' CYS . 2.7 m 50.7 23.73 1.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 24' ' ' MET . 68.3 t80 -109.44 155.86 20.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.543 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -59.79 138.07 57.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.212 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.82 -20.38 31.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -124.8 71.7 60.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.058 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.29 -9.43 25.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.031 1.542 . . . . 0.0 110.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.63 -35.79 6.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.104 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' TRP . 53.5 m-20 -93.48 -74.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 110.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.468 ' O ' ' CE3' ' A' ' 30' ' ' TRP . 82.9 t90 52.15 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.285 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.54 -170.61 1.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.99 -57.44 4.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.342 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -54.83 -27.37 41.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.372 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.64 -48.77 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . . . -60.11 -48.23 82.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -42.93 97.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -0.908 . . . . 0.0 110.428 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.551 ' CZ3' HG22 ' A' ' 11' ' ' VAL . 39.3 t90 -57.25 -47.66 80.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.311 -0.868 . . . . 0.0 110.506 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 13.1 mt -62.52 -43.24 99.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.963 . . . . 0.0 110.493 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.78 -26.99 67.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 0.0 110.439 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.433 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.2 -43.77 32.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.0 110.732 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.46 -27.82 60.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.97 . . . . 0.0 110.682 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -80.61 -47.5 14.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.97 . . . . 0.0 110.395 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.31 -48.37 4.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.258 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 121.13 12.15 5.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.13 106.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -1.132 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.1 -46.53 8.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -154.64 121.41 5.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.488 ' SD ' ' CG ' ' A' ' 52' ' ' HIS . 31.1 mmm -44.44 133.05 5.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.499 HG21 ' N ' ' A' ' 50' ' ' GLU . 5.9 t -74.46 -155.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 110.12 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' N ' HG21 ' A' ' 49' ' ' THR . 15.6 tt0 -87.63 -48.57 7.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -59.86 -26.67 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -63.57 -55.92 20.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.86 . . . . 0.0 110.441 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.5 m95 -61.6 -50.09 73.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -52.12 -45.94 65.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 0.0 110.309 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.559 ' CD1' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -62.19 -60.75 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.8 t -49.2 -27.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 110.259 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -71.86 -48.65 44.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -37.25 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -43.48 73.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.284 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -53.98 -46.59 71.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.267 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.32 -39.78 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.13 -36.54 55.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.454 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -76.36 2.64 12.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.432 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -116.53 -4.92 11.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -107.09 -44.09 4.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.158 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -114.01 -43.15 3.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.45 54.07 0.85 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.463 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 18.6 m -146.28 146.44 30.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -1.137 . . . . 0.0 110.114 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.2 t -104.85 95.65 9.35 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 68' ' ' THR . 47.4 Cg_endo -73.47 163.43 37.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.974 1.512 . . . . 0.0 110.484 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.65 -89.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.96 1.505 . . . . 0.0 110.457 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.506 ' O ' ' CG1' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -178.46 62.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.243 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -119.93 -54.17 2.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 110.18 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -25.42 63.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 t -72.31 -42.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.6 m -67.55 -29.73 69.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -38.76 5.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -99.34 -76.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 78' ' ' GLU . 54.7 p -42.86 -45.25 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.229 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.08 34.69 46.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -58.63 116.64 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.254 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.56 129.0 38.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.196 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -48.82 -37.1 18.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.7 -45.36 63.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 110.137 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -40.4 92.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.18 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.418 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 24.7 mm -66.26 -27.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -45.3 32.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.949 . . . . 0.0 110.317 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -53.21 46.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.34 -45.27 93.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 110.181 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.07 84.83 59.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 92' ' ' SER . 46.2 Cg_endo -73.47 86.7 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.971 1.511 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER 172.7 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.87 127.65 1.72 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.418 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.9 Cg_endo -72.91 -18.0 24.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.755 1.397 . . . . 0.0 110.435 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.08 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 2.8 m170 -75.61 -5.37 45.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 110.273 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 101' ' ' VAL . . . -78.23 -84.26 0.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -42.41 -29.18 0.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -1.11 . . . . 0.0 110.53 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.45 ' SG ' ' HB1' ' A' ' 104' ' ' ALA . 2.4 t -73.98 -49.28 25.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.409 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 17.4 ttmm -61.18 -35.19 76.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.407 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 97' ' ' GLY . 9.1 t -73.56 -42.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 98' ' ' ALA . . . -68.37 -21.6 64.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.319 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.44 67.22 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.45 ' HB1' ' SG ' ' A' ' 99' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.273 -1.133 . . . . 0.0 110.218 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 7.8 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.189 0.519 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -124.31 109.55 13.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.445 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 71.8 m -84.43 150.46 57.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.091 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.3 Cg_endo -76.13 162.28 92.41 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.486 -0.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.42 157.75 24.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.14 131.64 45.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -1.216 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 3' ' ' VAL . 66.3 m-85 -136.57 144.56 44.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.122 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 7.2 tt0 -112.65 126.95 55.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 60.5 t -108.65 94.54 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 42.4 t0 60.52 71.47 0.57 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.639 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.9 14.36 23.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 12.7 mmtt -108.83 152.19 25.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.071 -1.252 . . . . 0.0 110.103 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -106.29 136.39 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.41 117.53 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -100.4 115.92 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.542 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.7 mt -95.09 116.71 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 109.989 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -94.97 -163.38 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -42.42 126.03 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER 64.13 39.29 7.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m 48.12 50.16 16.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.14 113.81 20.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' MET . . . . . 0.431 ' CE ' HD12 ' A' ' 38' ' ' LEU . 4.4 tpt -50.8 145.8 6.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.166 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -143.2 18.14 1.91 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -125.2 59.97 26.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.27 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 -8.95 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.951 1.501 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.3 -36.03 52.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.45 -77.83 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t90 61.16 107.76 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -124.52 -178.15 4.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -45.86 77.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.266 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.71 -35.57 78.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.1 t -65.92 -54.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.58 -40.89 76.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.878 . . . . 0.0 110.322 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -62.62 1.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.349 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -51.04 -30.59 15.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.39 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.431 HD12 ' CE ' ' A' ' 24' ' ' MET . 2.2 mt -65.28 -52.26 55.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.369 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.431 ' HB3' HD11 ' A' ' 45' ' ' ILE . . . -62.08 -30.32 70.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.353 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -29.32 61.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.99 -37.87 54.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 110.34 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 tp -80.27 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.325 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -95.38 -84.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.161 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.63 39.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 39' ' ' ALA . 3.8 mt -79.7 88.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -45.06 -30.21 1.03 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 48' ' ' MET . 9.2 mttp -150.23 113.1 4.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 47' ' ' LYS . 52.6 mmm -42.75 120.61 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.4 p -66.34 150.96 48.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.0 110.23 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.69 52.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.217 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -40.29 85.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 110.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.555 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.71 -56.19 24.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.167 -0.958 . . . . 0.0 109.964 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.436 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.1 m95 -59.76 -28.58 67.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 110.003 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -66.48 -41.7 88.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.2 tp -68.55 -38.09 80.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.933 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.31 -39.67 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 53' ' ' TRP . 3.2 mtpp -64.91 -51.57 61.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.069 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.17 -41.14 78.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 110.114 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 110.056 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.2 mmm-85 -57.04 -36.28 70.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.24 -36.35 81.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.137 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.23 -30.74 66.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.449 ' HA ' ' OG1' ' A' ' 68' ' ' THR . 19.8 t90 -58.01 -27.31 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -95.65 29.67 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.213 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.04 -52.88 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -130.22 -78.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.21 25.12 0.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 63' ' ' TRP . 0.2 OUTLIER 58.46 -167.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 110.257 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.1 m 54.34 61.46 9.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 163.47 38.42 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.079 1.568 . . . . 0.0 110.48 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.3 -179.28 4.26 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.066 1.561 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 72' ' ' ILE . 11.3 tp -88.45 28.43 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -126.96 -31.62 2.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.199 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -21.98 44.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 79' ' ' THR . 31.5 t -67.31 -53.79 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t -72.2 -27.16 62.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.29 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.95 -37.57 1.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 110.196 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -142.05 53.86 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 75' ' ' VAL . 50.3 m -161.74 -37.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.158 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.3 33.92 18.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.64 124.43 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -1.126 . . . . 0.0 110.119 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.38 149.25 21.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.258 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -50.91 -27.04 6.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.97 -46.02 89.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.505 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 3.2 mp -63.67 -28.67 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -37.84 54.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.269 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.96 -26.26 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' A' ' 52' ' ' HIS . 14.8 mt -83.67 -57.03 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -91.59 169.05 11.97 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.53 -55.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.097 1.578 . . . . 0.0 110.466 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.76 104.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.69 77.2 0.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.7 Cg_endo -72.69 -10.85 25.56 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.022 1.538 . . . . 0.0 110.39 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.29 -77.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -74.96 -7.55 53.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.297 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.4 ' N ' ' CD2' ' A' ' 96' ' ' HIS . . . -76.29 -77.17 0.77 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.83 -35.09 4.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.174 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.5 m -68.1 -58.23 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 110.27 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -50.21 -26.96 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.04 -56.71 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . . . -61.4 -12.41 14.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.233 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.75 80.13 1.15 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.244 -1.151 . . . . 0.0 110.159 179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.283 0.563 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 111.35 0.91 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.247 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.446 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 99.1 m -105.24 148.33 36.06 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.98 177.89 37.38 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.346 -0.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.89 146.75 8.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.8 tt0 -120.11 127.62 52.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -1.099 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 29.2 m-85 -142.09 170.48 15.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.244 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -125.01 154.61 41.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 110.162 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 12' ' ' ASP . 44.3 t -131.37 101.62 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER 42.61 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.271 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.58 62.19 3.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -164.19 170.45 16.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -135.28 145.06 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.4 t -148.05 113.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.154 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.427 HG23 ' NE2' ' A' ' 25' ' ' GLN . 51.3 mt -99.35 145.15 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.0 110.272 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 22' ' ' CYS . 9.4 mt -123.82 108.83 12.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.72 -173.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 51.0 tt0 -66.79 -15.37 63.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 0.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.57 34.27 3.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.242 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.443 ' HA ' HD22 ' A' ' 18' ' ' LEU . 83.9 m 48.16 49.08 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.78 147.63 34.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 110.211 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.2 ttt -74.7 115.99 14.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.287 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' NE2' HG23 ' A' ' 17' ' ' ILE . 2.2 tt0 -88.77 28.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -168.25 69.22 0.81 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.323 -0.861 . . . . 0.0 110.198 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.71 -7.0 20.08 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.052 1.554 . . . . 0.0 110.488 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -78.0 -21.67 50.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -103.16 39.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 110.239 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.51 ' NE1' ' O ' ' A' ' 102' ' ' ALA . 83.8 t90 -71.79 137.14 47.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.129 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -144.84 -178.49 6.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.143 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.79 -62.29 1.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -54.49 -26.88 34.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -73.56 -56.76 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.55 -50.74 62.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.0 110.449 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.07 -46.87 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 59.3 t90 -51.62 -47.12 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.86 -37.64 88.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.347 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.4 81.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 46' ' ' GLN . 2.0 tmt_? -76.98 -37.17 55.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 110.376 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.82 -32.98 74.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.322 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mt -87.3 -72.08 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.113 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.34 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLN . . . 150.4 -19.05 1.04 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -47.07 96.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -1.158 . . . . 0.0 110.243 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 4.4 tm0? -89.29 -6.16 56.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -140.68 96.13 2.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.271 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.438 ' HE2' ' CD2' ' A' ' 52' ' ' HIS . 66.6 mmm -66.38 126.57 29.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 110.086 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 52' ' ' HIS . 4.8 t -78.59 172.57 13.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -59.37 -35.3 73.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.246 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.45 -29.3 70.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -69.96 -65.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.895 . . . . 0.0 110.247 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.7 m95 -49.62 -30.83 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tmtm? -67.97 -57.41 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.193 -0.942 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.83 -49.41 62.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.02 -31.78 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 110.242 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -62.41 -49.49 75.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 110.218 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 58' ' ' TYR . 5.7 t80 -63.49 -45.73 89.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -53.11 -41.05 64.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -40.71 71.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.271 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -58.36 -43.96 88.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.253 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -66.03 -39.37 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.162 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -79.17 -11.61 59.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.174 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -95.89 -25.17 16.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.29 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.6 m -54.43 -30.62 53.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.0 -54.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.9 73.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.7 m -155.56 -179.8 8.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 110.198 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.1 t -157.15 81.59 3.26 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 0.0 110.319 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 62' ' ' TYR . 47.1 Cg_endo -73.26 171.47 17.58 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.989 1.52 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.435 ' O ' HG21 ' A' ' 75' ' ' VAL . 46.3 Cg_endo -73.25 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.382 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.415 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.9 tt -116.4 14.43 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -74.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.6 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 71' ' ' PRO . 91.5 t -77.13 -34.22 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.276 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 77' ' ' LYS . 17.0 m -68.2 -32.29 72.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.166 -0.959 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 76' ' ' THR . 30.7 tttt -44.01 -27.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.295 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -107.71 -61.22 1.6 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.258 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -52.98 22.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.16 13.73 80.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.7 108.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -1.194 . . . . 0.0 110.191 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.85 126.36 10.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.2 -30.33 11.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -50.47 73.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.07 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -58.54 -50.37 74.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.005 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.46 HG22 ' HD3' ' A' ' 94' ' ' PRO . 54.7 mt -58.92 -26.99 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -39.7 64.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 110.117 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.08 -35.77 78.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 80.7 mt -74.18 -59.27 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.89 118.67 17.71 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.101 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.1 Cg_endo -72.56 -177.81 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.421 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 30.0 m 55.64 19.61 3.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 110.145 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.57 149.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' HIS . 46.6 Cg_endo -73.06 -90.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.952 1.501 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 94' ' ' PRO . . . 43.33 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 110.337 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 94' ' ' PRO . 11.2 m170 -73.52 -56.2 5.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -44.12 -56.92 5.09 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.65 -44.58 4.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -1.108 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -65.23 -54.5 28.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.195 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -42.83 -38.36 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 110.138 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -41.67 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.51 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -53.31 -45.4 68.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.268 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.7 51.25 0.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.234 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.722 0.296 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.21 -38.6 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.074 1.565 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.63 126.17 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.233 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -65.15 87.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 94.3 m -96.32 148.46 34.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -75.99 150.45 93.92 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.45 -0.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -161.87 157.66 29.46 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 21.0 pt-20 -110.64 160.81 16.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 75.9 m-85 -154.6 169.78 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.235 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.37 137.95 53.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.079 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' ASP . 10.9 t -141.35 121.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.461 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 41.38 74.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.33 -0.856 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.46 62.85 2.33 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -157.69 159.93 37.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.088 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -121.9 117.11 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 t -113.46 120.36 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -101.86 141.03 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD21 ' C ' ' A' ' 22' ' ' CYS . 6.9 mt -122.38 120.3 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.38 -169.71 2.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.4 tt0 -50.75 147.52 4.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER 64.32 20.91 12.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.423 ' C ' HD21 ' A' ' 18' ' ' LEU . 76.9 m 51.88 54.69 10.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.96 139.68 32.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.421 ' HE2' HG13 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -68.31 115.4 7.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 110.185 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -116.9 34.38 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -157.71 68.67 4.01 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.21 -0.62 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.968 1.51 . . . . 0.0 110.439 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.86 -25.86 40.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.12 26.9 9.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 110.334 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -75.64 141.3 42.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -155.29 -167.41 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.219 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.54 -33.65 66.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.195 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 24.0 mmtt -71.52 -37.62 71.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.421 HG13 ' HE2' ' A' ' 24' ' ' MET . 14.2 t -70.18 -51.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.131 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.53 81.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -67.2 -26.97 66.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CE2' ' OE1' ' A' ' 41' ' ' GLU . 49.9 t90 -66.93 -60.79 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.35 -39.0 75.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.81 71.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 3.6 ttm180 -76.86 -34.72 57.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 110.128 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' OE1' ' CE2' ' A' ' 37' ' ' TRP . 4.0 mt-10 -77.29 -26.64 52.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.01 -66.07 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.681 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.76 -31.9 40.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 101.96 -4.8 52.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.84 120.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -1.156 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -89.56 -26.42 20.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.09 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -135.53 103.55 5.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 0.0 110.146 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.413 ' SD ' ' HB3' ' A' ' 52' ' ' HIS . 15.5 mmm -48.13 119.02 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -71.58 -169.15 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -84.75 -20.76 30.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 3.7 mp0 -77.0 -45.05 28.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.413 ' HB3' ' SD ' ' A' ' 48' ' ' MET . 24.8 m170 -54.76 -52.7 61.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 5.3 m95 -67.41 -27.77 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.269 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -61.63 -65.8 0.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.15 -0.969 . . . . 0.0 109.966 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.84 -43.36 94.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.884 . . . . 0.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 52' ' ' HIS . 35.1 t -56.45 -29.37 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.863 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 14.4 mttt -75.29 -48.96 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.134 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.5 ' CE1' HG11 ' A' ' 75' ' ' VAL . 30.0 t80 -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -38.12 82.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -28.55 65.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.85 -42.39 40.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.325 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -66.89 -26.86 67.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -71.93 -2.69 18.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.254 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.19 11.94 36.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.248 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.53 -46.66 3.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.069 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -129.89 -34.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.26 56.01 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -139.95 -167.17 2.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -1.118 . . . . 0.0 110.255 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.55 93.46 3.54 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.6 Cg_endo -72.74 173.95 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.985 1.518 . . . . 0.0 110.45 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.446 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.6 Cg_endo -73.07 -160.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.978 1.515 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 72' ' ' ILE . 3.4 tp -111.87 2.8 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.281 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -24.87 25.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtt -87.57 -30.37 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.5 HG11 ' CE1' ' A' ' 58' ' ' TYR . 47.5 t -65.46 -29.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.2 m -62.34 -31.86 72.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -26.91 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.04 52.86 1.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 110.025 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.7 m -159.41 -74.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 49.77 0.4 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.0 147.56 33.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -1.193 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -98.96 131.67 44.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.924 . . . . 0.0 110.221 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -62.63 -32.32 73.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -64.54 -56.55 13.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.079 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -50.53 67.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.89 -34.98 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.987 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -61.76 -49.44 76.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.996 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 5.4 tp60 -66.18 -24.11 66.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mt -79.29 -29.51 42.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 110.09 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 16.6 m-85 -116.79 167.36 10.79 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.879 . . . . 0.0 110.042 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 92' ' ' SER . 51.3 Cg_endo -78.05 70.83 6.93 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.053 1.554 . . . . 0.0 110.622 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 91' ' ' PRO . 11.3 t 40.42 68.93 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.537 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.81 66.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.98 -12.5 23.79 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.01 1.531 . . . . 0.0 110.435 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 110.313 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 34.2 p80 -62.39 -24.62 67.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.77 -63.58 4.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' CYS . . . -48.96 -66.17 0.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.177 . . . . 0.0 110.418 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.416 ' C ' ' O ' ' A' ' 98' ' ' ALA . 8.7 t -41.92 -46.75 4.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.8 mtpt -52.52 -54.88 26.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.7 t -62.44 -25.95 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.965 . . . . 0.0 110.411 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.06 -32.95 69.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 100.07 46.63 1.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.37 122.79 35.63 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -1.187 . . . . 0.0 110.221 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.52 151.06 52.59 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.89 1.469 . . . . 0.0 110.424 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -45.07 149.95 0.82 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 0.0 110.182 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.74 -89.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.922 1.485 . . . . 0.0 110.465 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -148.56 80.19 1.44 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.36 -119.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 3.2 t 58.87 97.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -1.145 . . . . 0.0 110.2 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.193 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG2' ' CD ' ' A' ' 4' ' ' LYS . 9.0 tpt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.793 0.33 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.89 -57.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.957 1.504 . . . . 0.0 110.375 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.566 HG22 ' CE2' ' A' ' 9' ' ' TYR . 5.2 p -89.97 103.94 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.94 . . . . 0.0 110.067 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.458 ' CD ' ' HG2' ' A' ' 1' ' ' MET . 4.3 tptp -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 28.5 m -104.81 154.84 38.3 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 49.7 Cg_endo -76.11 152.45 96.48 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.605 -2.248 . . . . 0.0 110.467 -0.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.85 138.92 5.07 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.03 121.74 41.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.139 . . . . 0.0 110.239 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.566 ' CE2' HG22 ' A' ' 3' ' ' VAL . 35.8 m-85 -130.32 158.61 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.101 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 18.9 mt-30 -110.4 156.31 20.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.17 -0.956 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 14' ' ' LYS . 76.1 t -129.22 105.97 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.4 38.26 24.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.12 24.09 23.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 11.1 mmtt -115.28 175.0 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -131.71 135.66 47.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.226 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' LYS . 17.3 t -140.76 121.64 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 0.0 110.163 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 HD11 ' ND2' ' A' ' 26' ' ' ASN . 21.1 mt -99.66 108.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 53.5 mt -89.64 118.85 29.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 1.1 t0 -71.53 -172.71 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -50.22 -28.22 7.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -116.79 51.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 63.1 m 42.92 32.56 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.3 157.44 26.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -98.99 101.62 13.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.31 17.51 8.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.238 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.468 ' ND2' HD11 ' A' ' 17' ' ' ILE . 1.6 m-20 -148.48 78.22 9.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.01 -7.33 20.51 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.015 1.534 . . . . 0.0 110.475 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.72 -12.61 61.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 12.1 t70 -116.43 33.9 5.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.153 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -92.75 151.01 20.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.37 -171.65 2.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -69.65 -56.21 7.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.272 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -57.33 -39.3 75.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.882 . . . . 0.0 110.27 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.68 -51.74 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.38 -50.72 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 110.385 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -58.34 -41.59 84.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.4 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 50.0 t90 -55.55 -48.93 73.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.439 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.57 -51.13 69.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.444 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.0 -39.31 55.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 110.519 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.8 -67.1 0.53 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.938 . . . . 0.0 110.445 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -42.58 -26.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.559 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 40' ' ' ARG . 2.4 mp -83.85 -79.49 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.379 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.68 -79.28 0.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.18 38.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.34 115.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -1.148 . . . . 0.0 110.233 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -56.88 -45.14 82.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.878 . . . . 0.0 110.358 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.0 122.09 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.451 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 45.3 mmm -45.78 118.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.7 p -65.1 178.13 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -69.85 -23.75 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -35.05 57.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.552 ' CE1' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -62.57 -50.0 73.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.534 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m95 -66.26 -35.44 80.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.372 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -61.28 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.316 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -52.71 61.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 110.401 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 80.2 t -55.88 -28.76 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.487 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 ttmt -76.29 -38.27 56.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 110.389 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.25 -42.95 92.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -39.12 90.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.953 . . . . 0.0 110.283 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -36.92 67.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 43.6 tt0 -58.29 -44.95 88.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.33 -31.67 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.284 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.569 ' CZ2' ' HD2' ' A' ' 105' ' ' PRO . 91.5 t90 -67.81 -12.09 59.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 10.9 mt-10 -78.51 -47.64 16.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.23 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -53.03 4.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -78.9 -75.41 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.245 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.96 17.13 11.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.2 m -115.48 146.37 41.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -1.163 . . . . 0.0 110.205 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.5 99.82 26.77 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.942 . . . . 0.0 110.164 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.417 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.8 Cg_endo -73.19 173.55 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.1 Cg_endo -72.92 -160.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.4 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 tp -123.9 54.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -141.58 -44.06 0.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.8 mmm -74.84 -21.01 59.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.8 t -72.28 -32.32 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 m -44.33 -32.47 1.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -56.33 -51.45 68.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -65.6 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 p -68.91 -70.69 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.201 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.13 11.15 32.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.18 170.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -1.166 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -95.64 141.95 28.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.219 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 tp -69.2 -29.12 67.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 2.2 tt0 -61.16 -55.66 29.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.227 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -56.27 14.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.462 ' CG2' ' HG3' ' A' ' 94' ' ' PRO . 36.6 mt -56.17 -26.91 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.74 -58.4 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -34.48 70.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.552 HD23 ' CE1' ' A' ' 52' ' ' HIS . 21.3 mt -65.67 -51.66 57.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 110.134 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.521 ' CE1' ' HA3' ' A' ' 97' ' ' GLY . 1.5 t80 -128.64 128.57 23.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 110.048 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.4 Cg_endo -73.14 156.2 51.64 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.898 1.473 . . . . 0.0 110.417 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 49.4 m 56.81 31.37 19.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 62.19 147.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.513 ' O ' ' N ' ' A' ' 96' ' ' HIS . 45.7 Cg_endo -72.9 -92.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.889 1.468 . . . . 0.0 110.304 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 49.6 -89.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.169 -0.957 . . . . 0.0 110.358 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 94' ' ' PRO . 8.1 m-70 -68.05 -44.85 75.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' HA3' ' CE1' ' A' ' 90' ' ' PHE . . . -64.66 -41.77 97.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -55.74 -48.97 74.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -1.131 . . . . 0.0 110.335 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 100' ' ' LYS . 34.5 m -64.24 -55.39 21.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 99' ' ' CYS . 5.9 tttt -42.41 -49.9 5.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.27 -37.96 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.59 -8.58 55.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.5 48.02 77.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.09 112.7 65.14 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.211 -1.17 . . . . 0.0 110.197 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.569 ' HD2' ' CZ2' ' A' ' 63' ' ' TRP . 45.2 Cg_endo -72.58 177.53 7.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.948 1.499 . . . . 0.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.1 172.69 3.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.152 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.15 84.95 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.016 1.535 . . . . 0.0 110.418 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.72 -49.16 1.38 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.872 . . . . 0.0 110.221 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.72 121.23 1.21 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.414 ' O ' ' OXT' ' A' ' 111' ' ' VAL . 0.8 OUTLIER 60.98 26.04 16.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -1.178 . . . . 0.0 110.165 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.414 ' OXT' ' O ' ' A' ' 110' ' ' CYS . 20.5 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.552 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 46.2 Cg_endo -71.76 143.41 41.55 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.927 1.488 . . . . 0.0 110.395 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -122.19 152.72 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.331 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.89 151.71 1.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.064 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 6.0 p -125.35 161.88 47.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 49.3 Cg_endo -75.08 145.26 83.33 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.54 -2.275 . . . . 0.0 110.474 -0.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.61 152.56 18.01 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 51.4 mt-10 -103.68 141.9 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 110.381 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 77.7 m-85 -152.53 150.21 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -104.17 125.02 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 67.0 t -105.8 118.82 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.297 -0.877 . . . . 0.0 110.113 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 19.6 m-20 55.69 -89.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -141.41 50.6 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 158.91 44.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -1.144 . . . . 0.0 110.164 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -104.6 115.57 30.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.31 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.3 t -107.12 129.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 2.7 mp -115.59 116.58 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.308 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.443 HD21 ' HA ' ' A' ' 22' ' ' CYS . 10.8 mt -95.14 110.54 22.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.996 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' HB3' ' HB2' ' A' ' 23' ' ' PHE . 6.9 t70 -75.42 -161.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.274 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -64.31 137.31 57.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.1 t70 66.49 30.41 8.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 8.5 m 55.75 50.5 14.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.45 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . 1.6 m-30 -94.87 109.37 21.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.44 ' HG3' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -52.61 106.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.26 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' OE1' ' CB ' ' A' ' 19' ' ' ASP . 1.5 tp60 -108.86 35.88 3.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.231 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.464 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.8 p-10 -151.74 68.25 7.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 -7.51 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.003 1.528 . . . . 0.0 110.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -79.29 -46.65 17.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -84.61 -4.68 59.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.124 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.522 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 20.9 t90 -57.2 153.55 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -165.65 -160.06 0.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.544 ' OE2' ' CZ2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -74.39 -56.48 4.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.308 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -40.21 76.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -64.4 -49.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 0.0 110.293 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.42 -48.86 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.214 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.28 -57.67 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 92.3 t90 -49.23 -32.41 10.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD12 ' HG3' ' A' ' 24' ' ' MET . 0.9 OUTLIER -67.6 -61.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.216 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.0 -47.22 33.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.942 . . . . 0.0 110.21 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.405 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -65.3 -32.53 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -64.88 -33.36 75.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 0.0 110.152 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.459 HD23 ' HE3' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -91.39 -73.54 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.234 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.43 -76.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 40' ' ' ARG . . . 142.65 69.13 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 60.7 mt -96.87 114.11 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -1.15 . . . . 0.0 110.247 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -46.34 -29.47 1.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.298 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.78 130.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.324 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 21.5 mtp -44.0 128.1 5.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.234 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -89.12 178.7 6.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -43.94 76.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.43 -39.19 89.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.501 ' CE1' ' HB3' ' A' ' 89' ' ' LEU . 6.8 m170 -65.08 -64.49 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CZ2' ' SD ' ' A' ' 48' ' ' MET . 2.0 m95 -46.73 -38.03 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.115 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -57.56 12.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.48 -54.49 21.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.98 -33.86 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -68.04 -61.67 1.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -37.01 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -69.6 -48.18 60.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.296 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 59' ' ' LEU . 8.4 tpt180 -42.8 -38.55 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.306 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.17 -54.24 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.354 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.72 -43.88 58.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.377 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.407 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 2.2 t90 -63.81 -47.44 80.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.02 7.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.3 m -82.15 -47.35 12.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.0 -35.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 103.62 56.39 0.77 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.48 HG21 ' N ' ' A' ' 69' ' ' CYS . 31.5 m -128.61 157.5 41.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -1.148 . . . . 0.0 110.218 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.48 ' N ' HG21 ' A' ' 68' ' ' THR . 21.4 t -120.94 86.99 42.62 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 110.092 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.44 167.77 26.11 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.059 1.557 . . . . 0.0 110.416 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.4 -90.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.961 1.506 . . . . 0.0 110.43 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -175.51 74.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.88 -63.78 1.14 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.154 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -64.9 -11.63 40.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.417 ' O ' ' OG1' ' A' ' 79' ' ' THR . 58.3 t -69.83 -45.53 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 m -64.01 -40.53 96.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.201 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.47 -29.79 17.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.289 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -102.88 -71.0 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.512 ' HB ' ' CD1' ' A' ' 81' ' ' PHE . 61.6 p -49.68 -52.59 29.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.81 30.25 6.88 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.512 ' CD1' ' HB ' ' A' ' 79' ' ' THR . 10.4 m-85 -99.66 120.43 39.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.16 147.54 52.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.53 -28.27 59.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.07 -44.8 87.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -53.38 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.209 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 9.1 mt -53.02 -30.16 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 90' ' ' PHE . 1.5 m-85 -77.14 -36.26 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.283 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -44.89 91.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 3.4 mt -78.92 -53.64 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.296 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' O ' ' O ' ' A' ' 87' ' ' TYR . 1.1 m-85 -88.94 165.06 28.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.19 -179.29 4.57 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.068 1.562 . . . . 0.0 110.46 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.16 86.17 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' ' CD2' ' A' ' 96' ' ' HIS . . . 135.65 80.03 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.69 -0.02 8.81 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.497 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -79.56 -53.61 6.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 93' ' ' GLY . 23.3 p80 -77.2 -23.41 51.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.472 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -78.18 -71.8 1.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.91 -36.95 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -1.138 . . . . 0.0 110.405 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -71.28 -51.5 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.397 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -47.82 -44.11 28.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.326 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' ALA . 39.2 t -69.12 -55.32 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 101' ' ' VAL . . . -44.01 -35.45 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 0.0 110.162 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.74 63.28 1.77 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 177.93 78.73 0.13 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.258 -1.143 . . . . 0.0 110.299 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.61 -173.62 1.23 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.011 1.532 . . . . 0.0 110.42 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.483 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -79.82 165.7 45.69 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.231 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HD2' ' CG ' ' A' ' 106' ' ' LYS . 45.9 Cg_endo -73.06 136.83 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.964 1.507 . . . . 0.0 110.434 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.9 m -69.2 -43.9 73.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.43 37.06 2.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -48.22 172.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -1.191 . . . . 0.0 110.252 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.191 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.816 0.341 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.36 150.9 47.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.954 1.502 . . . . 0.0 110.336 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -73.35 125.13 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -81.5 83.43 6.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.361 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.45 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 36.5 m -82.49 154.47 68.78 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.511 ' HD3' ' CG ' ' A' ' 20' ' ' GLU . 50.3 Cg_endo -75.62 164.88 87.05 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.58 -0.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.21 160.85 28.05 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -104.34 152.08 22.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.192 . . . . 0.0 110.328 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -152.66 144.81 23.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -100.17 132.22 45.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.968 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 22.9 t -129.75 109.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.59 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 64.45 28.13 13.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.476 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.5 7.39 82.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 3.5 mttt -98.99 171.1 8.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -1.206 . . . . 0.0 110.087 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.32 123.73 49.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 110.282 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.42 138.18 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.7 mt -120.65 100.0 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.24 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.1 mt -74.49 118.39 17.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.232 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.74 -172.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.323 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.511 ' CG ' ' HD3' ' A' ' 6' ' ' PRO . 1.5 tt0 -62.01 -13.47 26.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 110.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -118.58 43.28 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.0 m 43.25 34.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.339 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -103.07 115.78 31.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 110.128 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' PHE . 1.3 ttt -41.88 137.67 1.7 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.921 . . . . 0.0 110.338 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 17.24 21.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.154 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -124.22 67.3 44.94 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.227 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.5 -6.63 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.054 1.555 . . . . 0.0 110.463 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -32.97 56.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 1.3 m-20 -97.41 -81.86 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.459 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 52.2 t90 59.47 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.6 178.44 7.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HG2' ' CZ2' ' A' ' 53' ' ' TRP . 1.8 tm-20 -65.64 -64.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -29.43 2.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.35 -62.54 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.326 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.59 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.56 -35.87 82.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -0.948 . . . . 0.0 110.421 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.442 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.448 HD22 HD11 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -66.37 -55.99 13.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.98 -31.55 60.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.456 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.412 ' HD3' ' C ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -74.45 -36.53 63.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.108 -0.995 . . . . 0.0 110.392 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.5 -26.99 61.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.448 HD11 HD22 ' A' ' 38' ' ' LEU . 6.9 mp -81.18 -42.79 20.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.447 ' OE1' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -110.24 -83.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 38.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.2 88.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -1.148 . . . . 0.0 110.281 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -45.41 -30.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.52 130.89 10.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 mmt -57.87 130.32 45.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 52' ' ' HIS . 10.0 t -86.55 160.02 19.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.204 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.75 -40.45 79.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.455 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HB2' HG21 ' A' ' 49' ' ' THR . 38.2 mt-10 -57.89 -37.0 73.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.437 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.463 ' HB2' HG22 ' A' ' 49' ' ' THR . 3.2 m170 -63.6 -64.43 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.285 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.474 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 5.0 m95 -54.8 -26.6 35.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 110.505 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -67.17 -67.31 0.46 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.96 -45.89 61.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.26 -48.21 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 110.168 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -54.83 -44.94 74.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.189 -0.945 . . . . 0.0 110.112 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.83 -58.04 9.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.471 ' CD1' ' HB3' ' A' ' 98' ' ' ALA . 6.3 mt -51.64 -33.44 33.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.354 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.34 -56.15 19.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.364 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.44 -37.33 7.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.472 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -36.89 70.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -70.36 -3.45 17.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.157 -0.965 . . . . 0.0 110.421 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.02 -25.6 10.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.4 m -88.4 -69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.9 -45.66 7.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.969 . . . . 0.0 110.123 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.97 68.68 1.26 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.501 HG21 ' N ' ' A' ' 69' ' ' CYS . 53.9 m -151.0 161.11 43.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -1.169 . . . . 0.0 110.326 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.501 ' N ' HG21 ' A' ' 68' ' ' THR . 1.6 m -110.79 84.33 4.13 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.53 172.05 16.51 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.1 1.579 . . . . 0.0 110.468 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.94 -161.95 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.001 1.527 . . . . 0.0 110.478 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -119.52 6.37 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.195 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -36.04 66.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -18.15 47.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -74.1 -46.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 110.195 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 5.6 m -62.01 -26.84 68.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -63.61 -28.49 69.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.57 -78.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.144 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 p -53.82 -27.73 31.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.982 . . . . 0.0 110.207 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 77.91 4.33 85.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.04 135.43 56.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -1.192 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.95 140.22 58.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.446 HD23 ' CD2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -63.71 -29.91 71.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.216 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -52.23 66.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.104 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -37.84 17.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.474 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 30.5 mt -73.32 -34.74 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.34 -0.85 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.465 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -61.53 -32.82 72.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -83.27 -48.42 10.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 110.184 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.444 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 57.2 mt -57.72 -28.68 64.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 87' ' ' TYR . 11.2 m-85 -129.01 168.03 17.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.026 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -173.54 1.27 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.93 1.49 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.28 94.75 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.39 76.65 0.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.474 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.2 Cg_endo -73.21 -9.01 22.85 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 110.444 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.5 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -46.52 -31.09 2.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.81 -61.89 5.48 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 59' ' ' LEU . . . -44.7 -56.42 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.1 m -47.6 -51.2 22.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.43 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 12.2 ttmt -53.25 -40.96 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.56 -52.06 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.56 -25.5 68.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.168 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.73 63.79 0.63 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.12 136.2 82.13 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.215 -1.167 . . . . 0.0 110.152 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.54 178.86 6.16 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.02 1.537 . . . . 0.0 110.438 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.24 77.09 7.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.124 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.95 -40.51 1.77 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.071 1.564 . . . . 0.0 110.398 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.6 p -106.72 -158.72 0.67 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 110.153 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.29 57.95 2.69 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 2.0 t -162.97 -175.19 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -1.13 . . . . 0.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.13 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.751 0.31 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.11 164.91 34.14 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 110.451 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.446 HG12 ' OE2' ' A' ' 41' ' ' GLU . 34.6 m -137.8 149.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.19 152.31 19.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.424 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 m -115.11 144.86 32.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.75 167.51 80.06 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.246 -0.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -178.98 142.22 5.24 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.451 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 6.3 tt0 -99.33 159.51 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -1.138 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 2.8 m-85 -161.43 166.79 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.199 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -112.01 124.84 53.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 110.256 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.509 HG21 ' CD2' ' A' ' 37' ' ' TRP . 35.3 t -99.14 98.24 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' VAL . 18.6 t70 43.2 73.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.75 56.23 25.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 170.81 20.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -1.145 . . . . 0.0 110.287 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -123.39 123.08 39.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.47 124.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.13 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.438 ' O ' HG22 ' A' ' 17' ' ' ILE . 1.1 tt -105.76 145.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 26.0 mt -112.08 112.7 24.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.407 ' OD1' ' HG3' ' A' ' 25' ' ' GLN . 19.9 m-20 -58.77 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.825 . . . . 0.0 110.229 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.23 -28.32 69.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 22' ' ' CYS . 8.3 m-20 -106.99 44.26 1.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' A' ' 21' ' ' ASP . 60.0 m 42.49 31.58 0.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.252 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -86.78 142.65 27.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 15.5 ttm -78.16 125.0 28.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HG3' ' OD1' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -95.34 0.33 53.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.34 68.53 14.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.96 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.99 -18.9 23.77 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.051 1.553 . . . . 0.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -66.11 -14.04 61.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.204 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.5 m-20 -113.39 6.64 17.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 51.7 t90 -46.32 158.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.547 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 1.2 m-20 178.4 -177.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.887 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -62.62 -45.05 94.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 110.163 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -26.78 68.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.169 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.2 -60.68 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.422 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.58 -29.51 51.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.394 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 2.8 mt-10 -75.81 -59.76 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.339 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.509 ' CD2' HG21 ' A' ' 11' ' ' VAL . 81.5 t90 -49.53 -35.57 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.378 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -51.23 20.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.304 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -55.71 -28.63 56.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -60.2 2.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.455 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.446 ' OE2' HG12 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -53.5 -26.86 22.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.81 -73.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.422 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.39 -52.69 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 24.71 1.57 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.433 HD13 ' HB2' ' A' ' 39' ' ' ALA . 3.9 mt -73.11 84.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -1.194 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -44.07 -29.79 0.66 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.45 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -150.37 111.51 4.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.451 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 23.1 mmm -48.92 155.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.08 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.475 HG23 ' ND1' ' A' ' 52' ' ' HIS . 5.2 t -106.94 -177.3 3.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.89 . . . . 0.0 110.282 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.56 -35.34 60.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.929 . . . . 0.0 110.226 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -40.61 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.284 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.495 ' CE1' HD22 ' A' ' 89' ' ' LEU . 5.6 m170 -62.43 -55.79 24.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 110.328 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.486 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.5 m95 -61.28 -26.92 68.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -67.09 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.93 . . . . 0.0 110.38 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD13 ' CE2' ' A' ' 81' ' ' PHE . 0.4 OUTLIER -54.36 -43.04 70.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 52' ' ' HIS . 25.0 t -52.98 -57.56 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.154 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -46.16 63.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.13 -43.52 70.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.69 -40.49 95.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -60.54 -28.67 68.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.97 -51.68 63.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -71.19 -26.99 63.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.558 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 65.8 t90 -80.9 -6.3 58.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 65' ' ' THR . 9.5 tt0 -77.4 -50.65 12.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 64' ' ' GLU . 18.7 m -44.71 -39.96 5.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.19 -58.61 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 131.07 43.19 0.19 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.455 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -105.1 113.91 27.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -1.156 . . . . 0.0 110.193 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.8 t -53.77 108.1 1.03 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.198 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 68' ' ' THR . 45.8 Cg_endo -73.06 169.61 21.81 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.9 1.474 . . . . 0.0 110.371 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.87 -162.49 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.003 1.528 . . . . 0.0 110.434 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 72' ' ' ILE . 8.8 tp -125.87 -0.75 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -91.0 -11.49 38.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.44 -30.01 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 110.405 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.92 -29.89 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.448 ' HA ' ' HB2' ' A' ' 81' ' ' PHE . 14.1 t -77.0 -36.2 56.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' N ' ' CG2' ' A' ' 76' ' ' THR . 0.1 OUTLIER -65.87 -29.33 69.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.56 0.04 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.276 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' GLY . 66.2 p -135.38 22.76 3.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' THR . . . 43.58 26.79 0.74 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.513 ' CE2' HD13 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -68.26 -163.94 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -1.135 . . . . 0.0 110.155 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.1 t -154.4 137.42 15.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 110.176 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 15.1 tp -50.42 -34.43 24.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.215 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.55 -35.1 70.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.64 -46.6 89.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 110.41 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 34.9 mt -76.87 -31.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -67.05 -32.18 73.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.289 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -86.68 -39.68 15.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -0.978 . . . . 0.0 110.273 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.495 HD22 ' CE1' ' A' ' 52' ' ' HIS . 19.8 mt -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 110.169 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.445 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 4.2 m-85 -109.11 171.28 4.59 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.6 Cg_endo -74.28 -61.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.091 1.574 . . . . 0.0 110.637 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.42 107.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.15 -0.969 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.24 75.43 0.93 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.506 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.0 Cg_endo -72.33 -16.77 27.78 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.047 1.551 . . . . 0.0 110.431 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -69.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.357 -0.839 . . . . 0.0 110.148 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -77.07 -8.0 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.18 -81.43 0.44 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.1 -32.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -1.078 . . . . 0.0 110.418 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -62.95 1.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -50.96 -51.28 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.131 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -48.76 -57.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -53.76 -34.48 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.09 -63.61 0.42 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 47.48 58.7 17.24 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.27 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.8 149.65 48.41 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.034 1.544 . . . . 0.0 110.463 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -119.44 137.66 25.66 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.247 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.77 94.95 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.024 1.539 . . . . 0.0 110.343 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -120.53 140.61 51.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.428 ' O ' ' SG ' ' A' ' 110' ' ' CYS . . . -147.24 64.89 0.42 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 109' ' ' GLY . 0.5 OUTLIER 178.77 56.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -1.117 . . . . 0.0 110.261 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.216 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 1' ' ' MET . 45.0 Cg_endo -72.8 159.85 47.48 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 110.444 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.445 HG12 ' CE2' ' A' ' 9' ' ' TYR . 6.4 t -118.71 -49.65 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.266 -0.897 . . . . 0.0 110.283 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.41 -156.73 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 6' ' ' PRO . 4.9 p -175.14 162.57 2.31 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 48.6 Cg_endo -74.72 153.67 99.28 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.611 0.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.34 167.26 40.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 5.9 mt-10 -120.58 148.57 43.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -1.194 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 97.2 m-85 -156.37 143.81 19.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -113.47 140.82 47.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 17.6 t -109.44 99.68 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 12.4 t70 55.32 -89.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -122.71 42.42 1.63 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 169.03 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -1.178 . . . . 0.0 110.205 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -127.34 138.15 52.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 110.281 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.0 128.69 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.066 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.473 ' O ' ' CB ' ' A' ' 25' ' ' GLN . 66.7 mt -116.15 102.59 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.428 ' CD2' ' C ' ' A' ' 22' ' ' CYS . 2.8 mt -87.14 132.17 33.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' GLU . 3.2 m-20 -117.44 -170.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.03 148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.576 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.6 t0 66.76 18.32 10.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.438 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 4.3 m 51.05 45.72 27.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 21' ' ' ASP . 1.5 m-85 -86.35 126.56 34.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 110.235 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.435 ' HG3' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -42.88 -36.06 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.242 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.473 ' CB ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 53.58 19.89 1.92 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.156 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.425 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -151.16 59.87 3.57 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.157 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.33 -30.33 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.031 1.543 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.43 73.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 0.0 110.26 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.21 30.15 2.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.453 ' CD2' ' N ' ' A' ' 31' ' ' ASP . 60.4 t90 -82.57 160.62 22.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -167.56 -169.21 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.192 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 18.7 mt-10 -71.32 -58.4 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -33.69 72.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.357 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.05 -57.57 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.99 66.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.0 110.406 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -54.6 41.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.461 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 76.7 t90 -59.19 -28.89 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.189 -0.944 . . . . 0.0 110.432 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -70.98 -41.42 71.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.447 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.74 -26.91 60.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.95 . . . . 0.0 110.591 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -75.9 -40.27 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.571 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -77.15 -33.81 56.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.687 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.3 mp -80.74 -68.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.105 -0.997 . . . . 0.0 110.572 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -79.59 -72.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 110.413 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.84 39.59 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 46' ' ' GLN . 11.3 mt -103.33 107.71 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' ILE . 14.0 mt-30 -43.28 -37.77 2.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -156.64 140.61 16.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.329 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -52.87 100.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 110.133 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -52.62 162.17 0.61 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 110.276 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.53 -27.62 4.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.95 -39.62 55.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.594 ' CE1' ' CD2' ' A' ' 89' ' ' LEU . 5.2 m80 -61.59 -41.03 96.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.527 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 1.4 m95 -74.09 -36.06 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.247 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -58.88 -45.64 89.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.554 HD11 ' CD2' ' A' ' 81' ' ' PHE . 5.9 mp -72.76 -58.27 3.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.41 ' O ' ' HB2' ' A' ' 60' ' ' ARG . 74.9 t -47.14 -30.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -76.45 -51.48 11.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.56 ' CE2' HG13 ' A' ' 75' ' ' VAL . 38.5 t80 -52.47 -48.34 65.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.6 -43.58 76.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 21.8 ttp180 -50.32 -39.8 46.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 110.426 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.16 -55.2 19.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -27.0 66.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.476 ' CD1' ' HB1' ' A' ' 104' ' ' ALA . 59.6 t90 -70.08 -21.62 63.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.284 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 -17.63 59.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.19 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 98.3 m -75.74 -70.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.336 -0.853 . . . . 0.0 110.156 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -125.31 30.63 5.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.402 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 43.9 80.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -178.07 5.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -1.117 . . . . 0.0 110.176 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 t -140.1 92.95 9.4 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.229 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.43 157.88 52.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.079 1.568 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.68 -159.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.045 1.55 . . . . 0.0 110.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.8 tt -125.25 46.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.86 -82.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -16.16 40.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.56 HG13 ' CE2' ' A' ' 58' ' ' TYR . 79.0 t -70.33 -40.85 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.148 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -54.12 -38.84 65.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -69.02 -34.1 74.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.142 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.79 -0.24 37.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.57 -77.55 0.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.348 -0.845 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.89 22.56 3.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.554 ' CD2' HD11 ' A' ' 55' ' ' LEU . 36.0 m-85 -81.64 102.98 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -1.144 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.44 127.89 6.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.297 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -47.84 -36.65 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.166 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.09 -49.74 72.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.034 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -50.83 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.441 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 36.4 mm -50.29 -39.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -37.18 80.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.59 -31.35 72.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.594 ' CD2' ' CE1' ' A' ' 52' ' ' HIS . 12.5 mt -76.72 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -94.07 147.91 34.26 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 92' ' ' SER . 46.6 Cg_endo -73.98 84.13 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.03 1.542 . . . . 0.0 110.407 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 91' ' ' PRO . 38.6 m 43.5 70.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.52 62.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.441 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.0 Cg_endo -73.63 -0.41 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.033 1.543 . . . . 0.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -98.97 -63.35 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.901 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.01 -14.24 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.277 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -77.06 -77.26 0.8 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.54 -37.15 1.56 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.32 -50.84 62.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.374 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.9 tptt -53.41 -48.57 68.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.293 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.24 -27.55 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.65 -19.8 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.39 63.15 1.66 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB1' ' CD1' ' A' ' 63' ' ' TRP . . . -143.85 76.99 15.15 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.207 -1.172 . . . . 0.0 110.161 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.36 141.59 32.14 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.003 1.528 . . . . 0.0 110.387 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 2.4 mttm -44.18 -59.52 3.67 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 110.109 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 106' ' ' LYS . 46.3 Cg_endo -72.74 106.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.046 1.55 . . . . 0.0 110.355 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.75 26.97 10.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.6 5.51 64.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.425 ' O ' HG22 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -82.72 -51.94 7.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -1.199 . . . . 0.0 110.176 179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 110' ' ' CYS . 58.7 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.25 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.732 0.301 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.15 -51.68 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.059 1.557 . . . . 0.0 110.534 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' CG2' ' HG3' ' A' ' 41' ' ' GLU . 57.4 t -119.89 169.52 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.379 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' N ' HG11 ' A' ' 3' ' ' VAL . 1.2 mtmm -109.07 147.31 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.5 m -142.89 159.43 56.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.968 . . . . 0.0 110.369 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.439 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.87 154.43 98.49 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.492 -0.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.06 142.62 7.79 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.05 128.05 45.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.262 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -131.63 161.94 31.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 110.213 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -104.94 142.33 34.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.117 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 53.9 t -127.8 96.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 11' ' ' VAL . 10.3 t70 41.98 85.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 110.311 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.48 65.46 2.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -168.32 161.43 12.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -1.181 . . . . 0.0 110.144 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' C ' HG23 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.32 126.36 42.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.392 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.403 HG23 ' C ' ' A' ' 15' ' ' LYS . 69.7 t -131.32 122.31 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 110.044 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.57 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.412 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 22' ' ' CYS . 16.2 mt -69.8 123.06 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.056 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.446 ' OD2' ' HG3' ' A' ' 25' ' ' GLN . 9.9 m-20 -99.66 -157.92 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.8 mm-40 -45.57 132.31 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 13.3 t70 62.32 30.55 17.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.022 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 74.5 m 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.46 95.28 9.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.4 ptm -54.21 149.98 9.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.446 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 1.7 mt-30 -127.04 40.56 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -126.05 72.47 70.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.028 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.0 -19.47 30.19 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.125 1.592 . . . . 0.0 110.574 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.68 -0.65 55.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -128.25 34.01 4.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.285 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -85.86 149.77 25.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -173.08 1.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -65.64 -39.19 91.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 110.209 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -68.31 -27.17 66.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.0 110.386 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 21.8 t -76.16 -55.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.01 74.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.473 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 3.3 tt0 -70.47 -57.43 4.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 110.419 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -56.77 -31.39 64.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -69.03 -63.27 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.346 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.5 -27.97 28.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -76.05 -34.74 59.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.459 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 1.9 tp10 -74.81 -28.58 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD12 HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -82.45 -76.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -80.23 -76.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.55 46.74 0.02 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.78 102.05 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -1.148 . . . . 0.0 110.148 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -42.52 97.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -136.32 115.48 12.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.9 mmm -56.83 125.22 21.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -72.9 165.45 24.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.204 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.02 -32.19 71.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -44.69 65.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -50.67 -54.46 22.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.194 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.507 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 1.8 m95 -62.5 -30.7 71.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.293 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -64.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD12 ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -51.63 -41.92 61.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.7 t -57.46 -41.59 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.944 . . . . 0.0 110.106 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.28 -56.92 8.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -47.97 -34.47 9.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.14 -49.26 52.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.085 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -52.01 52.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 110.084 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -40.46 72.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.089 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -62.64 -29.88 70.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.141 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.522 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 77.5 t90 -74.74 -31.17 61.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.69 -42.05 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.2 m -58.6 -40.64 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.47 -57.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.912 . . . . 0.0 110.066 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 119.18 83.48 0.85 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -155.6 171.8 19.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -1.164 . . . . 0.0 110.25 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.99 75.07 21.21 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 161.37 43.06 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.992 1.522 . . . . 0.0 110.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.59 -174.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.994 1.523 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 72' ' ' ILE . 3.6 tp -87.43 49.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.418 ' O ' ' OG1' ' A' ' 76' ' ' THR . 0.2 OUTLIER -97.74 -60.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.049 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ttm -73.93 -24.01 59.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.082 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' O ' ' OG1' ' A' ' 79' ' ' THR . 13.6 t -67.07 -37.94 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 72' ' ' ILE . 6.1 p -65.16 -26.76 68.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -28.98 70.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.36 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.35 48.13 1.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.234 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 43.9 m -154.69 -49.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.106 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.36 -15.04 60.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.532 ' CE2' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -54.17 98.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 110.16 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.2 t -70.16 148.59 48.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.233 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.52 -27.77 67.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -48.04 65.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.64 -40.64 79.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.19 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -72.42 -27.83 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 110.113 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 -43.14 75.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.172 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -54.12 10.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.133 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.87 -29.51 68.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.71 96.13 4.8 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 110.141 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.5 Cg_endo -72.87 88.43 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 12.9 t 176.47 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.96 141.55 5.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.48 -10.21 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.991 1.522 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -89.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.853 . . . . 0.0 110.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 21.5 m170 -77.14 -10.89 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.92 . . . . 0.0 110.215 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -79.21 -83.88 0.62 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.86 -34.76 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.291 -1.123 . . . . 0.0 110.341 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 100' ' ' LYS . 8.5 t -70.44 -64.46 0.89 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 26.6 tttm -43.18 -31.61 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.301 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.64 -52.31 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.212 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.14 -27.4 45.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.14 46.53 5.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -120.5 67.42 13.66 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.279 -1.13 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.44 169.42 21.77 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.997 1.525 . . . . 0.0 110.447 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.33 161.98 0.56 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.163 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.78 178.05 6.85 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.03 1.542 . . . . 0.0 110.423 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 p -102.18 135.84 43.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 110.166 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.13 -87.91 2.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 28.6 p -95.98 170.12 9.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 0.0 110.292 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.8 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.214 179.987 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.568 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 46.0 Cg_endo -71.96 81.03 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.027 1.541 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.458 HG22 ' HB3' ' A' ' 41' ' ' GLU . 48.3 t -67.66 116.87 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 110.332 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.64 143.19 58.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.877 . . . . 0.0 110.223 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 18.6 m -138.8 149.42 61.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -76.05 164.71 87.22 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.705 -2.206 . . . . 0.0 110.567 -0.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.48 156.66 25.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.01 154.54 18.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -1.123 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -147.59 147.21 29.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.34 117.56 34.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 39.5 t -112.12 102.88 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 110.401 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.9 m-20 55.24 -101.73 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.443 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.82 51.31 0.82 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 143.55 21.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -1.136 . . . . 0.0 110.102 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.87 123.87 43.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.99 140.55 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.326 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -124.61 100.66 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 110.183 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.3 mt -77.14 121.74 24.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.136 -0.977 . . . . 0.0 110.32 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -141.45 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.7 tt0 -66.09 133.51 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.508 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.4 t70 66.82 34.79 5.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 21' ' ' ASP . 60.5 m 44.05 42.71 5.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.508 ' CD2' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -86.85 144.19 27.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.143 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.76 112.61 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 110.248 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -105.85 31.1 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -152.32 65.86 6.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.54 -14.03 24.91 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.045 1.55 . . . . 0.0 110.399 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.99 -33.82 39.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 9.9 m-20 -103.42 -85.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.129 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.464 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 33.5 t90 58.98 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 110.297 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -163.5 179.43 7.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.69 -55.59 10.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.287 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -36.36 71.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.91 -61.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.97 -45.74 21.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.09 -45.41 87.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.0 t90 -58.13 -51.87 67.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.983 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -54.39 -40.87 68.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.245 -0.909 . . . . 0.0 110.506 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.92 69.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.921 . . . . 0.0 110.564 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.442 ' CD ' ' OE2' ' A' ' 41' ' ' GLU . 1.3 tmm_? -73.66 -45.22 53.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 110.562 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.458 ' HB3' HG22 ' A' ' 3' ' ' VAL . 2.0 mp0 -66.81 -33.9 76.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -68.13 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.348 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.89 -64.48 1.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.4 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.36 117.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -1.19 . . . . 0.0 110.26 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -74.69 -33.16 62.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.74 144.17 43.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.6 mmm -85.95 129.78 34.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.288 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 52' ' ' HIS . 3.5 t -73.69 170.77 14.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.18 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 3.8 mt-10 -67.89 -23.43 65.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.49 -40.06 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.898 . . . . 0.0 110.339 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.465 ' HB2' HG22 ' A' ' 49' ' ' THR . 2.5 m170 -59.84 -59.67 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -58.68 -30.24 67.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.243 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -63.79 -65.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.908 . . . . 0.0 110.215 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.01 -29.03 63.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 52' ' ' HIS . 48.2 t -65.52 -39.82 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.73 -31.5 57.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.5 -49.33 71.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.04 -31.35 71.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.039 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -27.6 63.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.0 -45.81 90.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.298 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.5 -29.91 61.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -66.02 -44.3 85.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -44.13 83.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -64.19 -67.76 0.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.24 -63.34 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.33 44.13 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 p -139.39 -158.63 0.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -1.105 . . . . 0.0 110.187 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 m -139.41 101.87 7.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 110.192 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.87 172.27 16.21 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.107 1.582 . . . . 0.0 110.364 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.52 -164.96 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.066 1.561 . . . . 0.0 110.368 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.448 HD11 ' HG2' ' A' ' 94' ' ' PRO . 1.0 OUTLIER -116.12 44.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.81 -66.79 0.9 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.7 mtp -60.04 -14.77 18.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.53 -58.21 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -28.18 69.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -28.12 69.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -106.68 -65.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.8 p -56.97 -35.09 68.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.7 79.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' HB3' HD12 ' A' ' 86' ' ' ILE . 4.2 m-85 -75.04 122.88 24.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -1.137 . . . . 0.0 110.242 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.453 ' CB ' ' HE2' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -53.67 136.26 39.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.01 -35.45 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.94 -36.03 77.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HE2' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -58.4 -53.1 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 110.174 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 81' ' ' PHE . 79.9 mt -65.9 -38.68 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.18 -37.57 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 109.946 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -48.2 25.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.6 mt -65.27 -11.72 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -173.08 104.89 0.32 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.31 -25.6 18.36 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.056 1.556 . . . . 0.0 110.381 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.7 m -75.92 0.52 18.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.27 147.78 5.81 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 98' ' ' ALA . 46.9 Cg_endo -73.09 -10.39 24.41 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.035 1.545 . . . . 0.0 110.346 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.22 -84.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.348 -0.845 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -76.72 -18.08 58.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.53 -67.1 1.73 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 94' ' ' PRO . . . -44.59 -38.09 4.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.124 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.88 -44.32 70.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -41.65 70.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.84 -37.24 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.5 70.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.72 50.19 1.85 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.55 81.96 0.3 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.251 -1.147 . . . . 0.0 110.252 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.41 -89.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.049 1.552 . . . . 0.0 110.482 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' HD3' ' HD2' ' A' ' 107' ' ' PRO . 0.7 OUTLIER -112.89 164.49 15.31 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 0.0 110.201 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.423 ' HD2' ' HD3' ' A' ' 106' ' ' LYS . 46.5 Cg_endo -73.09 -168.92 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.987 1.519 . . . . 0.0 110.452 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t -135.09 7.33 3.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.332 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.5 130.36 46.16 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 118.46 7.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.229 -179.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.5 121.61 7.25 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.925 1.487 . . . . 0.0 110.393 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.96 107.85 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 110.214 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -63.19 104.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.8 m -94.5 142.76 25.23 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.441 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.32 144.94 82.14 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.38 -0.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.94 165.11 30.6 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 144.59 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -1.111 . . . . 0.0 110.146 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -146.23 171.41 14.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.2 mt-30 -133.45 122.57 23.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.206 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 3.9 t -99.83 109.37 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.041 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 46.6 t0 56.33 -88.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.244 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.64 48.01 0.99 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 2.8 mttm -149.14 151.69 34.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -1.15 . . . . 0.0 110.257 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -112.53 111.28 22.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.56 140.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.7 107.87 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' CD2' ' C ' ' A' ' 22' ' ' CYS . 13.2 mt -83.65 124.59 30.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 3.1 t70 -66.39 -170.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -38.23 69.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.33 39.79 1.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.489 ' C ' ' CD2' ' A' ' 18' ' ' LEU . 67.4 m 44.85 39.63 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.55 151.15 22.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 132.82 34.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.31 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -108.26 -8.66 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -139.66 60.49 16.28 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.443 ' CG ' ' HB3' ' A' ' 105' ' ' PRO . 45.7 Cg_endo -73.15 -1.73 11.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.03 1.542 . . . . 0.0 110.464 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -31.28 62.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -106.09 36.54 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.244 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -61.19 144.04 54.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.181 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.14 175.59 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.49 -39.24 90.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.239 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 16.4 mttt -67.02 -31.79 72.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.49 -58.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.98 -46.75 68.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.256 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.26 -33.12 74.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 33.7 t90 -61.72 -48.44 80.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.45 -38.88 85.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.411 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.69 81.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.396 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.456 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 2.0 ttt-85 -71.63 -51.65 22.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.336 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.12 -26.84 65.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.427 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.5 mp -87.56 -72.08 0.54 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -42.7 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.384 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 118.12 21.11 4.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.433 ' N ' ' HA ' ' A' ' 40' ' ' ARG . 19.6 mt -79.63 105.6 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -1.108 . . . . 0.0 110.188 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -46.94 72.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' MET . 11.5 tptp -118.71 109.45 16.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' LYS . 4.6 tpt -42.8 150.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.271 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' ' HB2' ' A' ' 52' ' ' HIS . 30.7 p -84.75 174.18 10.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.26 -40.87 64.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 110.302 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' CB ' HD11 ' A' ' 89' ' ' LEU . 67.2 mm-40 -68.61 -33.7 74.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -55.42 -49.67 71.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.491 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.2 m95 -71.23 -26.93 63.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -62.54 -58.44 7.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD22 HG12 ' A' ' 86' ' ' ILE . 5.1 tp -68.42 -50.48 52.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.369 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 52' ' ' HIS . 95.5 t -52.44 -33.61 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -51.78 13.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.236 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.545 ' CZ ' HG21 ' A' ' 79' ' ' THR . 52.4 t80 -53.62 -31.53 47.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -44.78 63.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.164 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -49.13 -35.62 16.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.17 -51.75 68.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -41.88 98.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.428 ' O ' ' CD2' ' A' ' 63' ' ' TRP . 15.8 t90 -68.83 -12.51 61.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.221 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -14.27 35.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.244 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 96.2 m -97.82 -46.37 5.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.913 . . . . 0.0 110.145 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -124.94 -8.86 7.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 63' ' ' TRP . . . 65.83 45.44 88.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.19 147.57 40.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -117.32 103.13 51.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.28 152.69 50.34 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.971 1.511 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.87 -90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 0.0 110.346 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.469 ' CG1' ' CD1' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -169.42 57.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -135.56 -68.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.028 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.7 ttm -67.84 -14.36 62.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.043 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' O ' ' OG1' ' A' ' 79' ' ' THR . 93.8 t -70.56 -42.68 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.882 . . . . 0.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 81' ' ' PHE . 0.4 OUTLIER -68.09 -27.11 66.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.088 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -72.14 -33.5 67.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.826 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.23 -63.64 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.545 HG21 ' CZ ' ' A' ' 58' ' ' TYR . 46.9 p -60.6 -42.34 96.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.13 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.52 59.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.413 ' O ' HG22 ' A' ' 76' ' ' THR . 0.1 OUTLIER -51.66 149.72 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -1.19 . . . . 0.0 110.179 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -71.96 143.11 49.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.469 ' CD1' ' CG1' ' A' ' 72' ' ' ILE . 29.0 tp -73.32 -29.28 62.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -31.42 69.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.264 -0.898 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.473 ' HE2' ' NE2' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -65.3 -62.13 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.465 HG12 HD22 ' A' ' 55' ' ' LEU . 2.5 mp -51.26 -45.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.355 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 92' ' ' SER . 1.5 t80 -60.53 -33.73 73.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.473 ' NE2' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.71 -24.86 53.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.488 HD21 ' CG ' ' A' ' 52' ' ' HIS . 9.4 mt -76.13 -50.7 13.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.81 162.5 22.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 92' ' ' SER . 48.0 Cg_endo -74.92 76.7 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.115 1.587 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.486 ' HA ' ' CE1' ' A' ' 87' ' ' TYR . 0.8 OUTLIER 41.61 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.14 70.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.401 ' CB ' HD12 ' A' ' 72' ' ' ILE . 46.7 Cg_endo -72.99 -21.27 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.003 1.528 . . . . 0.0 110.432 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.54 -81.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.226 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -66.34 -16.09 63.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.76 -70.84 1.2 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.35 -42.34 61.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -1.161 . . . . 0.0 110.165 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.51 -48.41 81.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.22 -37.21 69.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.101 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.438 HG13 HG11 ' A' ' 56' ' ' VAL . 50.6 t -72.19 -31.96 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.13 -50.94 64.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.865 . . . . 0.0 110.213 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.03 43.41 1.78 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.08 116.78 66.67 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.224 -1.162 . . . . 0.0 110.079 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.443 ' HB3' ' CG ' ' A' ' 27' ' ' PRO . 48.2 Cg_endo -73.1 -94.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.864 1.455 . . . . 0.0 110.456 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' PRO . 13.2 mmtp 40.32 65.32 4.05 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.184 -0.947 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.53 -38.44 3.38 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.028 1.541 . . . . 0.0 110.572 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 m -152.9 -80.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.81 99.72 0.23 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -158.32 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -1.147 . . . . 0.0 110.255 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.126 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 120.742 0.306 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.29 135.04 21.91 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.003 1.528 . . . . 0.0 110.543 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 71.1 t -80.08 87.16 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.108 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 109.58 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.436 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 26.0 p -102.18 157.36 33.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HB3' ' HA ' ' A' ' 20' ' ' GLU . 47.7 Cg_endo -75.48 147.28 88.14 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.504 -0.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.03 174.86 46.88 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.72 144.38 44.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 0.0 110.148 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.09 165.94 26.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -116.26 137.94 51.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 77.7 t -133.84 118.64 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t0 46.34 52.33 10.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.304 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.98 39.61 97.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.0 tttt -131.02 166.92 19.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -1.172 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 103.34 9.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.8 t -99.03 130.95 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.139 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.73 115.96 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.6 mt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.185 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.433 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.3 t0 -59.55 -172.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.456 ' HA ' ' HB3' ' A' ' 6' ' ' PRO . 3.6 mt-10 -64.25 -23.21 67.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.827 . . . . 0.0 110.298 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -108.26 35.17 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.261 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.4 m 52.42 42.96 31.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.263 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -111.49 111.08 21.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 110.263 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -45.12 144.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.256 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.36 13.46 15.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.193 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -145.79 59.71 5.91 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.141 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.78 -8.14 21.9 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 0.0 110.517 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -27.4 65.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' TRP . 5.9 m-20 -92.82 -74.36 0.52 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 29' ' ' ASP . 68.9 t90 56.92 162.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.86 176.19 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.29 -51.22 39.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -32.96 74.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.73 -55.79 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.542 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . . . -53.79 -47.3 70.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.53 -26.88 66.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -68.73 -54.49 15.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.291 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -36.9 84.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.62 -37.26 86.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.465 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.09 -28.67 54.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.372 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 7.3 mm-40 -76.95 -27.6 54.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.96 . . . . 0.0 110.378 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.53 -21.43 17.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.283 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.406 ' HB3' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -127.29 -36.68 2.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.933 . . . . 0.0 110.324 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 96.96 21.93 19.32 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.407 HG21 ' HA ' ' A' ' 48' ' ' MET . 34.8 mt -59.03 97.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -1.161 . . . . 0.0 110.23 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.11 -43.77 51.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 109.984 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -136.32 115.09 12.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.449 ' HE2' ' HB3' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -42.55 137.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.208 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -81.07 139.38 35.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 -24.8 7.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 110.229 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -75.98 -45.55 34.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 48' ' ' MET . 22.6 m170 -51.8 -55.57 19.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.542 ' CH2' ' HB2' ' A' ' 35' ' ' ALA . 16.7 m95 -55.87 -29.24 59.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -52.9 48.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -37.12 85.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 52' ' ' HIS . 11.9 t -64.63 -38.19 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -54.29 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.424 ' CE1' HG11 ' A' ' 75' ' ' VAL . 17.2 t80 -51.84 -41.11 61.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.225 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -34.87 77.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.234 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -60.44 -30.14 69.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.93 -45.94 72.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.276 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -37.87 89.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 67' ' ' GLY . 48.9 t90 -64.03 -48.15 77.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.233 -0.917 . . . . 0.0 110.193 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.03 -12.74 60.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.7 m -91.23 -22.33 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.97 -43.79 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' TRP . . . 103.07 43.03 1.97 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.8 t -154.3 158.89 40.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 110.25 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.0 116.6 66.11 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 45.9 Cg_endo -72.71 174.28 12.03 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.832 1.438 . . . . 0.0 110.425 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 45.5 Cg_endo -72.1 -159.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.947 1.499 . . . . 0.0 110.46 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.9 tp -118.02 -1.4 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.375 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -90.19 -44.67 9.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -23.74 63.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.424 HG11 ' CE1' ' A' ' 58' ' ' TYR . 97.5 t -71.48 -41.93 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 110.317 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 80' ' ' GLY . 6.8 m -62.24 -45.4 93.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -45.34 -47.67 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.372 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.66 -32.35 70.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 p -103.84 -74.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 76' ' ' THR . . . 128.85 -12.23 6.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.8 m-30 -43.24 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -1.164 . . . . 0.0 110.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 80' ' ' GLY . 34.3 t -42.82 131.74 4.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.847 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tp -51.61 -37.65 51.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -40.55 72.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -64.11 -54.96 25.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 110.1 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.5 mt -51.64 -32.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 110.083 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -74.99 -35.86 62.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.105 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.22 62.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.28 -19.91 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.43 109.05 9.49 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -39.69 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.982 1.517 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -44.86 66.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 110.257 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.86 153.53 9.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -74.06 -162.41 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.96 1.505 . . . . 0.0 110.508 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 57.02 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 110.511 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' PRO . 36.3 m170 -66.6 -44.37 82.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.411 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -62.65 -66.93 2.31 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.67 -56.75 2.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -1.148 . . . . 0.0 110.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -50.44 -62.25 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -41.99 -49.61 4.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.216 -0.928 . . . . 0.0 110.526 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.26 -50.21 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.44 -19.23 65.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 70.03 1.36 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.0 161.0 27.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.239 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.73 131.42 17.16 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.065 1.56 . . . . 0.0 110.425 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -82.33 140.47 45.33 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.196 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' O ' ' CB ' ' A' ' 108' ' ' THR . 46.3 Cg_endo -72.94 -161.14 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.942 1.496 . . . . 0.0 110.424 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.406 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 0.5 OUTLIER 62.62 98.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.157 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.29 170.98 39.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.38 70.6 0.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.168 . . . . 0.0 110.241 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.163 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.756 0.312 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.64 130.18 14.48 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.056 1.556 . . . . 0.0 110.515 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 4' ' ' LYS . 4.9 p -91.52 154.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.118 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' N ' HG23 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -137.07 171.0 15.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.277 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.446 ' SG ' HD13 ' A' ' 18' ' ' LEU . 14.5 m -121.41 155.93 58.53 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.6 Cg_endo -76.19 158.01 97.87 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.545 -2.273 . . . . 0.0 110.403 -0.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.84 151.27 15.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.84 143.56 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -1.123 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -150.78 158.39 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.62 132.11 54.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 110.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.569 ' CG2' ' CD2' ' A' ' 37' ' ' TRP . 98.9 t -116.56 104.98 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 24.8 t0 55.14 -90.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -132.5 52.56 0.82 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.522 ' CD ' ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -153.15 152.51 31.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -1.144 . . . . 0.0 110.224 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.32 133.34 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 72.9 t -132.41 111.19 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 0.0 110.158 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 17' ' ' ILE . 11.5 tt -107.55 96.66 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 76.4 mt -61.65 122.94 16.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -152.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -37.4 87.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 22' ' ' CYS . 2.5 t0 -108.37 51.38 0.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 93.0 m 43.32 27.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.12 138.76 45.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 3.1 mtp -79.79 110.99 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.214 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.15 18.85 11.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.502 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 16.2 p-10 -135.12 52.34 7.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.5 Cg_endo -72.94 -22.64 19.53 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.999 1.526 . . . . 0.0 110.427 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -60.08 -18.0 43.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.44 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -127.2 36.92 4.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.897 . . . . 0.0 110.13 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.8 t90 -73.44 139.46 45.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.188 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.91 174.7 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 33' ' ' LYS . 25.4 pt-20 -66.42 -42.11 88.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 1.9 ttmm -67.85 -47.51 68.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.522 ' CG2' ' CD ' ' A' ' 14' ' ' LYS . 42.8 t -56.0 -54.41 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.8 -36.52 70.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.033 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.74 -44.73 93.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.569 ' CD2' ' CG2' ' A' ' 11' ' ' VAL . 38.0 t90 -64.64 -38.43 90.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.184 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -58.16 -51.68 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.29 -27.24 66.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -64.43 -49.03 73.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' OE1' ' HB ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.17 -28.19 53.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.413 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.9 mm? -84.34 -3.72 58.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.364 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.3 -46.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 122.51 12.72 4.99 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.437 ' O ' HG21 ' A' ' 45' ' ' ILE . 9.6 mt -76.16 79.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.14 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -50.21 60.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.263 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 131.31 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 71.4 mmm -74.38 121.01 20.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.43 -157.17 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -92.86 -27.86 16.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.188 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -48.38 35.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.613 ' CE1' ' CD2' ' A' ' 89' ' ' LEU . 23.2 m80 -51.25 -46.5 62.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.267 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.474 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.9 m95 -72.15 -31.27 65.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -64.01 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.19 -43.43 98.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.911 . . . . 0.0 110.265 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 52' ' ' HIS . 37.4 t -60.32 -27.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.257 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 tttt -76.64 -53.89 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -53.1 60.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.53 -51.31 60.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.92 -41.82 46.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 70' ' ' PRO . 4.9 t80 -65.74 -35.11 79.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.903 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.559 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 36.0 t90 -66.42 -22.24 66.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.76 -10.64 59.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -81.31 -49.13 11.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -152.0 -38.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.98 88.48 0.95 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.77 -178.5 7.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 0.0 110.238 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.46 84.87 15.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.496 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 45.0 Cg_endo -72.44 125.92 11.13 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.395 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.57 91.54 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.897 1.472 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 8.4 mm 48.56 -132.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 109.917 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 8.3 mttt 57.81 -97.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.052 -1.03 . . . . 0.0 110.36 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.55 -23.91 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.03 -1.044 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 72' ' ' ILE . 22.2 t -69.6 -47.18 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 110.301 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 73' ' ' LYS . 1.1 p -63.97 -34.86 78.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -43.99 -32.94 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 0.0 110.149 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.92 48.02 2.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.4 m -153.75 -70.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.54 87.35 1.92 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.16 104.55 2.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -1.131 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.4 143.3 40.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.6 tp -60.56 -26.87 67.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -41.48 74.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.45 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -65.84 -58.04 6.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.396 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.487 ' CG2' ' HG3' ' A' ' 94' ' ' PRO . 54.6 mt -46.29 -49.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 110.224 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -59.37 -41.39 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.17 -24.75 67.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.613 ' CD2' ' CE1' ' A' ' 52' ' ' HIS . 4.5 mt -79.48 -62.33 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 110.259 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.456 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 11.3 m-85 -85.08 170.81 12.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.123 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 42.5 Cg_endo -74.54 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.117 1.588 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.87 56.52 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.044 -1.035 . . . . 0.0 110.033 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.52 143.07 1.4 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HG3' ' CG2' ' A' ' 86' ' ' ILE . 45.5 Cg_endo -72.96 -90.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.954 1.502 . . . . 0.0 110.447 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . 53.91 -93.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 97' ' ' GLY . 8.7 m170 -69.63 -57.39 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 96' ' ' HIS . . . -43.65 -59.1 3.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.443 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -47.48 -48.65 26.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.125 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 99.7 m -53.78 -62.54 1.59 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 99' ' ' CYS . 15.0 mttp -44.16 -45.87 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 54.4 t -53.76 -55.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.344 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.15 -22.74 66.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 104' ' ' ALA . . . 114.07 -46.65 1.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' GLY . . . 42.15 72.35 1.14 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.354 -1.086 . . . . 0.0 110.276 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.559 ' HG2' ' CZ2' ' A' ' 63' ' ' TRP . 45.7 Cg_endo -72.65 -168.88 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.974 1.512 . . . . 0.0 110.487 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -112.29 155.29 43.81 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.89 174.47 11.85 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.978 1.515 . . . . 0.0 110.432 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.1 m -128.37 109.49 11.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.64 -105.34 0.46 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.8 t -176.28 -61.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -1.149 . . . . 0.0 110.272 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.189 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.729 0.3 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.27 -60.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.071 1.564 . . . . 0.0 110.467 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 41' ' ' GLU . 5.7 t -138.09 4.3 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.405 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 63.33 114.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.397 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 79.2 m -137.14 151.71 72.32 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 50.6 Cg_endo -78.62 162.91 87.29 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.316 -0.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.11 45.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 16.5 mt-10 -106.07 170.65 7.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.035 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 1.2 m-85 -169.52 171.21 7.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 110.344 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -132.6 137.97 47.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' A' ' 37' ' ' TRP . 75.8 t -117.71 106.88 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 51.18 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.96 60.06 0.68 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -161.44 164.26 29.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -1.132 . . . . 0.0 110.246 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.98 147.85 26.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 110.208 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.7 t -140.28 135.81 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 17' ' ' ILE . 4.5 mp -127.33 100.24 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 43.0 mt -73.36 131.78 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 5.1 t0 -83.85 -146.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 110.385 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.4 -48.54 69.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.343 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -98.67 39.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.95 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 55.7 m 56.56 31.99 20.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.377 -0.827 . . . . 0.0 110.026 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.94 155.09 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -98.61 113.66 25.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.26 16.03 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.98 64.74 71.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.63 -15.85 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.969 1.51 . . . . 0.0 110.357 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -15.96 62.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -116.53 12.89 15.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.324 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.8 t90 -63.77 147.87 50.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -0.898 . . . . 0.0 110.215 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.27 -154.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.11 -33.3 61.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -72.19 -39.87 68.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.274 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 41.2 t -72.9 -36.93 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.425 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.46 42.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.381 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.76 -46.62 89.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 110.427 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.569 ' CE2' HG21 ' A' ' 11' ' ' VAL . 77.6 t90 -60.25 -54.63 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.509 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.94 -41.11 58.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.598 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.06 85.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.562 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -35.58 74.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.477 ' HB3' ' CG2' ' A' ' 3' ' ' VAL . 2.9 mm-40 -77.1 -30.05 55.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 110.383 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -75.98 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.919 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.3 -61.26 1.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.07 42.52 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 75.5 mt -78.88 99.86 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -1.117 . . . . 0.0 110.214 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.59 -28.97 67.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -144.07 118.46 9.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.145 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.427 ' HG3' ' NE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -48.76 142.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.268 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.443 ' OG1' ' ND1' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -93.19 147.4 22.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.882 . . . . 0.0 110.301 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 16.2 pt-20 -57.53 -36.85 72.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mm-40 -66.87 -34.62 78.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.443 ' ND1' ' OG1' ' A' ' 49' ' ' THR . 19.0 m80 -69.09 -53.34 20.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 110.204 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.427 ' NE1' ' HG3' ' A' ' 48' ' ' MET . 5.0 m95 -58.28 -27.96 64.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -56.81 5.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -39.42 65.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.056 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -69.46 -32.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.13 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -49.78 69.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -65.9 -37.25 85.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.86 75.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 110.314 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 38.1 ttm-85 -60.08 -28.93 68.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 110.33 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 1.8 tt0 -56.77 -60.84 2.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -69.55 -26.57 64.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 110.198 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 60' ' ' ARG . 32.5 t90 -65.94 -20.16 66.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 110.338 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.96 -0.46 47.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -108.34 -60.52 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.933 . . . . 0.0 110.306 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' GLY . 4.8 m-85 -107.17 7.65 29.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' PHE . . . 45.91 69.83 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.23 147.31 25.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.7 t -116.19 83.71 13.04 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.62 169.85 21.36 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.953 1.502 . . . . 0.0 110.355 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.02 -160.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.012 1.533 . . . . 0.0 110.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 94' ' ' PRO . 25.1 mm -102.75 40.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.78 -58.82 1.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.256 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mmt -61.76 -28.85 69.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' OG1' ' A' ' 79' ' ' THR . 6.8 t -71.43 -38.07 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -27.03 68.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.87 -29.92 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.68 46.63 2.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.255 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 24.5 m -148.29 -50.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.243 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.68 1.16 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.35 143.93 51.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -1.171 . . . . 0.0 110.154 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 130.59 54.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.9 -34.24 62.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 19.8 tt0 -58.01 -55.23 37.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' CE ' HD12 ' A' ' 89' ' ' LEU . 1.3 tptm -51.97 -52.16 52.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.3 mt -54.94 -31.04 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.086 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -67.88 -51.16 51.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.222 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.57 68.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' CE ' ' A' ' 85' ' ' LYS . 13.8 mt -73.32 -66.73 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.244 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 102.29 51.17 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.07 94.76 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.918 1.483 . . . . 0.0 110.442 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 177.7 -37.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.21 131.85 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 95' ' ' ALA . 46.9 Cg_endo -73.37 -162.89 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.937 1.493 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 94' ' ' PRO . . . 56.08 -90.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.3 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 57.1 m-70 -59.43 -33.85 71.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -69.62 -67.15 2.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.62 -52.3 4.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -46.91 81.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.79 -36.73 48.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 t -74.43 -36.24 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.61 -21.69 61.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.94 72.33 0.95 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -135.21 103.62 10.53 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.192 -1.181 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.462 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 45.7 Cg_endo -72.79 113.93 3.89 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.009 1.531 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.43 105.96 0.57 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.92 . . . . 0.0 110.146 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 105' ' ' PRO . 46.8 Cg_endo -72.66 151.95 52.83 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.08 1.568 . . . . 0.0 110.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.9 m -109.53 49.02 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.332 -0.855 . . . . 0.0 110.212 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.3 116.88 2.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.31 155.55 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.158 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.177 179.95 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.85 98.35 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.083 1.57 . . . . 0.0 110.408 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.9 m -69.94 155.57 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.227 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -128.92 157.78 40.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 21.7 m -116.63 146.41 37.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 48.9 Cg_endo -75.5 174.21 53.98 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.357 -0.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 17' ' ' ILE . . . -176.34 173.03 46.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.532 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -150.82 138.35 19.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -1.115 . . . . 0.0 110.041 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 51.6 m-85 -145.22 171.31 14.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -104.47 111.56 24.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 91.6 t -118.86 107.79 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.263 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 11.0 t0 66.06 64.73 0.53 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 44.7 32.12 2.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.3 mttp -129.03 165.0 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.145 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -122.14 113.43 19.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 93.1 t -111.08 145.72 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.101 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.5 tt -137.53 109.61 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 110.223 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 56.4 mt -78.25 134.64 37.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 4.6 t0 -67.11 -167.97 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -17.92 65.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.26 38.14 3.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 53.1 m 47.68 39.09 9.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.1 155.55 16.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.455 ' HE1' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -90.24 90.68 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.418 ' NE2' HG12 ' A' ' 17' ' ' ILE . 9.5 pt20 -83.62 -4.21 58.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.455 ' O ' ' HE1' ' A' ' 24' ' ' MET . 1.8 t30 -121.39 62.74 12.6 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.86 -16.27 26.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.015 1.534 . . . . 0.0 110.396 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.436 ' OE2' ' HA ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -64.22 -25.06 67.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.69 0.37 30.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.533 ' CZ2' ' HB3' ' A' ' 35' ' ' ALA . 42.7 t90 -46.38 148.19 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -168.45 2.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.564 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 4.9 tt0 -74.93 -55.35 5.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -30.87 71.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 110.203 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.01 -50.04 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.533 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . . . -59.89 -50.83 72.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.62 -57.73 11.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 110.281 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 59.1 t90 -47.78 -36.85 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.64 -57.1 8.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.266 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.38 -28.49 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.306 -0.871 . . . . 0.0 110.189 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -62.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.892 . . . . 0.0 110.219 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -48.97 -37.0 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.318 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -80.78 -75.33 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.315 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.4 -76.8 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.68 38.65 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mt -79.73 104.4 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 110.034 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -78.8 -19.09 52.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.334 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -151.61 96.46 2.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.459 ' HE1' ' HB3' ' A' ' 52' ' ' HIS . 70.8 mmm -52.06 103.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.039 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.567 ' CG2' ' ND1' ' A' ' 52' ' ' HIS . 2.3 t -55.99 160.34 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.87 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -52.61 -36.63 56.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -0.936 . . . . 0.0 110.281 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -35.29 79.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.311 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.567 ' ND1' ' CG2' ' A' ' 49' ' ' THR . 22.4 m170 -65.16 -60.53 2.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.943 . . . . 0.0 110.541 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.564 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 5.4 m95 -57.02 -34.22 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.733 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -62.91 -60.1 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.163 -0.961 . . . . 0.0 110.464 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD12 ' CD2' ' A' ' 81' ' ' PHE . 1.9 tp -52.3 -39.16 60.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.6 -30.88 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.185 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -49.8 64.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.11 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.495 ' CD2' HG22 ' A' ' 79' ' ' THR . 0.7 OUTLIER -66.86 -34.35 77.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -66.13 -49.46 67.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -43.75 -46.18 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.95 -32.1 63.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.218 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.453 ' CG ' ' O ' ' A' ' 63' ' ' TRP . 78.7 t90 -81.63 8.75 9.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -113.36 -17.59 12.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.69 -46.02 3.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.082 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.79 -50.91 9.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.08 25.12 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 t -167.03 168.06 14.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -1.153 . . . . 0.0 110.109 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 23.5 p -114.01 104.72 54.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 172.02 16.41 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.015 1.534 . . . . 0.0 110.433 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.87 -169.83 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.6 mm -97.54 63.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -107.26 -63.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 mtm -74.77 -19.36 60.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.74 -29.99 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.231 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.436 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 84.0 m -59.32 -36.72 76.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.04 -28.19 54.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 -76.12 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.495 HG22 ' CD2' ' A' ' 58' ' ' TYR . 66.5 p -67.3 -51.16 56.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.279 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 106.75 9.07 31.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.475 ' CD2' HD12 ' A' ' 55' ' ' LEU . 3.0 m-85 -66.96 108.21 2.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -1.156 . . . . 0.0 110.142 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.07 139.38 47.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.419 HD22 ' CE1' ' A' ' 87' ' ' TYR . 1.4 tp -60.16 -27.86 67.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -49.32 72.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.154 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -51.52 -55.25 20.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 110.12 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.408 HG12 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mt -54.82 -39.19 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.17 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.419 ' CE1' HD22 ' A' ' 83' ' ' LEU . 3.1 m-85 -60.26 -36.84 78.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 110.218 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -75.31 -27.37 59.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 0.0 110.194 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.9 mt -92.48 -5.36 52.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.299 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.43 99.61 2.09 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.199 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.25 -17.53 24.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.996 1.524 . . . . 0.0 110.459 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.9 m -67.47 -29.89 69.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.85 147.71 8.48 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.12 -1.79 11.08 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.051 1.553 . . . . 0.0 110.48 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.453 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . -79.65 -86.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 110.239 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -73.85 -5.42 40.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.363 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -65.23 -94.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.69 -27.26 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 56.0 m -65.63 -79.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -43.04 -40.25 3.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 110.289 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.91 -48.72 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 110.247 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -65.39 -49.64 68.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.458 ' O ' ' HD3' ' A' ' 105' ' ' PRO . . . 133.61 54.38 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.27 111.51 28.46 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.228 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 103' ' ' GLY . 45.7 Cg_endo -73.62 -58.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.033 1.543 . . . . 0.0 110.527 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -116.47 107.51 46.85 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.53 -171.88 0.94 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.057 1.556 . . . . 0.0 110.323 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.88 69.45 1.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 110.226 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.42 -74.81 0.07 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.422 ' O ' HG22 ' A' ' 111' ' ' VAL . 1.6 t -82.63 -171.0 3.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -1.115 . . . . 0.0 110.131 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 110' ' ' CYS . 41.5 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.544 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 16.7 mtt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 120.705 0.288 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 45.9 Cg_endo -72.36 -166.03 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.974 1.513 . . . . 0.0 110.421 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 m -104.22 173.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.965 . . . . 0.0 110.255 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.33 107.92 3.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 26.3 p -88.13 158.73 49.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 110.098 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.45 145.05 82.3 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.667 -2.222 . . . . 0.0 110.476 -0.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.08 174.93 46.91 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 125.96 54.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 110.123 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -129.99 156.18 44.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -113.29 134.78 54.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 99.0 t -116.3 94.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.483 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' GLY . 1.1 m-20 48.29 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.542 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.0 59.52 3.31 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 1.3 mttt -166.6 153.2 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -1.138 . . . . 0.0 110.109 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -116.73 145.84 43.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 110.279 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.412 HG23 ' HE3' ' A' ' 24' ' ' MET . 38.7 t -141.99 138.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 17' ' ' ILE . 50.8 mt -117.36 96.85 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.367 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 5' ' ' CYS . 16.4 mt -75.02 121.91 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.43 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -69.84 -171.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -62.47 -16.89 57.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.29 36.72 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.61 29.07 3.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.231 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -84.57 141.14 30.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.215 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.412 ' HE3' HG23 ' A' ' 16' ' ' VAL . 2.5 ttt -89.46 115.06 26.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -92.7 22.89 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -133.2 67.06 76.62 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.321 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.07 -13.7 26.09 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.027 1.54 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -78.17 -10.81 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.192 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' TRP . 21.6 t70 -110.93 -5.12 14.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.455 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 12.0 t90 -44.0 143.15 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.188 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 18.6 m-20 -159.93 -163.43 1.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.469 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -74.52 -58.76 3.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -65.41 -31.03 71.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.188 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.5 t -66.99 -53.02 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.08 -53.83 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 2.7 tt0 -52.33 -36.23 52.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -70.08 -38.13 75.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.245 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -51.54 66.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.495 ' CB ' HD12 ' A' ' 45' ' ' ILE . . . -68.65 -26.53 65.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.468 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.7 -44.61 73.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.503 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.405 ' OE1' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -77.31 -36.93 53.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.144 -0.972 . . . . 0.0 110.797 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -58.56 2.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.677 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -16.63 55.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.472 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 85.48 14.64 67.88 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.495 HD12 ' CB ' ' A' ' 39' ' ' ALA . 8.0 mt -67.23 101.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -70.48 -13.87 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.235 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -168.32 120.21 0.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.481 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 31.5 mmm -67.74 131.68 46.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.29 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.0 p -78.68 -167.16 1.02 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.99 -52.61 7.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' OE1' ' HA ' ' A' ' 51' ' ' GLU . 9.5 mm-40 -56.61 -30.63 63.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.124 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.431 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -57.54 -61.05 2.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.193 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 3.7 m95 -57.21 -33.7 67.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 4.2 tmtm? -58.2 -57.14 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.198 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tp -56.9 -50.88 71.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.198 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -54.14 -29.04 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 54' ' ' LYS . 9.5 mmtt -73.44 -53.79 9.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 110.261 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 62' ' ' TYR . 3.1 t80 -51.3 -41.28 60.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 110.342 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -49.53 77.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.306 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.98 -60.34 4.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -27.01 4.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.29 -0.881 . . . . 0.0 110.361 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.8 -37.66 58.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.425 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.465 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 41.9 t90 -65.05 -22.22 66.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.314 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.19 -59.06 5.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.211 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -75.89 -58.52 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.247 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -65.3 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 110.209 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.23 18.94 3.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.8 t -141.22 174.22 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.148 . . . . 0.0 110.135 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 t -124.69 84.69 57.51 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.443 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.2 Cg_endo -73.17 173.73 13.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.981 1.516 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.7 Cg_endo -73.09 160.44 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.002 1.528 . . . . 0.0 110.313 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.1 tt -79.03 -7.06 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.145 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -55.1 -62.81 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.422 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -63.74 -27.08 68.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.071 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.84 -34.22 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -54.8 -27.65 43.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -65.04 -39.4 93.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -70.05 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.113 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 p -46.8 -39.09 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.91 8.7 84.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -55.4 171.82 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 15.8 m -113.94 147.23 38.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.326 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HA ' HD11 ' A' ' 86' ' ' ILE . 13.0 tp -60.44 -27.9 67.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 110.268 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -63.67 -59.95 3.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.272 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 83' ' ' LEU . 3.5 mt -47.01 -33.04 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.377 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.0 -36.32 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.923 . . . . 0.0 110.378 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.63 -24.36 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.37 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.22 -49.99 6.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -98.43 167.22 11.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.217 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.68 -89.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.998 1.525 . . . . 0.0 110.505 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.7 t -104.68 85.77 2.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 61.3 139.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.436 ' HG3' HG21 ' A' ' 86' ' ' ILE . 46.4 Cg_endo -73.05 -90.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.061 1.558 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 97' ' ' GLY . . . 62.28 -132.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 8.2 p-80 -42.28 -25.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.0 110.582 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.515 ' N ' ' CD2' ' A' ' 96' ' ' HIS . . . -66.63 -74.56 0.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.17 -48.1 4.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -1.107 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.4 t -57.01 -44.09 82.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.468 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -60.64 -58.22 9.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.373 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.0 t -46.76 -41.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.29 59.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.52 52.23 3.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -88.83 120.82 70.13 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.465 ' HG2' ' CZ2' ' A' ' 63' ' ' TRP . 46.0 Cg_endo -72.33 140.29 33.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.875 1.46 . . . . 0.0 110.486 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.31 147.88 45.78 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.17 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.49 -59.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.992 1.522 . . . . 0.0 110.576 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.1 p -69.88 173.6 6.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' O ' ' SG ' ' A' ' 110' ' ' CYS . . . -171.99 117.31 0.67 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 109' ' ' GLY . 70.9 m -149.92 88.99 1.57 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -1.167 . . . . 0.0 110.212 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.459 ' O ' HG12 ' A' ' 111' ' ' VAL . 21.5 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.152 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.8 0.333 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 1' ' ' MET . 46.1 Cg_endo -73.23 178.0 7.14 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.965 1.508 . . . . 0.0 110.377 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 t -69.1 125.91 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 110.131 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 133.68 55.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.157 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 62.3 m -103.09 150.38 37.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.4 Cg_endo -76.36 165.6 84.88 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.612 -2.245 . . . . 0.0 110.412 -0.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 154.91 20.26 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.33 152.56 27.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -1.144 . . . . 0.0 110.168 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -149.15 157.06 43.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.404 ' C ' ' CG2' ' A' ' 11' ' ' VAL . 1.1 tp60 -110.55 145.01 38.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.243 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 10' ' ' GLN . 22.7 t -148.79 110.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.023 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t0 58.51 -143.85 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.951 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.42 50.44 2.99 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.0 146.36 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.243 . . . . 0.0 110.319 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.98 143.18 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.098 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 17' ' ' ILE . 85.0 t -127.79 162.31 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.351 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.472 ' N ' HG13 ' A' ' 16' ' ' VAL . 8.7 tt -148.96 164.37 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' N ' HG12 ' A' ' 17' ' ' ILE . 16.6 mt -136.43 115.78 12.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.908 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -57.74 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.47 -20.71 66.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.32 38.85 2.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.5 m 48.46 42.57 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -96.52 145.13 25.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.44 ' SD ' HD13 ' A' ' 38' ' ' LEU . 2.1 mtp -82.81 105.43 13.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.33 19.42 13.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -129.51 71.81 82.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.69 -30.5 11.7 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.139 1.6 . . . . 0.0 110.418 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.09 -16.9 64.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.83 35.68 3.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -90.85 153.59 20.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.84 -168.08 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.463 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 2.5 mt-10 -72.12 -57.06 4.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.198 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.77 -29.99 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.34 -57.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . . . -55.44 -38.74 69.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.309 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -52.23 63.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ2' ' OE2' ' A' ' 41' ' ' GLU . 57.9 t90 -56.87 -33.13 66.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.44 HD13 ' SD ' ' A' ' 24' ' ' MET . 4.8 tt -69.57 -42.9 73.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.55 -31.43 72.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -74.63 -44.07 52.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.444 ' OE2' ' CZ2' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -62.97 -36.93 85.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.865 . . . . 0.0 110.145 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 42' ' ' LEU . 6.3 mp -83.46 -67.75 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 45' ' ' ILE . 4.3 tt0 -80.44 -66.38 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.61 -13.9 2.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.401 ' CD1' ' OE1' ' A' ' 43' ' ' GLU . 33.7 mt -44.19 134.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -106.77 3.85 26.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.212 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -161.03 91.29 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -44.95 123.85 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.3 t -73.83 158.42 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.257 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -34.47 55.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.24 -43.34 92.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.497 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -58.25 -56.66 19.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.224 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CZ2' ' SD ' ' A' ' 48' ' ' MET . 6.6 m95 -59.29 -27.31 65.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -67.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.61 -32.44 58.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.152 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 101' ' ' VAL . 29.0 t -68.72 -33.53 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.47 -42.43 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 110.136 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -44.42 94.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.15 -50.99 71.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 110.236 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -49.17 -50.05 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.381 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.78 -38.97 61.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.58 74.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -52.86 -46.52 67.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.16 -35.48 80.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.334 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.2 m -64.66 -33.99 77.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -142.11 -69.18 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.27 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.62 79.11 0.38 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 t -162.7 159.88 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -1.185 . . . . 0.0 110.18 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.6 t -112.6 82.52 4.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.42 160.25 44.99 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.15 -89.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.095 1.576 . . . . 0.0 110.454 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -172.14 42.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -64.83 1.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.15 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -40.22 95.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' OG1' ' A' ' 79' ' ' THR . 20.8 t -52.63 -37.17 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m -66.19 -33.58 76.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -74.17 -33.1 63.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.59 -35.39 62.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -107.44 -78.44 0.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.22 38.42 0.23 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -91.99 128.9 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 84' ' ' GLU . 72.4 m -77.83 134.68 37.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.898 . . . . 0.0 110.238 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 82' ' ' SER . 1.3 tp -42.8 -26.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -60.73 -53.3 59.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.34 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -47.92 79.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.64 -30.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -72.35 -48.08 44.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -38.5 80.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.497 HD22 ' CE1' ' A' ' 52' ' ' HIS . 8.1 mt -68.36 -65.58 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.084 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.479 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.1 m-85 -82.25 173.7 7.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.3 Cg_endo -73.65 -88.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.984 1.518 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -155.86 80.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.56 82.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.07 -17.63 24.66 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.932 1.49 . . . . 0.0 110.432 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.77 -88.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -76.81 -2.26 32.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.18 -70.41 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.81 -36.53 37.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.188 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.2 m -70.26 -52.74 20.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -33.25 36.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 110.173 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.407 HG13 HG22 ' A' ' 56' ' ' VAL . 25.1 t -73.62 -45.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.092 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -21.63 66.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 105' ' ' PRO . . . 82.74 53.9 3.41 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.55 107.85 29.74 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.205 -1.174 . . . . 0.0 110.135 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 103' ' ' GLY . 47.5 Cg_endo -74.21 0.81 7.99 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.019 1.536 . . . . 0.0 110.622 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.84 88.66 50.41 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.45 -46.81 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.042 1.548 . . . . 0.0 110.436 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.5 m -56.48 103.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.178 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.91 48.99 0.89 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -169.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.31 -1.112 . . . . 0.0 110.173 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.251 179.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.788 0.328 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.67 -178.29 3.33 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.989 1.521 . . . . 0.0 110.417 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.414 HG12 ' CE2' ' A' ' 9' ' ' TYR . 7.0 m -141.42 161.17 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.45 148.0 52.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.411 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.4 m -102.84 141.11 21.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.36 159.21 97.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 -2.153 . . . . 0.0 110.314 -0.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.77 136.34 3.01 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.444 ' OE2' ' CG1' ' A' ' 17' ' ' ILE . 12.4 tt0 -101.24 142.53 32.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -1.104 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.414 ' CE2' HG12 ' A' ' 3' ' ' VAL . 25.5 m-85 -150.68 148.49 28.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -101.77 143.95 31.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.065 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 43.7 t -120.37 94.87 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 110.448 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.41 63.68 2.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.52 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.53 14.48 79.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 11' ' ' VAL . 16.1 mmtt -102.82 169.96 8.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -1.205 . . . . 0.0 110.162 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.53 108.57 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.495 HG11 ' CB ' ' A' ' 24' ' ' MET . 55.2 t -116.73 145.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.26 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.444 ' CG1' ' OE2' ' A' ' 8' ' ' GLU . 3.6 mt -134.51 97.47 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.79 110.15 6.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.273 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -68.46 -141.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.77 -2.71 58.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.872 . . . . 0.0 110.145 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.42 38.01 4.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.3 m 47.9 49.14 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -119.69 116.19 25.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.495 ' CB ' HG11 ' A' ' 16' ' ' VAL . 1.8 ptp -51.83 -21.75 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.63 29.81 5.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.62 75.97 36.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 110.175 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.84 -21.46 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.007 1.53 . . . . 0.0 110.408 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -38.34 73.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.74 -2.77 57.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -61.93 125.6 24.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -0.969 . . . . 0.0 110.277 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.3 -162.9 1.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.464 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -72.14 -62.43 1.44 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.965 . . . . 0.0 110.284 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -48.29 -49.28 34.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.31 -52.1 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.236 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -50.77 -36.19 35.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 110.301 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 46.2 mt-10 -72.85 -36.61 67.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -60.49 -48.13 83.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.397 -0.815 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 42' ' ' LEU . 8.1 mt -67.36 -51.21 54.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 110.32 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.75 -29.17 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -77.07 -60.82 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.95 -35.35 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.499 HD13 ' N ' ' A' ' 42' ' ' LEU . 6.0 mp -80.16 -66.53 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -89.81 -47.62 7.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 119.47 13.69 6.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 63.2 mt -54.8 92.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -1.158 . . . . 0.0 110.173 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 44' ' ' GLY . 3.5 mp0 -57.48 -35.79 70.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.216 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 146.1 46.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.496 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -85.07 134.74 34.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.325 -0.859 . . . . 0.0 110.208 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -93.36 -179.13 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.42 -21.7 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -77.05 -36.25 56.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -71.09 -54.8 9.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.504 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 3.0 m95 -57.67 -33.22 68.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -67.33 -59.09 3.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.142 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.56 -35.77 31.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.89 -40.37 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -63.04 -35.44 80.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.2 -36.85 61.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.247 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.2 -29.43 68.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -59.64 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -44.85 -45.94 10.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.247 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -44.79 96.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.283 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 21.4 t90 -67.88 -14.5 63.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.329 -0.857 . . . . 0.0 110.287 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.17 -49.83 8.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.302 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.95 -49.09 16.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.65 -72.46 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.16 89.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.04 174.86 14.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -1.177 . . . . 0.0 110.014 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -153.58 57.52 1.95 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.409 ' CD ' ' N ' ' A' ' 69' ' ' CYS . 46.3 Cg_endo -73.02 171.79 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.975 1.513 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.68 171.7 16.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.098 1.578 . . . . 0.0 110.498 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 3.5 tp -68.08 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -178.54 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 109.98 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -27.18 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.048 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 t -77.04 -27.52 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -54.95 -38.82 68.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -36.97 16.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.463 ' HA ' ' OE1' ' A' ' 78' ' ' GLU . 13.5 mm-40 -87.98 -32.64 18.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.28 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -97.2 -74.91 0.56 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.01 36.88 1.09 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -92.64 88.31 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.188 -1.183 . . . . 0.0 110.228 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.4 m -49.29 136.07 16.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.44 HD13 ' CG2' ' A' ' 72' ' ' ILE . 1.2 mp -44.16 -31.92 1.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.282 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.22 -53.8 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.249 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -48.55 81.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 79.2 mt -53.37 -29.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.912 . . . . 0.0 110.151 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -77.02 -45.22 27.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.12 -33.56 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 110.267 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.91 -63.89 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.26 106.48 45.54 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.86 -38.13 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.973 1.512 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -49.3 -28.81 5.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.271 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.43 151.59 18.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 45.7 Cg_endo -73.41 -170.33 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.017 1.535 . . . . 0.0 110.445 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . 66.85 -84.34 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.339 -0.851 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -74.24 -34.05 63.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.03 -1.044 . . . . 0.0 110.379 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.2 -58.64 5.01 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.93 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -1.161 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 5.4 t -61.18 -51.06 70.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -48.82 -50.09 36.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 52.1 t -64.15 -35.65 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.423 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.64 69.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.71 36.24 29.79 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.12 126.9 55.49 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.281 -1.129 . . . . 0.0 110.177 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.78 131.32 15.69 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.888 1.468 . . . . 0.0 110.371 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -113.69 111.71 48.64 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.82 86.66 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.953 1.502 . . . . 0.0 110.391 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 108' ' ' THR . 9.8 t -55.65 117.63 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.885 . . . . 0.0 110.242 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.53 95.89 0.23 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.68 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -1.165 . . . . 0.0 110.185 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.281 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.731 0.301 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 166.8 28.79 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.038 1.546 . . . . 0.0 110.478 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 18' ' ' LEU . 48.3 t -107.24 -26.9 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 mttt 53.7 96.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.446 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 61.5 m -97.11 157.83 34.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.8 Cg_endo -75.5 170.8 70.85 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.387 -0.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -177.02 150.66 10.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -106.43 137.26 44.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -1.095 . . . . 0.0 110.301 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -134.66 170.64 15.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 140.65 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.272 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 39.5 t -122.98 99.13 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.0 110.036 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.468 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 10.0 t0 55.89 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -130.91 62.83 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.32 157.17 17.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -114.88 133.91 55.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.93 124.9 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.14 97.98 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' CD1' HG11 ' A' ' 3' ' ' VAL . 20.5 mt -67.48 108.54 2.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 18' ' ' LEU . 34.3 t0 -49.62 -179.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.819 . . . . 0.0 110.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -62.58 -15.81 53.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.915 . . . . 0.0 110.223 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 1.5 m-20 -117.07 41.99 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.0 m 48.2 49.91 16.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -109.65 161.45 15.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.428 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -89.73 108.85 19.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.233 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.82 4.57 28.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.505 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 4.3 m-20 -131.62 51.97 8.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.1 Cg_endo -72.56 -13.52 27.44 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.032 1.543 . . . . 0.0 110.474 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -37.65 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' TRP . 0.9 OUTLIER -95.78 -70.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 110.213 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.577 ' CD2' ' N ' ' A' ' 31' ' ' ASP . 37.2 t90 55.78 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.155 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.577 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -172.86 -172.93 0.91 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.87 -41.33 68.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -70.06 -32.43 70.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.9 t -70.04 -51.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.62 44.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.07 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -39.84 70.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.46 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 83.3 t90 -64.57 -31.79 73.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.877 . . . . 0.0 110.184 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.79 -44.18 67.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.352 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.36 67.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -76.76 -36.04 57.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 37' ' ' TRP . 3.2 mm-40 -77.18 -27.02 53.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.554 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.2 -62.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.551 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.04 -78.12 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.99 51.48 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.88 107.8 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -1.105 . . . . 0.0 110.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -42.73 -43.36 3.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.311 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 143.11 28.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.29 125.33 22.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.0 p -70.76 160.84 31.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.226 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.08 -27.34 32.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.6 -41.4 62.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 110.394 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -61.83 -48.81 78.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.438 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.504 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.0 m95 -65.82 -31.94 73.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.41 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 1.4 tttt -64.57 -66.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.94 -49.98 67.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.477 ' CG1' HG13 ' A' ' 101' ' ' VAL . 34.3 t -55.33 -31.41 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.33 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -70.29 -46.64 63.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.211 -0.93 . . . . 0.0 110.192 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -60.2 -34.72 74.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.378 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -43.3 86.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.0 110.453 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -55.81 27.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.436 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.06 -27.38 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.947 . . . . 0.0 110.347 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.576 ' CG ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -76.8 -42.32 41.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.569 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 19.2 t90 -58.18 -20.31 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.304 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.54 -42.14 30.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.31 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -60.26 3.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -116.99 -33.78 4.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 63' ' ' TRP . . . 93.01 71.59 1.17 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.3 t -166.09 -175.15 3.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.211 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.0 m -102.3 106.01 46.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.576 ' HG3' ' CG ' ' A' ' 62' ' ' TYR . 45.8 Cg_endo -72.94 144.92 39.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.052 1.553 . . . . 0.0 110.459 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 -178.28 3.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.091 1.574 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.8 62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -130.89 -50.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 74' ' ' MET . 0.9 OUTLIER -67.23 -37.75 84.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.282 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.461 ' O ' ' OG1' ' A' ' 79' ' ' THR . 57.1 t -65.59 -55.76 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.0 m -52.87 -26.84 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.17 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.92 -41.46 24.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.98 32.7 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.351 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 46.2 m -123.77 -22.33 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.13 78.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CG ' HG21 ' A' ' 79' ' ' THR . 3.3 m-85 -96.55 172.68 7.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.144 . . . . 0.0 110.121 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.6 148.92 34.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.65 -27.59 64.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 110.222 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.56 -52.2 64.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -33.21 68.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 94' ' ' PRO . 50.4 mt -73.67 -29.01 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 110.073 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -35.76 66.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -40.8 50.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -39.44 79.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 110.242 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 116.14 32.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.067 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.76 -7.82 20.61 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.579 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 92' ' ' SER . 1.3 t -104.11 21.3 16.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 59.06 161.04 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -73.09 -16.68 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.977 1.514 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 94' ' ' PRO . . . -45.57 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -77.2 -2.91 36.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 110.209 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.55 -91.96 0.16 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -43.1 -34.31 1.04 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.396 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.16 -62.37 1.66 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.02 -38.01 48.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.285 -0.884 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.477 HG13 ' CG1' ' A' ' 56' ' ' VAL . 52.6 t -58.97 -59.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.938 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.64 -7.07 45.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 110.305 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.79 79.45 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.11 90.63 13.62 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 110.201 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.44 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 46.1 Cg_endo -72.22 174.41 11.49 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.942 1.496 . . . . 0.0 110.443 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -141.83 107.82 5.91 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.357 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.61 118.83 5.77 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.954 1.502 . . . . 0.0 110.385 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.2 t -123.21 11.55 9.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 115.47 -162.69 12.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.4 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 30.1 p -98.49 17.91 17.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 110.202 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 110' ' ' CYS . 7.9 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.215 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.73 0.3 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.12 -33.0 7.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.061 1.558 . . . . 0.0 110.459 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.41 ' CG1' HD13 ' A' ' 18' ' ' LEU . 56.6 t -97.87 101.23 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.162 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -96.14 109.32 21.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.512 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 31.6 p -108.94 152.09 42.22 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.219 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 18' ' ' LEU . 49.1 Cg_endo -75.57 161.59 94.13 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.644 -2.232 . . . . 0.0 110.548 -0.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.02 47.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -104.66 121.69 44.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.163 . . . . 0.0 110.364 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -137.09 155.44 49.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -117.31 145.62 43.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.26 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 42.4 t -125.66 125.83 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.86 -91.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -137.98 59.44 0.61 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.16 170.34 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 110.225 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.02 136.21 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.459 HG13 ' HG2' ' A' ' 24' ' ' MET . 56.0 t -137.67 144.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mt -112.29 105.85 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 6' ' ' PRO . 11.8 mt -62.64 129.61 41.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.429 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.9 t0 -84.5 -160.43 0.47 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.45 -13.05 60.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -107.59 26.27 10.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.512 ' HA ' ' CB ' ' A' ' 5' ' ' CYS . 2.7 m 50.7 23.73 1.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 24' ' ' MET . 68.3 t80 -109.44 155.86 20.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.543 ' O ' ' CD2' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -59.79 138.07 57.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.212 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.82 -20.38 31.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -124.8 71.7 60.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.058 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.29 -9.43 25.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.031 1.542 . . . . 0.0 110.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.63 -35.79 6.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.104 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' TRP . 53.5 m-20 -93.48 -74.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 110.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.468 ' O ' ' CE3' ' A' ' 30' ' ' TRP . 82.9 t90 52.15 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.285 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.54 -170.61 1.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.99 -57.44 4.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.342 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -54.83 -27.37 41.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.372 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.64 -48.77 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.404 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . . . -60.11 -48.23 82.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -42.93 97.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -0.908 . . . . 0.0 110.428 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.551 ' CZ3' HG22 ' A' ' 11' ' ' VAL . 39.3 t90 -57.25 -47.66 80.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.311 -0.868 . . . . 0.0 110.506 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 13.1 mt -62.52 -43.24 99.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.963 . . . . 0.0 110.493 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.78 -26.99 67.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 0.0 110.439 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.433 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.2 -43.77 32.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.0 110.732 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.46 -27.82 60.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.97 . . . . 0.0 110.682 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -80.61 -47.5 14.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.97 . . . . 0.0 110.395 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.31 -48.37 4.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.258 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 121.13 12.15 5.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.13 106.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -1.132 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.1 -46.53 8.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -154.64 121.41 5.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.488 ' SD ' ' CG ' ' A' ' 52' ' ' HIS . 31.1 mmm -44.44 133.05 5.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.499 HG21 ' N ' ' A' ' 50' ' ' GLU . 5.9 t -74.46 -155.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 110.12 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' N ' HG21 ' A' ' 49' ' ' THR . 15.6 tt0 -87.63 -48.57 7.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -59.86 -26.67 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -63.57 -55.92 20.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.86 . . . . 0.0 110.441 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.5 m95 -61.6 -50.09 73.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -52.12 -45.94 65.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 0.0 110.309 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.559 ' CD1' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -62.19 -60.75 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.8 t -49.2 -27.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 110.259 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -71.86 -48.65 44.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -37.25 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -43.48 73.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.284 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -53.98 -46.59 71.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.267 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.32 -39.78 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.13 -36.54 55.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.454 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -76.36 2.64 12.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.432 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -116.53 -4.92 11.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -107.09 -44.09 4.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.158 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -114.01 -43.15 3.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.45 54.07 0.85 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.463 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 18.6 m -146.28 146.44 30.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -1.137 . . . . 0.0 110.114 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.2 t -104.85 95.65 9.35 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 68' ' ' THR . 47.4 Cg_endo -73.47 163.43 37.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.974 1.512 . . . . 0.0 110.484 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.65 -89.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.96 1.505 . . . . 0.0 110.457 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.506 ' O ' ' CG1' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -178.46 62.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.243 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -119.93 -54.17 2.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 110.18 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -25.42 63.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 t -72.31 -42.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.6 m -67.55 -29.73 69.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -38.76 5.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -99.34 -76.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 78' ' ' GLU . 54.7 p -42.86 -45.25 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.229 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.08 34.69 46.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -58.63 116.64 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.254 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.56 129.0 38.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.196 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -48.82 -37.1 18.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.7 -45.36 63.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 110.137 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -40.4 92.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.18 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.418 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 24.7 mm -66.26 -27.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -45.3 32.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.949 . . . . 0.0 110.317 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -53.21 46.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.34 -45.27 93.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 110.181 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.07 84.83 59.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 92' ' ' SER . 46.2 Cg_endo -73.47 86.7 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.971 1.511 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER 172.7 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.87 127.65 1.72 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.418 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.9 Cg_endo -72.91 -18.0 24.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.755 1.397 . . . . 0.0 110.435 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.08 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 2.8 m170 -75.61 -5.37 45.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 110.273 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 101' ' ' VAL . . . -78.23 -84.26 0.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 102' ' ' ALA . . . -42.41 -29.18 0.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -1.11 . . . . 0.0 110.53 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.45 ' SG ' ' HB1' ' A' ' 104' ' ' ALA . 2.4 t -73.98 -49.28 25.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.409 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 17.4 ttmm -61.18 -35.19 76.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.407 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 97' ' ' GLY . 9.1 t -73.56 -42.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 98' ' ' ALA . . . -68.37 -21.6 64.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.319 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.44 67.22 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.45 ' HB1' ' SG ' ' A' ' 99' ' ' CYS . . . -138.41 136.57 19.24 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.273 -1.133 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.64 143.48 37.97 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.943 1.496 . . . . 0.0 110.436 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -48.09 140.33 9.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.76 161.36 44.05 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.075 1.566 . . . . 0.0 110.501 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.0 m -102.77 118.48 36.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.9 172.64 17.48 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 16.8 p -137.35 173.96 11.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -1.154 . . . . 0.0 110.278 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 111' ' ' VAL . 19.3 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.211 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.813 0.339 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.93 -168.25 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.067 1.562 . . . . 0.0 110.341 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 7.8 m -141.38 170.43 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 110.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -124.31 109.55 13.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.445 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 71.8 m -84.43 150.46 57.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.091 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.3 Cg_endo -76.13 162.28 92.41 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.486 -0.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.42 157.75 24.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.14 131.64 45.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -1.216 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.441 ' CZ ' ' HB ' ' A' ' 3' ' ' VAL . 66.3 m-85 -136.57 144.56 44.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.122 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 7.2 tt0 -112.65 126.95 55.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 60.5 t -108.65 94.54 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 42.4 t0 60.52 71.47 0.57 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.639 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.9 14.36 23.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 12.7 mmtt -108.83 152.19 25.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.071 -1.252 . . . . 0.0 110.103 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -106.29 136.39 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.41 117.53 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.3 mp -100.4 115.92 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.542 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.7 mt -95.09 116.71 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 109.989 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -94.97 -163.38 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -42.42 126.03 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER 64.13 39.29 7.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m 48.12 50.16 16.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.14 113.81 20.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' MET . . . . . 0.431 ' CE ' HD12 ' A' ' 38' ' ' LEU . 4.4 tpt -50.8 145.8 6.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.166 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -143.2 18.14 1.91 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -125.2 59.97 26.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.27 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 -8.95 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.951 1.501 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.3 -36.03 52.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.45 -77.83 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t90 61.16 107.76 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -124.52 -178.15 4.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -45.86 77.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.266 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.71 -35.57 78.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.1 t -65.92 -54.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -56.58 -40.89 76.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.878 . . . . 0.0 110.322 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -62.62 1.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.349 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -51.04 -30.59 15.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.39 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.431 HD12 ' CE ' ' A' ' 24' ' ' MET . 2.2 mt -65.28 -52.26 55.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.369 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' HB3' HD11 ' A' ' 45' ' ' ILE . . . -62.08 -30.32 70.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.353 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -29.32 61.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.99 -37.87 54.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 110.34 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.2 tp -80.27 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.325 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -95.38 -84.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.161 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.63 39.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 39' ' ' ALA . 3.8 mt -79.7 88.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -45.06 -30.21 1.03 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 48' ' ' MET . 9.2 mttp -150.23 113.1 4.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 47' ' ' LYS . 52.6 mmm -42.75 120.61 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.4 p -66.34 150.96 48.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.0 110.23 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.69 52.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.217 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -40.29 85.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 110.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.555 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -56.71 -56.19 24.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.167 -0.958 . . . . 0.0 109.964 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.1 m95 -59.76 -28.58 67.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 110.003 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -66.48 -41.7 88.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.441 ' O ' ' CD1' ' A' ' 59' ' ' LEU . 3.2 tp -68.55 -38.09 80.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.933 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.31 -39.67 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 53' ' ' TRP . 3.2 mtpp -64.91 -51.57 61.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.069 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.17 -41.14 78.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 110.114 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 110.056 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.2 mmm-85 -57.04 -36.28 70.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.24 -36.35 81.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.137 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.23 -30.74 66.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.449 ' HA ' ' OG1' ' A' ' 68' ' ' THR . 19.8 t90 -58.01 -27.31 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -95.65 29.67 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.213 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.04 -52.88 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -130.22 -78.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.21 25.12 0.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 63' ' ' TRP . 0.2 OUTLIER 58.46 -167.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 110.257 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.1 m 54.34 61.46 9.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 163.47 38.42 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.079 1.568 . . . . 0.0 110.48 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.3 -179.28 4.26 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.066 1.561 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 72' ' ' ILE . 11.3 tp -88.45 28.43 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -126.96 -31.62 2.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.199 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -21.98 44.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' O ' ' HB ' ' A' ' 79' ' ' THR . 31.5 t -67.31 -53.79 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t -72.2 -27.16 62.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.29 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.95 -37.57 1.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 110.196 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -142.05 53.86 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 75' ' ' VAL . 50.3 m -161.74 -37.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.158 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.3 33.92 18.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.64 124.43 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -1.126 . . . . 0.0 110.119 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.38 149.25 21.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.258 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -50.91 -27.04 6.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.97 -46.02 89.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.505 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 3.2 mp -63.67 -28.67 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -37.84 54.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.269 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.96 -26.26 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.555 HD22 ' CE1' ' A' ' 52' ' ' HIS . 14.8 mt -83.67 -57.03 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -91.59 169.05 11.97 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.53 -55.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.097 1.578 . . . . 0.0 110.466 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.76 104.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.69 77.2 0.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.7 Cg_endo -72.69 -10.85 25.56 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.022 1.538 . . . . 0.0 110.39 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.29 -77.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -74.96 -7.55 53.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.297 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.4 ' N ' ' CD2' ' A' ' 96' ' ' HIS . . . -76.29 -77.17 0.77 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.83 -35.09 4.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.174 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.5 m -68.1 -58.23 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 110.27 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -50.21 -26.96 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.04 -56.71 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . . . -61.4 -12.41 14.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.233 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.75 80.13 1.15 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -177.47 76.88 0.24 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.244 -1.151 . . . . 0.0 110.159 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.88 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.961 1.506 . . . . 0.0 110.475 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -164.7 70.57 1.5 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 0.0 110.264 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.34 163.69 37.15 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.111 1.585 . . . . 0.0 110.467 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.1 161.52 39.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.23 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.99 106.51 0.56 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.88 46.27 1.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.159 . . . . 0.0 110.271 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.195 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.797 0.332 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.8 158.81 49.66 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.025 1.54 . . . . 0.0 110.453 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -93.4 116.0 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.21 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 111.35 0.91 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.247 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.446 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 99.1 m -105.24 148.33 36.06 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.98 177.89 37.38 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.346 -0.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.89 146.75 8.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.8 tt0 -120.11 127.62 52.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -1.099 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 29.2 m-85 -142.09 170.48 15.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.244 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -125.01 154.61 41.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 110.162 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 12' ' ' ASP . 44.3 t -131.37 101.62 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER 42.61 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.271 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.58 62.19 3.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.403 ' HA ' ' HE3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -164.19 170.45 16.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -135.28 145.06 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 78.4 t -148.05 113.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.154 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.427 HG23 ' NE2' ' A' ' 25' ' ' GLN . 51.3 mt -99.35 145.15 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.0 110.272 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 22' ' ' CYS . 9.4 mt -123.82 108.83 12.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.72 -173.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 51.0 tt0 -66.79 -15.37 63.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 0.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.57 34.27 3.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.242 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.443 ' HA ' HD22 ' A' ' 18' ' ' LEU . 83.9 m 48.16 49.08 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.78 147.63 34.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 110.211 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.2 ttt -74.7 115.99 14.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.287 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' NE2' HG23 ' A' ' 17' ' ' ILE . 2.2 tt0 -88.77 28.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -168.25 69.22 0.81 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.323 -0.861 . . . . 0.0 110.198 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.474 ' CG ' ' HB3' ' A' ' 105' ' ' PRO . 46.3 Cg_endo -72.71 -7.0 20.08 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.052 1.554 . . . . 0.0 110.488 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -78.0 -21.67 50.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -103.16 39.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 110.239 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.51 ' NE1' ' O ' ' A' ' 102' ' ' ALA . 83.8 t90 -71.79 137.14 47.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.129 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -144.84 -178.49 6.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.143 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.79 -62.29 1.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -54.49 -26.88 34.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -73.56 -56.76 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.55 -50.74 62.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.0 110.449 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.07 -46.87 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 59.3 t90 -51.62 -47.12 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.86 -37.64 88.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.347 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.4 81.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 46' ' ' GLN . 2.0 tmt_? -76.98 -37.17 55.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 110.376 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.82 -32.98 74.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.322 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mt -87.3 -72.08 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.113 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.34 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLN . . . 150.4 -19.05 1.04 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -47.07 96.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -1.158 . . . . 0.0 110.243 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 4.4 tm0? -89.29 -6.16 56.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -140.68 96.13 2.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.271 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.438 ' HE2' ' CD2' ' A' ' 52' ' ' HIS . 66.6 mmm -66.38 126.57 29.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 110.086 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.418 HG21 ' HB2' ' A' ' 52' ' ' HIS . 4.8 t -78.59 172.57 13.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -59.37 -35.3 73.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.246 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.45 -29.3 70.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.495 ' CE1' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -69.96 -65.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.895 . . . . 0.0 110.247 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.457 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.7 m95 -49.62 -30.83 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tmtm? -67.97 -57.41 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.193 -0.942 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.83 -49.41 62.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.02 -31.78 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 110.242 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -62.41 -49.49 75.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 110.218 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 58' ' ' TYR . 5.7 t80 -63.49 -45.73 89.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -53.11 -41.05 64.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -40.71 71.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.271 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -58.36 -43.96 88.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.253 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.445 ' CZ ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -66.03 -39.37 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.162 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.437 ' CZ2' ' HD2' ' A' ' 105' ' ' PRO . 29.0 t90 -79.17 -11.61 59.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.174 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -95.89 -25.17 16.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.29 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.6 m -54.43 -30.62 53.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.0 -54.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.9 73.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.7 m -155.56 -179.8 8.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 110.198 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.1 t -157.15 81.59 3.26 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 0.0 110.319 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.445 ' HG3' ' CZ ' ' A' ' 62' ' ' TYR . 47.1 Cg_endo -73.26 171.47 17.58 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.989 1.52 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.435 ' O ' HG21 ' A' ' 75' ' ' VAL . 46.3 Cg_endo -73.25 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.382 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.415 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.9 tt -116.4 14.43 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -74.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.6 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 71' ' ' PRO . 91.5 t -77.13 -34.22 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.276 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 77' ' ' LYS . 17.0 m -68.2 -32.29 72.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.166 -0.959 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 76' ' ' THR . 30.7 tttt -44.01 -27.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.295 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -107.71 -61.22 1.6 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.258 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -52.98 22.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.16 13.73 80.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.7 108.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -1.194 . . . . 0.0 110.191 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.85 126.36 10.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.2 -30.33 11.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -50.47 73.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.07 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -58.54 -50.37 74.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.005 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.46 HG22 ' HD3' ' A' ' 94' ' ' PRO . 54.7 mt -58.92 -26.99 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -39.7 64.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 110.117 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.08 -35.77 78.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 80.7 mt -74.18 -59.27 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.89 118.67 17.71 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.101 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.1 Cg_endo -72.56 -177.81 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.421 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 30.0 m 55.64 19.61 3.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 110.145 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.57 149.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' HIS . 46.6 Cg_endo -73.06 -90.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.952 1.501 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 94' ' ' PRO . . . 43.33 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 110.337 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 94' ' ' PRO . 11.2 m170 -73.52 -56.2 5.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -44.12 -56.92 5.09 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.65 -44.58 4.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -1.108 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -65.23 -54.5 28.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.195 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -42.83 -38.36 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 110.138 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -41.67 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.51 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -53.31 -45.4 68.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.268 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.7 51.25 0.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.23 117.96 69.83 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.234 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HB3' ' CG ' ' A' ' 27' ' ' PRO . 46.4 Cg_endo -72.73 -46.4 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.989 1.52 . . . . 0.0 110.436 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.9 120.39 41.89 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.53 98.08 1.01 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.902 1.474 . . . . 0.0 110.424 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.3 m -55.76 97.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.08 -47.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.0 63.97 0.24 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -1.1 . . . . 0.0 110.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.174 179.952 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.242 0.544 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -65.15 87.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 94.3 m -96.32 148.46 34.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -75.99 150.45 93.92 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.45 -0.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -161.87 157.66 29.46 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 21.0 pt-20 -110.64 160.81 16.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 75.9 m-85 -154.6 169.78 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.235 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.37 137.95 53.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.079 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' ASP . 10.9 t -141.35 121.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.461 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 41.38 74.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.33 -0.856 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.46 62.85 2.33 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -157.69 159.93 37.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.088 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -121.9 117.11 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 t -113.46 120.36 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -101.86 141.03 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.534 HD22 ' C ' ' A' ' 22' ' ' CYS . 6.9 mt -122.38 120.3 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.38 -169.71 2.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.4 tt0 -50.75 147.52 4.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER 64.32 20.91 12.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.534 ' C ' HD22 ' A' ' 18' ' ' LEU . 76.9 m 51.88 54.69 10.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.96 139.68 32.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.404 ' SD ' ' HA2' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -68.31 115.4 7.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 110.185 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -116.9 34.38 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -157.71 68.67 4.01 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.21 -0.62 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.968 1.51 . . . . 0.0 110.439 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.86 -25.86 40.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.12 26.9 9.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 110.334 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -75.64 141.3 42.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -155.29 -167.41 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.219 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.54 -33.65 66.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.195 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 24.0 mmtt -71.52 -37.62 71.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.18 -51.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.53 81.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -67.2 -26.97 66.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CE2' ' OE1' ' A' ' 41' ' ' GLU . 49.9 t90 -66.93 -60.79 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.35 -39.0 75.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.81 71.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 3.6 ttm180 -76.86 -34.72 57.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 110.128 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' OE1' ' CE2' ' A' ' 37' ' ' TRP . 4.0 mt-10 -77.29 -26.64 52.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.01 -66.07 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.681 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.76 -31.9 40.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 101.96 -4.8 52.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.84 120.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -1.156 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -89.56 -26.42 20.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.09 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.53 103.55 5.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 52' ' ' HIS . 15.5 mmm -48.13 119.02 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -71.58 -169.15 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -84.75 -20.76 30.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 3.7 mp0 -77.0 -45.05 28.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.435 ' O ' HG23 ' A' ' 56' ' ' VAL . 24.8 m170 -54.76 -52.7 61.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 5.3 m95 -67.41 -27.77 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.269 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -61.63 -65.8 0.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.15 -0.969 . . . . 0.0 109.966 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.84 -43.36 94.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.884 . . . . 0.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 52' ' ' HIS . 35.1 t -56.45 -29.37 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.863 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 14.4 mttt -75.29 -48.96 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.134 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.565 ' CE1' HG13 ' A' ' 75' ' ' VAL . 30.0 t80 -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -38.12 82.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -28.55 65.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.85 -42.39 40.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.325 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -66.89 -26.86 67.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -71.93 -2.69 18.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.254 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.19 11.94 36.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.248 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.53 -46.66 3.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.069 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -129.89 -34.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.26 56.01 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -139.95 -167.17 2.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -1.118 . . . . 0.0 110.255 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.55 93.46 3.54 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.6 Cg_endo -72.74 173.95 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.985 1.518 . . . . 0.0 110.45 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.6 Cg_endo -73.07 -160.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.978 1.515 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 72' ' ' ILE . 3.4 tp -111.87 2.8 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.281 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -24.87 25.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtt -87.57 -30.37 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.565 HG13 ' CE1' ' A' ' 58' ' ' TYR . 47.5 t -65.46 -29.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.2 m -62.34 -31.86 72.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -26.91 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.04 52.86 1.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 110.025 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.7 m -159.41 -74.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 49.77 0.4 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.0 147.56 33.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -1.193 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -98.96 131.67 44.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.924 . . . . 0.0 110.221 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -62.63 -32.32 73.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -64.54 -56.55 13.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.079 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -50.53 67.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.41 HD13 HG12 ' A' ' 72' ' ' ILE . 66.8 mt -56.89 -34.98 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.987 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -61.76 -49.44 76.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.996 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 5.4 tp60 -66.18 -24.11 66.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mt -79.29 -29.51 42.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 110.09 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' TYR . 16.6 m-85 -116.79 167.36 10.79 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.879 . . . . 0.0 110.042 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 92' ' ' SER . 51.3 Cg_endo -78.05 70.83 6.93 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.053 1.554 . . . . 0.0 110.622 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 91' ' ' PRO . 11.3 t 40.42 68.93 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.537 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.81 66.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.98 -12.5 23.79 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.01 1.531 . . . . 0.0 110.435 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 110.313 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 34.2 p80 -62.39 -24.62 67.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.77 -63.58 4.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' CYS . . . -48.96 -66.17 0.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.177 . . . . 0.0 110.418 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 8.7 t -41.92 -46.75 4.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.8 mtpt -52.52 -54.88 26.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 101' ' ' VAL . 8.7 t -62.44 -25.95 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.965 . . . . 0.0 110.411 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.06 -32.95 69.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA2' ' SD ' ' A' ' 24' ' ' MET . . . 100.07 46.63 1.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.678 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.182 -1.187 . . . . 0.0 110.221 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 3' ' ' VAL . 5.2 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.314 0.578 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 28.5 m -104.81 154.84 38.3 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -76.11 152.45 96.48 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.605 -2.248 . . . . 0.0 110.467 -0.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.85 138.92 5.07 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.03 121.74 41.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.139 . . . . 0.0 110.239 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 3' ' ' VAL . 35.8 m-85 -130.32 158.61 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.101 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 5.4 mt-30 -110.4 156.31 20.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.17 -0.956 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 14' ' ' LYS . 76.1 t -129.22 105.97 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.4 38.26 24.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.12 24.09 23.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 11.1 mmtt -115.28 175.0 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.66 47.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.425 HG11 ' CZ3' ' A' ' 37' ' ' TRP . 17.3 t -140.76 121.64 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 0.0 110.163 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.1 mt -99.66 108.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 53.5 mt -89.64 118.85 29.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 1.1 t0 -71.53 -172.71 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -50.22 -28.22 7.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -116.79 51.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 63.1 m 42.92 32.56 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.3 157.44 26.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -98.99 101.62 13.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.31 17.51 8.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.238 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -148.48 78.22 9.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.01 -7.33 20.51 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.015 1.534 . . . . 0.0 110.475 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.72 -12.61 61.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 12.1 t70 -116.43 33.9 5.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.153 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 75.0 t90 -92.75 151.01 20.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.37 -171.65 2.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -69.65 -56.21 7.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.272 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -57.33 -39.3 75.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.882 . . . . 0.0 110.27 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.68 -51.74 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.38 -50.72 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 110.385 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -58.34 -41.59 84.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.4 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.425 ' CZ3' HG11 ' A' ' 16' ' ' VAL . 50.0 t90 -55.55 -48.93 73.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.439 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.487 HD23 HD13 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.57 -51.13 69.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.444 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -51.0 -39.31 55.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 110.519 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.8 -67.1 0.53 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.938 . . . . 0.0 110.445 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' OE1' HG11 ' A' ' 3' ' ' VAL . 1.1 tt0 -42.58 -26.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.559 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 38' ' ' LEU . 2.4 mp -83.85 -79.49 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.379 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.68 -79.28 0.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.18 38.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.442 HD12 ' HB1' ' A' ' 39' ' ' ALA . 96.7 mt -75.34 115.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -1.148 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -56.88 -45.14 82.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.878 . . . . 0.0 110.358 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.0 122.09 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.451 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 45.3 mmm -45.78 118.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.7 p -65.1 178.13 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -69.85 -23.75 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -35.05 57.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.556 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -62.57 -50.0 73.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.533 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m95 -66.26 -35.44 80.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.372 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -61.28 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.316 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -52.71 61.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 110.401 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 102' ' ' ALA . 80.2 t -55.88 -28.76 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.487 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 ttmt -76.29 -38.27 56.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 110.389 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.25 -42.95 92.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -39.12 90.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.953 . . . . 0.0 110.283 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -36.92 67.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 43.6 tt0 -58.29 -44.95 88.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.33 -31.67 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.284 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -67.81 -12.09 59.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 10.9 mt-10 -78.51 -47.64 16.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.23 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -53.03 4.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -78.9 -75.41 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.245 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.96 17.13 11.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.2 m -115.48 146.37 41.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -1.163 . . . . 0.0 110.205 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.5 99.82 26.77 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.942 . . . . 0.0 110.164 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.8 Cg_endo -73.19 173.55 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.1 Cg_endo -72.92 -160.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.4 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 72' ' ' ILE . 1.6 tp -123.9 54.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -141.58 -44.06 0.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.8 mmm -74.84 -21.01 59.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.8 t -72.28 -32.32 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 m -44.33 -32.47 1.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -56.33 -51.45 68.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -65.6 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 p -68.91 -70.69 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.201 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.13 11.15 32.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.18 170.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -1.166 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -95.64 141.95 28.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.219 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 tp -69.2 -29.12 67.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 2.2 tt0 -61.16 -55.66 29.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.227 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -56.27 14.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.571 HG23 ' HG3' ' A' ' 94' ' ' PRO . 36.6 mt -56.17 -26.91 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.74 -58.4 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -34.48 70.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 52' ' ' HIS . 21.3 mt -65.67 -51.66 57.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 110.134 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.536 ' CE1' ' HA3' ' A' ' 97' ' ' GLY . 1.5 t80 -128.64 128.57 23.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 110.048 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.4 Cg_endo -73.14 156.2 51.64 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.898 1.473 . . . . 0.0 110.417 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 49.4 m 56.81 31.37 19.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 62.19 147.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.705 ' HB2' ' HB2' ' A' ' 98' ' ' ALA . 45.7 Cg_endo -72.9 -92.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.889 1.468 . . . . 0.0 110.304 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 49.6 -89.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.169 -0.957 . . . . 0.0 110.358 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 94' ' ' PRO . 8.1 m-70 -68.05 -44.85 75.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 90' ' ' PHE . . . -64.66 -41.77 97.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 94' ' ' PRO . . . -55.74 -48.97 74.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -1.131 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 100' ' ' LYS . 34.5 m -64.24 -55.39 21.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 99' ' ' CYS . 5.9 tttt -42.41 -49.9 5.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.27 -37.96 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HB2' HG13 ' A' ' 56' ' ' VAL . . . -72.59 -8.58 55.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.5 48.02 77.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.211 -1.17 . . . . 0.0 110.197 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.346 0.593 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.89 151.71 1.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.064 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 6.0 p -125.35 161.88 47.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.3 Cg_endo -75.08 145.26 83.33 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.54 -2.275 . . . . 0.0 110.474 -0.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.61 152.56 18.01 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 51.4 mt-10 -103.68 141.9 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 110.381 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 77.7 m-85 -152.53 150.21 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -104.17 125.02 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 67.0 t -105.8 118.82 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.297 -0.877 . . . . 0.0 110.113 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 19.6 m-20 55.69 -89.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -141.41 50.6 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 158.91 44.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -1.144 . . . . 0.0 110.164 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.641 ' HG2' HD11 ' A' ' 17' ' ' ILE . 6.1 tttt -104.6 115.57 30.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.31 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.603 ' C ' HD12 ' A' ' 17' ' ' ILE . 25.3 t -107.12 129.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.641 HD11 ' HG2' ' A' ' 15' ' ' LYS . 2.7 mp -115.59 116.58 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.308 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 22' ' ' CYS . 10.8 mt -95.14 110.54 22.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.996 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 23' ' ' PHE . 6.9 t70 -75.42 -161.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.274 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -64.31 137.31 57.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.1 t70 66.49 30.41 8.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.71 ' HA ' HD22 ' A' ' 18' ' ' LEU . 8.5 m 55.75 50.5 14.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . 1.6 m-30 -94.87 109.37 21.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.61 106.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.26 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' OE1' ' CB ' ' A' ' 19' ' ' ASP . 1.5 tp60 -108.86 35.88 3.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.231 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 8.8 p-10 -151.74 68.25 7.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 -7.51 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.003 1.528 . . . . 0.0 110.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -79.29 -46.65 17.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -84.61 -4.68 59.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.124 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.63 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 20.9 t90 -57.2 153.55 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -165.65 -160.06 0.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.544 ' OE2' ' CZ2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -74.39 -56.48 4.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.308 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -40.21 76.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -64.4 -49.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 0.0 110.293 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.63 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -55.42 -48.86 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.214 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.28 -57.67 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 92.3 t90 -49.23 -32.41 10.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -61.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.873 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -48.0 -47.22 33.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.942 . . . . 0.0 110.21 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -65.3 -32.53 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' TRP . 3.5 tt0 -64.88 -33.36 75.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 0.0 110.152 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.408 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -91.39 -73.54 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.234 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.43 -76.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 40' ' ' ARG . . . 142.65 69.13 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.873 HD12 ' HB1' ' A' ' 39' ' ' ALA . 60.7 mt -96.87 114.11 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -1.15 . . . . 0.0 110.247 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -46.34 -29.47 1.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.298 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.78 130.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.324 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 21.5 mtp -44.0 128.1 5.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.234 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -89.12 178.7 6.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -43.94 76.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.43 -39.19 89.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.517 ' NE2' ' HB3' ' A' ' 89' ' ' LEU . 6.8 m170 -65.08 -64.49 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CZ2' ' SD ' ' A' ' 48' ' ' MET . 2.0 m95 -46.73 -38.03 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.115 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -57.56 12.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.48 -54.49 21.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.98 -33.86 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -68.04 -61.67 1.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -37.01 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -69.6 -48.18 60.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.296 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 59' ' ' LEU . 8.4 tpt180 -42.8 -38.55 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.306 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.17 -54.24 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.354 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.72 -43.88 58.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.377 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.415 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 2.2 t90 -63.81 -47.44 80.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.02 7.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.3 m -82.15 -47.35 12.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.0 -35.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 103.62 56.39 0.77 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.5 m -128.61 157.5 41.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -1.148 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 t -120.94 86.99 42.62 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.44 167.77 26.11 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.059 1.557 . . . . 0.0 110.416 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.4 -90.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.961 1.506 . . . . 0.0 110.43 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -175.51 74.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.88 -63.78 1.14 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.154 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -64.9 -11.63 40.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.83 -45.53 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 m -64.01 -40.53 96.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.201 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.47 -29.79 17.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.289 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -102.88 -71.0 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.523 ' HB ' ' CD1' ' A' ' 81' ' ' PHE . 61.6 p -49.68 -52.59 29.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.81 30.25 6.88 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD1' ' HB ' ' A' ' 79' ' ' THR . 10.4 m-85 -99.66 120.43 39.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.16 147.54 52.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -56.53 -28.27 59.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.07 -44.8 87.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -53.38 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.209 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 9.1 mt -53.02 -30.16 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 90' ' ' PHE . 1.5 m-85 -77.14 -36.26 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.283 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.91 -44.89 91.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.396 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.517 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 3.4 mt -78.92 -53.64 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.296 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.1 m-85 -88.94 165.06 28.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.19 -179.29 4.57 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.068 1.562 . . . . 0.0 110.46 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.16 86.17 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' ' CD2' ' A' ' 96' ' ' HIS . . . 135.65 80.03 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.69 -0.02 8.81 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.497 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -79.56 -53.61 6.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 93' ' ' GLY . 23.3 p80 -77.2 -23.41 51.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.472 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -78.18 -71.8 1.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.91 -36.95 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -1.138 . . . . 0.0 110.405 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -71.28 -51.5 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.397 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -47.82 -44.11 28.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.326 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' ALA . 39.2 t -69.12 -55.32 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 101' ' ' VAL . . . -44.01 -35.45 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 0.0 110.162 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . 82.74 63.28 1.77 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 103' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.258 -1.143 . . . . 0.0 110.299 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.243 0.544 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -81.5 83.43 6.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.361 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 36.5 m -82.49 154.47 68.78 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD3' ' CG ' ' A' ' 20' ' ' GLU . 50.3 Cg_endo -75.62 164.88 87.05 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.58 -0.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.21 160.85 28.05 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -104.34 152.08 22.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.192 . . . . 0.0 110.328 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -152.66 144.81 23.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -100.17 132.22 45.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.968 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 22.9 t -129.75 109.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.59 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 64.45 28.13 13.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.476 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.5 7.39 82.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 3.5 mttt -98.99 171.1 8.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -1.206 . . . . 0.0 110.087 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.32 123.73 49.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 110.282 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.42 138.18 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.7 mt -120.65 100.0 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.24 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 18' ' ' LEU . 23.1 mt -74.49 118.39 17.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.232 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.74 -172.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.323 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.519 ' CG ' ' HD3' ' A' ' 6' ' ' PRO . 1.5 tt0 -62.01 -13.47 26.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 110.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -118.58 43.28 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.0 m 43.25 34.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.339 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -103.07 115.78 31.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 110.128 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' PHE . 1.3 ttt -41.88 137.67 1.7 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.921 . . . . 0.0 110.338 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 17.24 21.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.154 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -124.22 67.3 44.94 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.227 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.5 -6.63 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.054 1.555 . . . . 0.0 110.463 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -32.97 56.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 1.3 m-20 -97.41 -81.86 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 52.2 t90 59.47 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.6 178.44 7.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.485 ' HG2' ' CZ2' ' A' ' 53' ' ' TRP . 1.8 tm-20 -65.64 -64.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -29.43 2.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.35 -62.54 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.326 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.59 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.56 -35.87 82.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -0.948 . . . . 0.0 110.421 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.442 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -66.37 -55.99 13.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.98 -31.55 60.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.456 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -36.53 63.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.108 -0.995 . . . . 0.0 110.392 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.5 -26.99 61.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HB3' ' OE1' ' A' ' 43' ' ' GLU . 6.9 mp -81.18 -42.79 20.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -110.24 -83.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 38.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.2 88.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -1.148 . . . . 0.0 110.281 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -45.41 -30.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.52 130.89 10.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 mmt -57.87 130.32 45.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 52' ' ' HIS . 10.0 t -86.55 160.02 19.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.204 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.75 -40.45 79.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.455 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.89 -37.0 73.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.437 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.609 ' H ' HG23 ' A' ' 49' ' ' THR . 3.2 m170 -63.6 -64.43 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.285 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.485 ' CZ2' ' HG2' ' A' ' 32' ' ' GLU . 5.0 m95 -54.8 -26.6 35.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 110.505 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -67.17 -67.31 0.46 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.96 -45.89 61.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.26 -48.21 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 110.168 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -54.83 -44.94 74.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.189 -0.945 . . . . 0.0 110.112 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.83 -58.04 9.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.64 -33.44 33.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.354 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.34 -56.15 19.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.364 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.44 -37.33 7.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.472 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -36.89 70.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -70.36 -3.45 17.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.157 -0.965 . . . . 0.0 110.421 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.02 -25.6 10.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.4 m -88.4 -69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.9 -45.66 7.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.969 . . . . 0.0 110.123 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.97 68.68 1.26 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 53.9 m -151.0 161.11 43.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -1.169 . . . . 0.0 110.326 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 m -110.79 84.33 4.13 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 68' ' ' THR . 46.7 Cg_endo -73.53 172.05 16.51 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.1 1.579 . . . . 0.0 110.468 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.94 -161.95 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.001 1.527 . . . . 0.0 110.478 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -119.52 6.37 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.195 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -36.04 66.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -18.15 47.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -74.1 -46.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 110.195 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 5.6 m -62.01 -26.84 68.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -63.61 -28.49 69.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.57 -78.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.144 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 p -53.82 -27.73 31.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.982 . . . . 0.0 110.207 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 77.91 4.33 85.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.04 135.43 56.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -1.192 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.95 140.22 58.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -63.71 -29.91 71.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.216 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -52.23 66.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.104 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -37.84 17.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.632 HD13 HD11 ' A' ' 72' ' ' ILE . 30.5 mt -73.32 -34.74 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.34 -0.85 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CE2' HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -61.53 -32.82 72.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -83.27 -48.42 10.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 110.184 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 57.2 mt -57.72 -28.68 64.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 87' ' ' TYR . 11.2 m-85 -129.01 168.03 17.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.026 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -173.54 1.27 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.93 1.49 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.28 94.75 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.39 76.65 0.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.2 Cg_endo -73.21 -9.01 22.85 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 110.444 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.5 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -46.52 -31.09 2.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.81 -61.89 5.48 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -44.7 -56.42 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.1 m -47.6 -51.2 22.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 12.2 ttmt -53.25 -40.96 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 96.5 t -59.56 -52.06 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.56 -25.5 68.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.168 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.73 63.79 0.63 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.215 -1.167 . . . . 0.0 110.152 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.24 0.543 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.19 152.31 19.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 m -115.11 144.86 32.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.75 167.51 80.06 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.246 -0.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -178.98 142.22 5.24 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 6.3 tt0 -99.33 159.51 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -1.138 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 2.8 m-85 -161.43 166.79 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.199 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -112.01 124.84 53.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 110.256 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' ASP . 35.3 t -99.14 98.24 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' VAL . 18.6 t70 43.2 73.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.75 56.23 25.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 170.81 20.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -1.145 . . . . 0.0 110.287 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -123.39 123.08 39.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.513 HG13 ' HE2' ' A' ' 24' ' ' MET . 46.5 t -141.47 124.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.13 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 25' ' ' GLN . 1.1 tt -105.76 145.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 18' ' ' LEU . 26.0 mt -112.08 112.7 24.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 25' ' ' GLN . 19.9 m-20 -58.77 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.825 . . . . 0.0 110.229 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.23 -28.32 69.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 22' ' ' CYS . 8.3 m-20 -106.99 44.26 1.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' A' ' 21' ' ' ASP . 60.0 m 42.49 31.58 0.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.252 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -86.78 142.65 27.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.513 ' HE2' HG13 ' A' ' 16' ' ' VAL . 15.5 ttm -78.16 125.0 28.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.557 ' HB2' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -95.34 0.33 53.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.34 68.53 14.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.96 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.99 -18.9 23.77 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.051 1.553 . . . . 0.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -66.11 -14.04 61.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.204 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.5 m-20 -113.39 6.64 17.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 51.7 t90 -46.32 158.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.547 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 1.2 m-20 178.4 -177.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.887 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -62.62 -45.05 94.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 110.163 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -26.78 68.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.169 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.2 -60.68 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.422 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -54.58 -29.51 51.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.394 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 2.8 mt-10 -75.81 -59.76 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.339 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -49.53 -35.57 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.501 HD23 ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -72.52 -51.23 20.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.304 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.71 -28.63 56.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -60.2 2.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.455 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -26.86 22.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD1' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -87.81 -73.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.422 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.39 -52.69 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 24.71 1.57 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.9 mt -73.11 84.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -1.194 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -44.07 -29.79 0.66 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.45 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -150.37 111.51 4.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.461 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 23.1 mmm -48.92 155.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.08 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.709 HG22 ' ND1' ' A' ' 52' ' ' HIS . 5.2 t -106.94 -177.3 3.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.89 . . . . 0.0 110.282 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.56 -35.34 60.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.929 . . . . 0.0 110.226 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -40.61 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.284 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.709 ' ND1' HG22 ' A' ' 49' ' ' THR . 5.6 m170 -62.43 -55.79 24.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 110.328 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.488 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 4.5 m95 -61.28 -26.92 68.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -67.09 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.93 . . . . 0.0 110.38 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -43.04 70.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -52.98 -57.56 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.154 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -46.16 63.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.13 -43.52 70.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.69 -40.49 95.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -60.54 -28.67 68.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.97 -51.68 63.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -71.19 -26.99 63.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.567 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 65.8 t90 -80.9 -6.3 58.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 65' ' ' THR . 9.5 tt0 -77.4 -50.65 12.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 64' ' ' GLU . 18.7 m -44.71 -39.96 5.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.19 -58.61 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 131.07 43.19 0.19 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -105.1 113.91 27.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -1.156 . . . . 0.0 110.193 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.8 t -53.77 108.1 1.03 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.198 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 68' ' ' THR . 45.8 Cg_endo -73.06 169.61 21.81 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.9 1.474 . . . . 0.0 110.371 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.87 -162.49 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.003 1.528 . . . . 0.0 110.434 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 86' ' ' ILE . 8.8 tp -125.87 -0.75 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -91.0 -11.49 38.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.44 -30.01 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 110.405 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.92 -29.89 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 81' ' ' PHE . 14.1 t -77.0 -36.2 56.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -65.87 -29.33 69.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.56 0.04 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.276 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' GLY . 66.2 p -135.38 22.76 3.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' THR . . . 43.58 26.79 0.74 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.488 ' HB2' ' HA ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -68.26 -163.94 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -1.135 . . . . 0.0 110.155 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.1 t -154.4 137.42 15.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 110.176 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 15.1 tp -50.42 -34.43 24.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.215 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.55 -35.1 70.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.64 -46.6 89.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 110.41 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 72' ' ' ILE . 34.9 mt -76.87 -31.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -67.05 -32.18 73.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.289 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -86.68 -39.68 15.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -0.978 . . . . 0.0 110.273 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.577 HD22 ' CE1' ' A' ' 52' ' ' HIS . 19.8 mt -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 110.169 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.426 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 4.2 m-85 -109.11 171.28 4.59 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.6 Cg_endo -74.28 -61.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.091 1.574 . . . . 0.0 110.637 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.42 107.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.15 -0.969 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.24 75.43 0.93 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.524 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.0 Cg_endo -72.33 -16.77 27.78 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.047 1.551 . . . . 0.0 110.431 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -69.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.357 -0.839 . . . . 0.0 110.148 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -77.07 -8.0 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.18 -81.43 0.44 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.1 -32.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -1.078 . . . . 0.0 110.418 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -62.95 1.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -50.96 -51.28 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.131 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -48.76 -57.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -53.76 -34.48 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.09 -63.61 0.42 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.27 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 9' ' ' TYR . 6.4 t . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.233 0.539 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.41 -156.73 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 4.9 p -175.14 162.57 2.31 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.6 Cg_endo -74.72 153.67 99.28 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.611 0.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.34 167.26 40.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 5.9 mt-10 -120.58 148.57 43.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -1.194 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 97.2 m-85 -156.37 143.81 19.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -113.47 140.82 47.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 17.6 t -109.44 99.68 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 12.4 t70 55.32 -89.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -122.71 42.42 1.63 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 169.03 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -1.178 . . . . 0.0 110.205 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -127.34 138.15 52.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 110.281 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.0 128.69 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.066 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 66.7 mt -116.15 102.59 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 22' ' ' CYS . 2.8 mt -87.14 132.17 33.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' GLU . 3.2 m-20 -117.44 -170.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.03 148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.582 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.6 t0 66.76 18.32 10.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.623 ' HA ' HD22 ' A' ' 18' ' ' LEU . 4.3 m 51.05 45.72 27.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.613 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 m-85 -86.35 126.56 34.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 110.235 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.664 ' HG2' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -42.88 -36.06 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.242 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 53.58 19.89 1.92 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.156 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.425 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -151.16 59.87 3.57 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.157 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.33 -30.33 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.031 1.543 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.43 73.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 0.0 110.26 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.21 30.15 2.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 35' ' ' ALA . 60.4 t90 -82.57 160.62 22.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.453 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -167.56 -169.21 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.192 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.431 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 18.7 mt-10 -71.32 -58.4 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -33.69 72.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.357 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.05 -57.57 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.59 ' HB2' ' NE1' ' A' ' 30' ' ' TRP . . . -55.23 -36.99 66.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.0 110.406 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -54.6 41.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.461 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 76.7 t90 -59.19 -28.89 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.189 -0.944 . . . . 0.0 110.432 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' A' ' 24' ' ' MET . 0.2 OUTLIER -70.98 -41.42 71.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.447 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.74 -26.91 60.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.95 . . . . 0.0 110.591 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -75.9 -40.27 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.571 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -77.15 -33.81 56.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.687 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.3 mp -80.74 -68.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.105 -0.997 . . . . 0.0 110.572 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -79.59 -72.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 110.413 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.84 39.59 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 46' ' ' GLN . 11.3 mt -103.33 107.71 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' ILE . 14.0 mt-30 -43.28 -37.77 2.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -156.64 140.61 16.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.329 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -52.87 100.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 110.133 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -52.62 162.17 0.61 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 110.276 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.53 -27.62 4.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.95 -39.62 55.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.729 ' CE1' HD22 ' A' ' 89' ' ' LEU . 5.2 m80 -61.59 -41.03 96.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.513 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 1.4 m95 -74.09 -36.06 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.247 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -58.88 -45.64 89.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 81' ' ' PHE . 5.9 mp -72.76 -58.27 3.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 52' ' ' HIS . 74.9 t -47.14 -30.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -76.45 -51.48 11.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.931 ' CE2' HG13 ' A' ' 75' ' ' VAL . 38.5 t80 -52.47 -48.34 65.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.6 -43.58 76.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 21.8 ttp180 -50.32 -39.8 46.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 110.426 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.16 -55.2 19.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -27.0 66.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 59.6 t90 -70.08 -21.62 63.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.284 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 -17.63 59.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.19 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.555 HG22 ' HD2' ' A' ' 66' ' ' PHE . 98.3 m -75.74 -70.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.336 -0.853 . . . . 0.0 110.156 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.555 ' HD2' HG22 ' A' ' 65' ' ' THR . 4.3 m-85 -125.31 30.63 5.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 43.9 80.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -178.07 5.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -1.117 . . . . 0.0 110.176 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 t -140.1 92.95 9.4 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.229 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.43 157.88 52.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.079 1.568 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.68 -159.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.045 1.55 . . . . 0.0 110.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 72' ' ' ILE . 7.8 tt -125.25 46.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.86 -82.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -16.16 40.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.931 HG13 ' CE2' ' A' ' 58' ' ' TYR . 79.0 t -70.33 -40.85 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.148 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -54.12 -38.84 65.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -69.02 -34.1 74.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.142 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.79 -0.24 37.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.57 -77.55 0.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.348 -0.845 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.89 22.56 3.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.537 ' CD2' HD11 ' A' ' 55' ' ' LEU . 36.0 m-85 -81.64 102.98 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -1.144 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.44 127.89 6.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.297 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -47.84 -36.65 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.166 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.09 -49.74 72.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.034 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -50.83 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 81' ' ' PHE . 36.4 mm -50.29 -39.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -37.18 80.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.59 -31.35 72.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.729 HD22 ' CE1' ' A' ' 52' ' ' HIS . 12.5 mt -76.72 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -94.07 147.91 34.26 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 92' ' ' SER . 46.6 Cg_endo -73.98 84.13 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.03 1.542 . . . . 0.0 110.407 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 91' ' ' PRO . 38.6 m 43.5 70.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.52 62.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.466 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.0 Cg_endo -73.63 -0.41 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.033 1.543 . . . . 0.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -98.97 -63.35 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.901 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.01 -14.24 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.277 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -77.06 -77.26 0.8 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.54 -37.15 1.56 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.32 -50.84 62.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.374 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.9 tptt -53.41 -48.57 68.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.293 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.24 -27.55 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.65 -19.8 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.39 63.15 1.66 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.207 -1.172 . . . . 0.0 110.161 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 4' ' ' LYS . 57.4 t . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.232 0.539 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.529 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.2 mtmm -109.07 147.31 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.5 m -142.89 159.43 56.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.968 . . . . 0.0 110.369 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.87 154.43 98.49 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.492 -0.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.06 142.62 7.79 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.406 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.05 128.05 45.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.262 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -131.63 161.94 31.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 110.213 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -104.94 142.33 34.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.117 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 53.9 t -127.8 96.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 11' ' ' VAL . 10.3 t70 41.98 85.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 110.311 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.48 65.46 2.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -168.32 161.43 12.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -1.181 . . . . 0.0 110.144 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 126.36 42.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -131.32 122.31 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 110.044 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.57 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.412 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 18' ' ' LEU . 16.2 mt -69.8 123.06 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.056 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.575 ' OD2' ' NE2' ' A' ' 25' ' ' GLN . 9.9 m-20 -99.66 -157.92 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.8 mm-40 -45.57 132.31 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 13.3 t70 62.32 30.55 17.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.022 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 74.5 m 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.46 95.28 9.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.4 ptm -54.21 149.98 9.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.575 ' NE2' ' OD2' ' A' ' 19' ' ' ASP . 2.5 mt-30 -127.04 40.56 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -126.05 72.47 70.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.028 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.0 -19.47 30.19 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.125 1.592 . . . . 0.0 110.574 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.68 -0.65 55.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -128.25 34.01 4.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.285 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.411 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 67.4 t90 -85.86 149.77 25.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -173.08 1.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -65.64 -39.19 91.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 110.209 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -68.31 -27.17 66.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.0 110.386 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.489 HG22 ' HD3' ' A' ' 14' ' ' LYS . 21.8 t -76.16 -55.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.592 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -61.13 -34.01 74.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.473 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 3.3 tt0 -70.47 -57.43 4.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 110.419 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -56.77 -31.39 64.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -69.03 -63.27 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.346 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -53.5 -27.97 28.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -76.05 -34.74 59.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 1.9 tp10 -74.81 -28.58 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.561 ' CD1' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -82.45 -76.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -80.23 -76.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.55 46.74 0.02 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.601 HD12 ' HB1' ' A' ' 39' ' ' ALA . 8.8 mt -81.78 102.05 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -1.148 . . . . 0.0 110.148 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -42.52 97.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -136.32 115.48 12.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.9 mmm -56.83 125.22 21.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -72.9 165.45 24.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.204 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.02 -32.19 71.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -44.69 65.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.404 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.6 m170 -50.67 -54.46 22.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.592 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 1.8 m95 -62.5 -30.7 71.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.293 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -64.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -51.63 -41.92 61.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 52' ' ' HIS . 45.7 t -57.46 -41.59 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.944 . . . . 0.0 110.106 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.28 -56.92 8.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -47.97 -34.47 9.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.14 -49.26 52.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.085 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -52.01 52.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 110.084 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -40.46 72.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.089 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -62.64 -29.88 70.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.141 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.541 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 77.5 t90 -74.74 -31.17 61.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.69 -42.05 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.2 m -58.6 -40.64 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.47 -57.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.912 . . . . 0.0 110.066 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 119.18 83.48 0.85 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -155.6 171.8 19.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -1.164 . . . . 0.0 110.25 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.99 75.07 21.21 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 161.37 43.06 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.992 1.522 . . . . 0.0 110.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.59 -174.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.994 1.523 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.726 HG13 HG23 ' A' ' 76' ' ' THR . 3.6 tp -87.43 49.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' OG1' ' A' ' 76' ' ' THR . 0.2 OUTLIER -97.74 -60.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.049 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ttm -73.93 -24.01 59.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.082 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' A' ' 79' ' ' THR . 13.6 t -67.07 -37.94 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.726 HG23 HG13 ' A' ' 72' ' ' ILE . 6.1 p -65.16 -26.76 68.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -28.98 70.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.36 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.35 48.13 1.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.234 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 43.9 m -154.69 -49.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.106 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.36 -15.04 60.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.48 ' HB3' HD11 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -54.17 98.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 110.16 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.935 ' O ' HD12 ' A' ' 86' ' ' ILE . 2.2 t -70.16 148.59 48.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.233 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 72' ' ' ILE . 22.3 tp -60.52 -27.77 67.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -48.04 65.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.64 -40.64 79.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.19 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 82' ' ' SER . 3.4 mt -72.42 -27.83 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 110.113 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 -43.14 75.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.172 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -54.12 10.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.133 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.87 -29.51 68.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.71 96.13 4.8 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 110.141 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.5 Cg_endo -72.87 88.43 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 12.9 t 176.47 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.96 141.55 5.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.48 -10.21 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.991 1.522 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -89.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.853 . . . . 0.0 110.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 21.5 m170 -77.14 -10.89 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.92 . . . . 0.0 110.215 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -79.21 -83.88 0.62 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.86 -34.76 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.291 -1.123 . . . . 0.0 110.341 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 100' ' ' LYS . 8.5 t -70.44 -64.46 0.89 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 26.6 tttm -43.18 -31.61 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.301 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.64 -52.31 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.212 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.14 -27.4 45.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.14 46.53 5.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.279 -1.13 . . . . 0.0 110.148 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.282 0.563 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.64 143.19 58.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.877 . . . . 0.0 110.223 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 18.6 m -138.8 149.42 61.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -76.05 164.71 87.22 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.705 -2.206 . . . . 0.0 110.567 -0.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.48 156.66 25.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.01 154.54 18.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -1.123 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -147.59 147.21 29.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.34 117.56 34.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.12 102.88 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 110.401 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.24 -101.73 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.82 51.31 0.82 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 143.55 21.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -1.136 . . . . 0.0 110.102 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.87 123.87 43.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.99 140.55 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.326 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -124.61 100.66 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 110.183 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.616 HD22 ' CA ' ' A' ' 22' ' ' CYS . 20.3 mt -77.14 121.74 24.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.136 -0.977 . . . . 0.0 110.32 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -141.45 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.7 tt0 -66.09 133.51 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.524 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.4 t70 66.82 34.79 5.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.616 ' CA ' HD22 ' A' ' 18' ' ' LEU . 60.5 m 44.05 42.71 5.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.524 ' CD2' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -86.85 144.19 27.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.143 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.76 112.61 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 110.248 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -105.85 31.1 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -152.32 65.86 6.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.54 -14.03 24.91 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.045 1.55 . . . . 0.0 110.399 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.99 -33.82 39.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 9.9 m-20 -103.42 -85.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.129 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.469 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 33.5 t90 58.98 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 110.297 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -163.5 179.43 7.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.69 -55.59 10.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.287 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -36.36 71.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.91 -61.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.97 -45.74 21.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.09 -45.41 87.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.0 t90 -58.13 -51.87 67.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.983 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -54.39 -40.87 68.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.245 -0.909 . . . . 0.0 110.506 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.92 69.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.921 . . . . 0.0 110.564 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.442 ' CD ' ' OE2' ' A' ' 41' ' ' GLU . 1.3 tmm_? -73.66 -45.22 53.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 110.562 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.442 ' OE2' ' CD ' ' A' ' 40' ' ' ARG . 2.0 mp0 -66.81 -33.9 76.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -68.13 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.348 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.89 -64.48 1.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.4 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.36 117.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -1.19 . . . . 0.0 110.26 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -74.69 -33.16 62.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.74 144.17 43.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.6 mmm -85.95 129.78 34.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.288 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.711 HG23 ' H ' ' A' ' 52' ' ' HIS . 3.5 t -73.69 170.77 14.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.18 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 3.8 mt-10 -67.89 -23.43 65.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.49 -40.06 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.898 . . . . 0.0 110.339 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.711 ' H ' HG23 ' A' ' 49' ' ' THR . 2.5 m170 -59.84 -59.67 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -58.68 -30.24 67.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.243 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -63.79 -65.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.908 . . . . 0.0 110.215 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.01 -29.03 63.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 52' ' ' HIS . 48.2 t -65.52 -39.82 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.73 -31.5 57.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.5 -49.33 71.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.04 -31.35 71.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.039 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -27.6 63.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.0 -45.81 90.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.298 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.5 -29.91 61.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.672 ' NE1' ' HB1' ' A' ' 104' ' ' ALA . 88.6 t90 -66.02 -44.3 85.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -44.13 83.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -64.19 -67.76 0.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.24 -63.34 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.33 44.13 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 p -139.39 -158.63 0.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -1.105 . . . . 0.0 110.187 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 m -139.41 101.87 7.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 110.192 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.87 172.27 16.21 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.107 1.582 . . . . 0.0 110.364 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' CG ' ' HD3' ' A' ' 73' ' ' LYS . 45.6 Cg_endo -72.52 -164.96 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.066 1.561 . . . . 0.0 110.368 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -116.12 44.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HD3' ' CG ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -92.81 -66.79 0.9 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.7 mtp -60.04 -14.77 18.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.53 -58.21 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -28.18 69.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -28.12 69.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -106.68 -65.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.8 p -56.97 -35.09 68.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.7 79.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -75.04 122.88 24.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -1.137 . . . . 0.0 110.242 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.481 ' CB ' ' HE2' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -53.67 136.26 39.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.01 -35.45 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.94 -36.03 77.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HE2' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -58.4 -53.1 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 110.174 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.559 HG21 ' HG3' ' A' ' 94' ' ' PRO . 79.9 mt -65.9 -38.68 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.18 -37.57 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 109.946 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -48.2 25.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.431 HD22 ' CE1' ' A' ' 52' ' ' HIS . 22.6 mt -65.27 -11.72 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 0.1 OUTLIER -173.08 104.89 0.32 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 90' ' ' PHE . 45.2 Cg_endo -72.31 -25.6 18.36 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.056 1.556 . . . . 0.0 110.381 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.7 m -75.92 0.52 18.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.27 147.78 5.81 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 46.9 Cg_endo -73.09 -10.39 24.41 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.035 1.545 . . . . 0.0 110.346 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.22 -84.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.348 -0.845 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -76.72 -18.08 58.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.53 -67.1 1.73 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . -44.59 -38.09 4.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.124 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.88 -44.32 70.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -41.65 70.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.84 -37.24 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.5 70.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.72 50.19 1.85 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.672 ' HB1' ' NE1' ' A' ' 63' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.251 -1.147 . . . . 0.0 110.252 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.52 HG11 ' CD1' ' A' ' 18' ' ' LEU . 54.2 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.193 0.52 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -63.19 104.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.8 m -94.5 142.76 25.23 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.32 144.94 82.14 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.38 -0.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.94 165.11 30.6 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 144.59 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -1.111 . . . . 0.0 110.146 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -146.23 171.41 14.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.2 mt-30 -133.45 122.57 23.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.206 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 3.9 t -99.83 109.37 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.041 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 46.6 t0 56.33 -88.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.244 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.64 48.01 0.99 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 2.8 mttm -149.14 151.69 34.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -1.15 . . . . 0.0 110.257 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -112.53 111.28 22.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.56 140.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.7 107.87 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.749 HD22 ' C ' ' A' ' 22' ' ' CYS . 13.2 mt -83.65 124.59 30.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 3.1 t70 -66.39 -170.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -38.23 69.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.33 39.79 1.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.749 ' C ' HD22 ' A' ' 18' ' ' LEU . 67.4 m 44.85 39.63 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.55 151.15 22.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 132.82 34.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.31 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -108.26 -8.66 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -139.66 60.49 16.28 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.15 -1.73 11.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.03 1.542 . . . . 0.0 110.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -31.28 62.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -106.09 36.54 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.244 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -61.19 144.04 54.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.181 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.14 175.59 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.49 -39.24 90.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.239 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 16.4 mttt -67.02 -31.79 72.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.447 ' O ' HD12 ' A' ' 38' ' ' LEU . 49.1 t -71.49 -58.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -52.98 -46.75 68.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.26 -33.12 74.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 33.7 t90 -61.72 -48.44 80.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.45 -38.88 85.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.411 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.69 81.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.396 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.45 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 2.0 ttt-85 -71.63 -51.65 22.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.336 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.12 -26.84 65.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.427 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.5 mp -87.56 -72.08 0.54 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -42.7 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.384 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 118.12 21.11 4.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.438 ' N ' ' HA ' ' A' ' 40' ' ' ARG . 19.6 mt -79.63 105.6 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -1.108 . . . . 0.0 110.188 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -46.94 72.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' MET . 11.5 tptp -118.71 109.45 16.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' LYS . 4.6 tpt -42.8 150.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.271 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 52' ' ' HIS . 30.7 p -84.75 174.18 10.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.26 -40.87 64.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 110.302 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.442 ' CB ' HD11 ' A' ' 89' ' ' LEU . 67.2 mm-40 -68.61 -33.7 74.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -55.42 -49.67 71.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.2 m95 -71.23 -26.93 63.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -62.54 -58.44 7.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.42 -50.48 52.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.369 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 52' ' ' HIS . 95.5 t -52.44 -33.61 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -51.78 13.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.236 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.529 ' CZ ' HG22 ' A' ' 79' ' ' THR . 52.4 t80 -53.62 -31.53 47.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -44.78 63.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.164 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -49.13 -35.62 16.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.17 -51.75 68.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -41.88 98.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.428 ' O ' ' CD2' ' A' ' 63' ' ' TRP . 15.8 t90 -68.83 -12.51 61.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.221 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -14.27 35.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.244 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.568 HG22 ' CD2' ' A' ' 66' ' ' PHE . 96.2 m -97.82 -46.37 5.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.913 . . . . 0.0 110.145 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.568 ' CD2' HG22 ' A' ' 65' ' ' THR . 60.9 m-85 -124.94 -8.86 7.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 63' ' ' TRP . . . 65.83 45.44 88.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.19 147.57 40.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -117.32 103.13 51.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.28 152.69 50.34 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.971 1.511 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.87 -90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 0.0 110.346 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.629 HG12 HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -169.42 57.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -135.56 -68.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.028 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.7 ttm -67.84 -14.36 62.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.043 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.424 ' O ' ' OG1' ' A' ' 79' ' ' THR . 93.8 t -70.56 -42.68 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.882 . . . . 0.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -27.11 66.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -72.14 -33.5 67.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.826 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.23 -63.64 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CZ ' ' A' ' 58' ' ' TYR . 46.9 p -60.6 -42.34 96.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.13 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.52 59.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.66 149.72 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -1.19 . . . . 0.0 110.179 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -71.96 143.11 49.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.629 HD11 HG12 ' A' ' 72' ' ' ILE . 29.0 tp -73.32 -29.28 62.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -31.42 69.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.264 -0.898 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -62.13 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.457 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.5 mp -51.26 -45.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.355 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 92' ' ' SER . 1.5 t80 -60.53 -33.73 73.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.71 -24.86 53.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.519 HD22 ' CG ' ' A' ' 52' ' ' HIS . 9.4 mt -76.13 -50.7 13.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 101' ' ' VAL . 74.1 m-85 -97.81 162.5 22.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 92' ' ' SER . 48.0 Cg_endo -74.92 76.7 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.115 1.587 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.453 ' HA ' ' CE1' ' A' ' 87' ' ' TYR . 0.8 OUTLIER 41.61 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.14 70.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' CB ' HD13 ' A' ' 72' ' ' ILE . 46.7 Cg_endo -72.99 -21.27 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.003 1.528 . . . . 0.0 110.432 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.54 -81.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.226 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -66.34 -16.09 63.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.76 -70.84 1.2 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.35 -42.34 61.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -1.161 . . . . 0.0 110.165 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.51 -48.41 81.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.22 -37.21 69.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.101 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.527 HG21 ' CE1' ' A' ' 90' ' ' PHE . 50.6 t -72.19 -31.96 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.13 -50.94 64.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.865 . . . . 0.0 110.213 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.03 43.41 1.78 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.224 -1.162 . . . . 0.0 110.079 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 41' ' ' GLU . 71.1 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.192 0.52 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 109.58 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 26.0 p -102.18 157.36 33.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 47.7 Cg_endo -75.48 147.28 88.14 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.504 -0.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.03 174.86 46.88 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.72 144.38 44.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 0.0 110.148 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.09 165.94 26.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -116.26 137.94 51.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 77.7 t -133.84 118.64 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t0 46.34 52.33 10.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.304 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.98 39.61 97.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.0 tttt -131.02 166.92 19.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -1.172 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 103.34 9.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.8 t -99.03 130.95 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.139 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.73 115.96 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 22' ' ' CYS . 10.6 mt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.185 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.3 t0 -59.55 -172.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.25 -23.21 67.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.827 . . . . 0.0 110.298 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -108.26 35.17 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.261 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.604 ' HA ' HD22 ' A' ' 18' ' ' LEU . 1.4 m 52.42 42.96 31.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.263 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -111.49 111.08 21.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 110.263 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -45.12 144.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.256 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.36 13.46 15.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.193 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -145.79 59.71 5.91 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.141 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.78 -8.14 21.9 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 0.0 110.517 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -27.4 65.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' TRP . 5.9 m-20 -92.82 -74.36 0.52 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 29' ' ' ASP . 68.9 t90 56.92 162.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.86 176.19 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.29 -51.22 39.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -32.96 74.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.73 -55.79 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.703 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -53.79 -47.3 70.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.53 -26.88 66.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -68.73 -54.49 15.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.291 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.535 HD23 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -62.93 -36.9 84.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.62 -37.26 86.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.09 -28.67 54.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.372 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 7.3 mm-40 -76.95 -27.6 54.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.96 . . . . 0.0 110.378 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.535 HD13 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -96.53 -21.43 17.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.283 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HB3' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -127.29 -36.68 2.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.933 . . . . 0.0 110.324 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 96.96 21.93 19.32 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 43' ' ' GLU . 34.8 mt -59.03 97.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -1.161 . . . . 0.0 110.23 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.11 -43.77 51.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 109.984 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -136.32 115.09 12.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -42.55 137.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.208 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -81.07 139.38 35.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 -24.8 7.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 110.229 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -75.98 -45.55 34.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 56' ' ' VAL . 22.6 m170 -51.8 -55.57 19.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.703 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 16.7 m95 -55.87 -29.24 59.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -52.9 48.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -37.12 85.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 52' ' ' HIS . 11.9 t -64.63 -38.19 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -54.29 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.415 ' CE1' HG13 ' A' ' 75' ' ' VAL . 17.2 t80 -51.84 -41.11 61.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.225 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -34.87 77.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.234 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -60.44 -30.14 69.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.93 -45.94 72.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.276 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -37.87 89.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 67' ' ' GLY . 48.9 t90 -64.03 -48.15 77.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.233 -0.917 . . . . 0.0 110.193 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.03 -12.74 60.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.7 m -91.23 -22.33 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.97 -43.79 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' TRP . . . 103.07 43.03 1.97 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.8 t -154.3 158.89 40.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 110.25 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.0 116.6 66.11 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.47 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 45.9 Cg_endo -72.71 174.28 12.03 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.832 1.438 . . . . 0.0 110.425 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 45.5 Cg_endo -72.1 -159.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.947 1.499 . . . . 0.0 110.46 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 72' ' ' ILE . 7.9 tp -118.02 -1.4 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.375 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -90.19 -44.67 9.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -23.74 63.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 58' ' ' TYR . 97.5 t -71.48 -41.93 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 110.317 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 80' ' ' GLY . 6.8 m -62.24 -45.4 93.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -45.34 -47.67 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.372 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.66 -32.35 70.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 p -103.84 -74.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 76' ' ' THR . . . 128.85 -12.23 6.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.8 m-30 -43.24 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -1.164 . . . . 0.0 110.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 80' ' ' GLY . 34.3 t -42.82 131.74 4.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.847 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tp -51.61 -37.65 51.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -40.55 72.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -64.11 -54.96 25.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 110.1 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.5 mt -51.64 -32.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 110.083 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -74.99 -35.86 62.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.105 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.22 62.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.28 -19.91 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.43 109.05 9.49 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -39.69 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.982 1.517 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -44.86 66.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 110.257 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.86 153.53 9.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -74.06 -162.41 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.96 1.505 . . . . 0.0 110.508 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 57.02 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 110.511 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' PRO . 36.3 m170 -66.6 -44.37 82.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.411 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -62.65 -66.93 2.31 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.67 -56.75 2.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -1.148 . . . . 0.0 110.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -50.44 -62.25 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -41.99 -49.61 4.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.216 -0.928 . . . . 0.0 110.526 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.26 -50.21 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.44 -19.23 65.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 70.03 1.36 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.239 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 41' ' ' GLU . 4.9 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.269 0.557 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 171.0 15.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.277 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' HD13 ' A' ' 18' ' ' LEU . 14.5 m -121.41 155.93 58.53 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.6 Cg_endo -76.19 158.01 97.87 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.545 -2.273 . . . . 0.0 110.403 -0.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.84 151.27 15.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.84 143.56 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -1.123 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -150.78 158.39 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.62 132.11 54.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 110.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 37' ' ' TRP . 98.9 t -116.56 104.98 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 24.8 t0 55.14 -90.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -132.5 52.56 0.82 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.623 ' CD ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -153.15 152.51 31.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -1.144 . . . . 0.0 110.224 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.32 133.34 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.665 HG22 HD21 ' A' ' 26' ' ' ASN . 72.9 t -132.41 111.19 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 0.0 110.158 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 17' ' ' ILE . 11.5 tt -107.55 96.66 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.573 HD13 ' SG ' ' A' ' 5' ' ' CYS . 76.4 mt -61.65 122.94 16.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -152.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -37.4 87.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 22' ' ' CYS . 2.5 t0 -108.37 51.38 0.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 93.0 m 43.32 27.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.12 138.76 45.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.424 ' HG3' HD11 ' A' ' 38' ' ' LEU . 3.1 mtp -79.79 110.99 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.214 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.15 18.85 11.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.665 HD21 HG22 ' A' ' 16' ' ' VAL . 16.2 p-10 -135.12 52.34 7.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.5 Cg_endo -72.94 -22.64 19.53 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.999 1.526 . . . . 0.0 110.427 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -60.08 -18.0 43.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -127.2 36.92 4.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.897 . . . . 0.0 110.13 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 31.8 t90 -73.44 139.46 45.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.91 174.7 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 33' ' ' LYS . 25.4 pt-20 -66.42 -42.11 88.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 1.9 ttmm -67.85 -47.51 68.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.623 HG21 ' CD ' ' A' ' 14' ' ' LYS . 42.8 t -56.0 -54.41 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -56.8 -36.52 70.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.74 -44.73 93.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.624 ' CD2' HG22 ' A' ' 11' ' ' VAL . 38.0 t90 -64.64 -38.43 90.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.184 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -58.16 -51.68 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.29 -27.24 66.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -64.43 -49.03 73.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB3' HG11 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.17 -28.19 53.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.413 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 42' ' ' LEU . 2.9 mm? -84.34 -3.72 58.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.364 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.3 -46.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 122.51 12.72 4.99 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 45' ' ' ILE . 9.6 mt -76.16 79.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.14 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -50.21 60.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.263 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 131.31 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 71.4 mmm -74.38 121.01 20.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -76.43 -157.17 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 49' ' ' THR . 7.5 mp0 -92.86 -27.86 16.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -48.38 35.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.69 ' NE2' HD22 ' A' ' 89' ' ' LEU . 23.2 m80 -51.25 -46.5 62.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.267 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.9 m95 -72.15 -31.27 65.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -64.01 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.19 -43.43 98.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.911 . . . . 0.0 110.265 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 52' ' ' HIS . 37.4 t -60.32 -27.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.257 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 tttt -76.64 -53.89 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.561 ' CD2' HG13 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -53.1 60.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.53 -51.31 60.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.92 -41.82 46.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.51 ' CE2' ' HG3' ' A' ' 70' ' ' PRO . 4.9 t80 -65.74 -35.11 79.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.903 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.43 ' O ' ' CE3' ' A' ' 63' ' ' TRP . 36.0 t90 -66.42 -22.24 66.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.76 -10.64 59.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -81.31 -49.13 11.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -152.0 -38.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.98 88.48 0.95 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.77 -178.5 7.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 0.0 110.238 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.46 84.87 15.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 45.0 Cg_endo -72.44 125.92 11.13 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.395 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.57 91.54 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.897 1.472 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 73' ' ' LYS . 8.4 mm 48.56 -132.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 109.917 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' H ' HG22 ' A' ' 72' ' ' ILE . 8.3 mttt 57.81 -97.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.052 -1.03 . . . . 0.0 110.36 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.55 -23.91 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.03 -1.044 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.561 HG13 ' CD2' ' A' ' 58' ' ' TYR . 22.2 t -69.6 -47.18 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 110.301 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 73' ' ' LYS . 1.1 p -63.97 -34.86 78.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -43.99 -32.94 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 0.0 110.149 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.92 48.02 2.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.4 m -153.75 -70.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.54 87.35 1.92 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.16 104.55 2.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -1.131 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.4 143.3 40.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 83' ' ' LEU . 7.6 tp -60.56 -26.87 67.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -41.48 74.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.45 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -65.84 -58.04 6.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.396 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 94' ' ' PRO . 54.6 mt -46.29 -49.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 110.224 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -59.37 -41.39 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.17 -24.75 67.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.69 HD22 ' NE2' ' A' ' 52' ' ' HIS . 4.5 mt -79.48 -62.33 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 110.259 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 11.3 m-85 -85.08 170.81 12.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.123 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 42.5 Cg_endo -74.54 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.117 1.588 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.87 56.52 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.044 -1.035 . . . . 0.0 110.033 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.52 143.07 1.4 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HG3' HG23 ' A' ' 86' ' ' ILE . 45.5 Cg_endo -72.96 -90.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.954 1.502 . . . . 0.0 110.447 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . 53.91 -93.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 97' ' ' GLY . 5.1 m-70 -69.63 -57.39 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 96' ' ' HIS . . . -43.65 -59.1 3.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -47.48 -48.65 26.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.125 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 99.7 m -53.78 -62.54 1.59 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 99' ' ' CYS . 15.0 mttp -44.16 -45.87 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 54.4 t -53.76 -55.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.344 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.15 -22.74 66.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 104' ' ' ALA . . . 114.07 -46.65 1.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.354 -1.086 . . . . 0.0 110.276 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 41' ' ' GLU . 5.7 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.169 0.509 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 63.33 114.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.397 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 79.2 m -137.14 151.71 72.32 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.6 Cg_endo -78.62 162.91 87.29 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.316 -0.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.11 45.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 16.5 mt-10 -106.07 170.65 7.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.035 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 1.2 m-85 -169.52 171.21 7.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 110.344 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -132.6 137.97 47.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.583 HG22 ' CE2' ' A' ' 37' ' ' TRP . 75.8 t -117.71 106.88 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 51.18 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.96 60.06 0.68 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -161.44 164.26 29.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -1.132 . . . . 0.0 110.246 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.98 147.85 26.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 110.208 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.421 HG21 ' CG2' ' A' ' 11' ' ' VAL . 65.7 t -140.28 135.81 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 17' ' ' ILE . 4.5 mp -127.33 100.24 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 18' ' ' LEU . 43.0 mt -73.36 131.78 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -83.85 -146.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 110.385 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.4 -48.54 69.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.343 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -98.67 39.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.95 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 55.7 m 56.56 31.99 20.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.377 -0.827 . . . . 0.0 110.026 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.94 155.09 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -98.61 113.66 25.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.26 16.03 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.98 64.74 71.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.63 -15.85 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.969 1.51 . . . . 0.0 110.357 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -15.96 62.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -116.53 12.89 15.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.324 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.687 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 24.8 t90 -63.77 147.87 50.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -0.898 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.27 -154.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.11 -33.3 61.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -72.19 -39.87 68.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.274 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 41.2 t -72.9 -36.93 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.425 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -69.91 -50.46 42.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.381 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.76 -46.62 89.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 110.427 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.583 ' CE2' HG22 ' A' ' 11' ' ' VAL . 77.6 t90 -60.25 -54.63 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.509 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.94 -41.11 58.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.598 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.879 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -65.84 -37.06 85.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.562 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -35.58 74.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 3' ' ' VAL . 2.9 mm-40 -77.1 -30.05 55.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 110.383 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -75.98 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.919 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.3 -61.26 1.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.07 42.52 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.879 HD12 ' HB1' ' A' ' 39' ' ' ALA . 75.5 mt -78.88 99.86 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -1.117 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.59 -28.97 67.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -144.07 118.46 9.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.145 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.419 ' HG3' ' NE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -48.76 142.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.268 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 147.4 22.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.882 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 16.2 pt-20 -57.53 -36.85 72.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mm-40 -66.87 -34.62 78.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -69.09 -53.34 20.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 110.204 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.419 ' NE1' ' HG3' ' A' ' 48' ' ' MET . 5.0 m95 -58.28 -27.96 64.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -56.81 5.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -39.42 65.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.056 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -69.46 -32.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.13 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -49.78 69.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -65.9 -37.25 85.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.86 75.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 110.314 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 38.1 ttm-85 -60.08 -28.93 68.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 110.33 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 1.8 tt0 -56.77 -60.84 2.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -69.55 -26.57 64.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 110.198 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 60' ' ' ARG . 32.5 t90 -65.94 -20.16 66.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 110.338 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.96 -0.46 47.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -108.34 -60.52 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.933 . . . . 0.0 110.306 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' GLY . 4.8 m-85 -107.17 7.65 29.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' PHE . . . 45.91 69.83 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.23 147.31 25.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.7 t -116.19 83.71 13.04 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.62 169.85 21.36 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.953 1.502 . . . . 0.0 110.355 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.02 -160.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.012 1.533 . . . . 0.0 110.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 72' ' ' ILE . 25.1 mm -102.75 40.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.78 -58.82 1.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.256 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mmt -61.76 -28.85 69.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' O ' ' OG1' ' A' ' 79' ' ' THR . 6.8 t -71.43 -38.07 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.579 HG23 ' H ' ' A' ' 81' ' ' PHE . 1.0 OUTLIER -63.79 -27.03 68.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.87 -29.92 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.68 46.63 2.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.255 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 24.5 m -148.29 -50.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.243 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.68 1.16 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -127.35 143.93 51.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -1.171 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 130.59 54.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.9 -34.24 62.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 19.8 tt0 -58.01 -55.23 37.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.447 ' CE ' HD11 ' A' ' 89' ' ' LEU . 1.3 tptm -51.97 -52.16 52.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 94' ' ' PRO . 57.3 mt -54.94 -31.04 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.086 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -67.88 -51.16 51.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.222 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.57 68.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.447 HD11 ' CE ' ' A' ' 85' ' ' LYS . 13.8 mt -73.32 -66.73 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.244 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 102.29 51.17 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.07 94.76 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.918 1.483 . . . . 0.0 110.442 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 177.7 -37.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.21 131.85 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HB2' HG13 ' A' ' 72' ' ' ILE . 46.9 Cg_endo -73.37 -162.89 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.937 1.493 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 56.08 -90.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.3 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.47 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 57.1 m-70 -59.43 -33.85 71.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -69.62 -67.15 2.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.62 -52.3 4.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -46.91 81.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.79 -36.73 48.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 t -74.43 -36.24 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.61 -21.69 61.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.94 72.33 0.95 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.192 -1.181 . . . . 0.0 110.195 -179.939 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.282 0.563 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -128.92 157.78 40.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.7 m -116.63 146.41 37.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.5 174.21 53.98 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.357 -0.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' ILE . . . -176.34 173.03 46.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.532 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -150.82 138.35 19.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -1.115 . . . . 0.0 110.041 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 51.6 m-85 -145.22 171.31 14.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -104.47 111.56 24.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 91.6 t -118.86 107.79 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.263 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 11.0 t0 66.06 64.73 0.53 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 44.7 32.12 2.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.3 mttp -129.03 165.0 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.145 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -122.14 113.43 19.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 93.1 t -111.08 145.72 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.101 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 3.5 tt -137.53 109.61 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 110.223 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 56.4 mt -78.25 134.64 37.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 4.6 t0 -67.11 -167.97 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -17.92 65.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.26 38.14 3.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 53.1 m 47.68 39.09 9.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.1 155.55 16.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 90.68 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.421 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 19.5 pt20 -83.62 -4.21 58.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.457 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 1.8 t30 -121.39 62.74 12.6 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 45.8 Cg_endo -72.86 -16.27 26.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.015 1.534 . . . . 0.0 110.396 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -64.22 -25.06 67.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.69 0.37 30.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 42.7 t90 -46.38 148.19 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -168.45 2.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 4.9 tt0 -74.93 -55.35 5.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -30.87 71.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 110.203 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.01 -50.04 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -59.89 -50.83 72.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.62 -57.73 11.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 110.281 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 59.1 t90 -47.78 -36.85 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.64 -57.1 8.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.266 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -51.38 -28.49 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.306 -0.871 . . . . 0.0 110.189 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -62.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.892 . . . . 0.0 110.219 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -48.97 -37.0 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.318 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HA ' HD13 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -80.78 -75.33 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.315 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.4 -76.8 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.68 38.65 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.575 HD12 ' HB1' ' A' ' 39' ' ' ALA . 43.1 mt -79.73 104.4 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 110.034 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -78.8 -19.09 52.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.334 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -151.61 96.46 2.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 45' ' ' ILE . 70.8 mmm -52.06 103.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.039 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 1.0 HG22 ' ND1' ' A' ' 52' ' ' HIS . 2.3 t -55.99 160.34 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.87 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -52.61 -36.63 56.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -0.936 . . . . 0.0 110.281 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -35.29 79.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.311 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 1.0 ' ND1' HG22 ' A' ' 49' ' ' THR . 22.4 m170 -65.16 -60.53 2.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.943 . . . . 0.0 110.541 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.579 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 5.4 m95 -57.02 -34.22 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.733 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -62.91 -60.1 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.163 -0.961 . . . . 0.0 110.464 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 86' ' ' ILE . 1.9 tp -52.3 -39.16 60.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 52' ' ' HIS . 60.8 t -68.6 -30.88 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.185 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -49.8 64.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.11 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.587 ' CE2' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -66.86 -34.35 77.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -63.05 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -66.13 -49.46 67.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -43.75 -46.18 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.95 -32.1 63.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.218 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.453 ' CG ' ' O ' ' A' ' 63' ' ' TRP . 78.7 t90 -81.63 8.75 9.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -113.36 -17.59 12.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.69 -46.02 3.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.082 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.79 -50.91 9.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.08 25.12 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 t -167.03 168.06 14.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -1.153 . . . . 0.0 110.109 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 69' ' ' CYS . 23.5 p -114.01 104.72 54.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 172.02 16.41 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.015 1.534 . . . . 0.0 110.433 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.87 -169.83 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 72' ' ' ILE . 45.6 mm -97.54 63.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -107.26 -63.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 mtm -74.77 -19.36 60.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.74 -29.99 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.231 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 84.0 m -59.32 -36.72 76.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.04 -28.19 54.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 -76.12 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 ' CE2' ' A' ' 58' ' ' TYR . 66.5 p -67.3 -51.16 56.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.279 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 106.75 9.07 31.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.96 108.21 2.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -1.156 . . . . 0.0 110.142 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.07 139.38 47.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.16 -27.86 67.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -49.32 72.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.154 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -51.52 -55.25 20.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 110.12 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mt -54.82 -39.19 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.17 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.26 -36.84 78.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -75.31 -27.37 59.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 0.0 110.194 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.566 HD22 ' NE2' ' A' ' 52' ' ' HIS . 14.9 mt -92.48 -5.36 52.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.299 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -156.43 99.61 2.09 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.199 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 90' ' ' PHE . 46.1 Cg_endo -73.25 -17.53 24.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.996 1.524 . . . . 0.0 110.459 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.9 m -67.47 -29.89 69.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.85 147.71 8.48 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.12 -1.79 11.08 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.051 1.553 . . . . 0.0 110.48 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.453 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . -79.65 -86.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 110.239 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -73.85 -5.42 40.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.363 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 101' ' ' VAL . . . -65.23 -94.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -42.69 -27.26 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 56.0 m -65.63 -79.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -43.04 -40.25 3.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 110.289 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 97' ' ' GLY . 92.1 t -55.91 -48.72 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 110.247 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -65.39 -49.64 68.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.61 54.38 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.228 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.534 HG11 ' CH2' ' A' ' 37' ' ' TRP . 5.0 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.122 0.487 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.33 107.92 3.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 26.3 p -88.13 158.73 49.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 110.098 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.45 145.05 82.3 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.667 -2.222 . . . . 0.0 110.476 -0.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.08 174.93 46.91 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 125.96 54.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 110.123 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -129.99 156.18 44.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -113.29 134.78 54.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 99.0 t -116.3 94.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.483 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' GLY . 1.1 m-20 48.29 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.542 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.0 59.52 3.31 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 1.3 mttt -166.6 153.2 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -1.138 . . . . 0.0 110.109 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -116.73 145.84 43.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 110.279 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.99 138.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.13 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 17' ' ' ILE . 50.8 mt -117.36 96.85 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.367 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.646 HD22 ' HA ' ' A' ' 22' ' ' CYS . 16.4 mt -75.02 121.91 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -69.84 -171.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -62.47 -16.89 57.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.29 36.72 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.646 ' HA ' HD22 ' A' ' 18' ' ' LEU . 1.3 m 50.61 29.07 3.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -84.57 141.14 30.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.215 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.5 ttt -89.46 115.06 26.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -92.7 22.89 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -133.2 67.06 76.62 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.321 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.07 -13.7 26.09 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.027 1.54 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -78.17 -10.81 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.192 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' TRP . 21.6 t70 -110.93 -5.12 14.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.455 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 12.0 t90 -44.0 143.15 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.188 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 18.6 m-20 -159.93 -163.43 1.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.474 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -74.52 -58.76 3.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -65.41 -31.03 71.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.188 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.5 t -66.99 -53.02 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.483 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -63.08 -53.83 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 2.7 tt0 -52.33 -36.23 52.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.534 ' CH2' HG11 ' A' ' 3' ' ' VAL . 28.1 t90 -70.08 -38.13 75.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -51.54 66.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.709 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -68.65 -26.53 65.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.7 -44.61 73.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.503 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -77.31 -36.93 53.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.144 -0.972 . . . . 0.0 110.797 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -58.56 2.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.677 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -16.63 55.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.472 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 85.48 14.64 67.88 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.709 HD12 ' HB1' ' A' ' 39' ' ' ALA . 8.0 mt -67.23 101.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -70.48 -13.87 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.235 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -168.32 120.21 0.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.508 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 31.5 mmm -67.74 131.68 46.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.29 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.0 p -78.68 -167.16 1.02 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.99 -52.61 7.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -56.61 -30.63 63.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.124 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.54 -61.05 2.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.193 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.483 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 3.7 m95 -57.21 -33.7 67.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 4.2 tmtm? -58.2 -57.14 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.198 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tp -56.9 -50.88 71.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.198 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' HIS . 47.7 t -54.14 -29.04 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 54' ' ' LYS . 9.5 mmtt -73.44 -53.79 9.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 110.261 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.427 ' O ' ' HB2' ' A' ' 62' ' ' TYR . 3.1 t80 -51.3 -41.28 60.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 110.342 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -49.53 77.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.306 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.98 -60.34 4.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -27.01 4.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.29 -0.881 . . . . 0.0 110.361 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.8 -37.66 58.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.425 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 41.9 t90 -65.05 -22.22 66.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.314 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.19 -59.06 5.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.211 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -75.89 -58.52 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.247 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -65.3 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 110.209 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.23 18.94 3.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.537 HG23 ' HD3' ' A' ' 70' ' ' PRO . 8.8 t -141.22 174.22 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.148 . . . . 0.0 110.135 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 t -124.69 84.69 57.51 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD3' HG23 ' A' ' 68' ' ' THR . 46.2 Cg_endo -73.17 173.73 13.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.981 1.516 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.7 Cg_endo -73.09 160.44 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.002 1.528 . . . . 0.0 110.313 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.1 tt -79.03 -7.06 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.145 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -55.1 -62.81 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -63.74 -27.08 68.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.071 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.84 -34.22 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -54.8 -27.65 43.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -65.04 -39.4 93.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -70.05 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.113 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 p -46.8 -39.09 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.91 8.7 84.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -55.4 171.82 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.807 ' O ' HD12 ' A' ' 86' ' ' ILE . 15.8 m -113.94 147.23 38.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 13.0 tp -60.44 -27.9 67.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 110.268 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -63.67 -59.95 3.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.272 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.807 HD12 ' O ' ' A' ' 82' ' ' SER . 3.5 mt -47.01 -33.04 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.377 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -77.0 -36.32 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.923 . . . . 0.0 110.378 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.63 -24.36 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.37 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.22 -49.99 6.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -98.43 167.22 11.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.217 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.68 -89.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.998 1.525 . . . . 0.0 110.505 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.7 t -104.68 85.77 2.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 61.3 139.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 46.4 Cg_endo -73.05 -90.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.061 1.558 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 62.28 -132.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 95' ' ' ALA . 23.2 p80 -42.28 -25.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.0 110.582 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 95' ' ' ALA . . . -66.63 -74.56 0.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.17 -48.1 4.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -1.107 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.4 t -57.01 -44.09 82.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.468 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -60.64 -58.22 9.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.373 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.0 t -46.76 -41.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.29 59.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.52 52.23 3.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.524 HG21 ' HG3' ' A' ' 41' ' ' GLU . 13.2 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.308 0.575 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 133.68 55.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.157 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 62.3 m -103.09 150.38 37.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.4 Cg_endo -76.36 165.6 84.88 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.612 -2.245 . . . . 0.0 110.412 -0.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 154.91 20.26 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.33 152.56 27.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -1.144 . . . . 0.0 110.168 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -149.15 157.06 43.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.481 ' C ' HG23 ' A' ' 11' ' ' VAL . 1.1 tp60 -110.55 145.01 38.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.243 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.481 HG23 ' C ' ' A' ' 10' ' ' GLN . 22.7 t -148.79 110.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.023 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t0 58.51 -143.85 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.951 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.42 50.44 2.99 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.0 146.36 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.243 . . . . 0.0 110.319 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.98 143.18 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.098 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 17' ' ' ILE . 85.0 t -127.79 162.31 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.351 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.476 HG12 ' N ' ' A' ' 18' ' ' LEU . 8.7 tt -148.96 164.37 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' ' 17' ' ' ILE . 16.6 mt -136.43 115.78 12.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.908 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -57.74 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.47 -20.71 66.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.32 38.85 2.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.5 m 48.46 42.57 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -96.52 145.13 25.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.431 ' SD ' HD12 ' A' ' 38' ' ' LEU . 2.1 mtp -82.81 105.43 13.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.33 19.42 13.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -129.51 71.81 82.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.69 -30.5 11.7 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.139 1.6 . . . . 0.0 110.418 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.09 -16.9 64.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.83 35.68 3.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -90.85 153.59 20.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.84 -168.08 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.497 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 2.5 mt-10 -72.12 -57.06 4.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.198 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.77 -29.99 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.34 -57.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -55.44 -38.74 69.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.309 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -52.23 63.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ2' ' OE2' ' A' ' 41' ' ' GLU . 57.9 t90 -56.87 -33.13 66.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 38' ' ' LEU . 4.8 tt -69.57 -42.9 73.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.55 -31.43 72.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -74.63 -44.07 52.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HG3' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -62.97 -36.93 85.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.865 . . . . 0.0 110.145 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -83.46 -67.75 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 45' ' ' ILE . 4.3 tt0 -80.44 -66.38 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.61 -13.9 2.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.401 ' CD1' ' OE1' ' A' ' 43' ' ' GLU . 33.7 mt -44.19 134.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -106.77 3.85 26.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.212 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -161.03 91.29 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -44.95 123.85 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 52' ' ' HIS . 3.3 t -73.83 158.42 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.257 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -34.47 55.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.24 -43.34 92.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.799 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -58.25 -56.66 19.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.224 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.651 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 6.6 m95 -59.29 -27.31 65.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -67.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.61 -32.44 58.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.152 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.72 -33.53 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.47 -42.43 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 110.136 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -44.42 94.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.15 -50.99 71.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 110.236 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -49.17 -50.05 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.381 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.78 -38.97 61.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.58 74.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -52.86 -46.52 67.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.16 -35.48 80.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.334 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.2 m -64.66 -33.99 77.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -142.11 -69.18 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.27 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.62 79.11 0.38 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.447 HG23 ' HD3' ' A' ' 70' ' ' PRO . 5.3 t -162.7 159.88 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -1.185 . . . . 0.0 110.18 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.6 t -112.6 82.52 4.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD3' HG23 ' A' ' 68' ' ' THR . 45.1 Cg_endo -73.42 160.25 44.99 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.15 -89.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.095 1.576 . . . . 0.0 110.454 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -172.14 42.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -64.83 1.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.15 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -40.22 95.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' OG1' ' A' ' 79' ' ' THR . 20.8 t -52.63 -37.17 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m -66.19 -33.58 76.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -74.17 -33.1 63.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.59 -35.39 62.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -107.44 -78.44 0.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.22 38.42 0.23 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -91.99 128.9 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 84' ' ' GLU . 72.4 m -77.83 134.68 37.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.898 . . . . 0.0 110.238 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 82' ' ' SER . 1.3 tp -42.8 -26.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -60.73 -53.3 59.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.34 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -47.92 79.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.64 -30.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -72.35 -48.08 44.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -38.5 80.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD22 ' CE1' ' A' ' 52' ' ' HIS . 8.1 mt -68.36 -65.58 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.084 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.1 m-85 -82.25 173.7 7.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.3 Cg_endo -73.65 -88.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.984 1.518 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -155.86 80.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.56 82.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.07 -17.63 24.66 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.932 1.49 . . . . 0.0 110.432 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.77 -88.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -76.81 -2.26 32.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.18 -70.41 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.81 -36.53 37.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.188 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.2 m -70.26 -52.74 20.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -33.25 36.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 110.173 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.446 HG21 ' HZ ' ' A' ' 90' ' ' PHE . 25.1 t -73.62 -45.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.092 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -21.63 66.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.74 53.9 3.41 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.205 -1.174 . . . . 0.0 110.135 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 9' ' ' TYR . 7.0 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.275 0.559 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.45 148.0 52.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.4 m -102.84 141.11 21.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.36 159.21 97.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 -2.153 . . . . 0.0 110.314 -0.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.77 136.34 3.01 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' OE2' HG12 ' A' ' 17' ' ' ILE . 12.4 tt0 -101.24 142.53 32.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -1.104 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CE2' HG12 ' A' ' 3' ' ' VAL . 25.5 m-85 -150.68 148.49 28.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -101.77 143.95 31.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.065 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 43.7 t -120.37 94.87 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 110.448 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.41 63.68 2.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.52 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.53 14.48 79.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 11' ' ' VAL . 16.1 mmtt -102.82 169.96 8.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -1.205 . . . . 0.0 110.162 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.53 108.57 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.558 HG13 ' HB3' ' A' ' 24' ' ' MET . 55.2 t -116.73 145.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.26 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.448 HG12 ' OE2' ' A' ' 8' ' ' GLU . 3.6 mt -134.51 97.47 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.79 110.15 6.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.273 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -68.46 -141.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.77 -2.71 58.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.872 . . . . 0.0 110.145 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.42 38.01 4.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.3 m 47.9 49.14 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -119.69 116.19 25.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.558 ' HB3' HG13 ' A' ' 16' ' ' VAL . 1.8 ptp -51.83 -21.75 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.63 29.81 5.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.62 75.97 36.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 110.175 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.84 -21.46 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.007 1.53 . . . . 0.0 110.408 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -38.34 73.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.74 -2.77 57.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -61.93 125.6 24.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -0.969 . . . . 0.0 110.277 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.3 -162.9 1.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.495 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -72.14 -62.43 1.44 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.965 . . . . 0.0 110.284 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -48.29 -49.28 34.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.31 -52.1 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.236 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -50.77 -36.19 35.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 46.2 mt-10 -72.85 -36.61 67.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -60.49 -48.13 83.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.397 -0.815 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 42' ' ' LEU . 8.1 mt -67.36 -51.21 54.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 110.32 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -53.75 -29.17 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -77.07 -60.82 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.95 -35.35 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 38' ' ' LEU . 6.0 mp -80.16 -66.53 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -89.81 -47.62 7.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 119.47 13.69 6.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.488 HD12 ' HB1' ' A' ' 39' ' ' ALA . 63.2 mt -54.8 92.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -1.158 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 44' ' ' GLY . 3.5 mp0 -57.48 -35.79 70.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.216 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 146.1 46.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.508 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -85.07 134.74 34.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.325 -0.859 . . . . 0.0 110.208 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -93.36 -179.13 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.42 -21.7 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -77.05 -36.25 56.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -71.09 -54.8 9.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.515 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 3.0 m95 -57.67 -33.22 68.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -67.33 -59.09 3.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.142 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.56 -35.77 31.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.89 -40.37 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -63.04 -35.44 80.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.2 -36.85 61.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.247 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.2 -29.43 68.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -59.64 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -44.85 -45.94 10.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.247 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -44.79 96.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.283 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.541 ' O ' ' CE3' ' A' ' 63' ' ' TRP . 21.4 t90 -67.88 -14.5 63.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.329 -0.857 . . . . 0.0 110.287 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.17 -49.83 8.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.302 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.95 -49.09 16.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.65 -72.46 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.16 89.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.412 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.04 174.86 14.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -1.177 . . . . 0.0 110.014 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -153.58 57.52 1.95 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.412 ' HD3' ' HB ' ' A' ' 68' ' ' THR . 46.3 Cg_endo -73.02 171.79 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.975 1.513 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 45.9 Cg_endo -72.68 171.7 16.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.098 1.578 . . . . 0.0 110.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.798 HG21 ' CD1' ' A' ' 86' ' ' ILE . 3.5 tp -68.08 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -178.54 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 109.98 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -27.18 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.048 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 t -77.04 -27.52 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -54.95 -38.82 68.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -36.97 16.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.432 ' OE1' ' HA ' ' A' ' 78' ' ' GLU . 13.5 mm-40 -87.98 -32.64 18.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.28 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -97.2 -74.91 0.56 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.01 36.88 1.09 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -92.64 88.31 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.188 -1.183 . . . . 0.0 110.228 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.4 m -49.29 136.07 16.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 72' ' ' ILE . 1.2 mp -44.16 -31.92 1.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.282 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.22 -53.8 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.249 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -48.55 81.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.798 ' CD1' HG21 ' A' ' 72' ' ' ILE . 79.2 mt -53.37 -29.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.912 . . . . 0.0 110.151 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -77.02 -45.22 27.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.12 -33.56 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 110.267 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.91 -63.89 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.446 ' HE2' HG21 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -101.26 106.48 45.54 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.86 -38.13 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.973 1.512 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -49.3 -28.81 5.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.271 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.43 151.59 18.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.651 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 45.7 Cg_endo -73.41 -170.33 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.017 1.535 . . . . 0.0 110.445 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 66.85 -84.34 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.339 -0.851 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -74.24 -34.05 63.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.03 -1.044 . . . . 0.0 110.379 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.2 -58.64 5.01 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.93 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -1.161 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 5.4 t -61.18 -51.06 70.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -48.82 -50.09 36.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.446 HG21 ' HE2' ' A' ' 90' ' ' PHE . 52.1 t -64.15 -35.65 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.423 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.64 69.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.71 36.24 29.79 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.281 -1.129 . . . . 0.0 110.177 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.619 HG11 ' CD1' ' A' ' 18' ' ' LEU . 48.3 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.214 0.531 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 mttt 53.7 96.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.499 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 61.5 m -97.11 157.83 34.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.8 Cg_endo -75.5 170.8 70.85 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.387 -0.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -177.02 150.66 10.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -106.43 137.26 44.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -1.095 . . . . 0.0 110.301 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.482 ' CE2' HG13 ' A' ' 3' ' ' VAL . 73.0 m-85 -134.66 170.64 15.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 140.65 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.272 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 39.5 t -122.98 99.13 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.0 110.036 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 10.0 t0 55.89 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -130.91 62.83 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.32 157.17 17.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -114.88 133.91 55.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.93 124.9 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.14 97.98 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.619 ' CD1' HG11 ' A' ' 3' ' ' VAL . 20.5 mt -67.48 108.54 2.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 18' ' ' LEU . 34.3 t0 -49.62 -179.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.819 . . . . 0.0 110.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -62.58 -15.81 53.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.915 . . . . 0.0 110.223 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 1.5 m-20 -117.07 41.99 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.0 m 48.2 49.91 16.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -109.65 161.45 15.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.424 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -89.73 108.85 19.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.233 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.82 4.57 28.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.505 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 4.3 m-20 -131.62 51.97 8.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.1 Cg_endo -72.56 -13.52 27.44 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.032 1.543 . . . . 0.0 110.474 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -37.65 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' TRP . 0.9 OUTLIER -95.78 -70.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 110.213 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.577 ' CD2' ' N ' ' A' ' 31' ' ' ASP . 37.2 t90 55.78 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.155 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.577 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -172.86 -172.93 0.91 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.87 -41.33 68.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -70.06 -32.43 70.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.9 t -70.04 -51.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.62 44.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.07 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -39.84 70.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.481 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 83.3 t90 -64.57 -31.79 73.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.877 . . . . 0.0 110.184 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 24' ' ' MET . 5.3 mt -70.79 -44.18 67.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.352 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.36 67.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -76.76 -36.04 57.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 37' ' ' TRP . 3.2 mm-40 -77.18 -27.02 53.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.554 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.2 -62.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.551 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.04 -78.12 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.99 51.48 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.88 107.8 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -1.105 . . . . 0.0 110.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -42.73 -43.36 3.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.311 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 143.11 28.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.29 125.33 22.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 49' ' ' THR . 19.0 p -70.76 160.84 31.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.226 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.08 -27.34 32.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.6 -41.4 62.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 110.394 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -61.83 -48.81 78.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.438 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.0 m95 -65.82 -31.94 73.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.41 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 1.4 tttt -64.57 -66.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -53.94 -49.98 67.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 101' ' ' VAL . 34.3 t -55.33 -31.41 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.33 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -70.29 -46.64 63.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.211 -0.93 . . . . 0.0 110.192 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -60.2 -34.72 74.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.378 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -43.3 86.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.0 110.453 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -55.81 27.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.436 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.06 -27.38 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.947 . . . . 0.0 110.347 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.572 ' CG ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -76.8 -42.32 41.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.569 ' O ' ' CE3' ' A' ' 63' ' ' TRP . 19.2 t90 -58.18 -20.31 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.304 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.54 -42.14 30.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.31 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -60.26 3.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -116.99 -33.78 4.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 63' ' ' TRP . . . 93.01 71.59 1.17 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.3 t -166.09 -175.15 3.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.211 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.0 m -102.3 106.01 46.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.572 ' HG3' ' CG ' ' A' ' 62' ' ' TYR . 45.8 Cg_endo -72.94 144.92 39.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.052 1.553 . . . . 0.0 110.459 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 -178.28 3.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.091 1.574 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.8 62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -130.89 -50.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 74' ' ' MET . 0.9 OUTLIER -67.23 -37.75 84.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.282 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.1 t -65.59 -55.76 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.0 m -52.87 -26.84 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.17 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.92 -41.46 24.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.98 32.7 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.351 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.893 HG22 ' CD1' ' A' ' 81' ' ' PHE . 46.2 m -123.77 -22.33 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.13 78.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.893 ' CD1' HG22 ' A' ' 79' ' ' THR . 3.3 m-85 -96.55 172.68 7.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.144 . . . . 0.0 110.121 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.6 148.92 34.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.65 -27.59 64.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 110.222 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.56 -52.2 64.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -33.21 68.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 55' ' ' LEU . 50.4 mt -73.67 -29.01 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 110.073 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -35.76 66.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -40.8 50.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -39.44 79.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 110.242 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 116.14 32.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.067 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.76 -7.82 20.61 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.579 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 92' ' ' SER . 1.3 t -104.11 21.3 16.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 59.06 161.04 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -73.09 -16.68 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.977 1.514 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 94' ' ' PRO . . . -45.57 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -77.2 -2.91 36.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 110.209 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.55 -91.96 0.16 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -43.1 -34.31 1.04 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.396 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.16 -62.37 1.66 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.02 -38.01 48.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.285 -0.884 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.786 HG11 HG21 ' A' ' 56' ' ' VAL . 52.6 t -58.97 -59.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.938 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 56' ' ' VAL . . . -71.64 -7.07 45.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 110.305 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.79 79.45 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 110.201 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 18' ' ' LEU . 56.6 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.259 0.552 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -96.14 109.32 21.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 p -108.94 152.09 42.22 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.219 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.1 Cg_endo -75.57 161.59 94.13 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.644 -2.232 . . . . 0.0 110.548 -0.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.02 47.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -104.66 121.69 44.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.163 . . . . 0.0 110.364 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -137.09 155.44 49.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -117.31 145.62 43.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.26 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' GLY . 42.4 t -125.66 125.83 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.86 -91.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -137.98 59.44 0.61 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.16 170.34 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 110.225 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.02 136.21 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.603 HG13 ' HG2' ' A' ' 24' ' ' MET . 56.0 t -137.67 144.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mt -112.29 105.85 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 6' ' ' PRO . 11.8 mt -62.64 129.61 41.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.9 t0 -84.5 -160.43 0.47 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.45 -13.05 60.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -107.59 26.27 10.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 5' ' ' CYS . 2.7 m 50.7 23.73 1.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 24' ' ' MET . 68.3 t80 -109.44 155.86 20.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.603 ' HG2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -59.79 138.07 57.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.212 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -20.38 31.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -124.8 71.7 60.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.058 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.29 -9.43 25.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.031 1.542 . . . . 0.0 110.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.63 -35.79 6.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.104 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' TRP . 53.5 m-20 -93.48 -74.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 110.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.532 ' CE2' ' HB2' ' A' ' 35' ' ' ALA . 82.9 t90 52.15 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.285 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.54 -170.61 1.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.99 -57.44 4.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.342 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -54.83 -27.37 41.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.372 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.64 -48.77 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.671 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -60.11 -48.23 82.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -42.93 97.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -0.908 . . . . 0.0 110.428 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CZ3' HG21 ' A' ' 11' ' ' VAL . 39.3 t90 -57.25 -47.66 80.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.311 -0.868 . . . . 0.0 110.506 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 13.1 mt -62.52 -43.24 99.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.963 . . . . 0.0 110.493 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.78 -26.99 67.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 0.0 110.439 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.422 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.2 -43.77 32.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.0 110.732 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.46 -27.82 60.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.97 . . . . 0.0 110.682 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -80.61 -47.5 14.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.97 . . . . 0.0 110.395 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.31 -48.37 4.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.258 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 121.13 12.15 5.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.13 106.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -1.132 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.1 -46.53 8.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -154.64 121.41 5.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.488 ' SD ' ' CG ' ' A' ' 52' ' ' HIS . 31.1 mmm -44.44 133.05 5.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 50' ' ' GLU . 5.9 t -74.46 -155.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 110.12 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 49' ' ' THR . 15.6 tt0 -87.63 -48.57 7.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -59.86 -26.67 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -63.57 -55.92 20.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.86 . . . . 0.0 110.441 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.671 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 2.5 m95 -61.6 -50.09 73.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -52.12 -45.94 65.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 0.0 110.309 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.559 ' CD1' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -62.19 -60.75 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.8 t -49.2 -27.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 110.259 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -71.86 -48.65 44.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -37.25 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -43.48 73.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.284 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -53.98 -46.59 71.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.267 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.32 -39.78 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.13 -36.54 55.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.454 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -76.36 2.64 12.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.432 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -116.53 -4.92 11.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -107.09 -44.09 4.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.158 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -114.01 -43.15 3.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.45 54.07 0.85 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.491 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 18.6 m -146.28 146.44 30.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -1.137 . . . . 0.0 110.114 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.2 t -104.85 95.65 9.35 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 68' ' ' THR . 47.4 Cg_endo -73.47 163.43 37.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.974 1.512 . . . . 0.0 110.484 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 45.2 Cg_endo -72.65 -89.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.96 1.505 . . . . 0.0 110.457 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -178.46 62.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.243 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -119.93 -54.17 2.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 110.18 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -25.42 63.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 t -72.31 -42.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.6 m -67.55 -29.73 69.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -38.76 5.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -99.34 -76.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 78' ' ' GLU . 54.7 p -42.86 -45.25 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.229 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.08 34.69 46.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -58.63 116.64 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.254 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.56 129.0 38.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.196 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -48.82 -37.1 18.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.7 -45.36 63.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 110.137 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -40.4 92.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.18 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 24.7 mm -66.26 -27.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -45.3 32.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.949 . . . . 0.0 110.317 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -53.21 46.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.34 -45.27 93.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 110.181 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.07 84.83 59.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 92' ' ' SER . 46.2 Cg_endo -73.47 86.7 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.971 1.511 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER 172.7 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.87 127.65 1.72 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.9 Cg_endo -72.91 -18.0 24.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.755 1.397 . . . . 0.0 110.435 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.08 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 2.8 m170 -75.61 -5.37 45.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 110.273 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 101' ' ' VAL . . . -78.23 -84.26 0.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.41 -29.18 0.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -1.11 . . . . 0.0 110.53 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 t -73.98 -49.28 25.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.409 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 17.4 ttmm -61.18 -35.19 76.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.407 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 97' ' ' GLY . 9.1 t -73.56 -42.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.6 64.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.319 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.44 67.22 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.713 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.273 -1.133 . . . . 0.0 110.218 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 7.8 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.189 0.519 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -124.31 109.55 13.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 71.8 m -84.43 150.46 57.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.091 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.3 Cg_endo -76.13 162.28 92.41 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.486 -0.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.42 157.75 24.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.14 131.64 45.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -1.216 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 3' ' ' VAL . 66.3 m-85 -136.57 144.56 44.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.122 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 6.0 tt0 -112.65 126.95 55.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 60.5 t -108.65 94.54 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 42.4 t0 60.52 71.47 0.57 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.639 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.9 14.36 23.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 12.7 mmtt -108.83 152.19 25.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.071 -1.252 . . . . 0.0 110.103 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -106.29 136.39 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.41 117.53 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 26' ' ' ASN . 2.3 mp -100.4 115.92 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.542 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 18' ' ' LEU . 21.7 mt -95.09 116.71 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 109.989 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -94.97 -163.38 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -42.42 126.03 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER 64.13 39.29 7.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m 48.12 50.16 16.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.14 113.81 20.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' MET . . . . . 0.811 ' SD ' HD11 ' A' ' 38' ' ' LEU . 4.4 tpt -50.8 145.8 6.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.166 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -143.2 18.14 1.91 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.489 ' HB2' HD12 ' A' ' 17' ' ' ILE . 20.8 t30 -125.2 59.97 26.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.27 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 -8.95 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.951 1.501 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.3 -36.03 52.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.45 -77.83 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t90 61.16 107.76 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -124.52 -178.15 4.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -45.86 77.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.266 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.71 -35.57 78.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.1 t -65.92 -54.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -56.58 -40.89 76.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.878 . . . . 0.0 110.322 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -62.62 1.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.349 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -51.04 -30.59 15.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.39 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.811 HD11 ' SD ' ' A' ' 24' ' ' MET . 2.2 mt -65.28 -52.26 55.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.369 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.08 -30.32 70.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.353 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -29.32 61.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.99 -37.87 54.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 110.34 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 42' ' ' LEU . 10.2 tp -80.27 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -95.38 -84.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.161 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.63 39.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.8 mt -79.7 88.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -45.06 -30.21 1.03 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 48' ' ' MET . 9.2 mttp -150.23 113.1 4.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.462 ' HA ' HG21 ' A' ' 45' ' ' ILE . 52.6 mmm -42.75 120.61 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.4 p -66.34 150.96 48.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.0 110.23 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.69 52.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.217 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -40.29 85.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 110.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.71 -56.19 24.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.167 -0.958 . . . . 0.0 109.964 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.1 m95 -59.76 -28.58 67.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 110.003 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -66.48 -41.7 88.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.788 ' O ' HD12 ' A' ' 59' ' ' LEU . 3.2 tp -68.55 -38.09 80.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.933 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.31 -39.67 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' TRP . 3.2 mtpp -64.91 -51.57 61.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.069 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.17 -41.14 78.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 110.114 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 110.056 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.2 mmm-85 -57.04 -36.28 70.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.24 -36.35 81.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.137 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.23 -30.74 66.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.418 ' HA ' ' OG1' ' A' ' 68' ' ' THR . 19.8 t90 -58.01 -27.31 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -95.65 29.67 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.213 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.04 -52.88 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -130.22 -78.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.21 25.12 0.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER 58.46 -167.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 110.257 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 68' ' ' THR . 1.1 m 54.34 61.46 9.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 163.47 38.42 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.079 1.568 . . . . 0.0 110.48 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.3 -179.28 4.26 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.066 1.561 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 72' ' ' ILE . 11.3 tp -88.45 28.43 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -126.96 -31.62 2.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.199 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -21.98 44.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 79' ' ' THR . 31.5 t -67.31 -53.79 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t -72.2 -27.16 62.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.29 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.95 -37.57 1.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 110.196 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -142.05 53.86 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 75' ' ' VAL . 50.3 m -161.74 -37.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.158 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.3 33.92 18.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.64 124.43 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -1.126 . . . . 0.0 110.119 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.38 149.25 21.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.258 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -50.91 -27.04 6.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.97 -46.02 89.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.592 HD12 ' H ' ' A' ' 86' ' ' ILE . 3.2 mp -63.67 -28.67 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -37.84 54.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.269 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.96 -26.26 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.67 -57.03 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -91.59 169.05 11.97 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.53 -55.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.097 1.578 . . . . 0.0 110.466 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.76 104.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.69 77.2 0.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.7 Cg_endo -72.69 -10.85 25.56 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.022 1.538 . . . . 0.0 110.39 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.29 -77.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.96 -7.55 53.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.297 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.29 -77.17 0.77 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.83 -35.09 4.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.174 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.5 m -68.1 -58.23 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 110.27 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -50.21 -26.96 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.04 -56.71 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . . . -61.4 -12.41 14.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.233 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . 85.75 80.13 1.15 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 103' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.244 -1.151 . . . . 0.0 110.159 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.283 0.563 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 111.35 0.91 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.247 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.506 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 99.1 m -105.24 148.33 36.06 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.98 177.89 37.38 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.346 -0.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.89 146.75 8.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.8 tt0 -120.11 127.62 52.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -1.099 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 29.2 m-85 -142.09 170.48 15.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.244 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -125.01 154.61 41.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 110.162 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 12' ' ' ASP . 44.3 t -131.37 101.62 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER 42.61 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.271 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.58 62.19 3.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 170.45 16.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' C ' HG23 ' A' ' 16' ' ' VAL . 21.9 tttm -135.28 145.06 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 15' ' ' LYS . 78.4 t -148.05 113.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.154 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.3 mt -99.35 145.15 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.0 110.272 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 22' ' ' CYS . 9.4 mt -123.82 108.83 12.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.72 -173.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 51.0 tt0 -66.79 -15.37 63.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 0.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.57 34.27 3.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.242 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.622 ' HA ' HD22 ' A' ' 18' ' ' LEU . 83.9 m 48.16 49.08 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.78 147.63 34.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 110.211 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.2 ttt -74.7 115.99 14.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.287 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -88.77 28.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -168.25 69.22 0.81 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.323 -0.861 . . . . 0.0 110.198 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.71 -7.0 20.08 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.052 1.554 . . . . 0.0 110.488 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -78.0 -21.67 50.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -103.16 39.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 110.239 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.51 ' NE1' ' O ' ' A' ' 102' ' ' ALA . 83.8 t90 -71.79 137.14 47.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.129 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -144.84 -178.49 6.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.143 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.79 -62.29 1.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -54.49 -26.88 34.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -73.56 -56.76 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -52.55 -50.74 62.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.0 110.449 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.07 -46.87 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 59.3 t90 -51.62 -47.12 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.86 -37.64 88.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.347 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.4 81.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 46' ' ' GLN . 2.0 tmt_? -76.98 -37.17 55.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 110.376 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.82 -32.98 74.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.322 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mt -87.3 -72.08 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.113 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.34 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLN . . . 150.4 -19.05 1.04 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -47.07 96.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -1.158 . . . . 0.0 110.243 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 4.4 tm0? -89.29 -6.16 56.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -140.68 96.13 2.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.271 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.417 ' HE3' ' HB3' ' A' ' 52' ' ' HIS . 66.6 mmm -66.38 126.57 29.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 110.086 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 49' ' ' THR . 4.8 t -78.59 172.57 13.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -59.37 -35.3 73.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.246 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.45 -29.3 70.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CE1' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -69.96 -65.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.895 . . . . 0.0 110.247 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.503 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 4.7 m95 -49.62 -30.83 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tmtm? -67.97 -57.41 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.193 -0.942 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.83 -49.41 62.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.02 -31.78 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 110.242 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -62.41 -49.49 75.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 110.218 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 58' ' ' TYR . 5.7 t80 -63.49 -45.73 89.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -53.11 -41.05 64.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -40.71 71.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.271 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -58.36 -43.96 88.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.253 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.469 ' CZ ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -66.03 -39.37 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.162 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -79.17 -11.61 59.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.174 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -95.89 -25.17 16.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.29 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.6 m -54.43 -30.62 53.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.0 -54.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.9 73.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 69' ' ' CYS . 6.7 m -155.56 -179.8 8.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.634 ' H ' HG22 ' A' ' 68' ' ' THR . 49.1 t -157.15 81.59 3.26 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 0.0 110.319 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.469 ' HG3' ' CZ ' ' A' ' 62' ' ' TYR . 47.1 Cg_endo -73.26 171.47 17.58 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.989 1.52 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.25 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.9 tt -116.4 14.43 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -74.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.6 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 72' ' ' ILE . 91.5 t -77.13 -34.22 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.276 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 77' ' ' LYS . 17.0 m -68.2 -32.29 72.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.166 -0.959 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 76' ' ' THR . 30.7 tttt -44.01 -27.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.295 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -107.71 -61.22 1.6 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.258 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -52.98 22.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.16 13.73 80.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.7 108.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -1.194 . . . . 0.0 110.191 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.85 126.36 10.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.2 -30.33 11.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -50.47 73.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.07 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -58.54 -50.37 74.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.005 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.408 ' CG2' ' HD3' ' A' ' 94' ' ' PRO . 54.7 mt -58.92 -26.99 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -39.7 64.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 110.117 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.08 -35.77 78.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 80.7 mt -74.18 -59.27 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.89 118.67 17.71 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.101 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.1 Cg_endo -72.56 -177.81 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.421 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 30.0 m 55.64 19.61 3.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 110.145 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.57 149.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' HIS . 46.6 Cg_endo -73.06 -90.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.952 1.501 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 94' ' ' PRO . . . 43.33 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 110.337 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 94' ' ' PRO . 11.2 m170 -73.52 -56.2 5.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -44.12 -56.92 5.09 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.65 -44.58 4.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -1.108 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -65.23 -54.5 28.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.195 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -42.83 -38.36 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 110.138 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -41.67 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.51 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -53.31 -45.4 68.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.268 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.7 51.25 0.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.234 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.722 0.296 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.21 -38.6 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.074 1.565 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.63 126.17 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.233 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -65.15 87.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 94.3 m -96.32 148.46 34.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -75.99 150.45 93.92 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.45 -0.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -161.87 157.66 29.46 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 21.0 pt-20 -110.64 160.81 16.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 75.9 m-85 -154.6 169.78 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.235 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.37 137.95 53.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.079 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' ASP . 10.9 t -141.35 121.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.461 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 41.38 74.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.33 -0.856 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.46 62.85 2.33 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -157.69 159.93 37.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.088 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -121.9 117.11 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 t -113.46 120.36 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -101.86 141.03 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.534 HD22 ' C ' ' A' ' 22' ' ' CYS . 6.9 mt -122.38 120.3 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.38 -169.71 2.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.4 tt0 -50.75 147.52 4.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER 64.32 20.91 12.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.534 ' C ' HD22 ' A' ' 18' ' ' LEU . 76.9 m 51.88 54.69 10.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.96 139.68 32.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.404 ' SD ' ' HA2' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -68.31 115.4 7.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 110.185 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -116.9 34.38 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -157.71 68.67 4.01 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.21 -0.62 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.968 1.51 . . . . 0.0 110.439 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.86 -25.86 40.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.12 26.9 9.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 110.334 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -75.64 141.3 42.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -155.29 -167.41 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.219 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.54 -33.65 66.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.195 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 24.0 mmtt -71.52 -37.62 71.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.18 -51.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.53 81.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -67.2 -26.97 66.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CE2' ' OE1' ' A' ' 41' ' ' GLU . 49.9 t90 -66.93 -60.79 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.35 -39.0 75.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.81 71.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 3.6 ttm180 -76.86 -34.72 57.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 110.128 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' OE1' ' CE2' ' A' ' 37' ' ' TRP . 4.0 mt-10 -77.29 -26.64 52.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.01 -66.07 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.681 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.76 -31.9 40.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 101.96 -4.8 52.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.84 120.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -1.156 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -89.56 -26.42 20.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.09 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.53 103.55 5.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 52' ' ' HIS . 15.5 mmm -48.13 119.02 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -71.58 -169.15 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -84.75 -20.76 30.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 3.7 mp0 -77.0 -45.05 28.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.435 ' O ' HG23 ' A' ' 56' ' ' VAL . 24.8 m170 -54.76 -52.7 61.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 5.3 m95 -67.41 -27.77 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.269 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -61.63 -65.8 0.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.15 -0.969 . . . . 0.0 109.966 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.84 -43.36 94.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.884 . . . . 0.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 52' ' ' HIS . 35.1 t -56.45 -29.37 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.863 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 14.4 mttt -75.29 -48.96 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.134 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.565 ' CE1' HG13 ' A' ' 75' ' ' VAL . 30.0 t80 -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -38.12 82.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -28.55 65.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.85 -42.39 40.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.325 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -66.89 -26.86 67.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -71.93 -2.69 18.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.254 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.19 11.94 36.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.248 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.53 -46.66 3.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.069 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -129.89 -34.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.26 56.01 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -139.95 -167.17 2.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -1.118 . . . . 0.0 110.255 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.55 93.46 3.54 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.6 Cg_endo -72.74 173.95 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.985 1.518 . . . . 0.0 110.45 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.6 Cg_endo -73.07 -160.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.978 1.515 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 72' ' ' ILE . 3.4 tp -111.87 2.8 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.281 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -24.87 25.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtt -87.57 -30.37 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.565 HG13 ' CE1' ' A' ' 58' ' ' TYR . 47.5 t -65.46 -29.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.2 m -62.34 -31.86 72.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -26.91 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.04 52.86 1.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 110.025 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.7 m -159.41 -74.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 49.77 0.4 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.0 147.56 33.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -1.193 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -98.96 131.67 44.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.924 . . . . 0.0 110.221 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -62.63 -32.32 73.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -64.54 -56.55 13.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.079 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -50.53 67.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.41 HD13 HG12 ' A' ' 72' ' ' ILE . 66.8 mt -56.89 -34.98 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.987 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -61.76 -49.44 76.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.996 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 5.4 tp60 -66.18 -24.11 66.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mt -79.29 -29.51 42.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 110.09 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' TYR . 16.6 m-85 -116.79 167.36 10.79 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.879 . . . . 0.0 110.042 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 92' ' ' SER . 51.3 Cg_endo -78.05 70.83 6.93 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.053 1.554 . . . . 0.0 110.622 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 91' ' ' PRO . 11.3 t 40.42 68.93 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.537 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.81 66.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.98 -12.5 23.79 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.01 1.531 . . . . 0.0 110.435 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 110.313 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 34.2 p80 -62.39 -24.62 67.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.77 -63.58 4.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' CYS . . . -48.96 -66.17 0.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.177 . . . . 0.0 110.418 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 8.7 t -41.92 -46.75 4.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.8 mtpt -52.52 -54.88 26.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 101' ' ' VAL . 8.7 t -62.44 -25.95 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.965 . . . . 0.0 110.411 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.06 -32.95 69.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA2' ' SD ' ' A' ' 24' ' ' MET . . . 100.07 46.63 1.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.678 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . . . -112.37 122.79 35.63 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -1.187 . . . . 0.0 110.221 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.52 151.06 52.59 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.89 1.469 . . . . 0.0 110.424 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -45.07 149.95 0.82 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 0.0 110.182 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.74 -89.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.922 1.485 . . . . 0.0 110.465 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -148.56 80.19 1.44 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.36 -119.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 3.2 t 58.87 97.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -1.145 . . . . 0.0 110.2 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.193 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HG2' ' CD ' ' A' ' 4' ' ' LYS . 9.0 tpt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.793 0.33 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 45.3 Cg_endo -72.89 -57.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.957 1.504 . . . . 0.0 110.375 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 3' ' ' VAL . 5.2 p -89.97 103.94 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.94 . . . . 0.0 110.067 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.48 ' CD ' ' HG2' ' A' ' 1' ' ' MET . 4.3 tptp -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 28.5 m -104.81 154.84 38.3 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -76.11 152.45 96.48 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.605 -2.248 . . . . 0.0 110.467 -0.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.85 138.92 5.07 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.03 121.74 41.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.139 . . . . 0.0 110.239 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 3' ' ' VAL . 35.8 m-85 -130.32 158.61 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.101 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 5.4 mt-30 -110.4 156.31 20.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.17 -0.956 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 14' ' ' LYS . 76.1 t -129.22 105.97 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.4 38.26 24.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.12 24.09 23.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 11.1 mmtt -115.28 175.0 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.66 47.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.425 HG11 ' CZ3' ' A' ' 37' ' ' TRP . 17.3 t -140.76 121.64 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 0.0 110.163 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.1 mt -99.66 108.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 53.5 mt -89.64 118.85 29.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 1.1 t0 -71.53 -172.71 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -50.22 -28.22 7.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -116.79 51.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 63.1 m 42.92 32.56 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.3 157.44 26.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -98.99 101.62 13.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.31 17.51 8.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.238 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -148.48 78.22 9.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.01 -7.33 20.51 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.015 1.534 . . . . 0.0 110.475 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.72 -12.61 61.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 29' ' ' ASP . 12.1 t70 -116.43 33.9 5.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.153 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 75.0 t90 -92.75 151.01 20.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.37 -171.65 2.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -69.65 -56.21 7.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.272 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -57.33 -39.3 75.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.882 . . . . 0.0 110.27 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.68 -51.74 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.38 -50.72 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 110.385 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -58.34 -41.59 84.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.4 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.425 ' CZ3' HG11 ' A' ' 16' ' ' VAL . 50.0 t90 -55.55 -48.93 73.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.439 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.487 HD23 HD13 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.57 -51.13 69.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.444 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -51.0 -39.31 55.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 110.519 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.8 -67.1 0.53 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.938 . . . . 0.0 110.445 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' OE1' HG11 ' A' ' 3' ' ' VAL . 1.1 tt0 -42.58 -26.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.559 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 38' ' ' LEU . 2.4 mp -83.85 -79.49 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.379 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.68 -79.28 0.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.18 38.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.442 HD12 ' HB1' ' A' ' 39' ' ' ALA . 96.7 mt -75.34 115.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -1.148 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -56.88 -45.14 82.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.878 . . . . 0.0 110.358 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.0 122.09 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.451 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 45.3 mmm -45.78 118.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.7 p -65.1 178.13 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -69.85 -23.75 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -35.05 57.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.556 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -62.57 -50.0 73.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.533 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m95 -66.26 -35.44 80.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.372 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -61.28 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.316 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -52.71 61.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 110.401 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 102' ' ' ALA . 80.2 t -55.88 -28.76 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.487 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 ttmt -76.29 -38.27 56.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 110.389 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.25 -42.95 92.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -39.12 90.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.953 . . . . 0.0 110.283 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -36.92 67.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 43.6 tt0 -58.29 -44.95 88.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.33 -31.67 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.284 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.57 ' CZ2' ' HD2' ' A' ' 105' ' ' PRO . 91.5 t90 -67.81 -12.09 59.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 10.9 mt-10 -78.51 -47.64 16.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.23 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -53.03 4.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -78.9 -75.41 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.245 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.96 17.13 11.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.2 m -115.48 146.37 41.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -1.163 . . . . 0.0 110.205 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.5 99.82 26.77 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.942 . . . . 0.0 110.164 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.8 Cg_endo -73.19 173.55 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.1 Cg_endo -72.92 -160.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.4 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 72' ' ' ILE . 1.6 tp -123.9 54.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -141.58 -44.06 0.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.8 mmm -74.84 -21.01 59.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.8 t -72.28 -32.32 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 m -44.33 -32.47 1.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -56.33 -51.45 68.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -65.6 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 p -68.91 -70.69 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.201 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.13 11.15 32.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.18 170.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -1.166 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -95.64 141.95 28.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.219 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 tp -69.2 -29.12 67.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 2.2 tt0 -61.16 -55.66 29.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.227 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -56.27 14.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.571 HG23 ' HG3' ' A' ' 94' ' ' PRO . 36.6 mt -56.17 -26.91 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.74 -58.4 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -34.48 70.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 52' ' ' HIS . 21.3 mt -65.67 -51.66 57.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 110.134 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.536 ' CE1' ' HA3' ' A' ' 97' ' ' GLY . 1.5 t80 -128.64 128.57 23.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 110.048 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.4 Cg_endo -73.14 156.2 51.64 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.898 1.473 . . . . 0.0 110.417 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 49.4 m 56.81 31.37 19.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 62.19 147.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.705 ' HB2' ' HB2' ' A' ' 98' ' ' ALA . 45.7 Cg_endo -72.9 -92.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.889 1.468 . . . . 0.0 110.304 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 49.6 -89.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.169 -0.957 . . . . 0.0 110.358 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 94' ' ' PRO . 8.1 m-70 -68.05 -44.85 75.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 90' ' ' PHE . . . -64.66 -41.77 97.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 94' ' ' PRO . . . -55.74 -48.97 74.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -1.131 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 100' ' ' LYS . 34.5 m -64.24 -55.39 21.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 99' ' ' CYS . 5.9 tttt -42.41 -49.9 5.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.27 -37.96 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HB2' HG13 ' A' ' 56' ' ' VAL . . . -72.59 -8.58 55.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.5 48.02 77.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.09 112.7 65.14 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.211 -1.17 . . . . 0.0 110.197 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.57 ' HD2' ' CZ2' ' A' ' 63' ' ' TRP . 45.2 Cg_endo -72.58 177.53 7.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.948 1.499 . . . . 0.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.1 172.69 3.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.152 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.15 84.95 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.016 1.535 . . . . 0.0 110.418 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.72 -49.16 1.38 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.872 . . . . 0.0 110.221 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.72 121.23 1.21 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.414 ' O ' ' OXT' ' A' ' 111' ' ' VAL . 0.8 OUTLIER 60.98 26.04 16.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -1.178 . . . . 0.0 110.165 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.414 ' OXT' ' O ' ' A' ' 110' ' ' CYS . 20.5 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 46.2 Cg_endo -71.76 143.41 41.55 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.927 1.488 . . . . 0.0 110.395 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -122.19 152.72 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.331 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.89 151.71 1.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.064 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 6.0 p -125.35 161.88 47.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.3 Cg_endo -75.08 145.26 83.33 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.54 -2.275 . . . . 0.0 110.474 -0.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.61 152.56 18.01 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 51.4 mt-10 -103.68 141.9 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 110.381 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 77.7 m-85 -152.53 150.21 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -104.17 125.02 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 67.0 t -105.8 118.82 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.297 -0.877 . . . . 0.0 110.113 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 19.6 m-20 55.69 -89.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -141.41 50.6 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 158.91 44.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -1.144 . . . . 0.0 110.164 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.641 ' HG2' HD11 ' A' ' 17' ' ' ILE . 6.1 tttt -104.6 115.57 30.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.31 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.603 ' C ' HD12 ' A' ' 17' ' ' ILE . 25.3 t -107.12 129.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.641 HD11 ' HG2' ' A' ' 15' ' ' LYS . 2.7 mp -115.59 116.58 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.308 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 22' ' ' CYS . 10.8 mt -95.14 110.54 22.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.996 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 23' ' ' PHE . 6.9 t70 -75.42 -161.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.274 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -64.31 137.31 57.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.1 t70 66.49 30.41 8.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.71 ' HA ' HD22 ' A' ' 18' ' ' LEU . 8.5 m 55.75 50.5 14.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . 1.6 m-30 -94.87 109.37 21.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.61 106.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.26 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' OE1' ' CB ' ' A' ' 19' ' ' ASP . 1.5 tp60 -108.86 35.88 3.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.231 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 26' ' ' ASN . 8.8 p-10 -151.74 68.25 7.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 -7.51 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.003 1.528 . . . . 0.0 110.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -79.29 -46.65 17.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -84.61 -4.68 59.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.124 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.63 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 20.9 t90 -57.2 153.55 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -165.65 -160.06 0.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.544 ' OE2' ' CZ2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -74.39 -56.48 4.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.308 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -40.21 76.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -64.4 -49.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 0.0 110.293 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.63 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -55.42 -48.86 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.214 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.28 -57.67 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 92.3 t90 -49.23 -32.41 10.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -61.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.873 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -48.0 -47.22 33.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.942 . . . . 0.0 110.21 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -65.3 -32.53 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' TRP . 3.5 tt0 -64.88 -33.36 75.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 0.0 110.152 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.408 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -91.39 -73.54 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.234 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.43 -76.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 40' ' ' ARG . . . 142.65 69.13 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.873 HD12 ' HB1' ' A' ' 39' ' ' ALA . 60.7 mt -96.87 114.11 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -1.15 . . . . 0.0 110.247 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -46.34 -29.47 1.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.298 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.78 130.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.324 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 21.5 mtp -44.0 128.1 5.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.234 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -89.12 178.7 6.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -43.94 76.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.43 -39.19 89.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.517 ' NE2' ' HB3' ' A' ' 89' ' ' LEU . 6.8 m170 -65.08 -64.49 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CZ2' ' SD ' ' A' ' 48' ' ' MET . 2.0 m95 -46.73 -38.03 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.115 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -57.56 12.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.48 -54.49 21.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.98 -33.86 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -68.04 -61.67 1.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -37.01 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -69.6 -48.18 60.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.296 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 59' ' ' LEU . 8.4 tpt180 -42.8 -38.55 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.306 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.17 -54.24 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.354 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.72 -43.88 58.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.377 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.415 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 2.2 t90 -63.81 -47.44 80.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.02 7.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.3 m -82.15 -47.35 12.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.0 -35.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 103.62 56.39 0.77 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.5 m -128.61 157.5 41.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -1.148 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 t -120.94 86.99 42.62 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.44 167.77 26.11 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.059 1.557 . . . . 0.0 110.416 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.4 -90.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.961 1.506 . . . . 0.0 110.43 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -175.51 74.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.88 -63.78 1.14 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.154 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -64.9 -11.63 40.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.83 -45.53 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 m -64.01 -40.53 96.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.201 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.47 -29.79 17.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.289 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -102.88 -71.0 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.523 ' HB ' ' CD1' ' A' ' 81' ' ' PHE . 61.6 p -49.68 -52.59 29.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.81 30.25 6.88 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD1' ' HB ' ' A' ' 79' ' ' THR . 10.4 m-85 -99.66 120.43 39.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.16 147.54 52.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -56.53 -28.27 59.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.07 -44.8 87.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -53.38 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.209 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 9.1 mt -53.02 -30.16 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 90' ' ' PHE . 1.5 m-85 -77.14 -36.26 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.283 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.91 -44.89 91.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.396 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.517 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 3.4 mt -78.92 -53.64 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.296 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.1 m-85 -88.94 165.06 28.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.19 -179.29 4.57 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.068 1.562 . . . . 0.0 110.46 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.16 86.17 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' ' CD2' ' A' ' 96' ' ' HIS . . . 135.65 80.03 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.69 -0.02 8.81 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.497 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -79.56 -53.61 6.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 93' ' ' GLY . 23.3 p80 -77.2 -23.41 51.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.472 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -78.18 -71.8 1.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.91 -36.95 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -1.138 . . . . 0.0 110.405 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -71.28 -51.5 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.397 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -47.82 -44.11 28.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.326 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' ALA . 39.2 t -69.12 -55.32 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 101' ' ' VAL . . . -44.01 -35.45 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 0.0 110.162 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . 82.74 63.28 1.77 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 103' ' ' GLY . . . 177.93 78.73 0.13 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.258 -1.143 . . . . 0.0 110.299 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.61 -173.62 1.23 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.011 1.532 . . . . 0.0 110.42 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -79.82 165.7 45.69 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.231 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 106' ' ' LYS . 45.9 Cg_endo -73.06 136.83 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.964 1.507 . . . . 0.0 110.434 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.9 m -69.2 -43.9 73.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.43 37.06 2.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -48.22 172.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -1.191 . . . . 0.0 110.252 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.191 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.816 0.341 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.36 150.9 47.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.954 1.502 . . . . 0.0 110.336 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -73.35 125.13 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -81.5 83.43 6.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.361 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 36.5 m -82.49 154.47 68.78 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD3' ' CG ' ' A' ' 20' ' ' GLU . 50.3 Cg_endo -75.62 164.88 87.05 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.58 -0.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.21 160.85 28.05 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -104.34 152.08 22.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.192 . . . . 0.0 110.328 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -152.66 144.81 23.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -100.17 132.22 45.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.968 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 22.9 t -129.75 109.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.59 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 64.45 28.13 13.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.476 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.5 7.39 82.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 3.5 mttt -98.99 171.1 8.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -1.206 . . . . 0.0 110.087 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.32 123.73 49.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 110.282 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.42 138.18 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.7 mt -120.65 100.0 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.24 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 18' ' ' LEU . 23.1 mt -74.49 118.39 17.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.232 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.74 -172.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.323 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.519 ' CG ' ' HD3' ' A' ' 6' ' ' PRO . 1.5 tt0 -62.01 -13.47 26.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 110.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -118.58 43.28 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.0 m 43.25 34.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.339 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -103.07 115.78 31.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 110.128 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' PHE . 1.3 ttt -41.88 137.67 1.7 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.921 . . . . 0.0 110.338 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 17.24 21.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.154 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -124.22 67.3 44.94 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.227 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.5 -6.63 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.054 1.555 . . . . 0.0 110.463 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -32.97 56.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 1.3 m-20 -97.41 -81.86 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 52.2 t90 59.47 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.6 178.44 7.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.485 ' HG2' ' CZ2' ' A' ' 53' ' ' TRP . 1.8 tm-20 -65.64 -64.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -29.43 2.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.35 -62.54 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.326 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.59 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.56 -35.87 82.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -0.948 . . . . 0.0 110.421 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.442 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -66.37 -55.99 13.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.98 -31.55 60.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.456 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -36.53 63.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.108 -0.995 . . . . 0.0 110.392 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.5 -26.99 61.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HB3' ' OE1' ' A' ' 43' ' ' GLU . 6.9 mp -81.18 -42.79 20.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -110.24 -83.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 38.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.2 88.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -1.148 . . . . 0.0 110.281 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -45.41 -30.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.52 130.89 10.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 mmt -57.87 130.32 45.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 52' ' ' HIS . 10.0 t -86.55 160.02 19.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.204 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.75 -40.45 79.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.455 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.89 -37.0 73.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.437 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.609 ' H ' HG23 ' A' ' 49' ' ' THR . 3.2 m170 -63.6 -64.43 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.285 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.485 ' CZ2' ' HG2' ' A' ' 32' ' ' GLU . 5.0 m95 -54.8 -26.6 35.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 110.505 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -67.17 -67.31 0.46 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.96 -45.89 61.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.26 -48.21 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 110.168 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -54.83 -44.94 74.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.189 -0.945 . . . . 0.0 110.112 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.83 -58.04 9.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.64 -33.44 33.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.354 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.34 -56.15 19.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.364 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.44 -37.33 7.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.472 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -36.89 70.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -70.36 -3.45 17.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.157 -0.965 . . . . 0.0 110.421 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.02 -25.6 10.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.4 m -88.4 -69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.9 -45.66 7.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.969 . . . . 0.0 110.123 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.97 68.68 1.26 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 53.9 m -151.0 161.11 43.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -1.169 . . . . 0.0 110.326 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 m -110.79 84.33 4.13 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 68' ' ' THR . 46.7 Cg_endo -73.53 172.05 16.51 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.1 1.579 . . . . 0.0 110.468 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.94 -161.95 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.001 1.527 . . . . 0.0 110.478 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -119.52 6.37 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.195 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -36.04 66.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -18.15 47.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -74.1 -46.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 110.195 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 5.6 m -62.01 -26.84 68.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -63.61 -28.49 69.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.57 -78.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.144 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 p -53.82 -27.73 31.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.982 . . . . 0.0 110.207 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 77.91 4.33 85.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.04 135.43 56.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -1.192 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.95 140.22 58.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -63.71 -29.91 71.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.216 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -52.23 66.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.104 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -37.84 17.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.632 HD13 HD11 ' A' ' 72' ' ' ILE . 30.5 mt -73.32 -34.74 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.34 -0.85 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CE2' HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -61.53 -32.82 72.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -83.27 -48.42 10.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 110.184 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 57.2 mt -57.72 -28.68 64.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 87' ' ' TYR . 11.2 m-85 -129.01 168.03 17.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.026 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -173.54 1.27 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.93 1.49 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.28 94.75 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.39 76.65 0.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.2 Cg_endo -73.21 -9.01 22.85 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 110.444 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.5 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -46.52 -31.09 2.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.81 -61.89 5.48 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -44.7 -56.42 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.1 m -47.6 -51.2 22.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 12.2 ttmt -53.25 -40.96 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 96.5 t -59.56 -52.06 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.56 -25.5 68.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.168 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.73 63.79 0.63 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.12 136.2 82.13 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.215 -1.167 . . . . 0.0 110.152 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.54 178.86 6.16 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.02 1.537 . . . . 0.0 110.438 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.24 77.09 7.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.124 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.95 -40.51 1.77 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.071 1.564 . . . . 0.0 110.398 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.6 p -106.72 -158.72 0.67 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 110.153 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.29 57.95 2.69 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 2.0 t -162.97 -175.19 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -1.13 . . . . 0.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.13 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.751 0.31 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.11 164.91 34.14 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 110.451 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.8 149.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.19 152.31 19.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 m -115.11 144.86 32.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.75 167.51 80.06 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.246 -0.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -178.98 142.22 5.24 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.451 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 6.3 tt0 -99.33 159.51 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -1.138 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 2.8 m-85 -161.43 166.79 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.199 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -112.01 124.84 53.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 110.256 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' ASP . 35.3 t -99.14 98.24 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' VAL . 18.6 t70 43.2 73.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.75 56.23 25.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 170.81 20.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -1.145 . . . . 0.0 110.287 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -123.39 123.08 39.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.513 HG13 ' HE2' ' A' ' 24' ' ' MET . 46.5 t -141.47 124.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.13 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 25' ' ' GLN . 1.1 tt -105.76 145.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 18' ' ' LEU . 26.0 mt -112.08 112.7 24.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 25' ' ' GLN . 19.9 m-20 -58.77 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.825 . . . . 0.0 110.229 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.23 -28.32 69.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 22' ' ' CYS . 8.3 m-20 -106.99 44.26 1.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' A' ' 21' ' ' ASP . 60.0 m 42.49 31.58 0.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.252 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -86.78 142.65 27.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.513 ' HE2' HG13 ' A' ' 16' ' ' VAL . 15.5 ttm -78.16 125.0 28.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.557 ' HB2' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -95.34 0.33 53.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.34 68.53 14.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.96 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.99 -18.9 23.77 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.051 1.553 . . . . 0.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -66.11 -14.04 61.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.204 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.5 m-20 -113.39 6.64 17.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 51.7 t90 -46.32 158.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.547 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 1.2 m-20 178.4 -177.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.887 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -62.62 -45.05 94.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 110.163 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -26.78 68.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.169 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.2 -60.68 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.422 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -54.58 -29.51 51.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.394 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 2.8 mt-10 -75.81 -59.76 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.339 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -49.53 -35.57 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.501 HD23 ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -72.52 -51.23 20.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.304 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.71 -28.63 56.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -60.2 2.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.455 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -26.86 22.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD1' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -87.81 -73.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.422 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.39 -52.69 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 24.71 1.57 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.9 mt -73.11 84.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -1.194 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -44.07 -29.79 0.66 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.45 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -150.37 111.51 4.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.461 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 23.1 mmm -48.92 155.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.08 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.709 HG22 ' ND1' ' A' ' 52' ' ' HIS . 5.2 t -106.94 -177.3 3.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.89 . . . . 0.0 110.282 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.56 -35.34 60.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.929 . . . . 0.0 110.226 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -40.61 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.284 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.709 ' ND1' HG22 ' A' ' 49' ' ' THR . 5.6 m170 -62.43 -55.79 24.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 110.328 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.488 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 4.5 m95 -61.28 -26.92 68.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -67.09 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.93 . . . . 0.0 110.38 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -43.04 70.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -52.98 -57.56 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.154 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -46.16 63.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.13 -43.52 70.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.69 -40.49 95.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -60.54 -28.67 68.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.97 -51.68 63.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -71.19 -26.99 63.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.567 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 65.8 t90 -80.9 -6.3 58.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 65' ' ' THR . 9.5 tt0 -77.4 -50.65 12.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 64' ' ' GLU . 18.7 m -44.71 -39.96 5.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.19 -58.61 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 131.07 43.19 0.19 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -105.1 113.91 27.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -1.156 . . . . 0.0 110.193 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.8 t -53.77 108.1 1.03 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.198 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 68' ' ' THR . 45.8 Cg_endo -73.06 169.61 21.81 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.9 1.474 . . . . 0.0 110.371 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.87 -162.49 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.003 1.528 . . . . 0.0 110.434 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 86' ' ' ILE . 8.8 tp -125.87 -0.75 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -91.0 -11.49 38.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.44 -30.01 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 110.405 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.92 -29.89 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 81' ' ' PHE . 14.1 t -77.0 -36.2 56.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -65.87 -29.33 69.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.56 0.04 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.276 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' GLY . 66.2 p -135.38 22.76 3.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' THR . . . 43.58 26.79 0.74 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.488 ' HB2' ' HA ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -68.26 -163.94 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -1.135 . . . . 0.0 110.155 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.1 t -154.4 137.42 15.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 110.176 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 15.1 tp -50.42 -34.43 24.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.215 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.55 -35.1 70.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.64 -46.6 89.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 110.41 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 72' ' ' ILE . 34.9 mt -76.87 -31.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -67.05 -32.18 73.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.289 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -86.68 -39.68 15.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -0.978 . . . . 0.0 110.273 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.577 HD22 ' CE1' ' A' ' 52' ' ' HIS . 19.8 mt -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 110.169 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.426 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 4.2 m-85 -109.11 171.28 4.59 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.6 Cg_endo -74.28 -61.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.091 1.574 . . . . 0.0 110.637 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.42 107.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.15 -0.969 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.24 75.43 0.93 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.524 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.0 Cg_endo -72.33 -16.77 27.78 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.047 1.551 . . . . 0.0 110.431 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -69.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.357 -0.839 . . . . 0.0 110.148 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -77.07 -8.0 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.18 -81.43 0.44 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.1 -32.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -1.078 . . . . 0.0 110.418 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -62.95 1.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -50.96 -51.28 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.131 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -48.76 -57.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -53.76 -34.48 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.09 -63.61 0.42 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 47.48 58.7 17.24 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.27 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.8 149.65 48.41 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.034 1.544 . . . . 0.0 110.463 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -119.44 137.66 25.66 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.247 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.77 94.95 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.024 1.539 . . . . 0.0 110.343 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -120.53 140.61 51.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.428 ' O ' ' SG ' ' A' ' 110' ' ' CYS . . . -147.24 64.89 0.42 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 109' ' ' GLY . 0.5 OUTLIER 178.77 56.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -1.117 . . . . 0.0 110.261 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.216 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.531 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 1' ' ' MET . 45.0 Cg_endo -72.8 159.85 47.48 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 110.444 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 9' ' ' TYR . 6.4 t -118.71 -49.65 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.266 -0.897 . . . . 0.0 110.283 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.41 -156.73 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 4.9 p -175.14 162.57 2.31 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.6 Cg_endo -74.72 153.67 99.28 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.611 0.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.34 167.26 40.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 5.9 mt-10 -120.58 148.57 43.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -1.194 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 97.2 m-85 -156.37 143.81 19.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -113.47 140.82 47.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 17.6 t -109.44 99.68 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 12.4 t70 55.32 -89.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -122.71 42.42 1.63 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 169.03 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -1.178 . . . . 0.0 110.205 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -127.34 138.15 52.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 110.281 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.0 128.69 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.066 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 66.7 mt -116.15 102.59 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 22' ' ' CYS . 2.8 mt -87.14 132.17 33.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' GLU . 3.2 m-20 -117.44 -170.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.03 148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.582 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.6 t0 66.76 18.32 10.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.623 ' HA ' HD22 ' A' ' 18' ' ' LEU . 4.3 m 51.05 45.72 27.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.613 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 m-85 -86.35 126.56 34.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 110.235 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.664 ' HG2' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -42.88 -36.06 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.242 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 53.58 19.89 1.92 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.156 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.425 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -151.16 59.87 3.57 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.157 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.33 -30.33 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.031 1.543 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.43 73.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 0.0 110.26 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.21 30.15 2.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 35' ' ' ALA . 60.4 t90 -82.57 160.62 22.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -167.56 -169.21 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.192 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.431 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 18.7 mt-10 -71.32 -58.4 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -33.69 72.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.357 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.05 -57.57 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.59 ' HB2' ' NE1' ' A' ' 30' ' ' TRP . . . -55.23 -36.99 66.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.0 110.406 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -54.6 41.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.461 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 76.7 t90 -59.19 -28.89 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.189 -0.944 . . . . 0.0 110.432 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' A' ' 24' ' ' MET . 0.2 OUTLIER -70.98 -41.42 71.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.447 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.74 -26.91 60.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.95 . . . . 0.0 110.591 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -75.9 -40.27 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.571 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -77.15 -33.81 56.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.687 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.3 mp -80.74 -68.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.105 -0.997 . . . . 0.0 110.572 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -79.59 -72.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 110.413 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.84 39.59 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 46' ' ' GLN . 11.3 mt -103.33 107.71 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' ILE . 14.0 mt-30 -43.28 -37.77 2.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -156.64 140.61 16.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.329 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -52.87 100.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 110.133 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -52.62 162.17 0.61 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 110.276 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.53 -27.62 4.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.95 -39.62 55.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.729 ' CE1' HD22 ' A' ' 89' ' ' LEU . 5.2 m80 -61.59 -41.03 96.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.513 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 1.4 m95 -74.09 -36.06 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.247 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -58.88 -45.64 89.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 81' ' ' PHE . 5.9 mp -72.76 -58.27 3.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 52' ' ' HIS . 74.9 t -47.14 -30.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -76.45 -51.48 11.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.931 ' CE2' HG13 ' A' ' 75' ' ' VAL . 38.5 t80 -52.47 -48.34 65.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.6 -43.58 76.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 21.8 ttp180 -50.32 -39.8 46.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 110.426 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.16 -55.2 19.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -27.0 66.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 59.6 t90 -70.08 -21.62 63.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.284 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 -17.63 59.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.19 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.555 HG22 ' HD2' ' A' ' 66' ' ' PHE . 98.3 m -75.74 -70.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.336 -0.853 . . . . 0.0 110.156 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.555 ' HD2' HG22 ' A' ' 65' ' ' THR . 4.3 m-85 -125.31 30.63 5.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 43.9 80.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -178.07 5.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -1.117 . . . . 0.0 110.176 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 t -140.1 92.95 9.4 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.229 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.43 157.88 52.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.079 1.568 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.68 -159.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.045 1.55 . . . . 0.0 110.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 72' ' ' ILE . 7.8 tt -125.25 46.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.86 -82.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -16.16 40.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.931 HG13 ' CE2' ' A' ' 58' ' ' TYR . 79.0 t -70.33 -40.85 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.148 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -54.12 -38.84 65.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -69.02 -34.1 74.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.142 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.79 -0.24 37.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.57 -77.55 0.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.348 -0.845 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.89 22.56 3.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.537 ' CD2' HD11 ' A' ' 55' ' ' LEU . 36.0 m-85 -81.64 102.98 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -1.144 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.44 127.89 6.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.297 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -47.84 -36.65 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.166 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.09 -49.74 72.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.034 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -50.83 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 81' ' ' PHE . 36.4 mm -50.29 -39.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -37.18 80.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.59 -31.35 72.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.729 HD22 ' CE1' ' A' ' 52' ' ' HIS . 12.5 mt -76.72 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -94.07 147.91 34.26 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 92' ' ' SER . 46.6 Cg_endo -73.98 84.13 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.03 1.542 . . . . 0.0 110.407 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 91' ' ' PRO . 38.6 m 43.5 70.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.52 62.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.466 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.0 Cg_endo -73.63 -0.41 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.033 1.543 . . . . 0.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -98.97 -63.35 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.901 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.01 -14.24 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.277 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -77.06 -77.26 0.8 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.54 -37.15 1.56 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.32 -50.84 62.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.374 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.9 tptt -53.41 -48.57 68.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.293 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.24 -27.55 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.65 -19.8 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.39 63.15 1.66 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.85 76.99 15.15 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.207 -1.172 . . . . 0.0 110.161 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.36 141.59 32.14 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.003 1.528 . . . . 0.0 110.387 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 2.4 mttm -44.18 -59.52 3.67 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 110.109 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 106' ' ' LYS . 46.3 Cg_endo -72.74 106.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.046 1.55 . . . . 0.0 110.355 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.75 26.97 10.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.6 5.51 64.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -51.94 7.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -1.199 . . . . 0.0 110.176 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.25 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.732 0.301 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.15 -51.68 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.059 1.557 . . . . 0.0 110.534 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 4' ' ' LYS . 57.4 t -119.89 169.52 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.379 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.529 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.2 mtmm -109.07 147.31 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.5 m -142.89 159.43 56.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.968 . . . . 0.0 110.369 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.87 154.43 98.49 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.492 -0.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.06 142.62 7.79 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.406 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.05 128.05 45.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.262 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -131.63 161.94 31.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 110.213 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -104.94 142.33 34.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.117 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 53.9 t -127.8 96.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 11' ' ' VAL . 10.3 t70 41.98 85.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 110.311 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.48 65.46 2.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -168.32 161.43 12.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -1.181 . . . . 0.0 110.144 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 126.36 42.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -131.32 122.31 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 110.044 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.57 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.412 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 18' ' ' LEU . 16.2 mt -69.8 123.06 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.056 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.575 ' OD2' ' NE2' ' A' ' 25' ' ' GLN . 9.9 m-20 -99.66 -157.92 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.8 mm-40 -45.57 132.31 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 13.3 t70 62.32 30.55 17.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.022 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 74.5 m 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.46 95.28 9.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.4 ptm -54.21 149.98 9.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.575 ' NE2' ' OD2' ' A' ' 19' ' ' ASP . 2.5 mt-30 -127.04 40.56 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -126.05 72.47 70.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.028 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.0 -19.47 30.19 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.125 1.592 . . . . 0.0 110.574 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.68 -0.65 55.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -128.25 34.01 4.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.285 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.411 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 67.4 t90 -85.86 149.77 25.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -173.08 1.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -65.64 -39.19 91.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 110.209 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -68.31 -27.17 66.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.0 110.386 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.489 HG22 ' HD3' ' A' ' 14' ' ' LYS . 21.8 t -76.16 -55.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.592 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -61.13 -34.01 74.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.473 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 3.3 tt0 -70.47 -57.43 4.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 110.419 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -56.77 -31.39 64.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -69.03 -63.27 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.346 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -53.5 -27.97 28.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -76.05 -34.74 59.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 1.9 tp10 -74.81 -28.58 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.561 ' CD1' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -82.45 -76.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -80.23 -76.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.55 46.74 0.02 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.601 HD12 ' HB1' ' A' ' 39' ' ' ALA . 8.8 mt -81.78 102.05 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -1.148 . . . . 0.0 110.148 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -42.52 97.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -136.32 115.48 12.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.9 mmm -56.83 125.22 21.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -72.9 165.45 24.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.204 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.02 -32.19 71.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -44.69 65.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.404 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.6 m170 -50.67 -54.46 22.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.592 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 1.8 m95 -62.5 -30.7 71.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.293 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -64.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -51.63 -41.92 61.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 52' ' ' HIS . 45.7 t -57.46 -41.59 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.944 . . . . 0.0 110.106 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.28 -56.92 8.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -47.97 -34.47 9.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.14 -49.26 52.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.085 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -52.01 52.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 110.084 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -40.46 72.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.089 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -62.64 -29.88 70.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.141 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.541 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 77.5 t90 -74.74 -31.17 61.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.69 -42.05 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.2 m -58.6 -40.64 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.47 -57.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.912 . . . . 0.0 110.066 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 119.18 83.48 0.85 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -155.6 171.8 19.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -1.164 . . . . 0.0 110.25 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.99 75.07 21.21 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 161.37 43.06 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.992 1.522 . . . . 0.0 110.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.59 -174.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.994 1.523 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.726 HG13 HG23 ' A' ' 76' ' ' THR . 3.6 tp -87.43 49.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' OG1' ' A' ' 76' ' ' THR . 0.2 OUTLIER -97.74 -60.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.049 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ttm -73.93 -24.01 59.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.082 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' A' ' 79' ' ' THR . 13.6 t -67.07 -37.94 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.726 HG23 HG13 ' A' ' 72' ' ' ILE . 6.1 p -65.16 -26.76 68.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -28.98 70.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.36 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.35 48.13 1.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.234 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 43.9 m -154.69 -49.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.106 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.36 -15.04 60.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.48 ' HB3' HD11 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -54.17 98.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 110.16 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.935 ' O ' HD12 ' A' ' 86' ' ' ILE . 2.2 t -70.16 148.59 48.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.233 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 72' ' ' ILE . 22.3 tp -60.52 -27.77 67.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -48.04 65.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.64 -40.64 79.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.19 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 82' ' ' SER . 3.4 mt -72.42 -27.83 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 110.113 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 -43.14 75.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.172 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -54.12 10.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.133 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.87 -29.51 68.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.71 96.13 4.8 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 110.141 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.5 Cg_endo -72.87 88.43 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 12.9 t 176.47 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.96 141.55 5.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.48 -10.21 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.991 1.522 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -89.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.853 . . . . 0.0 110.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 21.5 m170 -77.14 -10.89 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.92 . . . . 0.0 110.215 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -79.21 -83.88 0.62 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.86 -34.76 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.291 -1.123 . . . . 0.0 110.341 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 100' ' ' LYS . 8.5 t -70.44 -64.46 0.89 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 26.6 tttm -43.18 -31.61 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.301 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.64 -52.31 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.212 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.14 -27.4 45.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.14 46.53 5.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -120.5 67.42 13.66 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.279 -1.13 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.44 169.42 21.77 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.997 1.525 . . . . 0.0 110.447 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.33 161.98 0.56 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.163 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.78 178.05 6.85 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.03 1.542 . . . . 0.0 110.423 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 p -102.18 135.84 43.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 110.166 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.13 -87.91 2.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 28.6 p -95.98 170.12 9.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 0.0 110.292 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 111' ' ' VAL . 33.8 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.568 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 46.0 Cg_endo -71.96 81.03 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.027 1.541 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.66 116.87 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 110.332 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.64 143.19 58.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.877 . . . . 0.0 110.223 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 18.6 m -138.8 149.42 61.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -76.05 164.71 87.22 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.705 -2.206 . . . . 0.0 110.567 -0.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.48 156.66 25.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.01 154.54 18.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -1.123 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -147.59 147.21 29.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.34 117.56 34.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.12 102.88 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 110.401 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.24 -101.73 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.82 51.31 0.82 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 143.55 21.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -1.136 . . . . 0.0 110.102 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.87 123.87 43.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.99 140.55 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.326 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -124.61 100.66 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 110.183 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.616 HD22 ' CA ' ' A' ' 22' ' ' CYS . 20.3 mt -77.14 121.74 24.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.136 -0.977 . . . . 0.0 110.32 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -141.45 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.7 tt0 -66.09 133.51 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.524 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.4 t70 66.82 34.79 5.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.616 ' CA ' HD22 ' A' ' 18' ' ' LEU . 60.5 m 44.05 42.71 5.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.524 ' CD2' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -86.85 144.19 27.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.143 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.76 112.61 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 110.248 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -105.85 31.1 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -152.32 65.86 6.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.54 -14.03 24.91 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.045 1.55 . . . . 0.0 110.399 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.99 -33.82 39.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 9.9 m-20 -103.42 -85.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.129 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.469 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 33.5 t90 58.98 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 110.297 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -163.5 179.43 7.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.69 -55.59 10.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.287 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -36.36 71.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.91 -61.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.97 -45.74 21.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.09 -45.41 87.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.0 t90 -58.13 -51.87 67.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.983 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -54.39 -40.87 68.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.245 -0.909 . . . . 0.0 110.506 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.92 69.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.921 . . . . 0.0 110.564 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.442 ' CD ' ' OE2' ' A' ' 41' ' ' GLU . 1.3 tmm_? -73.66 -45.22 53.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 110.562 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.442 ' OE2' ' CD ' ' A' ' 40' ' ' ARG . 2.0 mp0 -66.81 -33.9 76.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -68.13 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.348 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.89 -64.48 1.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.4 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.36 117.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -1.19 . . . . 0.0 110.26 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -74.69 -33.16 62.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.74 144.17 43.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.6 mmm -85.95 129.78 34.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.288 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.711 HG23 ' H ' ' A' ' 52' ' ' HIS . 3.5 t -73.69 170.77 14.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.18 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 3.8 mt-10 -67.89 -23.43 65.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.49 -40.06 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.898 . . . . 0.0 110.339 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.711 ' H ' HG23 ' A' ' 49' ' ' THR . 2.5 m170 -59.84 -59.67 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -58.68 -30.24 67.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.243 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -63.79 -65.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.908 . . . . 0.0 110.215 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.01 -29.03 63.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 52' ' ' HIS . 48.2 t -65.52 -39.82 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.73 -31.5 57.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.5 -49.33 71.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.04 -31.35 71.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.039 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -27.6 63.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.0 -45.81 90.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.298 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.5 -29.91 61.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.672 ' NE1' ' HB1' ' A' ' 104' ' ' ALA . 88.6 t90 -66.02 -44.3 85.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -44.13 83.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -64.19 -67.76 0.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.24 -63.34 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.33 44.13 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 p -139.39 -158.63 0.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -1.105 . . . . 0.0 110.187 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 m -139.41 101.87 7.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 110.192 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.87 172.27 16.21 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.107 1.582 . . . . 0.0 110.364 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' CG ' ' HD3' ' A' ' 73' ' ' LYS . 45.6 Cg_endo -72.52 -164.96 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.066 1.561 . . . . 0.0 110.368 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -116.12 44.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HD3' ' CG ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -92.81 -66.79 0.9 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.7 mtp -60.04 -14.77 18.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.53 -58.21 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -28.18 69.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -28.12 69.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -106.68 -65.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.8 p -56.97 -35.09 68.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.7 79.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -75.04 122.88 24.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -1.137 . . . . 0.0 110.242 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.481 ' CB ' ' HE2' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -53.67 136.26 39.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.01 -35.45 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.94 -36.03 77.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HE2' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -58.4 -53.1 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 110.174 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.559 HG21 ' HG3' ' A' ' 94' ' ' PRO . 79.9 mt -65.9 -38.68 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.18 -37.57 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 109.946 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -48.2 25.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.431 HD22 ' CE1' ' A' ' 52' ' ' HIS . 22.6 mt -65.27 -11.72 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 0.1 OUTLIER -173.08 104.89 0.32 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 90' ' ' PHE . 45.2 Cg_endo -72.31 -25.6 18.36 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.056 1.556 . . . . 0.0 110.381 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.7 m -75.92 0.52 18.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.27 147.78 5.81 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 46.9 Cg_endo -73.09 -10.39 24.41 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.035 1.545 . . . . 0.0 110.346 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.22 -84.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.348 -0.845 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -76.72 -18.08 58.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.53 -67.1 1.73 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . -44.59 -38.09 4.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.124 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.88 -44.32 70.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -41.65 70.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.84 -37.24 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.5 70.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.72 50.19 1.85 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.672 ' HB1' ' NE1' ' A' ' 63' ' ' TRP . . . -175.55 81.96 0.3 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.251 -1.147 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.41 -89.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.049 1.552 . . . . 0.0 110.482 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HD3' ' HD2' ' A' ' 107' ' ' PRO . 0.7 OUTLIER -112.89 164.49 15.31 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 0.0 110.201 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.404 ' HD2' ' HD3' ' A' ' 106' ' ' LYS . 46.5 Cg_endo -73.09 -168.92 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.987 1.519 . . . . 0.0 110.452 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t -135.09 7.33 3.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.332 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.5 130.36 46.16 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 118.46 7.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.229 -179.976 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.5 121.61 7.25 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.925 1.487 . . . . 0.0 110.393 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.52 HG11 ' CD1' ' A' ' 18' ' ' LEU . 54.2 t -66.96 107.85 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 110.214 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -63.19 104.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.8 m -94.5 142.76 25.23 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.32 144.94 82.14 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.38 -0.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.94 165.11 30.6 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 144.59 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -1.111 . . . . 0.0 110.146 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -146.23 171.41 14.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.2 mt-30 -133.45 122.57 23.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.206 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 3.9 t -99.83 109.37 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.041 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 46.6 t0 56.33 -88.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.244 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.64 48.01 0.99 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 2.8 mttm -149.14 151.69 34.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -1.15 . . . . 0.0 110.257 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -112.53 111.28 22.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.56 140.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.7 107.87 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.749 HD22 ' C ' ' A' ' 22' ' ' CYS . 13.2 mt -83.65 124.59 30.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 3.1 t70 -66.39 -170.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -38.23 69.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.33 39.79 1.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.749 ' C ' HD22 ' A' ' 18' ' ' LEU . 67.4 m 44.85 39.63 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.55 151.15 22.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 132.82 34.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.31 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -108.26 -8.66 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -139.66 60.49 16.28 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.42 ' CG ' ' HB3' ' A' ' 105' ' ' PRO . 45.7 Cg_endo -73.15 -1.73 11.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.03 1.542 . . . . 0.0 110.464 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -31.28 62.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -106.09 36.54 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.244 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -61.19 144.04 54.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.181 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.14 175.59 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.49 -39.24 90.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.239 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 16.4 mttt -67.02 -31.79 72.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.447 ' O ' HD12 ' A' ' 38' ' ' LEU . 49.1 t -71.49 -58.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -52.98 -46.75 68.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.26 -33.12 74.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 33.7 t90 -61.72 -48.44 80.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.45 -38.88 85.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.411 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.69 81.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.396 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.45 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 2.0 ttt-85 -71.63 -51.65 22.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.336 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.12 -26.84 65.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.427 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.5 mp -87.56 -72.08 0.54 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -42.7 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.384 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 118.12 21.11 4.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.438 ' N ' ' HA ' ' A' ' 40' ' ' ARG . 19.6 mt -79.63 105.6 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -1.108 . . . . 0.0 110.188 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -46.94 72.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' MET . 11.5 tptp -118.71 109.45 16.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' LYS . 4.6 tpt -42.8 150.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.271 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 52' ' ' HIS . 30.7 p -84.75 174.18 10.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.26 -40.87 64.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 110.302 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.442 ' CB ' HD11 ' A' ' 89' ' ' LEU . 67.2 mm-40 -68.61 -33.7 74.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -55.42 -49.67 71.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.2 m95 -71.23 -26.93 63.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -62.54 -58.44 7.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.42 -50.48 52.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.369 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 52' ' ' HIS . 95.5 t -52.44 -33.61 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -51.78 13.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.236 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.529 ' CZ ' HG22 ' A' ' 79' ' ' THR . 52.4 t80 -53.62 -31.53 47.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -44.78 63.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.164 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -49.13 -35.62 16.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.17 -51.75 68.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -41.88 98.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.428 ' O ' ' CD2' ' A' ' 63' ' ' TRP . 15.8 t90 -68.83 -12.51 61.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.221 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -14.27 35.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.244 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.568 HG22 ' CD2' ' A' ' 66' ' ' PHE . 96.2 m -97.82 -46.37 5.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.913 . . . . 0.0 110.145 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.568 ' CD2' HG22 ' A' ' 65' ' ' THR . 60.9 m-85 -124.94 -8.86 7.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 63' ' ' TRP . . . 65.83 45.44 88.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.19 147.57 40.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -117.32 103.13 51.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.28 152.69 50.34 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.971 1.511 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.87 -90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 0.0 110.346 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.629 HG12 HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -169.42 57.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -135.56 -68.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.028 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.7 ttm -67.84 -14.36 62.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.043 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.424 ' O ' ' OG1' ' A' ' 79' ' ' THR . 93.8 t -70.56 -42.68 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.882 . . . . 0.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -27.11 66.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -72.14 -33.5 67.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.826 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.23 -63.64 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CZ ' ' A' ' 58' ' ' TYR . 46.9 p -60.6 -42.34 96.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.13 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.52 59.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.66 149.72 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -1.19 . . . . 0.0 110.179 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -71.96 143.11 49.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.629 HD11 HG12 ' A' ' 72' ' ' ILE . 29.0 tp -73.32 -29.28 62.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -31.42 69.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.264 -0.898 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -62.13 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.457 HD12 ' H ' ' A' ' 86' ' ' ILE . 2.5 mp -51.26 -45.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.355 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 92' ' ' SER . 1.5 t80 -60.53 -33.73 73.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.71 -24.86 53.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.519 HD22 ' CG ' ' A' ' 52' ' ' HIS . 9.4 mt -76.13 -50.7 13.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 101' ' ' VAL . 74.1 m-85 -97.81 162.5 22.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 92' ' ' SER . 48.0 Cg_endo -74.92 76.7 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.115 1.587 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.453 ' HA ' ' CE1' ' A' ' 87' ' ' TYR . 0.8 OUTLIER 41.61 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.14 70.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' CB ' HD13 ' A' ' 72' ' ' ILE . 46.7 Cg_endo -72.99 -21.27 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.003 1.528 . . . . 0.0 110.432 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.54 -81.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.226 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -66.34 -16.09 63.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.76 -70.84 1.2 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.35 -42.34 61.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -1.161 . . . . 0.0 110.165 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.51 -48.41 81.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.22 -37.21 69.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.101 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.527 HG21 ' CE1' ' A' ' 90' ' ' PHE . 50.6 t -72.19 -31.96 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.13 -50.94 64.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.865 . . . . 0.0 110.213 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.03 43.41 1.78 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.08 116.78 66.67 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.224 -1.162 . . . . 0.0 110.079 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 106' ' ' LYS . 48.2 Cg_endo -73.1 -94.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.864 1.455 . . . . 0.0 110.456 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' PRO . 13.2 mmtp 40.32 65.32 4.05 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.184 -0.947 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.53 -38.44 3.38 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.028 1.541 . . . . 0.0 110.572 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 m -152.9 -80.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.81 99.72 0.23 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -158.32 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -1.147 . . . . 0.0 110.255 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.126 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 120.742 0.306 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.29 135.04 21.91 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.003 1.528 . . . . 0.0 110.543 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 41' ' ' GLU . 71.1 t -80.08 87.16 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.108 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 109.58 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 26.0 p -102.18 157.36 33.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 47.7 Cg_endo -75.48 147.28 88.14 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.504 -0.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.03 174.86 46.88 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.72 144.38 44.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 0.0 110.148 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.09 165.94 26.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -116.26 137.94 51.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 77.7 t -133.84 118.64 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t0 46.34 52.33 10.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.304 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.98 39.61 97.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.0 tttt -131.02 166.92 19.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -1.172 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 103.34 9.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.8 t -99.03 130.95 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.139 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.73 115.96 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 22' ' ' CYS . 10.6 mt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.185 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.3 t0 -59.55 -172.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.25 -23.21 67.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.827 . . . . 0.0 110.298 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -108.26 35.17 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.261 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.604 ' HA ' HD22 ' A' ' 18' ' ' LEU . 1.4 m 52.42 42.96 31.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.263 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -111.49 111.08 21.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 110.263 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -45.12 144.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.256 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.36 13.46 15.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.193 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -145.79 59.71 5.91 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.141 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.78 -8.14 21.9 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 0.0 110.517 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -27.4 65.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' TRP . 5.9 m-20 -92.82 -74.36 0.52 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 29' ' ' ASP . 68.9 t90 56.92 162.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.86 176.19 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.29 -51.22 39.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -32.96 74.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.73 -55.79 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.703 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -53.79 -47.3 70.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.53 -26.88 66.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -68.73 -54.49 15.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.291 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.535 HD23 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -62.93 -36.9 84.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.62 -37.26 86.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.09 -28.67 54.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.372 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 7.3 mm-40 -76.95 -27.6 54.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.96 . . . . 0.0 110.378 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.535 HD13 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -96.53 -21.43 17.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.283 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HB3' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -127.29 -36.68 2.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.933 . . . . 0.0 110.324 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 96.96 21.93 19.32 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 43' ' ' GLU . 34.8 mt -59.03 97.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -1.161 . . . . 0.0 110.23 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.11 -43.77 51.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 109.984 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -136.32 115.09 12.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -42.55 137.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.208 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -81.07 139.38 35.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 -24.8 7.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 110.229 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -75.98 -45.55 34.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 56' ' ' VAL . 22.6 m170 -51.8 -55.57 19.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.703 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 16.7 m95 -55.87 -29.24 59.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -52.9 48.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -37.12 85.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 52' ' ' HIS . 11.9 t -64.63 -38.19 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -54.29 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.415 ' CE1' HG13 ' A' ' 75' ' ' VAL . 17.2 t80 -51.84 -41.11 61.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.225 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -34.87 77.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.234 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -60.44 -30.14 69.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.93 -45.94 72.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.276 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -37.87 89.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 67' ' ' GLY . 48.9 t90 -64.03 -48.15 77.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.233 -0.917 . . . . 0.0 110.193 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.03 -12.74 60.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.7 m -91.23 -22.33 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.97 -43.79 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' TRP . . . 103.07 43.03 1.97 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.8 t -154.3 158.89 40.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 110.25 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.0 116.6 66.11 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.47 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 45.9 Cg_endo -72.71 174.28 12.03 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.832 1.438 . . . . 0.0 110.425 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 45.5 Cg_endo -72.1 -159.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.947 1.499 . . . . 0.0 110.46 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 72' ' ' ILE . 7.9 tp -118.02 -1.4 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.375 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -90.19 -44.67 9.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -23.74 63.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 58' ' ' TYR . 97.5 t -71.48 -41.93 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 110.317 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 80' ' ' GLY . 6.8 m -62.24 -45.4 93.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -45.34 -47.67 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.372 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.66 -32.35 70.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 p -103.84 -74.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 76' ' ' THR . . . 128.85 -12.23 6.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.8 m-30 -43.24 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -1.164 . . . . 0.0 110.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 80' ' ' GLY . 34.3 t -42.82 131.74 4.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.847 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tp -51.61 -37.65 51.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -40.55 72.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -64.11 -54.96 25.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 110.1 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.5 mt -51.64 -32.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 110.083 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -74.99 -35.86 62.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.105 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.22 62.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.28 -19.91 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.43 109.05 9.49 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -39.69 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.982 1.517 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -44.86 66.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 110.257 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.86 153.53 9.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -74.06 -162.41 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.96 1.505 . . . . 0.0 110.508 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 57.02 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 110.511 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' PRO . 36.3 m170 -66.6 -44.37 82.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.411 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -62.65 -66.93 2.31 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.67 -56.75 2.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -1.148 . . . . 0.0 110.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -50.44 -62.25 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -41.99 -49.61 4.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.216 -0.928 . . . . 0.0 110.526 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.26 -50.21 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.44 -19.23 65.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 70.03 1.36 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.0 161.0 27.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.239 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.73 131.42 17.16 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.065 1.56 . . . . 0.0 110.425 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -82.33 140.47 45.33 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.196 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' O ' ' CB ' ' A' ' 108' ' ' THR . 46.3 Cg_endo -72.94 -161.14 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.942 1.496 . . . . 0.0 110.424 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.406 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 0.5 OUTLIER 62.62 98.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.157 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.29 170.98 39.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.38 70.6 0.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.168 . . . . 0.0 110.241 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.163 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.756 0.312 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.64 130.18 14.48 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.056 1.556 . . . . 0.0 110.515 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 41' ' ' GLU . 4.9 p -91.52 154.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.118 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 171.0 15.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.277 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' HD13 ' A' ' 18' ' ' LEU . 14.5 m -121.41 155.93 58.53 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.6 Cg_endo -76.19 158.01 97.87 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.545 -2.273 . . . . 0.0 110.403 -0.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.84 151.27 15.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.84 143.56 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -1.123 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -150.78 158.39 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.62 132.11 54.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 110.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 37' ' ' TRP . 98.9 t -116.56 104.98 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 24.8 t0 55.14 -90.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -132.5 52.56 0.82 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.623 ' CD ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -153.15 152.51 31.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -1.144 . . . . 0.0 110.224 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.32 133.34 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.665 HG22 HD21 ' A' ' 26' ' ' ASN . 72.9 t -132.41 111.19 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 0.0 110.158 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 17' ' ' ILE . 11.5 tt -107.55 96.66 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.573 HD13 ' SG ' ' A' ' 5' ' ' CYS . 76.4 mt -61.65 122.94 16.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -152.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -37.4 87.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 22' ' ' CYS . 2.5 t0 -108.37 51.38 0.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 93.0 m 43.32 27.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.12 138.76 45.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.424 ' HG3' HD11 ' A' ' 38' ' ' LEU . 3.1 mtp -79.79 110.99 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.214 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.15 18.85 11.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.665 HD21 HG22 ' A' ' 16' ' ' VAL . 16.2 p-10 -135.12 52.34 7.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.5 Cg_endo -72.94 -22.64 19.53 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.999 1.526 . . . . 0.0 110.427 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -60.08 -18.0 43.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -127.2 36.92 4.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.897 . . . . 0.0 110.13 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 31.8 t90 -73.44 139.46 45.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.91 174.7 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 33' ' ' LYS . 25.4 pt-20 -66.42 -42.11 88.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 1.9 ttmm -67.85 -47.51 68.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.623 HG21 ' CD ' ' A' ' 14' ' ' LYS . 42.8 t -56.0 -54.41 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -56.8 -36.52 70.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.74 -44.73 93.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.624 ' CD2' HG22 ' A' ' 11' ' ' VAL . 38.0 t90 -64.64 -38.43 90.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.184 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -58.16 -51.68 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.29 -27.24 66.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -64.43 -49.03 73.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB3' HG11 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.17 -28.19 53.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.413 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 42' ' ' LEU . 2.9 mm? -84.34 -3.72 58.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.364 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.3 -46.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 122.51 12.72 4.99 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 45' ' ' ILE . 9.6 mt -76.16 79.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.14 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -50.21 60.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.263 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 131.31 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 71.4 mmm -74.38 121.01 20.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -76.43 -157.17 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 49' ' ' THR . 7.5 mp0 -92.86 -27.86 16.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -48.38 35.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.69 ' NE2' HD22 ' A' ' 89' ' ' LEU . 23.2 m80 -51.25 -46.5 62.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.267 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.9 m95 -72.15 -31.27 65.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -64.01 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.19 -43.43 98.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.911 . . . . 0.0 110.265 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 52' ' ' HIS . 37.4 t -60.32 -27.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.257 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 tttt -76.64 -53.89 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.561 ' CD2' HG13 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -53.1 60.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.53 -51.31 60.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.92 -41.82 46.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.51 ' CE2' ' HG3' ' A' ' 70' ' ' PRO . 4.9 t80 -65.74 -35.11 79.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.903 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.552 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 36.0 t90 -66.42 -22.24 66.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.76 -10.64 59.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -81.31 -49.13 11.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -152.0 -38.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.98 88.48 0.95 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.77 -178.5 7.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 0.0 110.238 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.46 84.87 15.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 45.0 Cg_endo -72.44 125.92 11.13 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.395 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.57 91.54 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.897 1.472 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 73' ' ' LYS . 8.4 mm 48.56 -132.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 109.917 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' H ' HG22 ' A' ' 72' ' ' ILE . 8.3 mttt 57.81 -97.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.052 -1.03 . . . . 0.0 110.36 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.55 -23.91 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.03 -1.044 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.561 HG13 ' CD2' ' A' ' 58' ' ' TYR . 22.2 t -69.6 -47.18 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 110.301 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 73' ' ' LYS . 1.1 p -63.97 -34.86 78.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -43.99 -32.94 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 0.0 110.149 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.92 48.02 2.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.4 m -153.75 -70.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.54 87.35 1.92 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.16 104.55 2.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -1.131 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.4 143.3 40.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 83' ' ' LEU . 7.6 tp -60.56 -26.87 67.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -41.48 74.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.45 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -65.84 -58.04 6.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.396 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 94' ' ' PRO . 54.6 mt -46.29 -49.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 110.224 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -59.37 -41.39 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.17 -24.75 67.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.69 HD22 ' NE2' ' A' ' 52' ' ' HIS . 4.5 mt -79.48 -62.33 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 110.259 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 11.3 m-85 -85.08 170.81 12.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.123 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 42.5 Cg_endo -74.54 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.117 1.588 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.87 56.52 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.044 -1.035 . . . . 0.0 110.033 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.52 143.07 1.4 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HG3' HG23 ' A' ' 86' ' ' ILE . 45.5 Cg_endo -72.96 -90.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.954 1.502 . . . . 0.0 110.447 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . 53.91 -93.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 97' ' ' GLY . 5.1 m-70 -69.63 -57.39 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 96' ' ' HIS . . . -43.65 -59.1 3.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -47.48 -48.65 26.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.125 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 99.7 m -53.78 -62.54 1.59 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 99' ' ' CYS . 15.0 mttp -44.16 -45.87 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 54.4 t -53.76 -55.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.344 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.15 -22.74 66.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 104' ' ' ALA . . . 114.07 -46.65 1.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' GLY . . . 42.15 72.35 1.14 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.354 -1.086 . . . . 0.0 110.276 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HG2' ' CZ2' ' A' ' 63' ' ' TRP . 45.7 Cg_endo -72.65 -168.88 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.974 1.512 . . . . 0.0 110.487 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -112.29 155.29 43.81 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.89 174.47 11.85 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.978 1.515 . . . . 0.0 110.432 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.1 m -128.37 109.49 11.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.64 -105.34 0.46 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.8 t -176.28 -61.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -1.149 . . . . 0.0 110.272 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.189 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.729 0.3 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.27 -60.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.071 1.564 . . . . 0.0 110.467 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 41' ' ' GLU . 5.7 t -138.09 4.3 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.405 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 63.33 114.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.397 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 79.2 m -137.14 151.71 72.32 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.6 Cg_endo -78.62 162.91 87.29 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.316 -0.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.11 45.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 16.5 mt-10 -106.07 170.65 7.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.035 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 1.2 m-85 -169.52 171.21 7.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 110.344 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -132.6 137.97 47.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.583 HG22 ' CE2' ' A' ' 37' ' ' TRP . 75.8 t -117.71 106.88 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 51.18 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.96 60.06 0.68 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -161.44 164.26 29.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -1.132 . . . . 0.0 110.246 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.98 147.85 26.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 110.208 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.421 HG21 ' CG2' ' A' ' 11' ' ' VAL . 65.7 t -140.28 135.81 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 17' ' ' ILE . 4.5 mp -127.33 100.24 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 18' ' ' LEU . 43.0 mt -73.36 131.78 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -83.85 -146.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 110.385 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.4 -48.54 69.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.343 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -98.67 39.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.95 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 55.7 m 56.56 31.99 20.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.377 -0.827 . . . . 0.0 110.026 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.94 155.09 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -98.61 113.66 25.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.26 16.03 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.98 64.74 71.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.63 -15.85 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.969 1.51 . . . . 0.0 110.357 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -15.96 62.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -116.53 12.89 15.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.324 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.687 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 24.8 t90 -63.77 147.87 50.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -0.898 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.27 -154.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.11 -33.3 61.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -72.19 -39.87 68.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.274 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 41.2 t -72.9 -36.93 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.425 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -69.91 -50.46 42.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.381 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.76 -46.62 89.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 110.427 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.583 ' CE2' HG22 ' A' ' 11' ' ' VAL . 77.6 t90 -60.25 -54.63 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.509 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.94 -41.11 58.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.598 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.879 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -65.84 -37.06 85.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.562 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -35.58 74.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 3' ' ' VAL . 2.9 mm-40 -77.1 -30.05 55.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 110.383 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -75.98 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.919 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.3 -61.26 1.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.07 42.52 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.879 HD12 ' HB1' ' A' ' 39' ' ' ALA . 75.5 mt -78.88 99.86 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -1.117 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.59 -28.97 67.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -144.07 118.46 9.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.145 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.419 ' HG3' ' NE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -48.76 142.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.268 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 147.4 22.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.882 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 16.2 pt-20 -57.53 -36.85 72.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mm-40 -66.87 -34.62 78.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -69.09 -53.34 20.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 110.204 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.419 ' NE1' ' HG3' ' A' ' 48' ' ' MET . 5.0 m95 -58.28 -27.96 64.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -56.81 5.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -39.42 65.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.056 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -69.46 -32.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.13 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -49.78 69.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -65.9 -37.25 85.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.86 75.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 110.314 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 38.1 ttm-85 -60.08 -28.93 68.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 110.33 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 1.8 tt0 -56.77 -60.84 2.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -69.55 -26.57 64.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 110.198 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 60' ' ' ARG . 32.5 t90 -65.94 -20.16 66.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 110.338 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.96 -0.46 47.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -108.34 -60.52 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.933 . . . . 0.0 110.306 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' GLY . 4.8 m-85 -107.17 7.65 29.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' PHE . . . 45.91 69.83 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.23 147.31 25.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.7 t -116.19 83.71 13.04 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.62 169.85 21.36 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.953 1.502 . . . . 0.0 110.355 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.02 -160.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.012 1.533 . . . . 0.0 110.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.583 ' O ' HG22 ' A' ' 72' ' ' ILE . 25.1 mm -102.75 40.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.78 -58.82 1.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.256 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mmt -61.76 -28.85 69.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' O ' ' OG1' ' A' ' 79' ' ' THR . 6.8 t -71.43 -38.07 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.579 HG23 ' H ' ' A' ' 81' ' ' PHE . 1.0 OUTLIER -63.79 -27.03 68.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.87 -29.92 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.68 46.63 2.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.255 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 24.5 m -148.29 -50.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.243 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.68 1.16 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -127.35 143.93 51.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -1.171 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 130.59 54.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.9 -34.24 62.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 19.8 tt0 -58.01 -55.23 37.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.447 ' CE ' HD11 ' A' ' 89' ' ' LEU . 1.3 tptm -51.97 -52.16 52.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 94' ' ' PRO . 57.3 mt -54.94 -31.04 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.086 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -67.88 -51.16 51.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.222 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.57 68.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.447 HD11 ' CE ' ' A' ' 85' ' ' LYS . 13.8 mt -73.32 -66.73 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.244 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 102.29 51.17 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.07 94.76 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.918 1.483 . . . . 0.0 110.442 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 177.7 -37.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.21 131.85 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HB2' HG13 ' A' ' 72' ' ' ILE . 46.9 Cg_endo -73.37 -162.89 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.937 1.493 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 56.08 -90.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.3 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.47 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 57.1 m-70 -59.43 -33.85 71.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -69.62 -67.15 2.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.62 -52.3 4.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -46.91 81.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.79 -36.73 48.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 t -74.43 -36.24 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.61 -21.69 61.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.94 72.33 0.95 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . . . -135.21 103.62 10.53 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.192 -1.181 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.447 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 45.7 Cg_endo -72.79 113.93 3.89 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.009 1.531 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -49.43 105.96 0.57 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.92 . . . . 0.0 110.146 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 105' ' ' PRO . 46.8 Cg_endo -72.66 151.95 52.83 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.08 1.568 . . . . 0.0 110.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.6 ' O ' HG22 ' A' ' 108' ' ' THR . 84.9 m -109.53 49.02 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.332 -0.855 . . . . 0.0 110.212 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.3 116.88 2.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.31 155.55 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.158 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.177 179.95 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.85 98.35 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.083 1.57 . . . . 0.0 110.408 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.9 m -69.94 155.57 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.227 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -128.92 157.78 40.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.7 m -116.63 146.41 37.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.5 174.21 53.98 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.357 -0.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' ILE . . . -176.34 173.03 46.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.532 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -150.82 138.35 19.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -1.115 . . . . 0.0 110.041 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 51.6 m-85 -145.22 171.31 14.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -104.47 111.56 24.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 91.6 t -118.86 107.79 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.263 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 11.0 t0 66.06 64.73 0.53 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 44.7 32.12 2.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.3 mttp -129.03 165.0 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.145 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -122.14 113.43 19.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 93.1 t -111.08 145.72 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.101 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 3.5 tt -137.53 109.61 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 110.223 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 56.4 mt -78.25 134.64 37.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 4.6 t0 -67.11 -167.97 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -17.92 65.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.26 38.14 3.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 53.1 m 47.68 39.09 9.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.1 155.55 16.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 90.68 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.421 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 19.5 pt20 -83.62 -4.21 58.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.457 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 1.8 t30 -121.39 62.74 12.6 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 45.8 Cg_endo -72.86 -16.27 26.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.015 1.534 . . . . 0.0 110.396 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -64.22 -25.06 67.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.69 0.37 30.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 42.7 t90 -46.38 148.19 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -168.45 2.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 4.9 tt0 -74.93 -55.35 5.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -30.87 71.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 110.203 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.01 -50.04 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -59.89 -50.83 72.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.62 -57.73 11.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 110.281 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 59.1 t90 -47.78 -36.85 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.64 -57.1 8.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.266 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -51.38 -28.49 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.306 -0.871 . . . . 0.0 110.189 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -62.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.892 . . . . 0.0 110.219 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -48.97 -37.0 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.318 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' HA ' HD13 ' A' ' 42' ' ' LEU . 0.8 OUTLIER -80.78 -75.33 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.315 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.4 -76.8 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.68 38.65 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.575 HD12 ' HB1' ' A' ' 39' ' ' ALA . 43.1 mt -79.73 104.4 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 110.034 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -78.8 -19.09 52.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.334 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -151.61 96.46 2.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 45' ' ' ILE . 70.8 mmm -52.06 103.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.039 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 1.0 HG22 ' ND1' ' A' ' 52' ' ' HIS . 2.3 t -55.99 160.34 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.87 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -52.61 -36.63 56.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -0.936 . . . . 0.0 110.281 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -35.29 79.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.311 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 1.0 ' ND1' HG22 ' A' ' 49' ' ' THR . 22.4 m170 -65.16 -60.53 2.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.943 . . . . 0.0 110.541 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.579 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 5.4 m95 -57.02 -34.22 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.733 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -62.91 -60.1 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.163 -0.961 . . . . 0.0 110.464 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 86' ' ' ILE . 1.9 tp -52.3 -39.16 60.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 52' ' ' HIS . 60.8 t -68.6 -30.88 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.185 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -49.8 64.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.11 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.587 ' CE2' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -66.86 -34.35 77.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -63.05 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -66.13 -49.46 67.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -43.75 -46.18 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.95 -32.1 63.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.218 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.453 ' CG ' ' O ' ' A' ' 63' ' ' TRP . 78.7 t90 -81.63 8.75 9.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -113.36 -17.59 12.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.69 -46.02 3.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.082 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.79 -50.91 9.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.08 25.12 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 t -167.03 168.06 14.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -1.153 . . . . 0.0 110.109 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 69' ' ' CYS . 23.5 p -114.01 104.72 54.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 172.02 16.41 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.015 1.534 . . . . 0.0 110.433 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.87 -169.83 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 72' ' ' ILE . 45.6 mm -97.54 63.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -107.26 -63.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 mtm -74.77 -19.36 60.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.74 -29.99 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.231 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 84.0 m -59.32 -36.72 76.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.04 -28.19 54.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 -76.12 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 ' CE2' ' A' ' 58' ' ' TYR . 66.5 p -67.3 -51.16 56.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.279 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 106.75 9.07 31.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.96 108.21 2.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -1.156 . . . . 0.0 110.142 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.07 139.38 47.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.16 -27.86 67.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -49.32 72.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.154 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -51.52 -55.25 20.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 110.12 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mt -54.82 -39.19 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.17 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.26 -36.84 78.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -75.31 -27.37 59.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 0.0 110.194 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.566 HD22 ' NE2' ' A' ' 52' ' ' HIS . 14.9 mt -92.48 -5.36 52.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.299 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -156.43 99.61 2.09 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.199 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 90' ' ' PHE . 46.1 Cg_endo -73.25 -17.53 24.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.996 1.524 . . . . 0.0 110.459 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.9 m -67.47 -29.89 69.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.85 147.71 8.48 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.12 -1.79 11.08 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.051 1.553 . . . . 0.0 110.48 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.453 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . -79.65 -86.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 110.239 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -73.85 -5.42 40.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.363 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 101' ' ' VAL . . . -65.23 -94.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -42.69 -27.26 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 56.0 m -65.63 -79.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -43.04 -40.25 3.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 110.289 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 97' ' ' GLY . 92.1 t -55.91 -48.72 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 110.247 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -65.39 -49.64 68.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 105' ' ' PRO . . . 133.61 54.38 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.27 111.51 28.46 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.228 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 103' ' ' GLY . 45.7 Cg_endo -73.62 -58.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.033 1.543 . . . . 0.0 110.527 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -116.47 107.51 46.85 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.53 -171.88 0.94 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.057 1.556 . . . . 0.0 110.323 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.88 69.45 1.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 110.226 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.42 -74.81 0.07 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.6 t -82.63 -171.0 3.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -1.115 . . . . 0.0 110.131 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.238 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.544 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 16.7 mtt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 120.705 0.288 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 45.9 Cg_endo -72.36 -166.03 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.974 1.513 . . . . 0.0 110.421 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.534 HG11 ' CH2' ' A' ' 37' ' ' TRP . 5.0 m -104.22 173.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.965 . . . . 0.0 110.255 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.33 107.92 3.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 26.3 p -88.13 158.73 49.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 110.098 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.45 145.05 82.3 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.667 -2.222 . . . . 0.0 110.476 -0.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.08 174.93 46.91 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 125.96 54.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 110.123 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -129.99 156.18 44.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -113.29 134.78 54.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 99.0 t -116.3 94.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.483 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' GLY . 1.1 m-20 48.29 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.542 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.0 59.52 3.31 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 1.3 mttt -166.6 153.2 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -1.138 . . . . 0.0 110.109 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -116.73 145.84 43.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 110.279 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.99 138.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.13 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 17' ' ' ILE . 50.8 mt -117.36 96.85 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.367 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.646 HD22 ' HA ' ' A' ' 22' ' ' CYS . 16.4 mt -75.02 121.91 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -69.84 -171.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -62.47 -16.89 57.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.29 36.72 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.646 ' HA ' HD22 ' A' ' 18' ' ' LEU . 1.3 m 50.61 29.07 3.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -84.57 141.14 30.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.215 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.5 ttt -89.46 115.06 26.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -92.7 22.89 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -133.2 67.06 76.62 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.321 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.07 -13.7 26.09 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.027 1.54 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -78.17 -10.81 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.192 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' TRP . 21.6 t70 -110.93 -5.12 14.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.455 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 12.0 t90 -44.0 143.15 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.188 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 18.6 m-20 -159.93 -163.43 1.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.474 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -74.52 -58.76 3.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -65.41 -31.03 71.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.188 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.5 t -66.99 -53.02 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.483 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -63.08 -53.83 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 2.7 tt0 -52.33 -36.23 52.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.534 ' CH2' HG11 ' A' ' 3' ' ' VAL . 28.1 t90 -70.08 -38.13 75.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -51.54 66.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.709 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -68.65 -26.53 65.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.7 -44.61 73.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.503 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -77.31 -36.93 53.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.144 -0.972 . . . . 0.0 110.797 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -58.56 2.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.677 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -16.63 55.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.472 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 85.48 14.64 67.88 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.709 HD12 ' HB1' ' A' ' 39' ' ' ALA . 8.0 mt -67.23 101.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -70.48 -13.87 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.235 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -168.32 120.21 0.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.508 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 31.5 mmm -67.74 131.68 46.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.29 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.0 p -78.68 -167.16 1.02 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.99 -52.61 7.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -56.61 -30.63 63.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.124 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.54 -61.05 2.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.193 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.483 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 3.7 m95 -57.21 -33.7 67.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 4.2 tmtm? -58.2 -57.14 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.198 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tp -56.9 -50.88 71.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.198 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' HIS . 47.7 t -54.14 -29.04 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 54' ' ' LYS . 9.5 mmtt -73.44 -53.79 9.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 110.261 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.427 ' O ' ' HB2' ' A' ' 62' ' ' TYR . 3.1 t80 -51.3 -41.28 60.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 110.342 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -49.53 77.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.306 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.98 -60.34 4.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -27.01 4.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.29 -0.881 . . . . 0.0 110.361 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.8 -37.66 58.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.425 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.481 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 41.9 t90 -65.05 -22.22 66.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.314 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.19 -59.06 5.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.211 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -75.89 -58.52 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.247 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -65.3 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 110.209 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.23 18.94 3.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.537 HG23 ' HD3' ' A' ' 70' ' ' PRO . 8.8 t -141.22 174.22 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.148 . . . . 0.0 110.135 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 t -124.69 84.69 57.51 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD3' HG23 ' A' ' 68' ' ' THR . 46.2 Cg_endo -73.17 173.73 13.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.981 1.516 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.7 Cg_endo -73.09 160.44 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.002 1.528 . . . . 0.0 110.313 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.1 tt -79.03 -7.06 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.145 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -55.1 -62.81 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -63.74 -27.08 68.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.071 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.84 -34.22 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -54.8 -27.65 43.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -65.04 -39.4 93.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -70.05 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.113 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 p -46.8 -39.09 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.91 8.7 84.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -55.4 171.82 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.807 ' O ' HD12 ' A' ' 86' ' ' ILE . 15.8 m -113.94 147.23 38.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 13.0 tp -60.44 -27.9 67.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 110.268 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -63.67 -59.95 3.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.272 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.807 HD12 ' O ' ' A' ' 82' ' ' SER . 3.5 mt -47.01 -33.04 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.377 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -77.0 -36.32 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.923 . . . . 0.0 110.378 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.63 -24.36 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.37 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.22 -49.99 6.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -98.43 167.22 11.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.217 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.68 -89.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.998 1.525 . . . . 0.0 110.505 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.7 t -104.68 85.77 2.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 61.3 139.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 46.4 Cg_endo -73.05 -90.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.061 1.558 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 62.28 -132.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 95' ' ' ALA . 23.2 p80 -42.28 -25.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.0 110.582 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 95' ' ' ALA . . . -66.63 -74.56 0.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.17 -48.1 4.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -1.107 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.4 t -57.01 -44.09 82.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.468 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -60.64 -58.22 9.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.373 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.0 t -46.76 -41.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.29 59.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.52 52.23 3.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -88.83 120.82 70.13 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.481 ' HG2' ' CZ2' ' A' ' 63' ' ' TRP . 46.0 Cg_endo -72.33 140.29 33.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.875 1.46 . . . . 0.0 110.486 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.31 147.88 45.78 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.17 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.49 -59.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.992 1.522 . . . . 0.0 110.576 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.1 p -69.88 173.6 6.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 110' ' ' CYS . . . -171.99 117.31 0.67 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 109' ' ' GLY . 70.9 m -149.92 88.99 1.57 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -1.167 . . . . 0.0 110.212 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 111' ' ' VAL . 21.5 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.152 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.8 0.333 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 1' ' ' MET . 46.1 Cg_endo -73.23 178.0 7.14 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.965 1.508 . . . . 0.0 110.377 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.524 HG21 ' HG3' ' A' ' 41' ' ' GLU . 13.2 t -69.1 125.91 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 133.68 55.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.157 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 62.3 m -103.09 150.38 37.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.4 Cg_endo -76.36 165.6 84.88 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.612 -2.245 . . . . 0.0 110.412 -0.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 154.91 20.26 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.33 152.56 27.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -1.144 . . . . 0.0 110.168 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -149.15 157.06 43.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.481 ' C ' HG23 ' A' ' 11' ' ' VAL . 1.1 tp60 -110.55 145.01 38.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.243 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.481 HG23 ' C ' ' A' ' 10' ' ' GLN . 22.7 t -148.79 110.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.023 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t0 58.51 -143.85 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.951 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.42 50.44 2.99 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.0 146.36 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.243 . . . . 0.0 110.319 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.98 143.18 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.098 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 17' ' ' ILE . 85.0 t -127.79 162.31 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.351 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.476 HG12 ' N ' ' A' ' 18' ' ' LEU . 8.7 tt -148.96 164.37 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' ' 17' ' ' ILE . 16.6 mt -136.43 115.78 12.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.908 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -57.74 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.47 -20.71 66.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.32 38.85 2.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.5 m 48.46 42.57 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -96.52 145.13 25.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.431 ' SD ' HD12 ' A' ' 38' ' ' LEU . 2.1 mtp -82.81 105.43 13.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.33 19.42 13.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -129.51 71.81 82.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.69 -30.5 11.7 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.139 1.6 . . . . 0.0 110.418 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.09 -16.9 64.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.83 35.68 3.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -90.85 153.59 20.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.84 -168.08 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.497 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 2.5 mt-10 -72.12 -57.06 4.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.198 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.77 -29.99 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.34 -57.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -55.44 -38.74 69.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.309 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -52.23 63.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ2' ' OE2' ' A' ' 41' ' ' GLU . 57.9 t90 -56.87 -33.13 66.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 38' ' ' LEU . 4.8 tt -69.57 -42.9 73.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.55 -31.43 72.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -74.63 -44.07 52.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HG3' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -62.97 -36.93 85.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.865 . . . . 0.0 110.145 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -83.46 -67.75 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 45' ' ' ILE . 4.3 tt0 -80.44 -66.38 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.61 -13.9 2.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.401 ' CD1' ' OE1' ' A' ' 43' ' ' GLU . 33.7 mt -44.19 134.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -106.77 3.85 26.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.212 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -161.03 91.29 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -44.95 123.85 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 52' ' ' HIS . 3.3 t -73.83 158.42 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.257 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -34.47 55.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.24 -43.34 92.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.799 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -58.25 -56.66 19.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.224 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.651 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 6.6 m95 -59.29 -27.31 65.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -67.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.61 -32.44 58.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.152 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.72 -33.53 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.47 -42.43 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 110.136 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -44.42 94.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.15 -50.99 71.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 110.236 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -49.17 -50.05 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.381 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.78 -38.97 61.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.58 74.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -52.86 -46.52 67.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.16 -35.48 80.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.334 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.2 m -64.66 -33.99 77.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -142.11 -69.18 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.27 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.62 79.11 0.38 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.447 HG23 ' HD3' ' A' ' 70' ' ' PRO . 5.3 t -162.7 159.88 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -1.185 . . . . 0.0 110.18 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.6 t -112.6 82.52 4.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD3' HG23 ' A' ' 68' ' ' THR . 45.1 Cg_endo -73.42 160.25 44.99 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.15 -89.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.095 1.576 . . . . 0.0 110.454 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -172.14 42.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -64.83 1.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.15 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -40.22 95.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' OG1' ' A' ' 79' ' ' THR . 20.8 t -52.63 -37.17 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m -66.19 -33.58 76.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -74.17 -33.1 63.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.59 -35.39 62.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -107.44 -78.44 0.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.22 38.42 0.23 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -91.99 128.9 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 84' ' ' GLU . 72.4 m -77.83 134.68 37.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.898 . . . . 0.0 110.238 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 82' ' ' SER . 1.3 tp -42.8 -26.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -60.73 -53.3 59.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.34 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -47.92 79.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.64 -30.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -72.35 -48.08 44.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -38.5 80.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD22 ' CE1' ' A' ' 52' ' ' HIS . 8.1 mt -68.36 -65.58 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.084 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.1 m-85 -82.25 173.7 7.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.3 Cg_endo -73.65 -88.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.984 1.518 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -155.86 80.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.56 82.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.07 -17.63 24.66 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.932 1.49 . . . . 0.0 110.432 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.77 -88.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -76.81 -2.26 32.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.18 -70.41 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.81 -36.53 37.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.188 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.2 m -70.26 -52.74 20.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -33.25 36.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 110.173 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.446 HG21 ' HZ ' ' A' ' 90' ' ' PHE . 25.1 t -73.62 -45.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.092 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -21.63 66.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 105' ' ' PRO . . . 82.74 53.9 3.41 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.55 107.85 29.74 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.205 -1.174 . . . . 0.0 110.135 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 103' ' ' GLY . 47.5 Cg_endo -74.21 0.81 7.99 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.019 1.536 . . . . 0.0 110.622 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.84 88.66 50.41 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.45 -46.81 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.042 1.548 . . . . 0.0 110.436 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.5 m -56.48 103.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.178 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.91 48.99 0.89 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -169.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.31 -1.112 . . . . 0.0 110.173 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.603 HG12 ' O ' ' A' ' 111' ' ' VAL . 45.0 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.251 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.788 0.328 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.67 -178.29 3.33 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.989 1.521 . . . . 0.0 110.417 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 9' ' ' TYR . 7.0 m -141.42 161.17 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.45 148.0 52.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.4 m -102.84 141.11 21.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.36 159.21 97.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 -2.153 . . . . 0.0 110.314 -0.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.77 136.34 3.01 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' OE2' HG12 ' A' ' 17' ' ' ILE . 12.4 tt0 -101.24 142.53 32.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -1.104 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CE2' HG12 ' A' ' 3' ' ' VAL . 25.5 m-85 -150.68 148.49 28.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -101.77 143.95 31.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.065 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 43.7 t -120.37 94.87 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 110.448 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.41 63.68 2.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.52 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.53 14.48 79.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 11' ' ' VAL . 16.1 mmtt -102.82 169.96 8.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -1.205 . . . . 0.0 110.162 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.53 108.57 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.558 HG13 ' HB3' ' A' ' 24' ' ' MET . 55.2 t -116.73 145.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.26 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.448 HG12 ' OE2' ' A' ' 8' ' ' GLU . 3.6 mt -134.51 97.47 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.79 110.15 6.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.273 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -68.46 -141.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.77 -2.71 58.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.872 . . . . 0.0 110.145 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.42 38.01 4.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.3 m 47.9 49.14 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -119.69 116.19 25.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.558 ' HB3' HG13 ' A' ' 16' ' ' VAL . 1.8 ptp -51.83 -21.75 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.63 29.81 5.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.62 75.97 36.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 110.175 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.84 -21.46 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.007 1.53 . . . . 0.0 110.408 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -38.34 73.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.74 -2.77 57.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -61.93 125.6 24.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -0.969 . . . . 0.0 110.277 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.3 -162.9 1.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.495 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -72.14 -62.43 1.44 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.965 . . . . 0.0 110.284 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -48.29 -49.28 34.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.31 -52.1 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.236 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -50.77 -36.19 35.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 46.2 mt-10 -72.85 -36.61 67.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -60.49 -48.13 83.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.397 -0.815 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 42' ' ' LEU . 8.1 mt -67.36 -51.21 54.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 110.32 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -53.75 -29.17 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -77.07 -60.82 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.95 -35.35 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 38' ' ' LEU . 6.0 mp -80.16 -66.53 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -89.81 -47.62 7.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 119.47 13.69 6.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.488 HD12 ' HB1' ' A' ' 39' ' ' ALA . 63.2 mt -54.8 92.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -1.158 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 44' ' ' GLY . 3.5 mp0 -57.48 -35.79 70.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.216 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 146.1 46.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.508 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -85.07 134.74 34.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.325 -0.859 . . . . 0.0 110.208 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -93.36 -179.13 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.42 -21.7 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -77.05 -36.25 56.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -71.09 -54.8 9.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.515 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 3.0 m95 -57.67 -33.22 68.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -67.33 -59.09 3.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.142 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.56 -35.77 31.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.89 -40.37 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -63.04 -35.44 80.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.2 -36.85 61.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.247 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.2 -29.43 68.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -59.64 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -44.85 -45.94 10.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.247 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -44.79 96.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.283 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.541 ' O ' ' CE3' ' A' ' 63' ' ' TRP . 21.4 t90 -67.88 -14.5 63.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.329 -0.857 . . . . 0.0 110.287 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.17 -49.83 8.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.302 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.95 -49.09 16.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.65 -72.46 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.16 89.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.412 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.04 174.86 14.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -1.177 . . . . 0.0 110.014 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -153.58 57.52 1.95 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.412 ' HD3' ' HB ' ' A' ' 68' ' ' THR . 46.3 Cg_endo -73.02 171.79 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.975 1.513 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 45.9 Cg_endo -72.68 171.7 16.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.098 1.578 . . . . 0.0 110.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.798 HG21 ' CD1' ' A' ' 86' ' ' ILE . 3.5 tp -68.08 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -178.54 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 109.98 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -27.18 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.048 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 t -77.04 -27.52 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -54.95 -38.82 68.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -36.97 16.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.432 ' OE1' ' HA ' ' A' ' 78' ' ' GLU . 13.5 mm-40 -87.98 -32.64 18.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.28 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -97.2 -74.91 0.56 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.01 36.88 1.09 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -92.64 88.31 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.188 -1.183 . . . . 0.0 110.228 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.4 m -49.29 136.07 16.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 72' ' ' ILE . 1.2 mp -44.16 -31.92 1.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.282 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.22 -53.8 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.249 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -48.55 81.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.798 ' CD1' HG21 ' A' ' 72' ' ' ILE . 79.2 mt -53.37 -29.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.912 . . . . 0.0 110.151 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -77.02 -45.22 27.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.12 -33.56 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 110.267 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.91 -63.89 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.446 ' HE2' HG21 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -101.26 106.48 45.54 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.86 -38.13 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.973 1.512 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -49.3 -28.81 5.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.271 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.43 151.59 18.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.651 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 45.7 Cg_endo -73.41 -170.33 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.017 1.535 . . . . 0.0 110.445 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 66.85 -84.34 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.339 -0.851 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -74.24 -34.05 63.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.03 -1.044 . . . . 0.0 110.379 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.2 -58.64 5.01 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.93 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -1.161 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 5.4 t -61.18 -51.06 70.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -48.82 -50.09 36.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.446 HG21 ' HE2' ' A' ' 90' ' ' PHE . 52.1 t -64.15 -35.65 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.423 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.64 69.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.71 36.24 29.79 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.12 126.9 55.49 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.281 -1.129 . . . . 0.0 110.177 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.78 131.32 15.69 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.888 1.468 . . . . 0.0 110.371 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -113.69 111.71 48.64 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.82 86.66 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.953 1.502 . . . . 0.0 110.391 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 108' ' ' THR . 9.8 t -55.65 117.63 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.885 . . . . 0.0 110.242 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.53 95.89 0.23 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.68 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -1.165 . . . . 0.0 110.185 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.281 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.731 0.301 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 166.8 28.79 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.038 1.546 . . . . 0.0 110.478 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.619 HG11 ' CD1' ' A' ' 18' ' ' LEU . 48.3 t -107.24 -26.9 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 mttt 53.7 96.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.499 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 61.5 m -97.11 157.83 34.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.8 Cg_endo -75.5 170.8 70.85 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.387 -0.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -177.02 150.66 10.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -106.43 137.26 44.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -1.095 . . . . 0.0 110.301 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.482 ' CE2' HG13 ' A' ' 3' ' ' VAL . 73.0 m-85 -134.66 170.64 15.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 140.65 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.272 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 39.5 t -122.98 99.13 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.0 110.036 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 10.0 t0 55.89 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -130.91 62.83 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.32 157.17 17.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -114.88 133.91 55.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.93 124.9 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.14 97.98 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.619 ' CD1' HG11 ' A' ' 3' ' ' VAL . 20.5 mt -67.48 108.54 2.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 18' ' ' LEU . 34.3 t0 -49.62 -179.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.819 . . . . 0.0 110.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -62.58 -15.81 53.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.915 . . . . 0.0 110.223 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 1.5 m-20 -117.07 41.99 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.0 m 48.2 49.91 16.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -109.65 161.45 15.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.424 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -89.73 108.85 19.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.233 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.82 4.57 28.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.505 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 4.3 m-20 -131.62 51.97 8.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.1 Cg_endo -72.56 -13.52 27.44 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.032 1.543 . . . . 0.0 110.474 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -37.65 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' TRP . 0.9 OUTLIER -95.78 -70.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 110.213 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.577 ' CD2' ' N ' ' A' ' 31' ' ' ASP . 37.2 t90 55.78 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.155 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.577 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -172.86 -172.93 0.91 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.87 -41.33 68.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -70.06 -32.43 70.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.9 t -70.04 -51.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.62 44.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.07 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -39.84 70.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.481 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 83.3 t90 -64.57 -31.79 73.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.877 . . . . 0.0 110.184 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 24' ' ' MET . 5.3 mt -70.79 -44.18 67.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.352 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.36 67.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -76.76 -36.04 57.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 37' ' ' TRP . 3.2 mm-40 -77.18 -27.02 53.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.554 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.2 -62.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.551 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.04 -78.12 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.99 51.48 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.88 107.8 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -1.105 . . . . 0.0 110.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -42.73 -43.36 3.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.311 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 143.11 28.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.29 125.33 22.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 49' ' ' THR . 19.0 p -70.76 160.84 31.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.226 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.08 -27.34 32.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.6 -41.4 62.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 110.394 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -61.83 -48.81 78.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.438 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.0 m95 -65.82 -31.94 73.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.41 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 1.4 tttt -64.57 -66.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -53.94 -49.98 67.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 101' ' ' VAL . 34.3 t -55.33 -31.41 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.33 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -70.29 -46.64 63.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.211 -0.93 . . . . 0.0 110.192 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -60.2 -34.72 74.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.378 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -43.3 86.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.0 110.453 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -55.81 27.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.436 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.06 -27.38 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.947 . . . . 0.0 110.347 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.572 ' CG ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -76.8 -42.32 41.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.569 ' O ' ' CE3' ' A' ' 63' ' ' TRP . 19.2 t90 -58.18 -20.31 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.304 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.54 -42.14 30.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.31 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -60.26 3.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -116.99 -33.78 4.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 63' ' ' TRP . . . 93.01 71.59 1.17 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.3 t -166.09 -175.15 3.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.211 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.0 m -102.3 106.01 46.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.572 ' HG3' ' CG ' ' A' ' 62' ' ' TYR . 45.8 Cg_endo -72.94 144.92 39.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.052 1.553 . . . . 0.0 110.459 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 -178.28 3.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.091 1.574 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.8 62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -130.89 -50.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.402 ' SD ' ' C ' ' A' ' 74' ' ' MET . 0.9 OUTLIER -67.23 -37.75 84.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.282 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.1 t -65.59 -55.76 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.0 m -52.87 -26.84 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.17 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.92 -41.46 24.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.98 32.7 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.351 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.893 HG22 ' CD1' ' A' ' 81' ' ' PHE . 46.2 m -123.77 -22.33 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.13 78.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.893 ' CD1' HG22 ' A' ' 79' ' ' THR . 3.3 m-85 -96.55 172.68 7.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.144 . . . . 0.0 110.121 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.6 148.92 34.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.65 -27.59 64.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 110.222 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.56 -52.2 64.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -33.21 68.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 55' ' ' LEU . 50.4 mt -73.67 -29.01 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 110.073 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -35.76 66.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -40.8 50.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -39.44 79.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 110.242 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 116.14 32.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.067 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.76 -7.82 20.61 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.579 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 92' ' ' SER . 1.3 t -104.11 21.3 16.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 59.06 161.04 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -73.09 -16.68 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.977 1.514 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 94' ' ' PRO . . . -45.57 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -77.2 -2.91 36.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 110.209 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.55 -91.96 0.16 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -43.1 -34.31 1.04 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.396 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.16 -62.37 1.66 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.02 -38.01 48.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.285 -0.884 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.786 HG11 HG21 ' A' ' 56' ' ' VAL . 52.6 t -58.97 -59.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.938 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 56' ' ' VAL . . . -71.64 -7.07 45.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 110.305 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.79 79.45 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.11 90.63 13.62 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 110.201 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.442 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 46.1 Cg_endo -72.22 174.41 11.49 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.942 1.496 . . . . 0.0 110.443 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -141.83 107.82 5.91 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.357 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.61 118.83 5.77 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.954 1.502 . . . . 0.0 110.385 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.2 t -123.21 11.55 9.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 115.47 -162.69 12.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 30.1 p -98.49 17.91 17.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 110.202 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 110' ' ' CYS . 7.9 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.215 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.73 0.3 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.12 -33.0 7.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.061 1.558 . . . . 0.0 110.459 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 18' ' ' LEU . 56.6 t -97.87 101.23 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.162 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -96.14 109.32 21.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 p -108.94 152.09 42.22 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.219 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.1 Cg_endo -75.57 161.59 94.13 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.644 -2.232 . . . . 0.0 110.548 -0.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.02 47.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -104.66 121.69 44.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.163 . . . . 0.0 110.364 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -137.09 155.44 49.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -117.31 145.62 43.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.26 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' GLY . 42.4 t -125.66 125.83 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.86 -91.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -137.98 59.44 0.61 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.16 170.34 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 110.225 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.02 136.21 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.603 HG13 ' HG2' ' A' ' 24' ' ' MET . 56.0 t -137.67 144.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mt -112.29 105.85 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 6' ' ' PRO . 11.8 mt -62.64 129.61 41.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.9 t0 -84.5 -160.43 0.47 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.45 -13.05 60.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -107.59 26.27 10.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 5' ' ' CYS . 2.7 m 50.7 23.73 1.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 24' ' ' MET . 68.3 t80 -109.44 155.86 20.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.603 ' HG2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -59.79 138.07 57.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.212 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.82 -20.38 31.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.456 ' N ' ' ND2' ' A' ' 26' ' ' ASN . 1.0 OUTLIER -124.8 71.7 60.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.058 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.29 -9.43 25.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.031 1.542 . . . . 0.0 110.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.63 -35.79 6.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.104 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' TRP . 53.5 m-20 -93.48 -74.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 110.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.532 ' CE2' ' HB2' ' A' ' 35' ' ' ALA . 82.9 t90 52.15 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.285 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.54 -170.61 1.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.99 -57.44 4.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.342 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -54.83 -27.37 41.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.372 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.64 -48.77 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.671 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -60.11 -48.23 82.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -42.93 97.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -0.908 . . . . 0.0 110.428 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CZ3' HG21 ' A' ' 11' ' ' VAL . 39.3 t90 -57.25 -47.66 80.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.311 -0.868 . . . . 0.0 110.506 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 13.1 mt -62.52 -43.24 99.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.963 . . . . 0.0 110.493 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.78 -26.99 67.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 0.0 110.439 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.422 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.2 -43.77 32.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.0 110.732 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.46 -27.82 60.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.97 . . . . 0.0 110.682 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -80.61 -47.5 14.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.97 . . . . 0.0 110.395 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.31 -48.37 4.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.258 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 121.13 12.15 5.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.13 106.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -1.132 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.1 -46.53 8.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -154.64 121.41 5.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.488 ' SD ' ' CG ' ' A' ' 52' ' ' HIS . 31.1 mmm -44.44 133.05 5.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 50' ' ' GLU . 5.9 t -74.46 -155.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 110.12 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 49' ' ' THR . 15.6 tt0 -87.63 -48.57 7.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -59.86 -26.67 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -63.57 -55.92 20.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.86 . . . . 0.0 110.441 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.671 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 2.5 m95 -61.6 -50.09 73.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -52.12 -45.94 65.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 0.0 110.309 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.559 ' CD1' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -62.19 -60.75 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.8 t -49.2 -27.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 110.259 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -71.86 -48.65 44.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -37.25 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -43.48 73.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.284 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -53.98 -46.59 71.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.267 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.32 -39.78 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.13 -36.54 55.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.454 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -76.36 2.64 12.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.432 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -116.53 -4.92 11.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -107.09 -44.09 4.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.158 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -114.01 -43.15 3.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.45 54.07 0.85 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.491 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 18.6 m -146.28 146.44 30.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -1.137 . . . . 0.0 110.114 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.2 t -104.85 95.65 9.35 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 68' ' ' THR . 47.4 Cg_endo -73.47 163.43 37.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.974 1.512 . . . . 0.0 110.484 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 45.2 Cg_endo -72.65 -89.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.96 1.505 . . . . 0.0 110.457 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -178.46 62.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.243 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -119.93 -54.17 2.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 110.18 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -25.42 63.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 t -72.31 -42.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.6 m -67.55 -29.73 69.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -38.76 5.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -99.34 -76.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 78' ' ' GLU . 54.7 p -42.86 -45.25 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.229 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.08 34.69 46.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -58.63 116.64 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.254 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.56 129.0 38.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.196 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -48.82 -37.1 18.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.7 -45.36 63.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 110.137 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -40.4 92.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.18 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 24.7 mm -66.26 -27.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -45.3 32.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.949 . . . . 0.0 110.317 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -53.21 46.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.34 -45.27 93.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 110.181 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.07 84.83 59.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 92' ' ' SER . 46.2 Cg_endo -73.47 86.7 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.971 1.511 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER 172.7 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.87 127.65 1.72 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.9 Cg_endo -72.91 -18.0 24.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.755 1.397 . . . . 0.0 110.435 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.08 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 2.8 m170 -75.61 -5.37 45.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 110.273 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 101' ' ' VAL . . . -78.23 -84.26 0.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.41 -29.18 0.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -1.11 . . . . 0.0 110.53 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 t -73.98 -49.28 25.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.409 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 17.4 ttmm -61.18 -35.19 76.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.407 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 97' ' ' GLY . 9.1 t -73.56 -42.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.6 64.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.319 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.44 67.22 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.713 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . . . -138.41 136.57 19.24 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.273 -1.133 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.64 143.48 37.97 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.943 1.496 . . . . 0.0 110.436 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -48.09 140.33 9.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.76 161.36 44.05 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.075 1.566 . . . . 0.0 110.501 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.0 m -102.77 118.48 36.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.9 172.64 17.48 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 16.8 p -137.35 173.96 11.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -1.154 . . . . 0.0 110.278 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.211 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.813 0.339 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.93 -168.25 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.067 1.562 . . . . 0.0 110.341 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 7.8 m -141.38 170.43 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 110.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -124.31 109.55 13.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 71.8 m -84.43 150.46 57.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.091 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.3 Cg_endo -76.13 162.28 92.41 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.486 -0.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.42 157.75 24.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.14 131.64 45.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -1.216 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 3' ' ' VAL . 66.3 m-85 -136.57 144.56 44.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.122 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 6.0 tt0 -112.65 126.95 55.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 60.5 t -108.65 94.54 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 42.4 t0 60.52 71.47 0.57 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.639 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.9 14.36 23.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 12.7 mmtt -108.83 152.19 25.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.071 -1.252 . . . . 0.0 110.103 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -106.29 136.39 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.41 117.53 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 26' ' ' ASN . 2.3 mp -100.4 115.92 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.542 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 18' ' ' LEU . 21.7 mt -95.09 116.71 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 109.989 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -94.97 -163.38 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -42.42 126.03 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER 64.13 39.29 7.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m 48.12 50.16 16.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.14 113.81 20.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' MET . . . . . 0.811 ' SD ' HD11 ' A' ' 38' ' ' LEU . 4.4 tpt -50.8 145.8 6.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.166 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -143.2 18.14 1.91 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' HB2' HD12 ' A' ' 17' ' ' ILE . 20.8 t30 -125.2 59.97 26.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.27 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 -8.95 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.951 1.501 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.3 -36.03 52.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.45 -77.83 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t90 61.16 107.76 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -124.52 -178.15 4.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -45.86 77.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.266 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.71 -35.57 78.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.1 t -65.92 -54.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -56.58 -40.89 76.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.878 . . . . 0.0 110.322 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -62.62 1.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.349 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -51.04 -30.59 15.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.39 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.811 HD11 ' SD ' ' A' ' 24' ' ' MET . 2.2 mt -65.28 -52.26 55.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.369 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.08 -30.32 70.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.353 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -29.32 61.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.99 -37.87 54.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 110.34 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.435 ' HA ' HD12 ' A' ' 42' ' ' LEU . 10.2 tp -80.27 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -95.38 -84.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.161 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.63 39.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.8 mt -79.7 88.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -45.06 -30.21 1.03 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 48' ' ' MET . 9.2 mttp -150.23 113.1 4.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.462 ' HA ' HG21 ' A' ' 45' ' ' ILE . 52.6 mmm -42.75 120.61 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.4 p -66.34 150.96 48.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.0 110.23 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.69 52.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.217 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -40.29 85.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 110.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.71 -56.19 24.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.167 -0.958 . . . . 0.0 109.964 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.1 m95 -59.76 -28.58 67.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 110.003 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -66.48 -41.7 88.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.788 ' O ' HD12 ' A' ' 59' ' ' LEU . 3.2 tp -68.55 -38.09 80.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.933 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.31 -39.67 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' TRP . 3.2 mtpp -64.91 -51.57 61.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.069 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.17 -41.14 78.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 110.114 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 110.056 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.2 mmm-85 -57.04 -36.28 70.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.24 -36.35 81.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.137 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.23 -30.74 66.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.418 ' HA ' ' OG1' ' A' ' 68' ' ' THR . 19.8 t90 -58.01 -27.31 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -95.65 29.67 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.213 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.04 -52.88 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -130.22 -78.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.21 25.12 0.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER 58.46 -167.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 110.257 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 68' ' ' THR . 1.1 m 54.34 61.46 9.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 163.47 38.42 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.079 1.568 . . . . 0.0 110.48 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.3 -179.28 4.26 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.066 1.561 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 72' ' ' ILE . 11.3 tp -88.45 28.43 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -126.96 -31.62 2.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.199 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -21.98 44.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 79' ' ' THR . 31.5 t -67.31 -53.79 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t -72.2 -27.16 62.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.29 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.95 -37.57 1.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 110.196 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -142.05 53.86 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 75' ' ' VAL . 50.3 m -161.74 -37.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.158 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.3 33.92 18.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.64 124.43 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -1.126 . . . . 0.0 110.119 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.38 149.25 21.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.258 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -50.91 -27.04 6.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.97 -46.02 89.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.592 HD12 ' H ' ' A' ' 86' ' ' ILE . 3.2 mp -63.67 -28.67 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -37.84 54.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.269 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.96 -26.26 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.67 -57.03 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -91.59 169.05 11.97 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.53 -55.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.097 1.578 . . . . 0.0 110.466 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.76 104.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.69 77.2 0.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.7 Cg_endo -72.69 -10.85 25.56 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.022 1.538 . . . . 0.0 110.39 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.29 -77.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.96 -7.55 53.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.297 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.29 -77.17 0.77 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.83 -35.09 4.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.174 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.5 m -68.1 -58.23 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 110.27 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -50.21 -26.96 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.04 -56.71 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . . . -61.4 -12.41 14.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.233 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . 85.75 80.13 1.15 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 103' ' ' GLY . . . -177.47 76.88 0.24 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.244 -1.151 . . . . 0.0 110.159 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.88 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.961 1.506 . . . . 0.0 110.475 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -164.7 70.57 1.5 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 0.0 110.264 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.34 163.69 37.15 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.111 1.585 . . . . 0.0 110.467 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.1 161.52 39.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.23 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.99 106.51 0.56 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.88 46.27 1.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.159 . . . . 0.0 110.271 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.195 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.797 0.332 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.8 158.81 49.66 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.025 1.54 . . . . 0.0 110.453 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -93.4 116.0 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.21 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 111.35 0.91 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.247 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.506 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 99.1 m -105.24 148.33 36.06 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.98 177.89 37.38 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.346 -0.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.89 146.75 8.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.8 tt0 -120.11 127.62 52.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -1.099 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 29.2 m-85 -142.09 170.48 15.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.244 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -125.01 154.61 41.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 110.162 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 12' ' ' ASP . 44.3 t -131.37 101.62 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER 42.61 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.271 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.58 62.19 3.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 170.45 16.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' C ' HG23 ' A' ' 16' ' ' VAL . 21.9 tttm -135.28 145.06 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 15' ' ' LYS . 78.4 t -148.05 113.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.154 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.3 mt -99.35 145.15 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.0 110.272 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 22' ' ' CYS . 9.4 mt -123.82 108.83 12.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.72 -173.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 51.0 tt0 -66.79 -15.37 63.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 0.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.57 34.27 3.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.242 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.622 ' HA ' HD22 ' A' ' 18' ' ' LEU . 83.9 m 48.16 49.08 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.78 147.63 34.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 110.211 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.2 ttt -74.7 115.99 14.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.287 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -88.77 28.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -168.25 69.22 0.81 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.323 -0.861 . . . . 0.0 110.198 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.483 ' CG ' ' HB3' ' A' ' 105' ' ' PRO . 46.3 Cg_endo -72.71 -7.0 20.08 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.052 1.554 . . . . 0.0 110.488 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -78.0 -21.67 50.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -103.16 39.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 110.239 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.51 ' NE1' ' O ' ' A' ' 102' ' ' ALA . 83.8 t90 -71.79 137.14 47.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.129 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -144.84 -178.49 6.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.143 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.79 -62.29 1.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -54.49 -26.88 34.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -73.56 -56.76 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -52.55 -50.74 62.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.0 110.449 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.07 -46.87 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 59.3 t90 -51.62 -47.12 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.86 -37.64 88.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.347 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.4 81.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 46' ' ' GLN . 2.0 tmt_? -76.98 -37.17 55.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 110.376 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.82 -32.98 74.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.322 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mt -87.3 -72.08 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.113 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.34 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLN . . . 150.4 -19.05 1.04 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -47.07 96.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -1.158 . . . . 0.0 110.243 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 4.4 tm0? -89.29 -6.16 56.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -140.68 96.13 2.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.271 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.417 ' HE3' ' HB3' ' A' ' 52' ' ' HIS . 66.6 mmm -66.38 126.57 29.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 110.086 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 49' ' ' THR . 4.8 t -78.59 172.57 13.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -59.37 -35.3 73.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.246 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.45 -29.3 70.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CE1' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -69.96 -65.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.895 . . . . 0.0 110.247 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.503 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 4.7 m95 -49.62 -30.83 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tmtm? -67.97 -57.41 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.193 -0.942 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.83 -49.41 62.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.02 -31.78 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 110.242 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -62.41 -49.49 75.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 110.218 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 58' ' ' TYR . 5.7 t80 -63.49 -45.73 89.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -53.11 -41.05 64.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -40.71 71.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.271 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -58.36 -43.96 88.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.253 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.469 ' CZ ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -66.03 -39.37 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.162 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.46 ' CZ2' ' HD2' ' A' ' 105' ' ' PRO . 29.0 t90 -79.17 -11.61 59.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.174 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -95.89 -25.17 16.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.29 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.6 m -54.43 -30.62 53.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.0 -54.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.9 73.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 69' ' ' CYS . 6.7 m -155.56 -179.8 8.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.634 ' H ' HG22 ' A' ' 68' ' ' THR . 49.1 t -157.15 81.59 3.26 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 0.0 110.319 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.469 ' HG3' ' CZ ' ' A' ' 62' ' ' TYR . 47.1 Cg_endo -73.26 171.47 17.58 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.989 1.52 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.25 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.9 tt -116.4 14.43 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -74.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.6 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 72' ' ' ILE . 91.5 t -77.13 -34.22 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.276 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 77' ' ' LYS . 17.0 m -68.2 -32.29 72.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.166 -0.959 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 76' ' ' THR . 30.7 tttt -44.01 -27.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.295 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -107.71 -61.22 1.6 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.258 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -52.98 22.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.16 13.73 80.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.7 108.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -1.194 . . . . 0.0 110.191 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.85 126.36 10.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.2 -30.33 11.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -50.47 73.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.07 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -58.54 -50.37 74.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.005 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.408 ' CG2' ' HD3' ' A' ' 94' ' ' PRO . 54.7 mt -58.92 -26.99 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -39.7 64.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 110.117 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.08 -35.77 78.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 80.7 mt -74.18 -59.27 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.89 118.67 17.71 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.101 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.1 Cg_endo -72.56 -177.81 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.421 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 30.0 m 55.64 19.61 3.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 110.145 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.57 149.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' HIS . 46.6 Cg_endo -73.06 -90.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.952 1.501 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 94' ' ' PRO . . . 43.33 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 110.337 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 94' ' ' PRO . 11.2 m170 -73.52 -56.2 5.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -44.12 -56.92 5.09 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.65 -44.58 4.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -1.108 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -65.23 -54.5 28.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.195 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -42.83 -38.36 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 110.138 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -41.67 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.51 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -53.31 -45.4 68.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.268 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.7 51.25 0.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.23 117.96 69.83 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.234 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.483 ' HB3' ' CG ' ' A' ' 27' ' ' PRO . 46.4 Cg_endo -72.73 -46.4 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.989 1.52 . . . . 0.0 110.436 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.9 120.39 41.89 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.53 98.08 1.01 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.902 1.474 . . . . 0.0 110.424 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.3 m -55.76 97.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.08 -47.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.0 63.97 0.24 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -1.1 . . . . 0.0 110.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.445 ' H ' HG12 ' A' ' 111' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.174 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.242 0.544 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -65.15 87.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 94.3 m -96.32 148.46 34.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -75.99 150.45 93.92 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.45 -0.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -161.87 157.66 29.46 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 21.0 pt-20 -110.64 160.81 16.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 75.9 m-85 -154.6 169.78 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.235 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.37 137.95 53.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.079 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' ASP . 10.9 t -141.35 121.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.461 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 41.38 74.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.33 -0.856 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.46 62.85 2.33 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -157.69 159.93 37.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.088 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -121.9 117.11 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 t -113.46 120.36 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -101.86 141.03 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.534 HD22 ' C ' ' A' ' 22' ' ' CYS . 6.9 mt -122.38 120.3 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.38 -169.71 2.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.4 tt0 -50.75 147.52 4.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER 64.32 20.91 12.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.534 ' C ' HD22 ' A' ' 18' ' ' LEU . 76.9 m 51.88 54.69 10.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.96 139.68 32.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.404 ' SD ' ' HA2' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -68.31 115.4 7.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 110.185 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -116.9 34.38 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -157.71 68.67 4.01 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.21 -0.62 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.968 1.51 . . . . 0.0 110.439 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.86 -25.86 40.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.12 26.9 9.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 110.334 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -75.64 141.3 42.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -155.29 -167.41 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.219 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.54 -33.65 66.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.195 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 24.0 mmtt -71.52 -37.62 71.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.18 -51.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.53 81.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -67.2 -26.97 66.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CE2' ' OE1' ' A' ' 41' ' ' GLU . 49.9 t90 -66.93 -60.79 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.35 -39.0 75.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.81 71.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 3.6 ttm180 -76.86 -34.72 57.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 110.128 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.478 ' OE1' ' CE2' ' A' ' 37' ' ' TRP . 4.0 mt-10 -77.29 -26.64 52.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.01 -66.07 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.681 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.76 -31.9 40.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 101.96 -4.8 52.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.84 120.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -1.156 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -89.56 -26.42 20.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.09 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.53 103.55 5.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 52' ' ' HIS . 15.5 mmm -48.13 119.02 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -71.58 -169.15 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -84.75 -20.76 30.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 3.7 mp0 -77.0 -45.05 28.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.435 ' O ' HG23 ' A' ' 56' ' ' VAL . 24.8 m170 -54.76 -52.7 61.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 5.3 m95 -67.41 -27.77 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.269 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -61.63 -65.8 0.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.15 -0.969 . . . . 0.0 109.966 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.84 -43.36 94.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.884 . . . . 0.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 52' ' ' HIS . 35.1 t -56.45 -29.37 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.863 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 14.4 mttt -75.29 -48.96 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.134 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.565 ' CE1' HG13 ' A' ' 75' ' ' VAL . 30.0 t80 -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -38.12 82.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -28.55 65.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.85 -42.39 40.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.325 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -66.89 -26.86 67.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -71.93 -2.69 18.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.254 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.19 11.94 36.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.248 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.53 -46.66 3.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.069 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -129.89 -34.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.26 56.01 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -139.95 -167.17 2.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -1.118 . . . . 0.0 110.255 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.55 93.46 3.54 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.6 Cg_endo -72.74 173.95 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.985 1.518 . . . . 0.0 110.45 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.6 Cg_endo -73.07 -160.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.978 1.515 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 72' ' ' ILE . 3.4 tp -111.87 2.8 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.281 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -24.87 25.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtt -87.57 -30.37 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.565 HG13 ' CE1' ' A' ' 58' ' ' TYR . 47.5 t -65.46 -29.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.2 m -62.34 -31.86 72.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -26.91 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.04 52.86 1.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 110.025 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.7 m -159.41 -74.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 49.77 0.4 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.0 147.56 33.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -1.193 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -98.96 131.67 44.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.924 . . . . 0.0 110.221 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -62.63 -32.32 73.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -64.54 -56.55 13.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.079 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -50.53 67.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.41 HD13 HG12 ' A' ' 72' ' ' ILE . 66.8 mt -56.89 -34.98 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.987 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -61.76 -49.44 76.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.996 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 5.4 tp60 -66.18 -24.11 66.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mt -79.29 -29.51 42.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 110.09 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' TYR . 16.6 m-85 -116.79 167.36 10.79 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.879 . . . . 0.0 110.042 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 92' ' ' SER . 51.3 Cg_endo -78.05 70.83 6.93 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.053 1.554 . . . . 0.0 110.622 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 91' ' ' PRO . 11.3 t 40.42 68.93 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.537 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.81 66.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.98 -12.5 23.79 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.01 1.531 . . . . 0.0 110.435 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 110.313 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 34.2 p80 -62.39 -24.62 67.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.77 -63.58 4.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' CYS . . . -48.96 -66.17 0.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.177 . . . . 0.0 110.418 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 8.7 t -41.92 -46.75 4.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.8 mtpt -52.52 -54.88 26.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 101' ' ' VAL . 8.7 t -62.44 -25.95 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.965 . . . . 0.0 110.411 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.06 -32.95 69.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA2' ' SD ' ' A' ' 24' ' ' MET . . . 100.07 46.63 1.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.678 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.182 -1.187 . . . . 0.0 110.221 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 3' ' ' VAL . 5.2 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.314 0.578 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 28.5 m -104.81 154.84 38.3 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -76.11 152.45 96.48 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.605 -2.248 . . . . 0.0 110.467 -0.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.85 138.92 5.07 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.03 121.74 41.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.139 . . . . 0.0 110.239 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 3' ' ' VAL . 35.8 m-85 -130.32 158.61 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.101 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 18.9 mt-30 -110.4 156.31 20.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.17 -0.956 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 14' ' ' LYS . 76.1 t -129.22 105.97 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.4 38.26 24.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.12 24.09 23.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 11.1 mmtt -115.28 175.0 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.66 47.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.425 HG11 ' CZ3' ' A' ' 37' ' ' TRP . 17.3 t -140.76 121.64 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 0.0 110.163 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.1 mt -99.66 108.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 53.5 mt -89.64 118.85 29.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 1.1 t0 -71.53 -172.71 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -50.22 -28.22 7.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -116.79 51.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 63.1 m 42.92 32.56 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.3 157.44 26.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -98.99 101.62 13.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.31 17.51 8.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.238 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -148.48 78.22 9.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.01 -7.33 20.51 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.015 1.534 . . . . 0.0 110.475 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.72 -12.61 61.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 12.1 t70 -116.43 33.9 5.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.153 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 75.0 t90 -92.75 151.01 20.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.37 -171.65 2.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -69.65 -56.21 7.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.272 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -57.33 -39.3 75.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.882 . . . . 0.0 110.27 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.68 -51.74 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.38 -50.72 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 110.385 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -58.34 -41.59 84.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.4 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.425 ' CZ3' HG11 ' A' ' 16' ' ' VAL . 50.0 t90 -55.55 -48.93 73.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.439 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.487 HD23 HD13 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.57 -51.13 69.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.444 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -51.0 -39.31 55.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 110.519 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.8 -67.1 0.53 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.938 . . . . 0.0 110.445 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' OE1' HG11 ' A' ' 3' ' ' VAL . 1.1 tt0 -42.58 -26.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.559 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 38' ' ' LEU . 2.4 mp -83.85 -79.49 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.379 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.68 -79.28 0.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.18 38.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.442 HD12 ' HB1' ' A' ' 39' ' ' ALA . 96.7 mt -75.34 115.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -1.148 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -56.88 -45.14 82.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.878 . . . . 0.0 110.358 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.0 122.09 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.451 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 45.3 mmm -45.78 118.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.7 p -65.1 178.13 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -69.85 -23.75 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -35.05 57.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.556 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -62.57 -50.0 73.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.533 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m95 -66.26 -35.44 80.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.372 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -61.28 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.316 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -52.71 61.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 110.401 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 102' ' ' ALA . 80.2 t -55.88 -28.76 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.487 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 ttmt -76.29 -38.27 56.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 110.389 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.25 -42.95 92.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -39.12 90.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.953 . . . . 0.0 110.283 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -36.92 67.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 43.6 tt0 -58.29 -44.95 88.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.33 -31.67 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.284 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -67.81 -12.09 59.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 10.9 mt-10 -78.51 -47.64 16.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.23 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -53.03 4.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -78.9 -75.41 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.245 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.96 17.13 11.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.2 m -115.48 146.37 41.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -1.163 . . . . 0.0 110.205 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.5 99.82 26.77 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.942 . . . . 0.0 110.164 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.8 Cg_endo -73.19 173.55 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.1 Cg_endo -72.92 -160.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.4 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.579 ' O ' HG23 ' A' ' 72' ' ' ILE . 1.6 tp -123.9 54.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -141.58 -44.06 0.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.8 mmm -74.84 -21.01 59.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.8 t -72.28 -32.32 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 m -44.33 -32.47 1.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -56.33 -51.45 68.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -65.6 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 p -68.91 -70.69 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.201 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.13 11.15 32.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.18 170.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -1.166 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -95.64 141.95 28.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.219 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 tp -69.2 -29.12 67.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 2.2 tt0 -61.16 -55.66 29.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.227 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -56.27 14.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.571 HG23 ' HG3' ' A' ' 94' ' ' PRO . 36.6 mt -56.17 -26.91 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.74 -58.4 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -34.48 70.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 52' ' ' HIS . 21.3 mt -65.67 -51.66 57.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 110.134 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.536 ' CE1' ' HA3' ' A' ' 97' ' ' GLY . 1.5 t80 -128.64 128.57 23.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 110.048 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.4 Cg_endo -73.14 156.2 51.64 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.898 1.473 . . . . 0.0 110.417 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 49.4 m 56.81 31.37 19.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 62.19 147.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.705 ' HB2' ' HB2' ' A' ' 98' ' ' ALA . 45.7 Cg_endo -72.9 -92.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.889 1.468 . . . . 0.0 110.304 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 49.6 -89.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.169 -0.957 . . . . 0.0 110.358 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 94' ' ' PRO . 8.1 m-70 -68.05 -44.85 75.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 90' ' ' PHE . . . -64.66 -41.77 97.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 94' ' ' PRO . . . -55.74 -48.97 74.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -1.131 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 100' ' ' LYS . 34.5 m -64.24 -55.39 21.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 99' ' ' CYS . 5.9 tttt -42.41 -49.9 5.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.27 -37.96 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HB2' HG13 ' A' ' 56' ' ' VAL . . . -72.59 -8.58 55.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.5 48.02 77.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.211 -1.17 . . . . 0.0 110.197 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.346 0.593 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.89 151.71 1.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.064 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 6.0 p -125.35 161.88 47.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.3 Cg_endo -75.08 145.26 83.33 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.54 -2.275 . . . . 0.0 110.474 -0.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.61 152.56 18.01 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 51.4 mt-10 -103.68 141.9 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 110.381 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 77.7 m-85 -152.53 150.21 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -104.17 125.02 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 67.0 t -105.8 118.82 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.297 -0.877 . . . . 0.0 110.113 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 19.6 m-20 55.69 -89.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -141.41 50.6 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 158.91 44.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -1.144 . . . . 0.0 110.164 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.641 ' HG2' HD11 ' A' ' 17' ' ' ILE . 6.1 tttt -104.6 115.57 30.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.31 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.603 ' C ' HD12 ' A' ' 17' ' ' ILE . 25.3 t -107.12 129.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.641 HD11 ' HG2' ' A' ' 15' ' ' LYS . 2.7 mp -115.59 116.58 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.308 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 22' ' ' CYS . 10.8 mt -95.14 110.54 22.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.996 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 23' ' ' PHE . 6.9 t70 -75.42 -161.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.274 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -64.31 137.31 57.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.1 t70 66.49 30.41 8.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.71 ' HA ' HD22 ' A' ' 18' ' ' LEU . 8.5 m 55.75 50.5 14.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . 1.6 m-30 -94.87 109.37 21.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.61 106.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.26 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' OE1' ' CB ' ' A' ' 19' ' ' ASP . 1.5 tp60 -108.86 35.88 3.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.231 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.464 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.8 p-10 -151.74 68.25 7.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 -7.51 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.003 1.528 . . . . 0.0 110.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -79.29 -46.65 17.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -84.61 -4.68 59.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.124 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.63 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 20.9 t90 -57.2 153.55 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -165.65 -160.06 0.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.544 ' OE2' ' CZ2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -74.39 -56.48 4.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.308 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -40.21 76.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -64.4 -49.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 0.0 110.293 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.63 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -55.42 -48.86 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.214 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.28 -57.67 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 92.3 t90 -49.23 -32.41 10.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -61.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.873 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -48.0 -47.22 33.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.942 . . . . 0.0 110.21 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -65.3 -32.53 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' TRP . 3.5 tt0 -64.88 -33.36 75.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 0.0 110.152 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.408 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -91.39 -73.54 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.234 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.43 -76.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 40' ' ' ARG . . . 142.65 69.13 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.873 HD12 ' HB1' ' A' ' 39' ' ' ALA . 60.7 mt -96.87 114.11 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -1.15 . . . . 0.0 110.247 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -46.34 -29.47 1.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.298 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.78 130.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.324 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 21.5 mtp -44.0 128.1 5.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.234 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -89.12 178.7 6.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -43.94 76.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.43 -39.19 89.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.517 ' NE2' ' HB3' ' A' ' 89' ' ' LEU . 6.8 m170 -65.08 -64.49 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CZ2' ' SD ' ' A' ' 48' ' ' MET . 2.0 m95 -46.73 -38.03 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.115 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -57.56 12.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.48 -54.49 21.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.98 -33.86 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -68.04 -61.67 1.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -37.01 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -69.6 -48.18 60.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.296 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 59' ' ' LEU . 8.4 tpt180 -42.8 -38.55 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.306 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.17 -54.24 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.354 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.72 -43.88 58.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.377 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.415 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 2.2 t90 -63.81 -47.44 80.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.02 7.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.3 m -82.15 -47.35 12.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.0 -35.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 103.62 56.39 0.77 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.5 m -128.61 157.5 41.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -1.148 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 t -120.94 86.99 42.62 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.44 167.77 26.11 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.059 1.557 . . . . 0.0 110.416 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.4 -90.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.961 1.506 . . . . 0.0 110.43 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -175.51 74.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.88 -63.78 1.14 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.154 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -64.9 -11.63 40.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.83 -45.53 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 m -64.01 -40.53 96.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.201 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.47 -29.79 17.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.289 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -102.88 -71.0 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.523 ' HB ' ' CD1' ' A' ' 81' ' ' PHE . 61.6 p -49.68 -52.59 29.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.81 30.25 6.88 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD1' ' HB ' ' A' ' 79' ' ' THR . 10.4 m-85 -99.66 120.43 39.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.16 147.54 52.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -56.53 -28.27 59.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.07 -44.8 87.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -53.38 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.209 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 9.1 mt -53.02 -30.16 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 90' ' ' PHE . 1.5 m-85 -77.14 -36.26 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.283 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -44.89 91.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.517 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 3.4 mt -78.92 -53.64 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.296 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.1 m-85 -88.94 165.06 28.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.19 -179.29 4.57 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.068 1.562 . . . . 0.0 110.46 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.16 86.17 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' ' CD2' ' A' ' 96' ' ' HIS . . . 135.65 80.03 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.69 -0.02 8.81 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.497 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -79.56 -53.61 6.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 93' ' ' GLY . 23.3 p80 -77.2 -23.41 51.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.472 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -78.18 -71.8 1.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.91 -36.95 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -1.138 . . . . 0.0 110.405 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -71.28 -51.5 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.397 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -47.82 -44.11 28.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.326 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' ALA . 39.2 t -69.12 -55.32 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 101' ' ' VAL . . . -44.01 -35.45 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 0.0 110.162 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . 82.74 63.28 1.77 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 103' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.258 -1.143 . . . . 0.0 110.299 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.243 0.544 . . . . 0.0 110.126 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -81.5 83.43 6.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.361 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 36.5 m -82.49 154.47 68.78 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD3' ' CG ' ' A' ' 20' ' ' GLU . 50.3 Cg_endo -75.62 164.88 87.05 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.58 -0.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.21 160.85 28.05 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -104.34 152.08 22.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.192 . . . . 0.0 110.328 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -152.66 144.81 23.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -100.17 132.22 45.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.968 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 22.9 t -129.75 109.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.59 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 64.45 28.13 13.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.476 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.5 7.39 82.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 3.5 mttt -98.99 171.1 8.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -1.206 . . . . 0.0 110.087 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.32 123.73 49.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 110.282 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.42 138.18 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.7 mt -120.65 100.0 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.24 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 18' ' ' LEU . 23.1 mt -74.49 118.39 17.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.232 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.74 -172.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.323 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.519 ' CG ' ' HD3' ' A' ' 6' ' ' PRO . 1.5 tt0 -62.01 -13.47 26.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 110.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -118.58 43.28 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.0 m 43.25 34.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.339 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -103.07 115.78 31.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 110.128 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' PHE . 1.3 ttt -41.88 137.67 1.7 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.921 . . . . 0.0 110.338 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 17.24 21.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.154 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -124.22 67.3 44.94 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.227 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.5 -6.63 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.054 1.555 . . . . 0.0 110.463 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -32.97 56.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 1.3 m-20 -97.41 -81.86 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 52.2 t90 59.47 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.6 178.44 7.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.485 ' HG2' ' CZ2' ' A' ' 53' ' ' TRP . 1.8 tm-20 -65.64 -64.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -29.43 2.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.35 -62.54 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.326 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.59 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.56 -35.87 82.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -0.948 . . . . 0.0 110.421 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.442 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -66.37 -55.99 13.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.98 -31.55 60.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.456 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -36.53 63.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.108 -0.995 . . . . 0.0 110.392 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.5 -26.99 61.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HB3' ' OE1' ' A' ' 43' ' ' GLU . 6.9 mp -81.18 -42.79 20.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -110.24 -83.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 38.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.2 88.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -1.148 . . . . 0.0 110.281 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -45.41 -30.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.52 130.89 10.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 mmt -57.87 130.32 45.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 52' ' ' HIS . 10.0 t -86.55 160.02 19.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.204 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.75 -40.45 79.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.455 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.89 -37.0 73.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.437 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.609 ' H ' HG23 ' A' ' 49' ' ' THR . 3.2 m170 -63.6 -64.43 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.285 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.485 ' CZ2' ' HG2' ' A' ' 32' ' ' GLU . 5.0 m95 -54.8 -26.6 35.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 110.505 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -67.17 -67.31 0.46 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.96 -45.89 61.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.26 -48.21 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 110.168 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -54.83 -44.94 74.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.189 -0.945 . . . . 0.0 110.112 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.83 -58.04 9.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.64 -33.44 33.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.354 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.34 -56.15 19.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.364 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.44 -37.33 7.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.472 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -36.89 70.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -70.36 -3.45 17.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.157 -0.965 . . . . 0.0 110.421 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.02 -25.6 10.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.4 m -88.4 -69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.9 -45.66 7.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.969 . . . . 0.0 110.123 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.97 68.68 1.26 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 53.9 m -151.0 161.11 43.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -1.169 . . . . 0.0 110.326 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 m -110.79 84.33 4.13 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 68' ' ' THR . 46.7 Cg_endo -73.53 172.05 16.51 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.1 1.579 . . . . 0.0 110.468 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.94 -161.95 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.001 1.527 . . . . 0.0 110.478 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -119.52 6.37 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.195 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -36.04 66.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -18.15 47.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -74.1 -46.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 110.195 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 5.6 m -62.01 -26.84 68.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -63.61 -28.49 69.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.57 -78.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.144 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 p -53.82 -27.73 31.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.982 . . . . 0.0 110.207 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 77.91 4.33 85.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.04 135.43 56.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -1.192 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.95 140.22 58.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -63.71 -29.91 71.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.216 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -52.23 66.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.104 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -37.84 17.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.632 HD13 HD11 ' A' ' 72' ' ' ILE . 30.5 mt -73.32 -34.74 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.34 -0.85 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CE2' HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -61.53 -32.82 72.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -83.27 -48.42 10.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 110.184 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 57.2 mt -57.72 -28.68 64.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 87' ' ' TYR . 11.2 m-85 -129.01 168.03 17.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.026 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -173.54 1.27 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.93 1.49 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.28 94.75 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.39 76.65 0.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.2 Cg_endo -73.21 -9.01 22.85 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 110.444 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.5 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -46.52 -31.09 2.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.81 -61.89 5.48 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -44.7 -56.42 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.1 m -47.6 -51.2 22.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 12.2 ttmt -53.25 -40.96 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 96.5 t -59.56 -52.06 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.56 -25.5 68.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.168 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.73 63.79 0.63 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.215 -1.167 . . . . 0.0 110.152 -179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.24 0.543 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.19 152.31 19.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 m -115.11 144.86 32.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.75 167.51 80.06 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.246 -0.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -178.98 142.22 5.24 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.451 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 6.3 tt0 -99.33 159.51 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -1.138 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 2.8 m-85 -161.43 166.79 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.199 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -112.01 124.84 53.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 110.256 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' ASP . 35.3 t -99.14 98.24 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' VAL . 18.6 t70 43.2 73.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.75 56.23 25.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 170.81 20.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -1.145 . . . . 0.0 110.287 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -123.39 123.08 39.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.513 HG13 ' HE2' ' A' ' 24' ' ' MET . 46.5 t -141.47 124.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.13 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 25' ' ' GLN . 1.1 tt -105.76 145.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 18' ' ' LEU . 26.0 mt -112.08 112.7 24.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 25' ' ' GLN . 19.9 m-20 -58.77 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.825 . . . . 0.0 110.229 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.23 -28.32 69.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 22' ' ' CYS . 8.3 m-20 -106.99 44.26 1.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' A' ' 21' ' ' ASP . 60.0 m 42.49 31.58 0.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.252 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -86.78 142.65 27.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.513 ' HE2' HG13 ' A' ' 16' ' ' VAL . 15.5 ttm -78.16 125.0 28.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.557 ' HB2' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -95.34 0.33 53.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.34 68.53 14.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.96 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.99 -18.9 23.77 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.051 1.553 . . . . 0.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -66.11 -14.04 61.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.204 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.5 m-20 -113.39 6.64 17.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 51.7 t90 -46.32 158.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.547 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 1.2 m-20 178.4 -177.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.887 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -62.62 -45.05 94.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 110.163 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -26.78 68.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.169 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.2 -60.68 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.422 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -54.58 -29.51 51.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.394 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 2.8 mt-10 -75.81 -59.76 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.339 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -49.53 -35.57 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.501 HD23 ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -72.52 -51.23 20.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.304 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.71 -28.63 56.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -60.2 2.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.455 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -26.86 22.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD1' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -87.81 -73.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.422 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.39 -52.69 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 24.71 1.57 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.9 mt -73.11 84.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -1.194 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -44.07 -29.79 0.66 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.45 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -150.37 111.51 4.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.461 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 23.1 mmm -48.92 155.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.08 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.709 HG22 ' ND1' ' A' ' 52' ' ' HIS . 5.2 t -106.94 -177.3 3.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.89 . . . . 0.0 110.282 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.56 -35.34 60.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.929 . . . . 0.0 110.226 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -40.61 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.284 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.709 ' ND1' HG22 ' A' ' 49' ' ' THR . 5.6 m170 -62.43 -55.79 24.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 110.328 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.488 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 4.5 m95 -61.28 -26.92 68.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -67.09 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.93 . . . . 0.0 110.38 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -43.04 70.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -52.98 -57.56 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.154 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -46.16 63.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.13 -43.52 70.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.69 -40.49 95.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -60.54 -28.67 68.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.97 -51.68 63.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -71.19 -26.99 63.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.567 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 65.8 t90 -80.9 -6.3 58.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 65' ' ' THR . 9.5 tt0 -77.4 -50.65 12.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 64' ' ' GLU . 18.7 m -44.71 -39.96 5.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.19 -58.61 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 131.07 43.19 0.19 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -105.1 113.91 27.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -1.156 . . . . 0.0 110.193 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.8 t -53.77 108.1 1.03 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.198 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 68' ' ' THR . 45.8 Cg_endo -73.06 169.61 21.81 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.9 1.474 . . . . 0.0 110.371 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.87 -162.49 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.003 1.528 . . . . 0.0 110.434 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 86' ' ' ILE . 8.8 tp -125.87 -0.75 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -91.0 -11.49 38.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.44 -30.01 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 110.405 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.92 -29.89 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 81' ' ' PHE . 14.1 t -77.0 -36.2 56.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -65.87 -29.33 69.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.56 0.04 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.276 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' GLY . 66.2 p -135.38 22.76 3.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' THR . . . 43.58 26.79 0.74 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.488 ' HB2' ' HA ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -68.26 -163.94 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -1.135 . . . . 0.0 110.155 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.1 t -154.4 137.42 15.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 110.176 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 15.1 tp -50.42 -34.43 24.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.215 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.55 -35.1 70.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.64 -46.6 89.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 110.41 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 72' ' ' ILE . 34.9 mt -76.87 -31.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -67.05 -32.18 73.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.289 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -86.68 -39.68 15.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -0.978 . . . . 0.0 110.273 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.577 HD22 ' CE1' ' A' ' 52' ' ' HIS . 19.8 mt -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 110.169 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.426 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 4.2 m-85 -109.11 171.28 4.59 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.6 Cg_endo -74.28 -61.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.091 1.574 . . . . 0.0 110.637 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.42 107.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.15 -0.969 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.24 75.43 0.93 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.524 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.0 Cg_endo -72.33 -16.77 27.78 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.047 1.551 . . . . 0.0 110.431 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -69.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.357 -0.839 . . . . 0.0 110.148 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -77.07 -8.0 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.18 -81.43 0.44 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.1 -32.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -1.078 . . . . 0.0 110.418 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -62.95 1.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -50.96 -51.28 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.131 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -48.76 -57.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -53.76 -34.48 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.09 -63.61 0.42 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.27 -179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 9' ' ' TYR . 6.4 t . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.233 0.539 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.41 -156.73 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 4.9 p -175.14 162.57 2.31 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.6 Cg_endo -74.72 153.67 99.28 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.611 0.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.34 167.26 40.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 5.9 mt-10 -120.58 148.57 43.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -1.194 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 97.2 m-85 -156.37 143.81 19.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -113.47 140.82 47.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 17.6 t -109.44 99.68 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 12.4 t70 55.32 -89.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -122.71 42.42 1.63 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 169.03 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -1.178 . . . . 0.0 110.205 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -127.34 138.15 52.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 110.281 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.0 128.69 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.066 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 66.7 mt -116.15 102.59 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 22' ' ' CYS . 2.8 mt -87.14 132.17 33.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' GLU . 3.2 m-20 -117.44 -170.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.03 148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.582 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.6 t0 66.76 18.32 10.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.623 ' HA ' HD22 ' A' ' 18' ' ' LEU . 4.3 m 51.05 45.72 27.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.613 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 m-85 -86.35 126.56 34.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 110.235 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.664 ' HG2' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -42.88 -36.06 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.242 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 53.58 19.89 1.92 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.156 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.425 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -151.16 59.87 3.57 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.157 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.33 -30.33 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.031 1.543 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.43 73.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 0.0 110.26 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.21 30.15 2.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 35' ' ' ALA . 60.4 t90 -82.57 160.62 22.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.453 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -167.56 -169.21 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.192 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.431 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 18.7 mt-10 -71.32 -58.4 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -33.69 72.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.357 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.05 -57.57 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.59 ' HB2' ' NE1' ' A' ' 30' ' ' TRP . . . -55.23 -36.99 66.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.0 110.406 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -54.6 41.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.461 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 76.7 t90 -59.19 -28.89 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.189 -0.944 . . . . 0.0 110.432 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' A' ' 24' ' ' MET . 0.2 OUTLIER -70.98 -41.42 71.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.447 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.74 -26.91 60.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.95 . . . . 0.0 110.591 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -75.9 -40.27 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.571 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -77.15 -33.81 56.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.687 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.3 mp -80.74 -68.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.105 -0.997 . . . . 0.0 110.572 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -79.59 -72.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 110.413 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.84 39.59 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 46' ' ' GLN . 11.3 mt -103.33 107.71 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' ILE . 14.0 mt-30 -43.28 -37.77 2.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -156.64 140.61 16.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.329 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -52.87 100.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 110.133 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -52.62 162.17 0.61 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 110.276 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.53 -27.62 4.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.95 -39.62 55.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.729 ' CE1' HD22 ' A' ' 89' ' ' LEU . 5.2 m80 -61.59 -41.03 96.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.513 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 1.4 m95 -74.09 -36.06 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.247 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -58.88 -45.64 89.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 81' ' ' PHE . 5.9 mp -72.76 -58.27 3.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 52' ' ' HIS . 74.9 t -47.14 -30.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -76.45 -51.48 11.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.931 ' CE2' HG13 ' A' ' 75' ' ' VAL . 38.5 t80 -52.47 -48.34 65.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.6 -43.58 76.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 21.8 ttp180 -50.32 -39.8 46.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 110.426 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.16 -55.2 19.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -27.0 66.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 59.6 t90 -70.08 -21.62 63.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.284 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 -17.63 59.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.19 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.555 HG22 ' HD2' ' A' ' 66' ' ' PHE . 98.3 m -75.74 -70.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.336 -0.853 . . . . 0.0 110.156 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.555 ' HD2' HG22 ' A' ' 65' ' ' THR . 4.3 m-85 -125.31 30.63 5.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 43.9 80.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -178.07 5.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -1.117 . . . . 0.0 110.176 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 t -140.1 92.95 9.4 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.229 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.43 157.88 52.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.079 1.568 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.68 -159.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.045 1.55 . . . . 0.0 110.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 72' ' ' ILE . 7.8 tt -125.25 46.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.86 -82.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -16.16 40.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.931 HG13 ' CE2' ' A' ' 58' ' ' TYR . 79.0 t -70.33 -40.85 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.148 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -54.12 -38.84 65.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -69.02 -34.1 74.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.142 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.79 -0.24 37.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.57 -77.55 0.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.348 -0.845 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.89 22.56 3.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.537 ' CD2' HD11 ' A' ' 55' ' ' LEU . 36.0 m-85 -81.64 102.98 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -1.144 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.44 127.89 6.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.297 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -47.84 -36.65 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.166 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.09 -49.74 72.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.034 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -50.83 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 81' ' ' PHE . 36.4 mm -50.29 -39.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -37.18 80.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.59 -31.35 72.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.729 HD22 ' CE1' ' A' ' 52' ' ' HIS . 12.5 mt -76.72 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -94.07 147.91 34.26 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 92' ' ' SER . 46.6 Cg_endo -73.98 84.13 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.03 1.542 . . . . 0.0 110.407 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 91' ' ' PRO . 38.6 m 43.5 70.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.52 62.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.466 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.0 Cg_endo -73.63 -0.41 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.033 1.543 . . . . 0.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -98.97 -63.35 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.901 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.01 -14.24 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.277 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -77.06 -77.26 0.8 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.54 -37.15 1.56 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.32 -50.84 62.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.374 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.9 tptt -53.41 -48.57 68.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.293 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.24 -27.55 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.65 -19.8 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.39 63.15 1.66 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.207 -1.172 . . . . 0.0 110.161 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 4' ' ' LYS . 57.4 t . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.232 0.539 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.529 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.2 mtmm -109.07 147.31 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.5 m -142.89 159.43 56.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.968 . . . . 0.0 110.369 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.87 154.43 98.49 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.492 -0.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.06 142.62 7.79 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.406 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.05 128.05 45.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.262 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -131.63 161.94 31.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 110.213 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -104.94 142.33 34.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.117 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 53.9 t -127.8 96.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 11' ' ' VAL . 10.3 t70 41.98 85.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 110.311 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.48 65.46 2.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -168.32 161.43 12.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -1.181 . . . . 0.0 110.144 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 126.36 42.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -131.32 122.31 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 110.044 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.57 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.412 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 18' ' ' LEU . 16.2 mt -69.8 123.06 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.056 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.9 m-20 -99.66 -157.92 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.8 mm-40 -45.57 132.31 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 13.3 t70 62.32 30.55 17.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.022 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 74.5 m 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.46 95.28 9.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.4 ptm -54.21 149.98 9.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.429 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 1.7 mt-30 -127.04 40.56 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -126.05 72.47 70.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.028 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.0 -19.47 30.19 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.125 1.592 . . . . 0.0 110.574 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.68 -0.65 55.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -128.25 34.01 4.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.285 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.411 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 67.4 t90 -85.86 149.77 25.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -173.08 1.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -65.64 -39.19 91.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 110.209 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -68.31 -27.17 66.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.0 110.386 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.489 HG22 ' HD3' ' A' ' 14' ' ' LYS . 21.8 t -76.16 -55.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.592 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -61.13 -34.01 74.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.473 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 3.3 tt0 -70.47 -57.43 4.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 110.419 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -56.77 -31.39 64.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -69.03 -63.27 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.346 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -53.5 -27.97 28.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -76.05 -34.74 59.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 1.9 tp10 -74.81 -28.58 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.561 ' CD1' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -82.45 -76.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -80.23 -76.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.55 46.74 0.02 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.601 HD12 ' HB1' ' A' ' 39' ' ' ALA . 8.8 mt -81.78 102.05 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -1.148 . . . . 0.0 110.148 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -42.52 97.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -136.32 115.48 12.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.9 mmm -56.83 125.22 21.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -72.9 165.45 24.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.204 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.02 -32.19 71.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -44.69 65.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.404 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.6 m170 -50.67 -54.46 22.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.592 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 1.8 m95 -62.5 -30.7 71.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.293 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -64.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -51.63 -41.92 61.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 52' ' ' HIS . 45.7 t -57.46 -41.59 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.944 . . . . 0.0 110.106 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.28 -56.92 8.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -47.97 -34.47 9.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.14 -49.26 52.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.085 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -52.01 52.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 110.084 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -40.46 72.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.089 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -62.64 -29.88 70.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.141 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.541 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 77.5 t90 -74.74 -31.17 61.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.69 -42.05 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.2 m -58.6 -40.64 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.47 -57.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.912 . . . . 0.0 110.066 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 119.18 83.48 0.85 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -155.6 171.8 19.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -1.164 . . . . 0.0 110.25 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.99 75.07 21.21 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 161.37 43.06 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.992 1.522 . . . . 0.0 110.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.59 -174.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.994 1.523 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.726 HG13 HG23 ' A' ' 76' ' ' THR . 3.6 tp -87.43 49.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' OG1' ' A' ' 76' ' ' THR . 0.2 OUTLIER -97.74 -60.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.049 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ttm -73.93 -24.01 59.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.082 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' A' ' 79' ' ' THR . 13.6 t -67.07 -37.94 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.726 HG23 HG13 ' A' ' 72' ' ' ILE . 6.1 p -65.16 -26.76 68.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -28.98 70.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.36 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.35 48.13 1.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.234 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 43.9 m -154.69 -49.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.106 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.36 -15.04 60.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.48 ' HB3' HD11 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -54.17 98.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 110.16 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.935 ' O ' HD12 ' A' ' 86' ' ' ILE . 2.2 t -70.16 148.59 48.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.233 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 72' ' ' ILE . 22.3 tp -60.52 -27.77 67.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -48.04 65.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.64 -40.64 79.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.19 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 82' ' ' SER . 3.4 mt -72.42 -27.83 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 110.113 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 -43.14 75.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.172 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -54.12 10.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.133 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.87 -29.51 68.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.71 96.13 4.8 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 110.141 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.5 Cg_endo -72.87 88.43 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 12.9 t 176.47 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.96 141.55 5.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.48 -10.21 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.991 1.522 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -89.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.853 . . . . 0.0 110.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 21.5 m170 -77.14 -10.89 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.92 . . . . 0.0 110.215 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -79.21 -83.88 0.62 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.86 -34.76 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.291 -1.123 . . . . 0.0 110.341 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 100' ' ' LYS . 8.5 t -70.44 -64.46 0.89 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 26.6 tttm -43.18 -31.61 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.301 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.64 -52.31 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.212 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.14 -27.4 45.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.14 46.53 5.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.279 -1.13 . . . . 0.0 110.148 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.282 0.563 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.64 143.19 58.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.877 . . . . 0.0 110.223 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 18.6 m -138.8 149.42 61.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -76.05 164.71 87.22 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.705 -2.206 . . . . 0.0 110.567 -0.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.48 156.66 25.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.01 154.54 18.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -1.123 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -147.59 147.21 29.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.34 117.56 34.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.12 102.88 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 110.401 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.24 -101.73 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.82 51.31 0.82 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 143.55 21.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -1.136 . . . . 0.0 110.102 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.87 123.87 43.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.99 140.55 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.326 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -124.61 100.66 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 110.183 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.616 HD22 ' CA ' ' A' ' 22' ' ' CYS . 20.3 mt -77.14 121.74 24.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.136 -0.977 . . . . 0.0 110.32 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -141.45 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.7 tt0 -66.09 133.51 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.524 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.4 t70 66.82 34.79 5.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.616 ' CA ' HD22 ' A' ' 18' ' ' LEU . 60.5 m 44.05 42.71 5.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.524 ' CD2' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -86.85 144.19 27.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.143 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.76 112.61 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 110.248 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -105.85 31.1 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -152.32 65.86 6.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.54 -14.03 24.91 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.045 1.55 . . . . 0.0 110.399 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.99 -33.82 39.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 9.9 m-20 -103.42 -85.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.129 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.469 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 33.5 t90 58.98 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 110.297 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -163.5 179.43 7.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.69 -55.59 10.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.287 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -36.36 71.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.91 -61.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.97 -45.74 21.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.09 -45.41 87.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.0 t90 -58.13 -51.87 67.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.983 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -54.39 -40.87 68.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.245 -0.909 . . . . 0.0 110.506 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.92 69.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.921 . . . . 0.0 110.564 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.442 ' CD ' ' OE2' ' A' ' 41' ' ' GLU . 1.3 tmm_? -73.66 -45.22 53.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 110.562 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.442 ' OE2' ' CD ' ' A' ' 40' ' ' ARG . 2.0 mp0 -66.81 -33.9 76.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -68.13 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.348 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.89 -64.48 1.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.4 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.36 117.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -1.19 . . . . 0.0 110.26 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -74.69 -33.16 62.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.74 144.17 43.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.6 mmm -85.95 129.78 34.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.288 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.711 HG23 ' H ' ' A' ' 52' ' ' HIS . 3.5 t -73.69 170.77 14.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.18 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 3.8 mt-10 -67.89 -23.43 65.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.49 -40.06 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.898 . . . . 0.0 110.339 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.711 ' H ' HG23 ' A' ' 49' ' ' THR . 2.5 m170 -59.84 -59.67 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -58.68 -30.24 67.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.243 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -63.79 -65.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.908 . . . . 0.0 110.215 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.01 -29.03 63.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 52' ' ' HIS . 48.2 t -65.52 -39.82 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.73 -31.5 57.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.5 -49.33 71.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.04 -31.35 71.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.039 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -27.6 63.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.0 -45.81 90.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.298 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.5 -29.91 61.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.672 ' NE1' ' HB1' ' A' ' 104' ' ' ALA . 88.6 t90 -66.02 -44.3 85.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -44.13 83.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -64.19 -67.76 0.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.24 -63.34 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.33 44.13 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 p -139.39 -158.63 0.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -1.105 . . . . 0.0 110.187 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 m -139.41 101.87 7.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 110.192 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.87 172.27 16.21 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.107 1.582 . . . . 0.0 110.364 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' CG ' ' HD3' ' A' ' 73' ' ' LYS . 45.6 Cg_endo -72.52 -164.96 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.066 1.561 . . . . 0.0 110.368 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.44 ' O ' ' CG1' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -116.12 44.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HD3' ' CG ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -92.81 -66.79 0.9 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.7 mtp -60.04 -14.77 18.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.53 -58.21 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -28.18 69.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -28.12 69.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -106.68 -65.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.8 p -56.97 -35.09 68.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.7 79.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -75.04 122.88 24.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -1.137 . . . . 0.0 110.242 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.481 ' CB ' ' HE2' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -53.67 136.26 39.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.01 -35.45 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.94 -36.03 77.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HE2' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -58.4 -53.1 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 110.174 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.559 HG21 ' HG3' ' A' ' 94' ' ' PRO . 79.9 mt -65.9 -38.68 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.18 -37.57 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 109.946 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -48.2 25.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.431 HD22 ' CE1' ' A' ' 52' ' ' HIS . 22.6 mt -65.27 -11.72 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 0.1 OUTLIER -173.08 104.89 0.32 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 90' ' ' PHE . 45.2 Cg_endo -72.31 -25.6 18.36 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.056 1.556 . . . . 0.0 110.381 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.7 m -75.92 0.52 18.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.27 147.78 5.81 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 46.9 Cg_endo -73.09 -10.39 24.41 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.035 1.545 . . . . 0.0 110.346 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.22 -84.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.348 -0.845 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -76.72 -18.08 58.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.53 -67.1 1.73 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . -44.59 -38.09 4.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.124 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.88 -44.32 70.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -41.65 70.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.84 -37.24 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.5 70.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.72 50.19 1.85 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.672 ' HB1' ' NE1' ' A' ' 63' ' ' TRP . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.251 -1.147 . . . . 0.0 110.252 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.52 HG11 ' CD1' ' A' ' 18' ' ' LEU . 54.2 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.193 0.52 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -63.19 104.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.8 m -94.5 142.76 25.23 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.32 144.94 82.14 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.38 -0.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.94 165.11 30.6 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 144.59 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -1.111 . . . . 0.0 110.146 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -146.23 171.41 14.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.2 mt-30 -133.45 122.57 23.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.206 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 3.9 t -99.83 109.37 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.041 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 46.6 t0 56.33 -88.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.244 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.64 48.01 0.99 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 2.8 mttm -149.14 151.69 34.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -1.15 . . . . 0.0 110.257 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -112.53 111.28 22.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.56 140.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.7 107.87 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.749 HD22 ' C ' ' A' ' 22' ' ' CYS . 13.2 mt -83.65 124.59 30.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 3.1 t70 -66.39 -170.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -38.23 69.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.33 39.79 1.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.749 ' C ' HD22 ' A' ' 18' ' ' LEU . 67.4 m 44.85 39.63 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.55 151.15 22.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 132.82 34.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.31 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -108.26 -8.66 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -139.66 60.49 16.28 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.15 -1.73 11.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.03 1.542 . . . . 0.0 110.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -31.28 62.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -106.09 36.54 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.244 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -61.19 144.04 54.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.181 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.14 175.59 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.49 -39.24 90.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.239 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 16.4 mttt -67.02 -31.79 72.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.447 ' O ' HD12 ' A' ' 38' ' ' LEU . 49.1 t -71.49 -58.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -52.98 -46.75 68.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.26 -33.12 74.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 33.7 t90 -61.72 -48.44 80.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.45 -38.88 85.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.411 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.69 81.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.396 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.45 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 2.0 ttt-85 -71.63 -51.65 22.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.336 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.12 -26.84 65.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.427 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.5 mp -87.56 -72.08 0.54 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -42.7 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.384 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 118.12 21.11 4.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.438 ' N ' ' HA ' ' A' ' 40' ' ' ARG . 19.6 mt -79.63 105.6 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -1.108 . . . . 0.0 110.188 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -46.94 72.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' MET . 11.5 tptp -118.71 109.45 16.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' LYS . 4.6 tpt -42.8 150.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.271 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 52' ' ' HIS . 30.7 p -84.75 174.18 10.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.26 -40.87 64.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 110.302 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.442 ' CB ' HD11 ' A' ' 89' ' ' LEU . 67.2 mm-40 -68.61 -33.7 74.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -55.42 -49.67 71.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.2 m95 -71.23 -26.93 63.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -62.54 -58.44 7.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.42 -50.48 52.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.369 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 52' ' ' HIS . 95.5 t -52.44 -33.61 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -51.78 13.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.236 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.529 ' CZ ' HG22 ' A' ' 79' ' ' THR . 52.4 t80 -53.62 -31.53 47.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -44.78 63.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.164 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -49.13 -35.62 16.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.17 -51.75 68.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -41.88 98.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.428 ' O ' ' CD2' ' A' ' 63' ' ' TRP . 15.8 t90 -68.83 -12.51 61.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.221 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -14.27 35.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.244 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.568 HG22 ' CD2' ' A' ' 66' ' ' PHE . 96.2 m -97.82 -46.37 5.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.913 . . . . 0.0 110.145 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.568 ' CD2' HG22 ' A' ' 65' ' ' THR . 60.9 m-85 -124.94 -8.86 7.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 63' ' ' TRP . . . 65.83 45.44 88.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.19 147.57 40.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -117.32 103.13 51.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.28 152.69 50.34 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.971 1.511 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.87 -90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 0.0 110.346 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.629 HG12 HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -169.42 57.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -135.56 -68.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.028 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.7 ttm -67.84 -14.36 62.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.043 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.424 ' O ' ' OG1' ' A' ' 79' ' ' THR . 93.8 t -70.56 -42.68 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.882 . . . . 0.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -27.11 66.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -72.14 -33.5 67.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.826 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.23 -63.64 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CZ ' ' A' ' 58' ' ' TYR . 46.9 p -60.6 -42.34 96.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.13 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.52 59.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.66 149.72 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -1.19 . . . . 0.0 110.179 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -71.96 143.11 49.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.629 HD11 HG12 ' A' ' 72' ' ' ILE . 29.0 tp -73.32 -29.28 62.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -31.42 69.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.264 -0.898 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HE2' ' NE2' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -65.3 -62.13 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 86' ' ' ILE . 2.5 mp -51.26 -45.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.355 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 92' ' ' SER . 1.5 t80 -60.53 -33.73 73.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' NE2' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.71 -24.86 53.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.519 HD22 ' CG ' ' A' ' 52' ' ' HIS . 9.4 mt -76.13 -50.7 13.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 101' ' ' VAL . 74.1 m-85 -97.81 162.5 22.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 92' ' ' SER . 48.0 Cg_endo -74.92 76.7 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.115 1.587 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.453 ' HA ' ' CE1' ' A' ' 87' ' ' TYR . 0.8 OUTLIER 41.61 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.14 70.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' CB ' HD13 ' A' ' 72' ' ' ILE . 46.7 Cg_endo -72.99 -21.27 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.003 1.528 . . . . 0.0 110.432 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.54 -81.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.226 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -66.34 -16.09 63.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.76 -70.84 1.2 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.35 -42.34 61.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -1.161 . . . . 0.0 110.165 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.51 -48.41 81.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.22 -37.21 69.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.101 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.527 HG21 ' CE1' ' A' ' 90' ' ' PHE . 50.6 t -72.19 -31.96 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.13 -50.94 64.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.865 . . . . 0.0 110.213 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.03 43.41 1.78 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.224 -1.162 . . . . 0.0 110.079 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 41' ' ' GLU . 71.1 t . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.192 0.52 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 109.58 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 26.0 p -102.18 157.36 33.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 47.7 Cg_endo -75.48 147.28 88.14 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.504 -0.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.03 174.86 46.88 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.72 144.38 44.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 0.0 110.148 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.09 165.94 26.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -116.26 137.94 51.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 77.7 t -133.84 118.64 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t0 46.34 52.33 10.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.304 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.98 39.61 97.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.0 tttt -131.02 166.92 19.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -1.172 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 103.34 9.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.8 t -99.03 130.95 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.139 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.73 115.96 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 22' ' ' CYS . 10.6 mt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.185 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.3 t0 -59.55 -172.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.25 -23.21 67.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.827 . . . . 0.0 110.298 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -108.26 35.17 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.261 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.604 ' HA ' HD22 ' A' ' 18' ' ' LEU . 1.4 m 52.42 42.96 31.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.263 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -111.49 111.08 21.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 110.263 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -45.12 144.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.256 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.36 13.46 15.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.193 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -145.79 59.71 5.91 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.141 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.78 -8.14 21.9 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 0.0 110.517 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -27.4 65.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' TRP . 5.9 m-20 -92.82 -74.36 0.52 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 29' ' ' ASP . 68.9 t90 56.92 162.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.86 176.19 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.29 -51.22 39.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -32.96 74.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.73 -55.79 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.703 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -53.79 -47.3 70.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.53 -26.88 66.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -68.73 -54.49 15.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.291 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.535 HD23 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -62.93 -36.9 84.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.62 -37.26 86.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.09 -28.67 54.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.372 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 7.3 mm-40 -76.95 -27.6 54.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.96 . . . . 0.0 110.378 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.535 HD13 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -96.53 -21.43 17.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.283 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HB3' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -127.29 -36.68 2.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.933 . . . . 0.0 110.324 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 96.96 21.93 19.32 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 43' ' ' GLU . 34.8 mt -59.03 97.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -1.161 . . . . 0.0 110.23 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.11 -43.77 51.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 109.984 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -136.32 115.09 12.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -42.55 137.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.208 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -81.07 139.38 35.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 -24.8 7.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 110.229 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -75.98 -45.55 34.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 56' ' ' VAL . 22.6 m170 -51.8 -55.57 19.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.703 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 16.7 m95 -55.87 -29.24 59.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -52.9 48.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -37.12 85.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 52' ' ' HIS . 11.9 t -64.63 -38.19 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -54.29 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.415 ' CE1' HG13 ' A' ' 75' ' ' VAL . 17.2 t80 -51.84 -41.11 61.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.225 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -34.87 77.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.234 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -60.44 -30.14 69.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.93 -45.94 72.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.276 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -37.87 89.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 67' ' ' GLY . 48.9 t90 -64.03 -48.15 77.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.233 -0.917 . . . . 0.0 110.193 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.03 -12.74 60.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.7 m -91.23 -22.33 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.97 -43.79 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' TRP . . . 103.07 43.03 1.97 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.8 t -154.3 158.89 40.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 110.25 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.0 116.6 66.11 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.47 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 45.9 Cg_endo -72.71 174.28 12.03 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.832 1.438 . . . . 0.0 110.425 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 45.5 Cg_endo -72.1 -159.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.947 1.499 . . . . 0.0 110.46 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 72' ' ' ILE . 7.9 tp -118.02 -1.4 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.375 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -90.19 -44.67 9.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -23.74 63.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 58' ' ' TYR . 97.5 t -71.48 -41.93 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 110.317 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 80' ' ' GLY . 6.8 m -62.24 -45.4 93.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -45.34 -47.67 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.372 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.66 -32.35 70.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 p -103.84 -74.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 76' ' ' THR . . . 128.85 -12.23 6.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.8 m-30 -43.24 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -1.164 . . . . 0.0 110.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 80' ' ' GLY . 34.3 t -42.82 131.74 4.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.847 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tp -51.61 -37.65 51.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -40.55 72.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -64.11 -54.96 25.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 110.1 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.5 mt -51.64 -32.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 110.083 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -74.99 -35.86 62.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.105 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.22 62.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.28 -19.91 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.43 109.05 9.49 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -39.69 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.982 1.517 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -44.86 66.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 110.257 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.86 153.53 9.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -74.06 -162.41 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.96 1.505 . . . . 0.0 110.508 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 57.02 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 110.511 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' PRO . 36.3 m170 -66.6 -44.37 82.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.411 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -62.65 -66.93 2.31 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.67 -56.75 2.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -1.148 . . . . 0.0 110.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -50.44 -62.25 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -41.99 -49.61 4.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.216 -0.928 . . . . 0.0 110.526 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.26 -50.21 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.44 -19.23 65.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 70.03 1.36 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.239 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 41' ' ' GLU . 4.9 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.269 0.557 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 171.0 15.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.277 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' HD13 ' A' ' 18' ' ' LEU . 14.5 m -121.41 155.93 58.53 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.6 Cg_endo -76.19 158.01 97.87 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.545 -2.273 . . . . 0.0 110.403 -0.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.84 151.27 15.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.84 143.56 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -1.123 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -150.78 158.39 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.62 132.11 54.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 110.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 37' ' ' TRP . 98.9 t -116.56 104.98 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 24.8 t0 55.14 -90.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -132.5 52.56 0.82 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.623 ' CD ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -153.15 152.51 31.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -1.144 . . . . 0.0 110.224 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.32 133.34 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.665 HG22 HD21 ' A' ' 26' ' ' ASN . 72.9 t -132.41 111.19 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 0.0 110.158 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 17' ' ' ILE . 11.5 tt -107.55 96.66 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.573 HD13 ' SG ' ' A' ' 5' ' ' CYS . 76.4 mt -61.65 122.94 16.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -152.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -37.4 87.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 22' ' ' CYS . 2.5 t0 -108.37 51.38 0.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 93.0 m 43.32 27.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.12 138.76 45.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.424 ' HG3' HD11 ' A' ' 38' ' ' LEU . 3.1 mtp -79.79 110.99 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.214 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.15 18.85 11.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.665 HD21 HG22 ' A' ' 16' ' ' VAL . 16.2 p-10 -135.12 52.34 7.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.5 Cg_endo -72.94 -22.64 19.53 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.999 1.526 . . . . 0.0 110.427 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -60.08 -18.0 43.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -127.2 36.92 4.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.897 . . . . 0.0 110.13 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 31.8 t90 -73.44 139.46 45.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.91 174.7 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 33' ' ' LYS . 25.4 pt-20 -66.42 -42.11 88.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 1.9 ttmm -67.85 -47.51 68.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.623 HG21 ' CD ' ' A' ' 14' ' ' LYS . 42.8 t -56.0 -54.41 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -56.8 -36.52 70.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.74 -44.73 93.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.624 ' CD2' HG22 ' A' ' 11' ' ' VAL . 38.0 t90 -64.64 -38.43 90.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.184 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -58.16 -51.68 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.29 -27.24 66.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -64.43 -49.03 73.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB3' HG11 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.17 -28.19 53.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.413 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 42' ' ' LEU . 2.9 mm? -84.34 -3.72 58.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.364 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.3 -46.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 122.51 12.72 4.99 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 45' ' ' ILE . 9.6 mt -76.16 79.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.14 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -50.21 60.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.263 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 131.31 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 71.4 mmm -74.38 121.01 20.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -76.43 -157.17 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 49' ' ' THR . 7.5 mp0 -92.86 -27.86 16.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -48.38 35.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.69 ' NE2' HD22 ' A' ' 89' ' ' LEU . 23.2 m80 -51.25 -46.5 62.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.267 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.9 m95 -72.15 -31.27 65.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -64.01 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.19 -43.43 98.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.911 . . . . 0.0 110.265 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 52' ' ' HIS . 37.4 t -60.32 -27.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.257 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 tttt -76.64 -53.89 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.561 ' CD2' HG13 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -53.1 60.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.53 -51.31 60.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.92 -41.82 46.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.51 ' CE2' ' HG3' ' A' ' 70' ' ' PRO . 4.9 t80 -65.74 -35.11 79.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.903 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.43 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 36.0 t90 -66.42 -22.24 66.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.76 -10.64 59.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -81.31 -49.13 11.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -152.0 -38.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.98 88.48 0.95 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.77 -178.5 7.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 0.0 110.238 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.46 84.87 15.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 45.0 Cg_endo -72.44 125.92 11.13 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.395 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.57 91.54 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.897 1.472 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 73' ' ' LYS . 8.4 mm 48.56 -132.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 109.917 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.455 ' H ' HG22 ' A' ' 72' ' ' ILE . 8.3 mttt 57.81 -97.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.052 -1.03 . . . . 0.0 110.36 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.55 -23.91 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.03 -1.044 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.561 HG13 ' CD2' ' A' ' 58' ' ' TYR . 22.2 t -69.6 -47.18 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 110.301 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 73' ' ' LYS . 1.1 p -63.97 -34.86 78.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -43.99 -32.94 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 0.0 110.149 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.92 48.02 2.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.4 m -153.75 -70.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.54 87.35 1.92 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.16 104.55 2.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -1.131 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.4 143.3 40.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 83' ' ' LEU . 7.6 tp -60.56 -26.87 67.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -41.48 74.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.45 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -65.84 -58.04 6.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.396 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 94' ' ' PRO . 54.6 mt -46.29 -49.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 110.224 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -59.37 -41.39 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.17 -24.75 67.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.69 HD22 ' NE2' ' A' ' 52' ' ' HIS . 4.5 mt -79.48 -62.33 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 110.259 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 11.3 m-85 -85.08 170.81 12.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.123 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 42.5 Cg_endo -74.54 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.117 1.588 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.87 56.52 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.044 -1.035 . . . . 0.0 110.033 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.52 143.07 1.4 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HG3' HG23 ' A' ' 86' ' ' ILE . 45.5 Cg_endo -72.96 -90.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.954 1.502 . . . . 0.0 110.447 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . 53.91 -93.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 97' ' ' GLY . 8.7 m170 -69.63 -57.39 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 96' ' ' HIS . . . -43.65 -59.1 3.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -47.48 -48.65 26.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.125 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 99.7 m -53.78 -62.54 1.59 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 99' ' ' CYS . 15.0 mttp -44.16 -45.87 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 54.4 t -53.76 -55.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.344 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.15 -22.74 66.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 104' ' ' ALA . . . 114.07 -46.65 1.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.354 -1.086 . . . . 0.0 110.276 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 41' ' ' GLU . 5.7 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.169 0.509 . . . . 0.0 110.405 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 63.33 114.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.397 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 79.2 m -137.14 151.71 72.32 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.6 Cg_endo -78.62 162.91 87.29 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.316 -0.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.11 45.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 16.5 mt-10 -106.07 170.65 7.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.035 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 1.2 m-85 -169.52 171.21 7.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 110.344 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -132.6 137.97 47.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.583 HG22 ' CE2' ' A' ' 37' ' ' TRP . 75.8 t -117.71 106.88 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 51.18 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.96 60.06 0.68 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -161.44 164.26 29.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -1.132 . . . . 0.0 110.246 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.98 147.85 26.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 110.208 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.421 HG21 ' CG2' ' A' ' 11' ' ' VAL . 65.7 t -140.28 135.81 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 17' ' ' ILE . 4.5 mp -127.33 100.24 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 18' ' ' LEU . 43.0 mt -73.36 131.78 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -83.85 -146.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 110.385 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.4 -48.54 69.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.343 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -98.67 39.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.95 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 55.7 m 56.56 31.99 20.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.377 -0.827 . . . . 0.0 110.026 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.94 155.09 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -98.61 113.66 25.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.26 16.03 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.98 64.74 71.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.63 -15.85 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.969 1.51 . . . . 0.0 110.357 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -15.96 62.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -116.53 12.89 15.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.324 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.687 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 24.8 t90 -63.77 147.87 50.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -0.898 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.27 -154.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.11 -33.3 61.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -72.19 -39.87 68.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.274 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 41.2 t -72.9 -36.93 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.425 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -69.91 -50.46 42.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.381 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.76 -46.62 89.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 110.427 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.583 ' CE2' HG22 ' A' ' 11' ' ' VAL . 77.6 t90 -60.25 -54.63 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.509 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.94 -41.11 58.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.598 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.879 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -65.84 -37.06 85.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.562 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -35.58 74.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 3' ' ' VAL . 2.9 mm-40 -77.1 -30.05 55.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 110.383 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -75.98 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.919 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.3 -61.26 1.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.07 42.52 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.879 HD12 ' HB1' ' A' ' 39' ' ' ALA . 75.5 mt -78.88 99.86 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -1.117 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.59 -28.97 67.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -144.07 118.46 9.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.145 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.419 ' HG3' ' NE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -48.76 142.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.268 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 147.4 22.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.882 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 16.2 pt-20 -57.53 -36.85 72.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mm-40 -66.87 -34.62 78.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -69.09 -53.34 20.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 110.204 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.419 ' NE1' ' HG3' ' A' ' 48' ' ' MET . 5.0 m95 -58.28 -27.96 64.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -56.81 5.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -39.42 65.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.056 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -69.46 -32.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.13 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -49.78 69.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -65.9 -37.25 85.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.86 75.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 110.314 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 38.1 ttm-85 -60.08 -28.93 68.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 110.33 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 1.8 tt0 -56.77 -60.84 2.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -69.55 -26.57 64.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 110.198 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 60' ' ' ARG . 32.5 t90 -65.94 -20.16 66.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 110.338 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.96 -0.46 47.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -108.34 -60.52 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.933 . . . . 0.0 110.306 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' GLY . 4.8 m-85 -107.17 7.65 29.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' PHE . . . 45.91 69.83 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.23 147.31 25.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.7 t -116.19 83.71 13.04 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.62 169.85 21.36 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.953 1.502 . . . . 0.0 110.355 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.02 -160.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.012 1.533 . . . . 0.0 110.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 72' ' ' ILE . 25.1 mm -102.75 40.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.78 -58.82 1.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.256 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mmt -61.76 -28.85 69.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' O ' ' OG1' ' A' ' 79' ' ' THR . 6.8 t -71.43 -38.07 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.579 HG23 ' H ' ' A' ' 81' ' ' PHE . 1.0 OUTLIER -63.79 -27.03 68.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.87 -29.92 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.68 46.63 2.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.255 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 24.5 m -148.29 -50.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.243 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.68 1.16 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -127.35 143.93 51.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -1.171 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 130.59 54.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.9 -34.24 62.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 19.8 tt0 -58.01 -55.23 37.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.447 ' CE ' HD11 ' A' ' 89' ' ' LEU . 1.3 tptm -51.97 -52.16 52.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 94' ' ' PRO . 57.3 mt -54.94 -31.04 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.086 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -67.88 -51.16 51.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.222 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.57 68.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.447 HD11 ' CE ' ' A' ' 85' ' ' LYS . 13.8 mt -73.32 -66.73 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.244 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 102.29 51.17 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.07 94.76 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.918 1.483 . . . . 0.0 110.442 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 177.7 -37.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.21 131.85 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HB2' HG13 ' A' ' 72' ' ' ILE . 46.9 Cg_endo -73.37 -162.89 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.937 1.493 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 56.08 -90.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.3 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.47 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 57.1 m-70 -59.43 -33.85 71.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -69.62 -67.15 2.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.62 -52.3 4.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -46.91 81.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.79 -36.73 48.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 t -74.43 -36.24 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.61 -21.69 61.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.94 72.33 0.95 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.192 -1.181 . . . . 0.0 110.195 -179.939 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.282 0.563 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -128.92 157.78 40.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.7 m -116.63 146.41 37.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.5 174.21 53.98 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.357 -0.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' ILE . . . -176.34 173.03 46.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.532 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -150.82 138.35 19.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -1.115 . . . . 0.0 110.041 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 51.6 m-85 -145.22 171.31 14.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -104.47 111.56 24.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 91.6 t -118.86 107.79 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.263 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 11.0 t0 66.06 64.73 0.53 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 44.7 32.12 2.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.3 mttp -129.03 165.0 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.145 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -122.14 113.43 19.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 93.1 t -111.08 145.72 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.101 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 3.5 tt -137.53 109.61 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 110.223 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 56.4 mt -78.25 134.64 37.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 4.6 t0 -67.11 -167.97 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -17.92 65.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.26 38.14 3.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 53.1 m 47.68 39.09 9.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.1 155.55 16.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 90.68 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.421 ' NE2' HG12 ' A' ' 17' ' ' ILE . 9.5 pt20 -83.62 -4.21 58.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.457 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 1.8 t30 -121.39 62.74 12.6 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 45.8 Cg_endo -72.86 -16.27 26.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.015 1.534 . . . . 0.0 110.396 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -64.22 -25.06 67.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.69 0.37 30.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 42.7 t90 -46.38 148.19 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -168.45 2.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 4.9 tt0 -74.93 -55.35 5.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -30.87 71.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 110.203 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.01 -50.04 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -59.89 -50.83 72.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.62 -57.73 11.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 110.281 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 59.1 t90 -47.78 -36.85 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.64 -57.1 8.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.266 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -51.38 -28.49 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.306 -0.871 . . . . 0.0 110.189 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -62.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.892 . . . . 0.0 110.219 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -48.97 -37.0 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.318 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -80.78 -75.33 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.315 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.4 -76.8 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.68 38.65 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.575 HD12 ' HB1' ' A' ' 39' ' ' ALA . 43.1 mt -79.73 104.4 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 110.034 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -78.8 -19.09 52.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.334 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -151.61 96.46 2.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 45' ' ' ILE . 70.8 mmm -52.06 103.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.039 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 1.0 HG22 ' ND1' ' A' ' 52' ' ' HIS . 2.3 t -55.99 160.34 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.87 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -52.61 -36.63 56.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -0.936 . . . . 0.0 110.281 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -35.29 79.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.311 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 1.0 ' ND1' HG22 ' A' ' 49' ' ' THR . 22.4 m170 -65.16 -60.53 2.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.943 . . . . 0.0 110.541 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.579 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 5.4 m95 -57.02 -34.22 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.733 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -62.91 -60.1 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.163 -0.961 . . . . 0.0 110.464 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 86' ' ' ILE . 1.9 tp -52.3 -39.16 60.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 52' ' ' HIS . 60.8 t -68.6 -30.88 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.185 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -49.8 64.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.11 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.587 ' CE2' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -66.86 -34.35 77.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -63.05 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -66.13 -49.46 67.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -43.75 -46.18 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.95 -32.1 63.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.218 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.453 ' CG ' ' O ' ' A' ' 63' ' ' TRP . 78.7 t90 -81.63 8.75 9.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -113.36 -17.59 12.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.69 -46.02 3.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.082 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.79 -50.91 9.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.08 25.12 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 t -167.03 168.06 14.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -1.153 . . . . 0.0 110.109 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 23.5 p -114.01 104.72 54.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 172.02 16.41 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.015 1.534 . . . . 0.0 110.433 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.87 -169.83 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 72' ' ' ILE . 45.6 mm -97.54 63.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -107.26 -63.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 mtm -74.77 -19.36 60.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.74 -29.99 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.231 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 84.0 m -59.32 -36.72 76.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.04 -28.19 54.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 -76.12 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 ' CE2' ' A' ' 58' ' ' TYR . 66.5 p -67.3 -51.16 56.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.279 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 106.75 9.07 31.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.96 108.21 2.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -1.156 . . . . 0.0 110.142 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.07 139.38 47.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.16 -27.86 67.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -49.32 72.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.154 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -51.52 -55.25 20.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 110.12 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mt -54.82 -39.19 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.17 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.26 -36.84 78.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -75.31 -27.37 59.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 0.0 110.194 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.566 HD22 ' NE2' ' A' ' 52' ' ' HIS . 14.9 mt -92.48 -5.36 52.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.299 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -156.43 99.61 2.09 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.199 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 90' ' ' PHE . 46.1 Cg_endo -73.25 -17.53 24.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.996 1.524 . . . . 0.0 110.459 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.9 m -67.47 -29.89 69.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.85 147.71 8.48 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.12 -1.79 11.08 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.051 1.553 . . . . 0.0 110.48 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.453 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . -79.65 -86.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 110.239 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -73.85 -5.42 40.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.363 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 101' ' ' VAL . . . -65.23 -94.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -42.69 -27.26 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 56.0 m -65.63 -79.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -43.04 -40.25 3.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 110.289 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 97' ' ' GLY . 92.1 t -55.91 -48.72 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 110.247 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -65.39 -49.64 68.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 133.61 54.38 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.228 179.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.534 HG11 ' CH2' ' A' ' 37' ' ' TRP . 5.0 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.122 0.487 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.33 107.92 3.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 26.3 p -88.13 158.73 49.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 110.098 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.45 145.05 82.3 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.667 -2.222 . . . . 0.0 110.476 -0.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.08 174.93 46.91 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 125.96 54.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 110.123 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -129.99 156.18 44.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -113.29 134.78 54.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 99.0 t -116.3 94.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.483 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' GLY . 1.1 m-20 48.29 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.542 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.0 59.52 3.31 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 1.3 mttt -166.6 153.2 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -1.138 . . . . 0.0 110.109 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -116.73 145.84 43.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 110.279 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.99 138.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.13 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 17' ' ' ILE . 50.8 mt -117.36 96.85 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.367 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.646 HD22 ' HA ' ' A' ' 22' ' ' CYS . 16.4 mt -75.02 121.91 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -69.84 -171.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -62.47 -16.89 57.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.29 36.72 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.646 ' HA ' HD22 ' A' ' 18' ' ' LEU . 1.3 m 50.61 29.07 3.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -84.57 141.14 30.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.215 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.5 ttt -89.46 115.06 26.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -92.7 22.89 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -133.2 67.06 76.62 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.321 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.07 -13.7 26.09 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.027 1.54 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -78.17 -10.81 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.192 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' TRP . 21.6 t70 -110.93 -5.12 14.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.455 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 12.0 t90 -44.0 143.15 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.188 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 18.6 m-20 -159.93 -163.43 1.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.474 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -74.52 -58.76 3.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -65.41 -31.03 71.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.188 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.5 t -66.99 -53.02 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.483 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -63.08 -53.83 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 2.7 tt0 -52.33 -36.23 52.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.534 ' CH2' HG11 ' A' ' 3' ' ' VAL . 28.1 t90 -70.08 -38.13 75.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -51.54 66.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.709 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -68.65 -26.53 65.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.7 -44.61 73.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.503 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -77.31 -36.93 53.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.144 -0.972 . . . . 0.0 110.797 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -58.56 2.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.677 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -16.63 55.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.472 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 85.48 14.64 67.88 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.709 HD12 ' HB1' ' A' ' 39' ' ' ALA . 8.0 mt -67.23 101.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -70.48 -13.87 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.235 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -168.32 120.21 0.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.508 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 31.5 mmm -67.74 131.68 46.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.29 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.0 p -78.68 -167.16 1.02 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.99 -52.61 7.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -56.61 -30.63 63.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.124 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.54 -61.05 2.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.193 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.483 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 3.7 m95 -57.21 -33.7 67.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 4.2 tmtm? -58.2 -57.14 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.198 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tp -56.9 -50.88 71.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.198 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' HIS . 47.7 t -54.14 -29.04 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 54' ' ' LYS . 9.5 mmtt -73.44 -53.79 9.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 110.261 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.427 ' O ' ' HB2' ' A' ' 62' ' ' TYR . 3.1 t80 -51.3 -41.28 60.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 110.342 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -49.53 77.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.306 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.98 -60.34 4.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -27.01 4.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.29 -0.881 . . . . 0.0 110.361 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.8 -37.66 58.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.425 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 41.9 t90 -65.05 -22.22 66.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.314 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.19 -59.06 5.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.211 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -75.89 -58.52 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.247 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -65.3 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 110.209 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.23 18.94 3.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.537 HG23 ' HD3' ' A' ' 70' ' ' PRO . 8.8 t -141.22 174.22 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.148 . . . . 0.0 110.135 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 t -124.69 84.69 57.51 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD3' HG23 ' A' ' 68' ' ' THR . 46.2 Cg_endo -73.17 173.73 13.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.981 1.516 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.7 Cg_endo -73.09 160.44 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.002 1.528 . . . . 0.0 110.313 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.1 tt -79.03 -7.06 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.145 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -55.1 -62.81 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -63.74 -27.08 68.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.071 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.84 -34.22 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -54.8 -27.65 43.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -65.04 -39.4 93.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -70.05 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.113 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 p -46.8 -39.09 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.91 8.7 84.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -55.4 171.82 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.807 ' O ' HD12 ' A' ' 86' ' ' ILE . 15.8 m -113.94 147.23 38.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 13.0 tp -60.44 -27.9 67.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 110.268 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -63.67 -59.95 3.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.272 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.807 HD12 ' O ' ' A' ' 82' ' ' SER . 3.5 mt -47.01 -33.04 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.377 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -77.0 -36.32 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.923 . . . . 0.0 110.378 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.63 -24.36 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.37 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.22 -49.99 6.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -98.43 167.22 11.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.217 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.68 -89.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.998 1.525 . . . . 0.0 110.505 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.7 t -104.68 85.77 2.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 61.3 139.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 46.4 Cg_endo -73.05 -90.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.061 1.558 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 62.28 -132.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 8.2 p-80 -42.28 -25.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.0 110.582 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.515 ' N ' ' CD2' ' A' ' 96' ' ' HIS . . . -66.63 -74.56 0.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.17 -48.1 4.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -1.107 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.4 t -57.01 -44.09 82.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.468 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -60.64 -58.22 9.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.373 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.0 t -46.76 -41.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.29 59.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.52 52.23 3.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.524 HG21 ' HG3' ' A' ' 41' ' ' GLU . 13.2 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.308 0.575 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 133.68 55.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.157 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 62.3 m -103.09 150.38 37.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.4 Cg_endo -76.36 165.6 84.88 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.612 -2.245 . . . . 0.0 110.412 -0.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 154.91 20.26 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.33 152.56 27.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -1.144 . . . . 0.0 110.168 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -149.15 157.06 43.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.481 ' C ' HG23 ' A' ' 11' ' ' VAL . 1.1 tp60 -110.55 145.01 38.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.243 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.481 HG23 ' C ' ' A' ' 10' ' ' GLN . 22.7 t -148.79 110.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.023 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t0 58.51 -143.85 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.951 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.42 50.44 2.99 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.0 146.36 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.243 . . . . 0.0 110.319 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.98 143.18 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.098 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 17' ' ' ILE . 85.0 t -127.79 162.31 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.351 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.476 HG12 ' N ' ' A' ' 18' ' ' LEU . 8.7 tt -148.96 164.37 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' ' 17' ' ' ILE . 16.6 mt -136.43 115.78 12.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.908 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -57.74 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.47 -20.71 66.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.32 38.85 2.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.5 m 48.46 42.57 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -96.52 145.13 25.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.431 ' SD ' HD12 ' A' ' 38' ' ' LEU . 2.1 mtp -82.81 105.43 13.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.33 19.42 13.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -129.51 71.81 82.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.69 -30.5 11.7 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.139 1.6 . . . . 0.0 110.418 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.09 -16.9 64.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.83 35.68 3.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -90.85 153.59 20.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.84 -168.08 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.497 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 2.5 mt-10 -72.12 -57.06 4.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.198 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.77 -29.99 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.34 -57.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -55.44 -38.74 69.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.309 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -52.23 63.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ2' ' OE2' ' A' ' 41' ' ' GLU . 57.9 t90 -56.87 -33.13 66.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 38' ' ' LEU . 4.8 tt -69.57 -42.9 73.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.55 -31.43 72.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -74.63 -44.07 52.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HG3' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -62.97 -36.93 85.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.865 . . . . 0.0 110.145 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -83.46 -67.75 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 45' ' ' ILE . 4.3 tt0 -80.44 -66.38 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.61 -13.9 2.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.401 ' CD1' ' OE1' ' A' ' 43' ' ' GLU . 33.7 mt -44.19 134.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -106.77 3.85 26.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.212 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -161.03 91.29 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -44.95 123.85 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 52' ' ' HIS . 3.3 t -73.83 158.42 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.257 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -34.47 55.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.24 -43.34 92.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.799 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -58.25 -56.66 19.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.224 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.651 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 6.6 m95 -59.29 -27.31 65.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -67.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.61 -32.44 58.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.152 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.72 -33.53 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.47 -42.43 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 110.136 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -44.42 94.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.15 -50.99 71.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 110.236 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -49.17 -50.05 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.381 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.78 -38.97 61.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.58 74.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -52.86 -46.52 67.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.16 -35.48 80.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.334 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.2 m -64.66 -33.99 77.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -142.11 -69.18 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.27 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.62 79.11 0.38 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.447 HG23 ' HD3' ' A' ' 70' ' ' PRO . 5.3 t -162.7 159.88 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -1.185 . . . . 0.0 110.18 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.6 t -112.6 82.52 4.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD3' HG23 ' A' ' 68' ' ' THR . 45.1 Cg_endo -73.42 160.25 44.99 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.15 -89.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.095 1.576 . . . . 0.0 110.454 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -172.14 42.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -64.83 1.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.15 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -40.22 95.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' OG1' ' A' ' 79' ' ' THR . 20.8 t -52.63 -37.17 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m -66.19 -33.58 76.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -74.17 -33.1 63.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.59 -35.39 62.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -107.44 -78.44 0.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.22 38.42 0.23 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -91.99 128.9 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 84' ' ' GLU . 72.4 m -77.83 134.68 37.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.898 . . . . 0.0 110.238 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 82' ' ' SER . 1.3 tp -42.8 -26.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -60.73 -53.3 59.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.34 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -47.92 79.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.64 -30.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -72.35 -48.08 44.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -38.5 80.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD22 ' CE1' ' A' ' 52' ' ' HIS . 8.1 mt -68.36 -65.58 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.084 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.1 m-85 -82.25 173.7 7.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.3 Cg_endo -73.65 -88.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.984 1.518 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -155.86 80.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.56 82.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.07 -17.63 24.66 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.932 1.49 . . . . 0.0 110.432 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.77 -88.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -76.81 -2.26 32.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.18 -70.41 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.81 -36.53 37.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.188 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.2 m -70.26 -52.74 20.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -33.25 36.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 110.173 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.446 HG21 ' HZ ' ' A' ' 90' ' ' PHE . 25.1 t -73.62 -45.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.092 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -21.63 66.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.74 53.9 3.41 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.205 -1.174 . . . . 0.0 110.135 179.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 9' ' ' TYR . 7.0 m . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.275 0.559 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.45 148.0 52.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.4 m -102.84 141.11 21.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.36 159.21 97.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 -2.153 . . . . 0.0 110.314 -0.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.77 136.34 3.01 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.448 ' OE2' HG12 ' A' ' 17' ' ' ILE . 12.4 tt0 -101.24 142.53 32.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -1.104 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CE2' HG12 ' A' ' 3' ' ' VAL . 25.5 m-85 -150.68 148.49 28.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -101.77 143.95 31.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.065 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 43.7 t -120.37 94.87 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 110.448 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.41 63.68 2.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.52 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.53 14.48 79.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 11' ' ' VAL . 16.1 mmtt -102.82 169.96 8.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -1.205 . . . . 0.0 110.162 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.53 108.57 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.558 HG13 ' HB3' ' A' ' 24' ' ' MET . 55.2 t -116.73 145.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.26 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.448 HG12 ' OE2' ' A' ' 8' ' ' GLU . 3.6 mt -134.51 97.47 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.79 110.15 6.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.273 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -68.46 -141.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.77 -2.71 58.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.872 . . . . 0.0 110.145 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.42 38.01 4.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.3 m 47.9 49.14 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -119.69 116.19 25.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.558 ' HB3' HG13 ' A' ' 16' ' ' VAL . 1.8 ptp -51.83 -21.75 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.63 29.81 5.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.62 75.97 36.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 110.175 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.84 -21.46 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.007 1.53 . . . . 0.0 110.408 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -38.34 73.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.74 -2.77 57.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -61.93 125.6 24.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -0.969 . . . . 0.0 110.277 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.3 -162.9 1.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.495 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -72.14 -62.43 1.44 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.965 . . . . 0.0 110.284 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -48.29 -49.28 34.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.31 -52.1 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.236 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -50.77 -36.19 35.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 46.2 mt-10 -72.85 -36.61 67.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -60.49 -48.13 83.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.397 -0.815 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 42' ' ' LEU . 8.1 mt -67.36 -51.21 54.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 110.32 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -53.75 -29.17 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -77.07 -60.82 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.95 -35.35 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 38' ' ' LEU . 6.0 mp -80.16 -66.53 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -89.81 -47.62 7.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 119.47 13.69 6.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.488 HD12 ' HB1' ' A' ' 39' ' ' ALA . 63.2 mt -54.8 92.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -1.158 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 44' ' ' GLY . 3.5 mp0 -57.48 -35.79 70.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.216 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 146.1 46.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.508 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -85.07 134.74 34.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.325 -0.859 . . . . 0.0 110.208 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -93.36 -179.13 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.42 -21.7 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -77.05 -36.25 56.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -71.09 -54.8 9.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.515 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 3.0 m95 -57.67 -33.22 68.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -67.33 -59.09 3.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.142 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.56 -35.77 31.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.89 -40.37 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -63.04 -35.44 80.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.2 -36.85 61.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.247 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.2 -29.43 68.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -59.64 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -44.85 -45.94 10.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.247 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -44.79 96.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.283 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 21.4 t90 -67.88 -14.5 63.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.329 -0.857 . . . . 0.0 110.287 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.17 -49.83 8.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.302 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.95 -49.09 16.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.65 -72.46 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.16 89.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.412 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.04 174.86 14.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -1.177 . . . . 0.0 110.014 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -153.58 57.52 1.95 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.412 ' HD3' ' HB ' ' A' ' 68' ' ' THR . 46.3 Cg_endo -73.02 171.79 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.975 1.513 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 45.9 Cg_endo -72.68 171.7 16.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.098 1.578 . . . . 0.0 110.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.798 HG21 ' CD1' ' A' ' 86' ' ' ILE . 3.5 tp -68.08 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -178.54 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 109.98 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -27.18 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.048 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 t -77.04 -27.52 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -54.95 -38.82 68.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -36.97 16.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 78' ' ' GLU . 13.5 mm-40 -87.98 -32.64 18.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.28 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -97.2 -74.91 0.56 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.01 36.88 1.09 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -92.64 88.31 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.188 -1.183 . . . . 0.0 110.228 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.4 m -49.29 136.07 16.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 72' ' ' ILE . 1.2 mp -44.16 -31.92 1.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.282 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.22 -53.8 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.249 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -48.55 81.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.798 ' CD1' HG21 ' A' ' 72' ' ' ILE . 79.2 mt -53.37 -29.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.912 . . . . 0.0 110.151 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -77.02 -45.22 27.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.12 -33.56 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 110.267 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.91 -63.89 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.446 ' HE2' HG21 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -101.26 106.48 45.54 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.86 -38.13 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.973 1.512 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -49.3 -28.81 5.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.271 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.43 151.59 18.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.651 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 45.7 Cg_endo -73.41 -170.33 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.017 1.535 . . . . 0.0 110.445 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 66.85 -84.34 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.339 -0.851 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -74.24 -34.05 63.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.03 -1.044 . . . . 0.0 110.379 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.2 -58.64 5.01 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.93 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -1.161 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 5.4 t -61.18 -51.06 70.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -48.82 -50.09 36.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.446 HG21 ' HE2' ' A' ' 90' ' ' PHE . 52.1 t -64.15 -35.65 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.423 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.64 69.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.71 36.24 29.79 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.281 -1.129 . . . . 0.0 110.177 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.619 HG11 ' CD1' ' A' ' 18' ' ' LEU . 48.3 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.214 0.531 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 mttt 53.7 96.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.499 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 61.5 m -97.11 157.83 34.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.8 Cg_endo -75.5 170.8 70.85 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.387 -0.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -177.02 150.66 10.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -106.43 137.26 44.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -1.095 . . . . 0.0 110.301 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.482 ' CE2' HG13 ' A' ' 3' ' ' VAL . 73.0 m-85 -134.66 170.64 15.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 140.65 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.272 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 39.5 t -122.98 99.13 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.0 110.036 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 10.0 t0 55.89 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -130.91 62.83 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.32 157.17 17.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -114.88 133.91 55.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.93 124.9 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.14 97.98 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.619 ' CD1' HG11 ' A' ' 3' ' ' VAL . 20.5 mt -67.48 108.54 2.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 18' ' ' LEU . 34.3 t0 -49.62 -179.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.819 . . . . 0.0 110.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -62.58 -15.81 53.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.915 . . . . 0.0 110.223 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 1.5 m-20 -117.07 41.99 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.0 m 48.2 49.91 16.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -109.65 161.45 15.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.424 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -89.73 108.85 19.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.233 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.82 4.57 28.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.505 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 4.3 m-20 -131.62 51.97 8.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.1 Cg_endo -72.56 -13.52 27.44 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.032 1.543 . . . . 0.0 110.474 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -37.65 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' TRP . 0.9 OUTLIER -95.78 -70.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 110.213 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.577 ' CD2' ' N ' ' A' ' 31' ' ' ASP . 37.2 t90 55.78 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.155 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.577 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -172.86 -172.93 0.91 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.87 -41.33 68.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -70.06 -32.43 70.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.9 t -70.04 -51.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.62 44.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.07 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -39.84 70.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.481 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 83.3 t90 -64.57 -31.79 73.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.877 . . . . 0.0 110.184 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 24' ' ' MET . 5.3 mt -70.79 -44.18 67.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.352 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.36 67.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -76.76 -36.04 57.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 37' ' ' TRP . 3.2 mm-40 -77.18 -27.02 53.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.554 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.2 -62.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.551 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.04 -78.12 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.99 51.48 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.88 107.8 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -1.105 . . . . 0.0 110.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -42.73 -43.36 3.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.311 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 143.11 28.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.29 125.33 22.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 49' ' ' THR . 19.0 p -70.76 160.84 31.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.226 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.08 -27.34 32.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.6 -41.4 62.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 110.394 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -61.83 -48.81 78.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.438 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.0 m95 -65.82 -31.94 73.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.41 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 1.4 tttt -64.57 -66.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -53.94 -49.98 67.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 101' ' ' VAL . 34.3 t -55.33 -31.41 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.33 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -70.29 -46.64 63.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.211 -0.93 . . . . 0.0 110.192 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -60.2 -34.72 74.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.378 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -43.3 86.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.0 110.453 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -55.81 27.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.436 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.06 -27.38 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.947 . . . . 0.0 110.347 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.572 ' CG ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -76.8 -42.32 41.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.569 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 19.2 t90 -58.18 -20.31 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.304 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.54 -42.14 30.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.31 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -60.26 3.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -116.99 -33.78 4.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 63' ' ' TRP . . . 93.01 71.59 1.17 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.3 t -166.09 -175.15 3.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.211 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.0 m -102.3 106.01 46.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.572 ' HG3' ' CG ' ' A' ' 62' ' ' TYR . 45.8 Cg_endo -72.94 144.92 39.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.052 1.553 . . . . 0.0 110.459 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 -178.28 3.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.091 1.574 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.8 62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -130.89 -50.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 74' ' ' MET . 0.9 OUTLIER -67.23 -37.75 84.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.282 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.1 t -65.59 -55.76 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.0 m -52.87 -26.84 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.17 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.92 -41.46 24.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.98 32.7 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.351 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.893 HG22 ' CD1' ' A' ' 81' ' ' PHE . 46.2 m -123.77 -22.33 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.13 78.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.893 ' CD1' HG22 ' A' ' 79' ' ' THR . 3.3 m-85 -96.55 172.68 7.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.144 . . . . 0.0 110.121 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.6 148.92 34.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.65 -27.59 64.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 110.222 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.56 -52.2 64.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -33.21 68.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 55' ' ' LEU . 50.4 mt -73.67 -29.01 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 110.073 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -35.76 66.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -40.8 50.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -39.44 79.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 110.242 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 116.14 32.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.067 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.76 -7.82 20.61 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.579 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 92' ' ' SER . 1.3 t -104.11 21.3 16.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 59.06 161.04 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -73.09 -16.68 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.977 1.514 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 94' ' ' PRO . . . -45.57 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -77.2 -2.91 36.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 110.209 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.55 -91.96 0.16 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -43.1 -34.31 1.04 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.396 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.16 -62.37 1.66 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.02 -38.01 48.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.285 -0.884 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.786 HG11 HG21 ' A' ' 56' ' ' VAL . 52.6 t -58.97 -59.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.938 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 56' ' ' VAL . . . -71.64 -7.07 45.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 110.305 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.79 79.45 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 110.201 -179.938 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 18' ' ' LEU . 56.6 t . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.259 0.552 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -96.14 109.32 21.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 p -108.94 152.09 42.22 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.219 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.1 Cg_endo -75.57 161.59 94.13 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.644 -2.232 . . . . 0.0 110.548 -0.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.02 47.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -104.66 121.69 44.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.163 . . . . 0.0 110.364 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -137.09 155.44 49.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -117.31 145.62 43.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.26 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' GLY . 42.4 t -125.66 125.83 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.86 -91.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -137.98 59.44 0.61 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.16 170.34 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 110.225 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.02 136.21 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.603 HG13 ' HG2' ' A' ' 24' ' ' MET . 56.0 t -137.67 144.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mt -112.29 105.85 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 6' ' ' PRO . 11.8 mt -62.64 129.61 41.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.418 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.9 t0 -84.5 -160.43 0.47 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.45 -13.05 60.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -107.59 26.27 10.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 5' ' ' CYS . 2.7 m 50.7 23.73 1.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 24' ' ' MET . 68.3 t80 -109.44 155.86 20.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.603 ' HG2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -59.79 138.07 57.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.212 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.82 -20.38 31.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -124.8 71.7 60.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.058 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.29 -9.43 25.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.031 1.542 . . . . 0.0 110.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.63 -35.79 6.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.104 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' TRP . 53.5 m-20 -93.48 -74.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 110.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.532 ' CE2' ' HB2' ' A' ' 35' ' ' ALA . 82.9 t90 52.15 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.285 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.54 -170.61 1.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.99 -57.44 4.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.342 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -54.83 -27.37 41.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.372 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.64 -48.77 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.671 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -60.11 -48.23 82.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -42.93 97.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -0.908 . . . . 0.0 110.428 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CZ3' HG21 ' A' ' 11' ' ' VAL . 39.3 t90 -57.25 -47.66 80.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.311 -0.868 . . . . 0.0 110.506 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 13.1 mt -62.52 -43.24 99.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.963 . . . . 0.0 110.493 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.78 -26.99 67.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 0.0 110.439 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.422 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.2 -43.77 32.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.0 110.732 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.46 -27.82 60.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.97 . . . . 0.0 110.682 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -80.61 -47.5 14.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.97 . . . . 0.0 110.395 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.31 -48.37 4.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.258 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 121.13 12.15 5.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.13 106.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -1.132 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.1 -46.53 8.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -154.64 121.41 5.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.488 ' SD ' ' CG ' ' A' ' 52' ' ' HIS . 31.1 mmm -44.44 133.05 5.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 50' ' ' GLU . 5.9 t -74.46 -155.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 110.12 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 49' ' ' THR . 15.6 tt0 -87.63 -48.57 7.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -59.86 -26.67 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -63.57 -55.92 20.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.86 . . . . 0.0 110.441 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.671 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 2.5 m95 -61.6 -50.09 73.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -52.12 -45.94 65.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 0.0 110.309 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.559 ' CD1' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -62.19 -60.75 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.8 t -49.2 -27.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 110.259 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -71.86 -48.65 44.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -37.25 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -43.48 73.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.284 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -53.98 -46.59 71.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.267 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.32 -39.78 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.13 -36.54 55.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.454 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -76.36 2.64 12.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.432 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -116.53 -4.92 11.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -107.09 -44.09 4.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.158 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -114.01 -43.15 3.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.45 54.07 0.85 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.491 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 18.6 m -146.28 146.44 30.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -1.137 . . . . 0.0 110.114 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.2 t -104.85 95.65 9.35 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 68' ' ' THR . 47.4 Cg_endo -73.47 163.43 37.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.974 1.512 . . . . 0.0 110.484 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 45.2 Cg_endo -72.65 -89.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.96 1.505 . . . . 0.0 110.457 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.506 ' O ' ' CG1' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -178.46 62.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.243 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -119.93 -54.17 2.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 110.18 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -25.42 63.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 t -72.31 -42.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.6 m -67.55 -29.73 69.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -38.76 5.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -99.34 -76.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 78' ' ' GLU . 54.7 p -42.86 -45.25 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.229 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.08 34.69 46.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -58.63 116.64 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.254 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.56 129.0 38.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.196 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -48.82 -37.1 18.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.7 -45.36 63.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 110.137 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -40.4 92.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.18 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 24.7 mm -66.26 -27.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -45.3 32.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.949 . . . . 0.0 110.317 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -53.21 46.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.34 -45.27 93.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 110.181 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.07 84.83 59.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 92' ' ' SER . 46.2 Cg_endo -73.47 86.7 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.971 1.511 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER 172.7 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.87 127.65 1.72 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.9 Cg_endo -72.91 -18.0 24.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.755 1.397 . . . . 0.0 110.435 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.08 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 2.8 m170 -75.61 -5.37 45.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 110.273 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 101' ' ' VAL . . . -78.23 -84.26 0.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.41 -29.18 0.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -1.11 . . . . 0.0 110.53 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 t -73.98 -49.28 25.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.409 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 17.4 ttmm -61.18 -35.19 76.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.407 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 97' ' ' GLY . 9.1 t -73.56 -42.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.6 64.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.319 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.44 67.22 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.713 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.273 -1.133 . . . . 0.0 110.218 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 7.8 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.189 0.519 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -124.31 109.55 13.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 71.8 m -84.43 150.46 57.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.091 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.3 Cg_endo -76.13 162.28 92.41 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.486 -0.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.42 157.75 24.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.14 131.64 45.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -1.216 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 3' ' ' VAL . 66.3 m-85 -136.57 144.56 44.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.122 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 7.2 tt0 -112.65 126.95 55.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 60.5 t -108.65 94.54 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 42.4 t0 60.52 71.47 0.57 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.639 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.9 14.36 23.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 12.7 mmtt -108.83 152.19 25.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.071 -1.252 . . . . 0.0 110.103 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -106.29 136.39 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.41 117.53 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 26' ' ' ASN . 2.3 mp -100.4 115.92 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.542 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 18' ' ' LEU . 21.7 mt -95.09 116.71 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 109.989 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -94.97 -163.38 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -42.42 126.03 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER 64.13 39.29 7.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m 48.12 50.16 16.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.14 113.81 20.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . 0.811 ' SD ' HD11 ' A' ' 38' ' ' LEU . 4.4 tpt -50.8 145.8 6.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.166 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -143.2 18.14 1.91 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.489 ' HB2' HD12 ' A' ' 17' ' ' ILE . 20.8 t30 -125.2 59.97 26.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.27 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 -8.95 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.951 1.501 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.3 -36.03 52.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.45 -77.83 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t90 61.16 107.76 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -124.52 -178.15 4.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -45.86 77.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.266 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.71 -35.57 78.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.1 t -65.92 -54.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -56.58 -40.89 76.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.878 . . . . 0.0 110.322 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -62.62 1.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.349 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -51.04 -30.59 15.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.39 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.811 HD11 ' SD ' ' A' ' 24' ' ' MET . 2.2 mt -65.28 -52.26 55.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.369 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.08 -30.32 70.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.353 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -29.32 61.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.99 -37.87 54.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 110.34 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 42' ' ' LEU . 10.2 tp -80.27 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -95.38 -84.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.161 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.63 39.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.8 mt -79.7 88.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -45.06 -30.21 1.03 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 48' ' ' MET . 9.2 mttp -150.23 113.1 4.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.462 ' HA ' HG21 ' A' ' 45' ' ' ILE . 52.6 mmm -42.75 120.61 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.4 p -66.34 150.96 48.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.0 110.23 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.69 52.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.217 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -40.29 85.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 110.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.71 -56.19 24.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.167 -0.958 . . . . 0.0 109.964 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.1 m95 -59.76 -28.58 67.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 110.003 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -66.48 -41.7 88.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.788 ' O ' HD12 ' A' ' 59' ' ' LEU . 3.2 tp -68.55 -38.09 80.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.933 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.31 -39.67 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' TRP . 3.2 mtpp -64.91 -51.57 61.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.069 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.17 -41.14 78.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 110.114 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 110.056 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.2 mmm-85 -57.04 -36.28 70.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.24 -36.35 81.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.137 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.23 -30.74 66.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.418 ' HA ' ' OG1' ' A' ' 68' ' ' THR . 19.8 t90 -58.01 -27.31 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -95.65 29.67 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.213 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.04 -52.88 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -130.22 -78.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.21 25.12 0.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER 58.46 -167.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 110.257 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 68' ' ' THR . 1.1 m 54.34 61.46 9.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 163.47 38.42 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.079 1.568 . . . . 0.0 110.48 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.3 -179.28 4.26 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.066 1.561 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 72' ' ' ILE . 11.3 tp -88.45 28.43 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -126.96 -31.62 2.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.199 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -21.98 44.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 79' ' ' THR . 31.5 t -67.31 -53.79 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t -72.2 -27.16 62.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.29 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.95 -37.57 1.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 110.196 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -142.05 53.86 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 75' ' ' VAL . 50.3 m -161.74 -37.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.158 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.3 33.92 18.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.64 124.43 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -1.126 . . . . 0.0 110.119 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.38 149.25 21.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.258 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -50.91 -27.04 6.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.97 -46.02 89.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 86' ' ' ILE . 3.2 mp -63.67 -28.67 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -37.84 54.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.269 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.96 -26.26 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.67 -57.03 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -91.59 169.05 11.97 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.53 -55.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.097 1.578 . . . . 0.0 110.466 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.76 104.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.69 77.2 0.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.7 Cg_endo -72.69 -10.85 25.56 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.022 1.538 . . . . 0.0 110.39 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.29 -77.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -74.96 -7.55 53.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.297 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.4 ' N ' ' CD2' ' A' ' 96' ' ' HIS . . . -76.29 -77.17 0.77 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.83 -35.09 4.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.174 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.5 m -68.1 -58.23 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 110.27 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -50.21 -26.96 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.04 -56.71 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . . . -61.4 -12.41 14.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.233 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . 85.75 80.13 1.15 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 103' ' ' GLY . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.244 -1.151 . . . . 0.0 110.159 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.283 0.563 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 111.35 0.91 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.247 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.506 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 99.1 m -105.24 148.33 36.06 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.98 177.89 37.38 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.346 -0.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.89 146.75 8.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.8 tt0 -120.11 127.62 52.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -1.099 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 29.2 m-85 -142.09 170.48 15.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.244 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -125.01 154.61 41.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 110.162 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 12' ' ' ASP . 44.3 t -131.37 101.62 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER 42.61 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.271 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.58 62.19 3.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 170.45 16.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' C ' HG23 ' A' ' 16' ' ' VAL . 21.9 tttm -135.28 145.06 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 15' ' ' LYS . 78.4 t -148.05 113.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.154 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.3 mt -99.35 145.15 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.0 110.272 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 22' ' ' CYS . 9.4 mt -123.82 108.83 12.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.72 -173.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 51.0 tt0 -66.79 -15.37 63.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 0.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.57 34.27 3.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.242 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.622 ' HA ' HD22 ' A' ' 18' ' ' LEU . 83.9 m 48.16 49.08 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.78 147.63 34.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 110.211 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.2 ttt -74.7 115.99 14.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.287 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -88.77 28.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -168.25 69.22 0.81 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.323 -0.861 . . . . 0.0 110.198 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.71 -7.0 20.08 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.052 1.554 . . . . 0.0 110.488 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -78.0 -21.67 50.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -103.16 39.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 110.239 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.51 ' NE1' ' O ' ' A' ' 102' ' ' ALA . 83.8 t90 -71.79 137.14 47.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.129 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -144.84 -178.49 6.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.143 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.79 -62.29 1.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -54.49 -26.88 34.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -73.56 -56.76 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -52.55 -50.74 62.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.0 110.449 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.07 -46.87 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 59.3 t90 -51.62 -47.12 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.86 -37.64 88.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.347 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.4 81.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 46' ' ' GLN . 2.0 tmt_? -76.98 -37.17 55.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 110.376 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.82 -32.98 74.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.322 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mt -87.3 -72.08 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.113 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.34 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLN . . . 150.4 -19.05 1.04 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -47.07 96.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -1.158 . . . . 0.0 110.243 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 4.4 tm0? -89.29 -6.16 56.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -140.68 96.13 2.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.271 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.417 ' HE3' ' HB3' ' A' ' 52' ' ' HIS . 66.6 mmm -66.38 126.57 29.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 110.086 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 49' ' ' THR . 4.8 t -78.59 172.57 13.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -59.37 -35.3 73.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.246 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.45 -29.3 70.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CE1' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -69.96 -65.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.895 . . . . 0.0 110.247 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.503 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 4.7 m95 -49.62 -30.83 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tmtm? -67.97 -57.41 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.193 -0.942 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.83 -49.41 62.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.02 -31.78 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 110.242 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -62.41 -49.49 75.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 110.218 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 58' ' ' TYR . 5.7 t80 -63.49 -45.73 89.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -53.11 -41.05 64.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -40.71 71.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.271 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -58.36 -43.96 88.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.253 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.469 ' CZ ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -66.03 -39.37 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.162 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -79.17 -11.61 59.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.174 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -95.89 -25.17 16.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.29 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.6 m -54.43 -30.62 53.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.0 -54.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.9 73.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 69' ' ' CYS . 6.7 m -155.56 -179.8 8.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.634 ' H ' HG22 ' A' ' 68' ' ' THR . 49.1 t -157.15 81.59 3.26 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 0.0 110.319 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.469 ' HG3' ' CZ ' ' A' ' 62' ' ' TYR . 47.1 Cg_endo -73.26 171.47 17.58 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.989 1.52 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.25 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.9 tt -116.4 14.43 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -74.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.6 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 72' ' ' ILE . 91.5 t -77.13 -34.22 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.276 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 77' ' ' LYS . 17.0 m -68.2 -32.29 72.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.166 -0.959 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 76' ' ' THR . 30.7 tttt -44.01 -27.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.295 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -107.71 -61.22 1.6 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.258 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -52.98 22.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.16 13.73 80.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.7 108.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -1.194 . . . . 0.0 110.191 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.85 126.36 10.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.2 -30.33 11.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -50.47 73.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.07 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -58.54 -50.37 74.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.005 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.408 ' CG2' ' HD3' ' A' ' 94' ' ' PRO . 54.7 mt -58.92 -26.99 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -39.7 64.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 110.117 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.08 -35.77 78.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 80.7 mt -74.18 -59.27 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.89 118.67 17.71 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.101 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.1 Cg_endo -72.56 -177.81 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.421 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 30.0 m 55.64 19.61 3.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 110.145 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.57 149.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' HIS . 46.6 Cg_endo -73.06 -90.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.952 1.501 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 94' ' ' PRO . . . 43.33 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 110.337 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 94' ' ' PRO . 11.2 m170 -73.52 -56.2 5.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -44.12 -56.92 5.09 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.65 -44.58 4.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -1.108 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -65.23 -54.5 28.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.195 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -42.83 -38.36 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 110.138 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -41.67 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.51 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -53.31 -45.4 68.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.268 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.7 51.25 0.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.234 179.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mtp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.722 0.296 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.21 -38.6 2.62 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.074 1.565 . . . . 0.0 110.424 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.1 t -113.63 126.17 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 110.233 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 tttp -65.15 87.52 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.238 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 94.3 m -96.32 148.46 34.52 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -75.99 150.45 93.92 Favored 'Cis proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.674 -2.219 . . . . 0.0 110.45 -0.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -161.87 157.66 29.46 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.488 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 21.0 pt-20 -110.64 160.81 16.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.239 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 75.9 m-85 -154.6 169.78 23.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 110.235 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -126.37 137.95 53.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.079 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 12' ' ' ASP . 10.9 t -141.35 121.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -0.923 . . . . 0.0 110.461 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 41.38 74.49 0.1 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.33 -0.856 . . . . 0.0 110.524 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.46 62.85 2.33 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -157.69 159.93 37.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 110.088 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mtpt -121.9 117.11 25.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.909 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 t -113.46 120.36 63.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 110.055 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 17.5 mt -101.86 141.03 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.174 -0.954 . . . . 0.0 110.199 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.534 HD22 ' C ' ' A' ' 22' ' ' CYS . 6.9 mt -122.38 120.3 33.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 110.252 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.38 -169.71 2.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.359 -0.838 . . . . 0.0 110.231 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.4 tt0 -50.75 147.52 4.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.292 -0.88 . . . . 0.0 110.205 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER 64.32 20.91 12.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 0.0 110.245 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.534 ' C ' HD22 ' A' ' 18' ' ' LEU . 76.9 m 51.88 54.69 10.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.96 139.68 32.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.404 ' SD ' ' HA2' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -68.31 115.4 7.7 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 110.185 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -116.9 34.38 5.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.305 -0.872 . . . . 0.0 110.198 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -157.71 68.67 4.01 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.232 -0.918 . . . . 0.0 110.213 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.21 -0.62 9.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.968 1.51 . . . . 0.0 110.439 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -79.86 -25.86 40.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.334 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.12 26.9 9.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.251 -0.906 . . . . 0.0 110.334 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -75.64 141.3 42.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.182 -0.949 . . . . 0.0 110.094 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -155.29 -167.41 2.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.219 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -72.54 -33.65 66.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.195 -0.941 . . . . 0.0 110.195 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 24.0 mmtt -71.52 -37.62 71.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.2 t -70.18 -51.22 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.131 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.53 81.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.0 110.069 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -67.2 -26.97 66.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 110.102 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CE2' ' OE1' ' A' ' 41' ' ' GLU . 49.9 t90 -66.93 -60.79 2.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.273 -0.892 . . . . 0.0 110.13 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.35 -39.0 75.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.318 -0.864 . . . . 0.0 110.123 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.54 -30.81 71.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.174 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 3.6 ttm180 -76.86 -34.72 57.79 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.23 -0.919 . . . . 0.0 110.128 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.478 ' OE1' ' CE2' ' A' ' 37' ' ' TRP . 4.0 mt-10 -77.29 -26.64 52.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.302 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.01 -66.07 0.95 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.266 -0.896 . . . . 0.0 110.681 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.76 -31.9 40.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 110.717 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 101.96 -4.8 52.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.8 mt -51.84 120.0 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.235 -1.156 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -89.56 -26.42 20.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.905 . . . . 0.0 110.09 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.53 103.55 5.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.28 -0.887 . . . . 0.0 110.146 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 52' ' ' HIS . 15.5 mmm -48.13 119.02 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.313 -0.867 . . . . 0.0 110.185 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -71.58 -169.15 0.4 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.248 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -84.75 -20.76 30.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.282 -0.886 . . . . 0.0 110.224 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 3.7 mp0 -77.0 -45.05 28.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.258 -0.901 . . . . 0.0 110.222 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.435 ' O ' HG23 ' A' ' 56' ' ' VAL . 24.8 m170 -54.76 -52.7 61.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.233 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 5.3 m95 -67.41 -27.77 67.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.254 -0.904 . . . . 0.0 110.269 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -61.63 -65.8 0.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.15 -0.969 . . . . 0.0 109.966 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.84 -43.36 94.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.884 . . . . 0.0 109.801 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 52' ' ' HIS . 35.1 t -56.45 -29.37 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.863 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 14.4 mttt -75.29 -48.96 20.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.134 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.565 ' CE1' HG13 ' A' ' 75' ' ' VAL . 30.0 t80 -55.51 -40.67 72.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -0.85 . . . . 0.0 110.306 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -38.12 82.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -28.55 65.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 110.357 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.85 -42.39 40.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 110.325 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -66.89 -26.86 67.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -71.93 -2.69 18.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.254 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -103.19 11.94 36.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.248 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.53 -46.66 3.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.234 -0.916 . . . . 0.0 110.069 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -129.89 -34.06 1.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.26 56.01 1.08 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -139.95 -167.17 2.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -1.118 . . . . 0.0 110.255 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.55 93.46 3.54 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 0.0 110.176 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.6 Cg_endo -72.74 173.95 12.59 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.985 1.518 . . . . 0.0 110.45 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.6 Cg_endo -73.07 -160.46 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.978 1.515 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 72' ' ' ILE . 3.4 tp -111.87 2.8 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.281 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.35 -24.87 25.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.2 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.2 mtt -87.57 -30.37 20.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.262 -0.899 . . . . 0.0 110.213 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.565 HG13 ' CE1' ' A' ' 58' ' ' TYR . 47.5 t -65.46 -29.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 110.198 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.2 m -62.34 -31.86 72.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 110.265 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -26.91 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -137.04 52.86 1.91 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.298 -0.876 . . . . 0.0 110.025 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 85.7 m -159.41 -74.5 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.904 . . . . 0.0 110.301 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.1 49.77 0.4 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.0 147.56 33.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -1.193 . . . . 0.0 110.225 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 t -98.96 131.67 44.85 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.222 -0.924 . . . . 0.0 110.221 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -62.63 -32.32 73.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.911 . . . . 0.0 110.162 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -64.54 -56.55 13.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -0.873 . . . . 0.0 110.079 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.57 -50.53 67.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.975 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.41 HD13 HG12 ' A' ' 72' ' ' ILE . 66.8 mt -56.89 -34.98 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.987 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -61.76 -49.44 76.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.311 -0.868 . . . . 0.0 109.996 179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 5.4 tp60 -66.18 -24.11 66.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.885 . . . . 0.0 110.019 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.5 mt -79.29 -29.51 42.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.837 . . . . 0.0 110.09 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' TYR . 16.6 m-85 -116.79 167.36 10.79 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.293 -0.879 . . . . 0.0 110.042 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 92' ' ' SER . 51.3 Cg_endo -78.05 70.83 6.93 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.053 1.554 . . . . 0.0 110.622 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 91' ' ' PRO . 11.3 t 40.42 68.93 0.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.316 -0.865 . . . . 0.0 110.537 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 156.81 66.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.98 -12.5 23.79 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 124.01 1.531 . . . . 0.0 110.435 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -85.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.86 . . . . 0.0 110.313 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 34.2 p80 -62.39 -24.62 67.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.224 -0.923 . . . . 0.0 110.312 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.77 -63.58 4.51 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 99' ' ' CYS . . . -48.96 -66.17 0.44 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.198 -1.177 . . . . 0.0 110.418 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 8.7 t -41.92 -46.75 4.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.291 -0.88 . . . . 0.0 110.548 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.8 mtpt -52.52 -54.88 26.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.191 -0.943 . . . . 0.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 101' ' ' VAL . 8.7 t -62.44 -25.95 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.965 . . . . 0.0 110.411 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.06 -32.95 69.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 110.277 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA2' ' SD ' ' A' ' 24' ' ' MET . . . 100.07 46.63 1.86 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.678 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . . . -112.37 122.79 35.63 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.182 -1.187 . . . . 0.0 110.221 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.52 151.06 52.59 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.89 1.469 . . . . 0.0 110.424 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -45.07 149.95 0.82 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 0.0 110.182 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.74 -89.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.922 1.485 . . . . 0.0 110.465 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 2.8 m -148.56 80.19 1.44 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -0.924 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.36 -119.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 3.2 t 58.87 97.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.253 -1.145 . . . . 0.0 110.2 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.193 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HG2' ' CD ' ' A' ' 4' ' ' LYS . 9.0 tpt . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.793 0.33 . . . . 0.0 110.144 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 45.3 Cg_endo -72.89 -57.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.957 1.504 . . . . 0.0 110.375 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 3' ' ' VAL . 5.2 p -89.97 103.94 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.94 . . . . 0.0 110.067 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.48 ' CD ' ' HG2' ' A' ' 1' ' ' MET . 4.3 tptp -88.95 131.53 35.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.124 -0.985 . . . . 0.0 110.318 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 28.5 m -104.81 154.84 38.3 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 110.205 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.7 Cg_endo -76.11 152.45 96.48 Favored 'Cis proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.605 -2.248 . . . . 0.0 110.467 -0.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.85 138.92 5.07 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.03 121.74 41.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -1.139 . . . . 0.0 110.239 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CE2' HG23 ' A' ' 3' ' ' VAL . 35.8 m-85 -130.32 158.61 39.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.291 -0.88 . . . . 0.0 110.101 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 18.9 mt-30 -110.4 156.31 20.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.17 -0.956 . . . . 0.0 110.358 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 14' ' ' LYS . 76.1 t -129.22 105.97 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 52.4 38.26 24.75 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.256 -0.902 . . . . 0.0 110.302 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.12 24.09 23.24 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 11.1 mmtt -115.28 175.0 5.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -1.142 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.66 47.02 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.226 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.425 HG11 ' CZ3' ' A' ' 37' ' ' TRP . 17.3 t -140.76 121.64 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 0.0 110.163 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.1 mt -99.66 108.35 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.211 -0.931 . . . . 0.0 110.25 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 53.5 mt -89.64 118.85 29.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 110.204 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 1.1 t0 -71.53 -172.71 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.283 -0.886 . . . . 0.0 110.3 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -50.22 -28.22 7.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -116.79 51.13 1.01 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.293 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 63.1 m 42.92 32.56 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 110.174 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.3 157.44 26.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 110.248 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -98.99 101.62 13.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.24 -0.913 . . . . 0.0 110.179 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.31 17.51 8.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.238 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -148.48 78.22 9.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.01 -7.33 20.51 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.015 1.534 . . . . 0.0 110.475 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.72 -12.61 61.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.309 -0.869 . . . . 0.0 110.205 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 29' ' ' ASP . 12.1 t70 -116.43 33.9 5.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.153 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.412 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 75.0 t90 -92.75 151.01 20.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 110.2 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -164.37 -171.65 2.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.234 -0.916 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -69.65 -56.21 7.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.189 -0.945 . . . . 0.0 110.272 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -57.33 -39.3 75.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.29 -0.882 . . . . 0.0 110.27 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.68 -51.74 68.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.193 -0.942 . . . . 0.0 110.303 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.38 -50.72 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.289 -0.882 . . . . 0.0 110.385 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 0.2 OUTLIER -58.34 -41.59 84.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.257 -0.902 . . . . 0.0 110.4 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.425 ' CZ3' HG11 ' A' ' 16' ' ' VAL . 50.0 t90 -55.55 -48.93 73.95 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.235 -0.916 . . . . 0.0 110.439 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.487 HD23 HD13 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -61.57 -51.13 69.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.444 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -51.0 -39.31 55.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.259 -0.9 . . . . 0.0 110.519 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.8 -67.1 0.53 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.198 -0.938 . . . . 0.0 110.445 -179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' OE1' HG11 ' A' ' 3' ' ' VAL . 1.1 tt0 -42.58 -26.91 0.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.289 -0.882 . . . . 0.0 110.559 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 38' ' ' LEU . 2.4 mp -83.85 -79.49 0.21 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.379 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -83.68 -79.28 0.21 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.18 38.48 0.02 OUTLIER Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.442 HD12 ' HB1' ' A' ' 39' ' ' ALA . 96.7 mt -75.34 115.5 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.248 -1.148 . . . . 0.0 110.233 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -56.88 -45.14 82.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.294 -0.878 . . . . 0.0 110.358 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.0 122.09 4.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -0.924 . . . . 0.0 110.358 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.451 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 45.3 mmm -45.78 118.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.7 p -65.1 178.13 0.91 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -69.85 -23.75 63.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.902 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.99 -35.05 57.45 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.556 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -62.57 -50.0 73.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.278 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.533 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 4.0 m95 -66.26 -35.44 80.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.252 -0.905 . . . . 0.0 110.372 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.73 -61.28 2.7 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.316 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.77 -52.71 61.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 110.401 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 102' ' ' ALA . 80.2 t -55.88 -28.76 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.909 . . . . 0.0 110.487 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 ttmt -76.29 -38.27 56.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 110.389 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -65.25 -42.95 92.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.254 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.76 -39.12 90.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.176 -0.953 . . . . 0.0 110.283 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -36.92 67.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' O ' ' HB2' ' A' ' 64' ' ' GLU . 43.6 tt0 -58.29 -44.95 88.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.33 -31.67 70.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 110.284 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.57 ' CZ2' ' HD2' ' A' ' 105' ' ' PRO . 91.5 t90 -67.81 -12.09 59.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 0.0 110.308 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 10.9 mt-10 -78.51 -47.64 16.92 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.236 -0.915 . . . . 0.0 110.23 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.09 -53.03 4.54 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.299 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -78.9 -75.41 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 110.245 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.96 17.13 11.3 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.2 m -115.48 146.37 41.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -1.163 . . . . 0.0 110.205 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -106.5 99.82 26.77 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.942 . . . . 0.0 110.164 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 46.8 Cg_endo -73.19 173.55 13.51 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.998 1.525 . . . . 0.0 110.445 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.1 Cg_endo -72.92 -160.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.4 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.579 ' O ' HG23 ' A' ' 72' ' ' ILE . 1.6 tp -123.9 54.66 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.204 -0.935 . . . . 0.0 110.181 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -141.58 -44.06 0.36 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.871 . . . . 0.0 110.119 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 36.8 mmm -74.84 -21.01 59.52 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 110.226 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.8 t -72.28 -32.32 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.136 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.0 m -44.33 -32.47 1.32 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 110.235 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -56.33 -51.45 68.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -65.6 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.234 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.5 p -68.91 -70.69 0.26 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.232 -0.917 . . . . 0.0 110.201 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 104.13 11.15 32.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -52.18 170.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -1.166 . . . . 0.0 110.202 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.1 p -95.64 141.95 28.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 110.219 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 17.9 tp -69.2 -29.12 67.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.185 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 2.2 tt0 -61.16 -55.66 29.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 110.227 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.5 -56.27 14.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.571 HG23 ' HG3' ' A' ' 94' ' ' PRO . 36.6 mt -56.17 -26.91 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.857 . . . . 0.0 110.196 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -68.74 -58.4 4.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.351 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.3 -34.48 70.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.208 -0.933 . . . . 0.0 110.371 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.556 HD22 ' CE1' ' A' ' 52' ' ' HIS . 21.3 mt -65.67 -51.66 57.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.128 -0.983 . . . . 0.0 110.134 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.536 ' CE1' ' HA3' ' A' ' 97' ' ' GLY . 1.5 t80 -128.64 128.57 23.53 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.343 -0.848 . . . . 0.0 110.048 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.4 Cg_endo -73.14 156.2 51.64 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.898 1.473 . . . . 0.0 110.417 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 49.4 m 56.81 31.37 19.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 62.19 147.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.705 ' HB2' ' HB2' ' A' ' 98' ' ' ALA . 45.7 Cg_endo -72.9 -92.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.889 1.468 . . . . 0.0 110.304 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 49.6 -89.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.169 -0.957 . . . . 0.0 110.358 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.513 ' N ' ' O ' ' A' ' 94' ' ' PRO . 8.1 m-70 -68.05 -44.85 75.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.425 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 90' ' ' PHE . . . -64.66 -41.77 97.58 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.705 ' HB2' ' HB2' ' A' ' 94' ' ' PRO . . . -55.74 -48.97 74.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.277 -1.131 . . . . 0.0 110.335 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 100' ' ' LYS . 34.5 m -64.24 -55.39 21.88 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.169 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 99' ' ' CYS . 5.9 tttt -42.41 -49.9 5.17 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.323 -0.861 . . . . 0.0 110.325 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.27 -37.96 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.188 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HB2' HG13 ' A' ' 56' ' ' VAL . . . -72.59 -8.58 55.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.276 -0.89 . . . . 0.0 110.195 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.5 48.02 77.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.09 112.7 65.14 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.211 -1.17 . . . . 0.0 110.197 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.57 ' HD2' ' CZ2' ' A' ' 63' ' ' TRP . 45.2 Cg_endo -72.58 177.53 7.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.948 1.499 . . . . 0.0 110.41 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -107.1 172.69 3.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.0 110.152 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.15 84.95 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.016 1.535 . . . . 0.0 110.418 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.72 -49.16 1.38 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -0.872 . . . . 0.0 110.221 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -150.72 121.23 1.21 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.414 ' O ' ' OXT' ' A' ' 111' ' ' VAL . 0.8 OUTLIER 60.98 26.04 16.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.198 -1.178 . . . . 0.0 110.165 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.414 ' OXT' ' O ' ' A' ' 110' ' ' CYS . 20.5 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.255 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 46.2 Cg_endo -71.76 143.41 41.55 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.927 1.488 . . . . 0.0 110.395 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -122.19 152.72 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.231 -0.918 . . . . 0.0 110.331 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.89 151.71 1.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.064 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 22' ' ' CYS . 6.0 p -125.35 161.88 47.48 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 110.257 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.3 Cg_endo -75.08 145.26 83.33 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.54 -2.275 . . . . 0.0 110.474 -0.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.61 152.56 18.01 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.46 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 51.4 mt-10 -103.68 141.9 35.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 110.381 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 77.7 m-85 -152.53 150.21 29.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 0.0 110.043 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -104.17 125.02 50.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 0.0 110.213 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 67.0 t -105.8 118.82 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.297 -0.877 . . . . 0.0 110.113 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 19.6 m-20 55.69 -89.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.187 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -141.41 50.6 0.73 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.98 158.91 44.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -1.144 . . . . 0.0 110.164 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.641 ' HG2' HD11 ' A' ' 17' ' ' ILE . 6.1 tttt -104.6 115.57 30.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.219 -0.926 . . . . 0.0 110.31 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.603 ' C ' HD12 ' A' ' 17' ' ' ILE . 25.3 t -107.12 129.67 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 110.082 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.641 HD11 ' HG2' ' A' ' 15' ' ' LYS . 2.7 mp -115.59 116.58 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.904 . . . . 0.0 110.308 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 22' ' ' CYS . 10.8 mt -95.14 110.54 22.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 109.996 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 23' ' ' PHE . 6.9 t70 -75.42 -161.7 0.16 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.274 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 1.0 OUTLIER -64.31 137.31 57.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.277 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 7.1 t70 66.49 30.41 8.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.71 ' HA ' HD22 ' A' ' 18' ' ' LEU . 8.5 m 55.75 50.5 14.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -0.922 . . . . 0.0 110.195 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 19' ' ' ASP . 1.6 m-30 -94.87 109.37 21.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 110.223 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.61 106.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.26 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' OE1' ' CB ' ' A' ' 19' ' ' ASP . 1.5 tp60 -108.86 35.88 3.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 0.0 110.231 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.464 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.8 p-10 -151.74 68.25 7.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.341 -0.849 . . . . 0.0 110.205 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.28 -7.51 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.003 1.528 . . . . 0.0 110.47 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -79.29 -46.65 17.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.303 -0.873 . . . . 0.0 110.16 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -84.61 -4.68 59.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.124 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.63 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 20.9 t90 -57.2 153.55 11.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.207 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -165.65 -160.06 0.44 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.544 ' OE2' ' CZ2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -74.39 -56.48 4.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 0.0 110.308 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.1 -40.21 76.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.245 -0.909 . . . . 0.0 110.414 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -64.4 -49.1 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.184 -0.947 . . . . 0.0 110.293 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.63 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -55.42 -48.86 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.214 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -57.28 -57.67 11.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 92.3 t90 -49.23 -32.41 10.54 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.21 -0.931 . . . . 0.0 110.179 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -61.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.873 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -48.0 -47.22 33.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.942 . . . . 0.0 110.21 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.428 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -65.3 -32.53 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.217 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 37' ' ' TRP . 3.5 tt0 -64.88 -33.36 75.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.369 -0.832 . . . . 0.0 110.152 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.408 HD21 ' HE3' ' A' ' 100' ' ' LYS . 0.8 OUTLIER -91.39 -73.54 0.54 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.304 -0.873 . . . . 0.0 110.234 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -82.43 -76.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.292 -0.88 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 40' ' ' ARG . . . 142.65 69.13 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.873 HD12 ' HB1' ' A' ' 39' ' ' ALA . 60.7 mt -96.87 114.11 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.245 -1.15 . . . . 0.0 110.247 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -46.34 -29.47 1.68 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 110.298 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.78 130.58 0.15 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 110.324 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 21.5 mtp -44.0 128.1 5.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.234 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.8 p -89.12 178.7 6.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.241 -0.912 . . . . 0.0 110.176 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -43.94 76.7 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.274 -0.891 . . . . 0.0 110.185 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.43 -39.19 89.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.0 110.228 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.517 ' NE2' ' HB3' ' A' ' 89' ' ' LEU . 6.8 m170 -65.08 -64.49 0.85 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.246 -0.909 . . . . 0.0 110.158 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CZ2' ' SD ' ' A' ' 48' ' ' MET . 2.0 m95 -46.73 -38.03 9.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 110.115 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 -57.56 12.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.174 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.48 -54.49 21.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.226 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.6 t -52.98 -33.86 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -68.04 -61.67 1.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -45.33 -37.01 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.198 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -69.6 -48.18 60.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 110.296 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 59' ' ' LEU . 8.4 tpt180 -42.8 -38.55 2.17 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.227 -0.921 . . . . 0.0 110.306 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -66.17 -54.24 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.354 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.72 -43.88 58.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.154 -0.966 . . . . 0.0 110.377 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.415 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 2.2 t90 -63.81 -47.44 80.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.67 -18.02 7.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.295 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.3 m -82.15 -47.35 12.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.233 -0.917 . . . . 0.0 110.259 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.0 -35.94 0.69 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.415 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 103.62 56.39 0.77 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.5 m -128.61 157.5 41.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -1.148 . . . . 0.0 110.218 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.4 t -120.94 86.99 42.62 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.257 -0.902 . . . . 0.0 110.092 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.44 167.77 26.11 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.059 1.557 . . . . 0.0 110.416 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.4 -90.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.961 1.506 . . . . 0.0 110.43 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -175.51 74.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.88 -63.78 1.14 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 0.0 110.154 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.0 mtm -64.9 -11.63 40.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.83 -45.53 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 7.4 m -64.01 -40.53 96.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.148 -0.97 . . . . 0.0 110.201 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.47 -29.79 17.56 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.289 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.4 tp10 -102.88 -71.0 0.74 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 0.0 110.214 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.523 ' HB ' ' CD1' ' A' ' 81' ' ' PHE . 61.6 p -49.68 -52.59 29.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.14 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.81 30.25 6.88 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.523 ' CD1' ' HB ' ' A' ' 79' ' ' THR . 10.4 m-85 -99.66 120.43 39.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 110.21 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.16 147.54 52.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.188 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -56.53 -28.27 59.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 0.0 110.208 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -58.07 -44.8 87.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.239 -0.913 . . . . 0.0 110.2 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -53.38 53.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 110.209 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 9.1 mt -53.02 -30.16 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 110.256 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.447 ' O ' ' O ' ' A' ' 90' ' ' PHE . 1.5 m-85 -77.14 -36.26 55.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.283 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -44.89 91.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.396 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.517 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 3.4 mt -78.92 -53.64 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 0.0 110.296 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.1 m-85 -88.94 165.06 28.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 110.312 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.19 -179.29 4.57 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.068 1.562 . . . . 0.0 110.46 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.16 86.17 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' ' CD2' ' A' ' 96' ' ' HIS . . . 135.65 80.03 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.69 -0.02 8.81 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.049 1.552 . . . . 0.0 110.497 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -79.56 -53.61 6.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 110.316 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 93' ' ' GLY . 23.3 p80 -77.2 -23.41 51.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.472 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.429 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -78.18 -71.8 1.2 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.91 -36.95 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.266 -1.138 . . . . 0.0 110.405 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.2 OUTLIER -71.28 -51.5 24.14 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.397 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.6 OUTLIER -47.82 -44.11 28.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 110.326 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 102' ' ' ALA . 39.2 t -69.12 -55.32 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.312 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 101' ' ' VAL . . . -44.01 -35.45 2.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 0.0 110.162 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . 82.74 63.28 1.77 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 103' ' ' GLY . . . 177.93 78.73 0.13 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.258 -1.143 . . . . 0.0 110.299 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.61 -173.62 1.23 Allowed 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.011 1.532 . . . . 0.0 110.42 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -79.82 165.7 45.69 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.231 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 106' ' ' LYS . 45.9 Cg_endo -73.06 136.83 25.41 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.964 1.507 . . . . 0.0 110.434 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.9 m -69.2 -43.9 73.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.199 -0.938 . . . . 0.0 110.227 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.43 37.06 2.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -48.22 172.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -1.191 . . . . 0.0 110.252 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.191 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.816 0.341 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.36 150.9 47.52 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.954 1.502 . . . . 0.0 110.336 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.1 t -73.35 125.13 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -81.5 83.43 6.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 110.361 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 36.5 m -82.49 154.47 68.78 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.245 -0.909 . . . . 0.0 110.096 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD3' ' CG ' ' A' ' 20' ' ' GLU . 50.3 Cg_endo -75.62 164.88 87.05 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.707 -2.206 . . . . 0.0 110.58 -0.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.21 160.85 28.05 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -104.34 152.08 22.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -1.192 . . . . 0.0 110.328 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -152.66 144.81 23.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 0.0 110.207 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -100.17 132.22 45.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.216 -0.927 . . . . 0.0 109.968 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 22.9 t -129.75 109.87 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.094 -1.004 . . . . 0.0 110.59 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 1.2 t0 64.45 28.13 13.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 110.476 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.5 7.39 82.28 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 3.5 mttt -98.99 171.1 8.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -1.206 . . . . 0.0 110.087 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.32 123.73 49.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.259 -0.9 . . . . 0.0 110.282 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.42 138.18 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.884 . . . . 0.0 110.1 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.7 mt -120.65 100.0 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -0.944 . . . . 0.0 110.24 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 18' ' ' LEU . 23.1 mt -74.49 118.39 17.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.175 -0.953 . . . . 0.0 110.232 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -59.74 -172.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.323 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.519 ' CG ' ' HD3' ' A' ' 6' ' ' PRO . 1.5 tt0 -62.01 -13.47 26.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.351 -0.843 . . . . 0.0 110.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -118.58 43.28 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 110.326 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.0 m 43.25 34.23 0.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 110.339 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' CZ ' ' HG3' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -103.07 115.78 31.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.27 -0.894 . . . . 0.0 110.128 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.42 ' C ' ' O ' ' A' ' 23' ' ' PHE . 1.3 ttt -41.88 137.67 1.7 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.227 -0.921 . . . . 0.0 110.338 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 17.24 21.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 110.154 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -124.22 67.3 44.94 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 110.227 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.5 -6.63 19.08 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.054 1.555 . . . . 0.0 110.463 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.15 -32.97 56.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 1.3 m-20 -97.41 -81.86 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.312 -0.867 . . . . 0.0 110.19 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.462 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 52.2 t90 59.47 120.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.286 -0.884 . . . . 0.0 110.171 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.6 178.44 7.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 0.0 110.172 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.485 ' HG2' ' CZ2' ' A' ' 53' ' ' TRP . 1.8 tm-20 -65.64 -64.3 0.89 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.26 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.52 -29.43 2.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 0.0 110.168 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.6 t -69.35 -62.54 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.909 . . . . 0.0 110.326 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -48.98 -42.59 38.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 110.276 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.56 -35.87 82.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.183 -0.948 . . . . 0.0 110.421 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 69.0 t90 -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.442 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.402 HD23 HD13 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -66.37 -55.99 13.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -0.896 . . . . 0.0 110.378 -179.773 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.98 -31.55 60.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.456 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -36.53 63.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.108 -0.995 . . . . 0.0 110.392 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.5 -26.99 61.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.347 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.461 ' HB3' ' OE1' ' A' ' 43' ' ' GLU . 6.9 mp -81.18 -42.79 20.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.19 -0.944 . . . . 0.0 110.331 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' OE1' ' HB3' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -110.24 -83.29 0.57 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.263 -0.898 . . . . 0.0 110.204 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 161.52 38.55 0.02 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.2 88.16 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.249 -1.148 . . . . 0.0 110.281 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -45.41 -30.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.292 -0.88 . . . . 0.0 110.128 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -154.52 130.89 10.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 110.183 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.8 mmt -57.87 130.32 45.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 110.181 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.609 HG23 ' H ' ' A' ' 52' ' ' HIS . 10.0 t -86.55 160.02 19.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.204 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.75 -40.45 79.75 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 110.455 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -57.89 -37.0 73.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.258 -0.901 . . . . 0.0 110.437 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.609 ' H ' HG23 ' A' ' 49' ' ' THR . 3.2 m170 -63.6 -64.43 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.169 -0.957 . . . . 0.0 110.285 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.485 ' CZ2' ' HG2' ' A' ' 32' ' ' GLU . 5.0 m95 -54.8 -26.6 35.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 110.505 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -67.17 -67.31 0.46 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.089 -1.007 . . . . 0.0 110.178 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.96 -45.89 61.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.944 . . . . 0.0 110.036 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.6 t -54.26 -48.21 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 110.168 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -54.83 -44.94 74.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.189 -0.945 . . . . 0.0 110.112 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.83 -58.04 9.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 110.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.64 -33.44 33.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.354 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.34 -56.15 19.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.293 -0.879 . . . . 0.0 110.364 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -46.44 -37.33 7.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.472 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.85 -36.89 70.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 110.456 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 49.2 t90 -70.36 -3.45 17.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.157 -0.965 . . . . 0.0 110.421 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.02 -25.6 10.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.215 -0.928 . . . . 0.0 110.448 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.4 m -88.4 -69.51 0.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.161 -0.962 . . . . 0.0 110.221 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.9 -45.66 7.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.149 -0.969 . . . . 0.0 110.123 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.97 68.68 1.26 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 53.9 m -151.0 161.11 43.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -1.169 . . . . 0.0 110.326 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.6 m -110.79 84.33 4.13 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 68' ' ' THR . 46.7 Cg_endo -73.53 172.05 16.51 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.1 1.579 . . . . 0.0 110.468 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.94 -161.95 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.001 1.527 . . . . 0.0 110.478 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -119.52 6.37 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -0.905 . . . . 0.0 110.195 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -36.04 66.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.312 -0.868 . . . . 0.0 110.192 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.11 -18.15 47.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.7 t -74.1 -46.5 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.368 -0.832 . . . . 0.0 110.195 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.412 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 5.6 m -62.01 -26.84 68.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -63.61 -28.49 69.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 110.273 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.57 -78.43 0.38 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.9 . . . . 0.0 110.144 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 p -53.82 -27.73 31.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.13 -0.982 . . . . 0.0 110.207 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 77.91 4.33 85.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.04 135.43 56.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -1.192 . . . . 0.0 110.128 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.95 140.22 58.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.0 110.151 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.63 HD21 ' CE2' ' A' ' 87' ' ' TYR . 0.4 OUTLIER -63.71 -29.91 71.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 110.216 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -52.23 66.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.299 -0.876 . . . . 0.0 110.104 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.33 -37.84 17.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.945 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.632 HD13 HD11 ' A' ' 72' ' ' ILE . 30.5 mt -73.32 -34.74 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.34 -0.85 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.63 ' CE2' HD21 ' A' ' 83' ' ' LEU . 0.2 OUTLIER -61.53 -32.82 72.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.327 -0.858 . . . . 0.0 110.045 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -83.27 -48.42 10.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 110.184 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 57.2 mt -57.72 -28.68 64.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.272 -0.893 . . . . 0.0 110.218 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 87' ' ' TYR . 11.2 m-85 -129.01 168.03 17.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.026 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.0 -173.54 1.27 Allowed 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.93 1.49 . . . . 0.0 110.245 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.28 94.75 0.27 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.256 -0.902 . . . . 0.0 110.208 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 127.39 76.65 0.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.497 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.2 Cg_endo -73.21 -9.01 22.85 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 124.052 1.554 . . . . 0.0 110.444 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.5 -88.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.229 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -46.52 -31.09 2.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 110.281 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.81 -61.89 5.48 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -44.7 -56.42 4.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -1.116 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.1 m -47.6 -51.2 22.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 12.2 ttmt -53.25 -40.96 65.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -0.937 . . . . 0.0 110.221 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 96.5 t -59.56 -52.06 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.56 -25.5 68.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 0.0 110.168 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.73 63.79 0.63 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.12 136.2 82.13 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.215 -1.167 . . . . 0.0 110.152 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.54 178.86 6.16 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.02 1.537 . . . . 0.0 110.438 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.24 77.09 7.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.124 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.95 -40.51 1.77 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.071 1.564 . . . . 0.0 110.398 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.6 p -106.72 -158.72 0.67 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 110.153 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 81.29 57.95 2.69 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 2.0 t -162.97 -175.19 4.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.28 -1.13 . . . . 0.0 110.175 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.13 179.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.751 0.31 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.11 164.91 34.14 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.056 1.556 . . . . 0.0 110.451 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.6 m -137.8 149.22 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.176 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.19 152.31 19.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 110.057 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 m -115.11 144.86 32.93 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.75 167.51 80.06 Favored 'Cis proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.703 -2.207 . . . . 0.0 110.246 -0.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -178.98 142.22 5.24 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.451 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 6.3 tt0 -99.33 159.51 14.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.265 -1.138 . . . . 0.0 110.038 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.451 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 2.8 m-85 -161.43 166.79 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.281 -0.887 . . . . 0.0 110.199 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -112.01 124.84 53.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 110.256 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' ASP . 35.3 t -99.14 98.24 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 0.0 110.158 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' VAL . 18.6 t70 43.2 73.04 0.15 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.232 -0.918 . . . . 0.0 110.164 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.75 56.23 25.4 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.85 170.81 20.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.254 -1.145 . . . . 0.0 110.287 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -123.39 123.08 39.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 0.0 110.137 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.513 HG13 ' HE2' ' A' ' 24' ' ' MET . 46.5 t -141.47 124.45 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.287 -0.883 . . . . 0.0 110.13 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' A' ' 25' ' ' GLN . 1.1 tt -105.76 145.14 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 0.0 110.205 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 18' ' ' LEU . 26.0 mt -112.08 112.7 24.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' OD2' ' HG3' ' A' ' 25' ' ' GLN . 19.9 m-20 -58.77 -162.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.381 -0.825 . . . . 0.0 110.229 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -65.23 -28.32 69.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 110.194 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 22' ' ' CYS . 8.3 m-20 -106.99 44.26 1.08 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.233 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' A' ' 21' ' ' ASP . 60.0 m 42.49 31.58 0.29 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 110.252 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -86.78 142.65 27.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.513 ' HE2' HG13 ' A' ' 16' ' ' VAL . 15.5 ttm -78.16 125.0 28.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 110.242 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.557 ' HB2' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -95.34 0.33 53.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.0 110.165 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.34 68.53 14.18 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.165 -0.96 . . . . 0.0 110.24 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.99 -18.9 23.77 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.051 1.553 . . . . 0.0 110.443 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -66.11 -14.04 61.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.344 -0.848 . . . . 0.0 110.204 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 1.5 m-20 -113.39 6.64 17.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 51.7 t90 -46.32 158.73 0.1 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.13 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.547 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 1.2 m-20 178.4 -177.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.887 . . . . 0.0 110.256 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -62.62 -45.05 94.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 110.163 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -26.78 68.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 110.169 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.9 t -75.2 -60.68 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 110.422 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.488 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -54.58 -29.51 51.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.278 -0.889 . . . . 0.0 110.394 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 2.8 mt-10 -75.81 -59.76 2.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.339 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 81.5 t90 -49.53 -35.57 20.61 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 0.0 110.378 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.501 HD23 ' CD1' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -72.52 -51.23 20.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 110.304 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.71 -28.63 56.73 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.274 -0.891 . . . . 0.0 110.403 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -60.2 2.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.455 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.5 -26.86 22.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 110.418 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.501 ' CD1' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -87.81 -73.34 0.49 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.19 -0.944 . . . . 0.0 110.422 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -80.39 -52.69 7.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.241 -0.912 . . . . 0.0 110.361 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.28 24.71 1.57 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.9 mt -73.11 84.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.171 -1.194 . . . . 0.0 110.0 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -44.07 -29.79 0.66 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 110.45 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -150.37 111.51 4.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 110.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.461 ' HG3' ' HG2' ' A' ' 36' ' ' GLU . 23.1 mmm -48.92 155.34 0.61 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.164 -0.96 . . . . 0.0 110.08 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.709 HG22 ' ND1' ' A' ' 52' ' ' HIS . 5.2 t -106.94 -177.3 3.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.277 -0.89 . . . . 0.0 110.282 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -75.56 -35.34 60.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.929 . . . . 0.0 110.226 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -62.35 -40.61 96.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.284 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.709 ' ND1' HG22 ' A' ' 49' ' ' THR . 5.6 m170 -62.43 -55.79 24.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 110.328 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.488 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 4.5 m95 -61.28 -26.92 68.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 110.4 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.89 -67.09 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.93 . . . . 0.0 110.38 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.36 -43.04 70.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.227 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.0 t -52.98 -57.56 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.268 -0.895 . . . . 0.0 110.154 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.53 -46.16 63.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.179 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.13 -43.52 70.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.187 -0.946 . . . . 0.0 110.2 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tt -61.69 -40.49 95.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.931 . . . . 0.0 110.358 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.2 ttt85 -60.54 -28.67 68.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.271 -0.893 . . . . 0.0 110.24 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.97 -51.68 63.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.85 . . . . 0.0 110.252 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -71.19 -26.99 63.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 110.26 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.567 ' CG ' ' HA2' ' A' ' 67' ' ' GLY . 65.8 t90 -80.9 -6.3 58.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.298 -0.876 . . . . 0.0 110.296 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 65' ' ' THR . 9.5 tt0 -77.4 -50.65 12.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.185 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 64' ' ' GLU . 18.7 m -44.71 -39.96 5.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.291 -0.88 . . . . 0.0 110.193 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.19 -58.61 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' HA2' ' CG ' ' A' ' 63' ' ' TRP . . . 131.07 43.19 0.19 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 0.3 OUTLIER -105.1 113.91 27.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -1.156 . . . . 0.0 110.193 179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.8 t -53.77 108.1 1.03 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.197 -0.94 . . . . 0.0 110.198 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 68' ' ' THR . 45.8 Cg_endo -73.06 169.61 21.81 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.9 1.474 . . . . 0.0 110.371 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.87 -162.49 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.003 1.528 . . . . 0.0 110.434 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.68 HD11 HD13 ' A' ' 86' ' ' ILE . 8.8 tp -125.87 -0.75 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -91.0 -11.49 38.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.279 -0.888 . . . . 0.0 110.36 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.44 -30.01 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.106 -0.996 . . . . 0.0 110.405 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.0 t -75.92 -29.89 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.264 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 81' ' ' PHE . 14.1 t -77.0 -36.2 56.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.251 -0.906 . . . . 0.0 110.35 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' N ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -65.87 -29.33 69.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.56 0.04 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.207 -0.933 . . . . 0.0 110.276 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' GLY . 66.2 p -135.38 22.76 3.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.233 -0.917 . . . . 0.0 110.306 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' THR . . . 43.58 26.79 0.74 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.488 ' HB2' ' HA ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -68.26 -163.94 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -1.135 . . . . 0.0 110.155 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.1 t -154.4 137.42 15.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.244 -0.91 . . . . 0.0 110.176 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 15.1 tp -50.42 -34.43 24.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.215 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -71.55 -35.1 70.52 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 0.0 110.164 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.64 -46.6 89.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.282 -0.886 . . . . 0.0 110.41 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.68 HD13 HD11 ' A' ' 72' ' ' ILE . 34.9 mt -76.87 -31.32 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.221 -0.925 . . . . 0.0 110.355 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -67.05 -32.18 73.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.113 -0.992 . . . . 0.0 110.289 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -86.68 -39.68 15.81 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -0.978 . . . . 0.0 110.273 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.577 HD22 ' CE1' ' A' ' 52' ' ' HIS . 19.8 mt -65.09 -33.99 77.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 110.169 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.426 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 4.2 m-85 -109.11 171.28 4.59 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 110.032 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.6 Cg_endo -74.28 -61.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.091 1.574 . . . . 0.0 110.637 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.42 107.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.15 -0.969 . . . . 0.0 110.164 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 107.24 75.43 0.93 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.524 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.0 Cg_endo -72.33 -16.77 27.78 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.047 1.551 . . . . 0.0 110.431 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -69.45 0.26 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.357 -0.839 . . . . 0.0 110.148 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -77.07 -8.0 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.198 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.18 -81.43 0.44 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.1 -32.04 0.23 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -1.078 . . . . 0.0 110.418 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.73 -62.95 1.17 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.256 -0.903 . . . . 0.0 110.235 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -50.96 -51.28 54.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.266 -0.896 . . . . 0.0 110.131 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.7 t -48.76 -57.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.543 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -53.76 -34.48 59.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 0.0 110.225 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.09 -63.61 0.42 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 47.48 58.7 17.24 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.27 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.8 149.65 48.41 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.034 1.544 . . . . 0.0 110.463 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -119.44 137.66 25.66 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.247 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.77 94.95 0.87 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.024 1.539 . . . . 0.0 110.343 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -120.53 140.61 51.21 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.327 -0.858 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.428 ' O ' ' SG ' ' A' ' 110' ' ' CYS . . . -147.24 64.89 0.42 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 109' ' ' GLY . 0.5 OUTLIER 178.77 56.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.302 -1.117 . . . . 0.0 110.261 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.216 179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.531 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 1' ' ' MET . 45.0 Cg_endo -72.8 159.85 47.48 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.961 1.506 . . . . 0.0 110.444 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 9' ' ' TYR . 6.4 t -118.71 -49.65 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.266 -0.897 . . . . 0.0 110.283 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.41 -156.73 0.21 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 110.096 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 4.9 p -175.14 162.57 2.31 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.229 -0.919 . . . . 0.0 110.127 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.6 Cg_endo -74.72 153.67 99.28 Favored 'Cis proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.611 0.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -168.34 167.26 40.11 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 5.9 mt-10 -120.58 148.57 43.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.169 -1.194 . . . . 0.0 110.217 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 8' ' ' GLU . 97.2 m-85 -156.37 143.81 19.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -113.47 140.82 47.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 0.0 110.283 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 17.6 t -109.44 99.68 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 110.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.447 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 12.4 t70 55.32 -89.9 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.179 -0.95 . . . . 0.0 110.224 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -122.71 42.42 1.63 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 169.03 18.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -1.178 . . . . 0.0 110.205 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -127.34 138.15 52.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 110.281 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.4 t -131.0 128.69 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.066 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 25' ' ' GLN . 66.7 mt -116.15 102.59 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 0.0 110.418 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 22' ' ' CYS . 2.8 mt -87.14 132.17 33.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.063 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' GLU . 3.2 m-20 -117.44 -170.56 1.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.213 -0.929 . . . . 0.0 110.237 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -43.03 148.47 0.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.315 -0.866 . . . . 0.0 110.224 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.582 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.6 t0 66.76 18.32 10.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.319 -0.863 . . . . 0.0 110.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.623 ' HA ' HD22 ' A' ' 18' ' ' LEU . 4.3 m 51.05 45.72 27.41 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.613 ' O ' HD23 ' A' ' 18' ' ' LEU . 1.5 m-85 -86.35 126.56 34.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.298 -0.876 . . . . 0.0 110.235 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.664 ' HG2' HD11 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -42.88 -36.06 1.39 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.268 -0.895 . . . . 0.0 110.242 179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 53.58 19.89 1.92 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.25 -0.906 . . . . 0.0 110.156 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.425 ' CB ' ' SD ' ' A' ' 24' ' ' MET . 0.8 OUTLIER -151.16 59.87 3.57 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 110.157 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.33 -30.33 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.031 1.543 . . . . 0.0 110.454 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.74 -34.43 73.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.903 . . . . 0.0 110.26 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -96.21 30.15 2.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.252 -0.905 . . . . 0.0 110.291 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 35' ' ' ALA . 60.4 t90 -82.57 160.62 22.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.249 -0.907 . . . . 0.0 110.197 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -167.56 -169.21 1.15 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 110.192 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.431 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 18.7 mt-10 -71.32 -58.4 3.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.334 -0.854 . . . . 0.0 110.447 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -33.69 72.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.287 -0.883 . . . . 0.0 110.357 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.05 -57.57 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.33 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.59 ' HB2' ' NE1' ' A' ' 30' ' ' TRP . . . -55.23 -36.99 66.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.925 . . . . 0.0 110.406 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -54.6 41.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.208 -0.933 . . . . 0.0 110.43 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.461 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 76.7 t90 -59.19 -28.89 67.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.189 -0.944 . . . . 0.0 110.432 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.664 HD11 ' HG2' ' A' ' 24' ' ' MET . 0.2 OUTLIER -70.98 -41.42 71.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.447 -179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.74 -26.91 60.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.95 . . . . 0.0 110.591 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ttt-85 -75.9 -40.27 54.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.228 -0.92 . . . . 0.0 110.571 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.461 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -77.15 -33.81 56.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.687 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.3 mp -80.74 -68.64 0.67 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.105 -0.997 . . . . 0.0 110.572 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -79.59 -72.82 0.38 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.289 -0.882 . . . . 0.0 110.413 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.84 39.59 0.05 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 46' ' ' GLN . 11.3 mt -103.33 107.71 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.189 -1.183 . . . . 0.0 110.1 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 45' ' ' ILE . 14.0 mt-30 -43.28 -37.77 2.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 110.233 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 pttm -156.64 140.61 16.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 110.329 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 30.2 mtp -52.87 100.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 110.133 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.8 p -52.62 162.17 0.61 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 110.276 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.53 -27.62 4.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 0.0 110.33 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.95 -39.62 55.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.153 -0.967 . . . . 0.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.729 ' CE1' HD22 ' A' ' 89' ' ' LEU . 5.2 m80 -61.59 -41.03 96.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.513 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 1.4 m95 -74.09 -36.06 64.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 110.247 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -58.88 -45.64 89.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.537 HD11 ' CD2' ' A' ' 81' ' ' PHE . 5.9 mp -72.76 -58.27 3.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 110.334 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 52' ' ' HIS . 74.9 t -47.14 -30.65 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.433 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -76.45 -51.48 11.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.12 -0.987 . . . . 0.0 110.316 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.931 ' CE2' HG13 ' A' ' 75' ' ' VAL . 38.5 t80 -52.47 -48.34 65.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 110.239 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 tt -68.6 -43.58 76.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.258 -0.901 . . . . 0.0 110.416 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 21.8 ttp180 -50.32 -39.8 46.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.269 -0.894 . . . . 0.0 110.426 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.16 -55.2 19.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 0.0 110.199 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -27.0 66.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 110.105 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.412 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 59.6 t90 -70.08 -21.62 63.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.284 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 -17.63 59.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.19 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.555 HG22 ' HD2' ' A' ' 66' ' ' PHE . 98.3 m -75.74 -70.61 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.336 -0.853 . . . . 0.0 110.156 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.555 ' HD2' HG22 ' A' ' 65' ' ' THR . 4.3 m-85 -125.31 30.63 5.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 110.255 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 43.9 80.32 0.05 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.39 -178.07 5.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.3 -1.117 . . . . 0.0 110.176 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 t -140.1 92.95 9.4 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 110.229 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.43 157.88 52.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.079 1.568 . . . . 0.0 110.533 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.68 -159.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.045 1.55 . . . . 0.0 110.456 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 72' ' ' ILE . 7.8 tt -125.25 46.48 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.86 -82.97 0.3 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 0.0 110.172 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -16.16 40.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.235 -0.916 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.931 HG13 ' CE2' ' A' ' 58' ' ' TYR . 79.0 t -70.33 -40.85 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 110.148 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.3 m -54.12 -38.84 65.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -69.02 -34.1 74.71 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.331 -0.856 . . . . 0.0 110.142 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.79 -0.24 37.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.182 -0.949 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 0.9 OUTLIER -127.57 -77.55 0.57 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.348 -0.845 . . . . 0.0 110.202 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.89 22.56 3.24 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.537 ' CD2' HD11 ' A' ' 55' ' ' LEU . 36.0 m-85 -81.64 102.98 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -1.144 . . . . 0.0 110.207 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.44 127.89 6.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.297 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -47.84 -36.65 12.31 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.863 . . . . 0.0 110.166 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -56.09 -49.74 72.98 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.034 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.29 -50.83 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -0.894 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.472 HD11 ' HB3' ' A' ' 81' ' ' PHE . 36.4 mm -50.29 -39.7 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -37.18 80.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -64.59 -31.35 72.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.22 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.729 HD22 ' CE1' ' A' ' 52' ' ' HIS . 12.5 mt -76.72 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.25 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -94.07 147.91 34.26 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.268 -0.895 . . . . 0.0 110.222 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.413 ' O ' ' C ' ' A' ' 92' ' ' SER . 46.6 Cg_endo -73.98 84.13 1.52 Allowed 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.03 1.542 . . . . 0.0 110.407 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 91' ' ' PRO . 38.6 m 43.5 70.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.251 -0.906 . . . . 0.0 110.234 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 169.52 62.76 0.04 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.466 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.0 Cg_endo -73.63 -0.41 9.3 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.033 1.543 . . . . 0.0 110.515 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 99' ' ' CYS . . . -98.97 -63.35 1.13 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.901 . . . . 0.0 110.301 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -77.01 -14.24 59.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.277 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -77.06 -77.26 0.8 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.54 -37.15 1.56 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.305 -1.115 . . . . 0.0 110.368 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -66.32 -50.84 62.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.926 . . . . 0.0 110.374 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 1.9 tptt -53.41 -48.57 68.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.321 -0.862 . . . . 0.0 110.293 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.24 -27.55 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.28 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.65 -19.8 58.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.39 63.15 1.66 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -143.85 76.99 15.15 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.207 -1.172 . . . . 0.0 110.161 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.36 141.59 32.14 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.003 1.528 . . . . 0.0 110.387 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.564 ' CB ' ' CD ' ' A' ' 107' ' ' PRO . 2.4 mttm -44.18 -59.52 3.67 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 110.109 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 106' ' ' LYS . 46.3 Cg_endo -72.74 106.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.046 1.55 . . . . 0.0 110.355 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.75 26.97 10.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.253 -0.904 . . . . 0.0 110.198 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.6 5.51 64.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.72 -51.94 7.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.162 -1.199 . . . . 0.0 110.176 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.25 179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.732 0.301 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.15 -51.68 0.16 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.059 1.557 . . . . 0.0 110.534 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 4' ' ' LYS . 57.4 t -119.89 169.52 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.911 . . . . 0.0 110.379 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.529 ' N ' HG12 ' A' ' 3' ' ' VAL . 1.2 mtmm -109.07 147.31 32.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 0.0 110.06 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.5 m -142.89 159.43 56.63 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.968 . . . . 0.0 110.369 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.87 154.43 98.49 Favored 'Cis proline' 0 C--N 1.312 -1.349 0 C-N-CA 121.581 -2.258 . . . . 0.0 110.492 -0.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.06 142.62 7.79 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.406 ' OE1' ' O ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -99.05 128.05 45.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.213 -1.169 . . . . 0.0 110.262 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -131.63 161.94 31.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.935 . . . . 0.0 110.213 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -104.94 142.33 34.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.117 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 53.9 t -127.8 96.07 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 0.0 110.27 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 11' ' ' VAL . 10.3 t70 41.98 85.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.363 -0.836 . . . . 0.0 110.311 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 49.48 65.46 2.78 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -168.32 161.43 12.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -1.181 . . . . 0.0 110.144 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.32 126.36 42.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.211 -0.931 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -131.32 122.31 50.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 110.044 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 mt -104.57 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -0.93 . . . . 0.0 110.412 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 18' ' ' LEU . 16.2 mt -69.8 123.06 20.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.056 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.9 m-20 -99.66 -157.92 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 110.225 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 3.8 mm-40 -45.57 132.31 8.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.471 ' HB3' ' O ' ' A' ' 20' ' ' GLU . 13.3 t70 62.32 30.55 17.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.233 -0.917 . . . . 0.0 110.022 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 21' ' ' ASP . 74.5 m 56.65 43.08 26.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 110.203 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.46 95.28 9.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.0 110.104 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 25.4 ptm -54.21 149.98 9.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.217 -0.927 . . . . 0.0 110.394 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.429 ' HG3' ' OD2' ' A' ' 19' ' ' ASP . 1.7 mt-30 -127.04 40.56 3.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -126.05 72.47 70.51 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 110.028 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.0 -19.47 30.19 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.125 1.592 . . . . 0.0 110.574 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -85.68 -0.65 55.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.895 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -128.25 34.01 4.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.224 -0.923 . . . . 0.0 110.285 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.411 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 67.4 t90 -85.86 149.77 25.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -173.08 1.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 110.198 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -65.64 -39.19 91.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 110.209 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -68.31 -27.17 66.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.905 . . . . 0.0 110.386 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.489 HG22 ' HD3' ' A' ' 14' ' ' LYS . 21.8 t -76.16 -55.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.175 -0.953 . . . . 0.0 110.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.592 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -61.13 -34.01 74.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 0.0 110.473 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 3.3 tt0 -70.47 -57.43 4.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.202 -0.936 . . . . 0.0 110.419 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -56.77 -31.39 64.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.245 -0.909 . . . . 0.0 110.425 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD23 ' CD1' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -69.03 -63.27 1.09 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.346 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.601 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -53.5 -27.97 28.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.233 -0.917 . . . . 0.0 110.316 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -76.05 -34.74 59.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.138 -0.976 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HG3' ' CG2' ' A' ' 3' ' ' VAL . 1.9 tp10 -74.81 -28.58 60.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.144 -0.973 . . . . 0.0 110.262 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.561 ' CD1' HD23 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -82.45 -76.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -80.23 -76.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 110.208 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 152.55 46.74 0.02 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.601 HD12 ' HB1' ' A' ' 39' ' ' ALA . 8.8 mt -81.78 102.05 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.248 -1.148 . . . . 0.0 110.148 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -42.52 97.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.887 . . . . 0.0 110.207 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -136.32 115.48 12.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 110.243 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.9 mmm -56.83 125.22 21.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -0.903 . . . . 0.0 110.153 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.4 p -72.9 165.45 24.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.204 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -61.02 -32.19 71.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.113 -0.992 . . . . 0.0 110.283 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.96 -44.69 65.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.404 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.6 m170 -50.67 -54.46 22.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.198 -0.939 . . . . 0.0 110.194 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.592 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 1.8 m95 -62.5 -30.7 71.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.229 -0.92 . . . . 0.0 110.293 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -64.13 1.01 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.218 -0.926 . . . . 0.0 110.098 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 81' ' ' PHE . 0.5 OUTLIER -51.63 -41.92 61.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.916 . . . . 0.0 110.028 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 52' ' ' HIS . 45.7 t -57.46 -41.59 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -0.944 . . . . 0.0 110.106 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.28 -56.92 8.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.288 -0.882 . . . . 0.0 110.068 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -47.97 -34.47 9.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.046 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.14 -49.26 52.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.895 . . . . 0.0 110.085 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -51.86 -52.01 52.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 0.0 110.084 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -40.46 72.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.869 . . . . 0.0 110.089 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -62.64 -29.88 70.95 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.399 -0.813 . . . . 0.0 110.141 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.541 ' CD1' ' HA2' ' A' ' 67' ' ' GLY . 77.5 t90 -74.74 -31.17 61.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.165 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -68.69 -42.05 78.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.0 110.154 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 39.2 m -58.6 -40.64 83.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 110.191 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -146.47 -57.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.912 . . . . 0.0 110.066 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.541 ' HA2' ' CD1' ' A' ' 63' ' ' TRP . . . 119.18 83.48 0.85 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -155.6 171.8 19.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -1.164 . . . . 0.0 110.25 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -141.99 75.07 21.21 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.279 -0.888 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 161.37 43.06 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.992 1.522 . . . . 0.0 110.456 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.59 -174.86 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.994 1.523 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.726 HG13 HG23 ' A' ' 76' ' ' THR . 3.6 tp -87.43 49.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.206 -0.934 . . . . 0.0 110.249 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' O ' ' OG1' ' A' ' 76' ' ' THR . 0.2 OUTLIER -97.74 -60.57 1.54 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 0.0 110.049 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 ttm -73.93 -24.01 59.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.082 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' A' ' 79' ' ' THR . 13.6 t -67.07 -37.94 80.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.187 -0.946 . . . . 0.0 110.089 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.726 HG23 HG13 ' A' ' 72' ' ' ILE . 6.1 p -65.16 -26.76 68.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.914 . . . . 0.0 110.161 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -28.98 70.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.277 -0.889 . . . . 0.0 110.36 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.35 48.13 1.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 110.234 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' VAL . 43.9 m -154.69 -49.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.106 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.36 -15.04 60.58 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.48 ' HB3' HD11 ' A' ' 86' ' ' ILE . 0.9 OUTLIER -54.17 98.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 110.16 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.935 ' O ' HD12 ' A' ' 86' ' ' ILE . 2.2 t -70.16 148.59 48.5 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 110.233 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.589 HD13 HG21 ' A' ' 72' ' ' ILE . 22.3 tp -60.52 -27.77 67.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 110.102 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.39 -48.04 65.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 0.0 110.186 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.64 -40.64 79.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 110.19 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.935 HD12 ' O ' ' A' ' 82' ' ' SER . 3.4 mt -72.42 -27.83 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -0.918 . . . . 0.0 110.113 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -68.9 -43.14 75.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 110.172 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -54.12 10.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -0.888 . . . . 0.0 110.133 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.87 -29.51 68.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.71 96.13 4.8 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.214 -0.929 . . . . 0.0 110.141 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.5 Cg_endo -72.87 88.43 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 0.0 110.406 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 12.9 t 176.47 -41.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.243 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 122.96 141.55 5.94 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.48 -10.21 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.991 1.522 . . . . 0.0 110.412 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -89.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.853 . . . . 0.0 110.233 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 21.5 m170 -77.14 -10.89 59.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.92 . . . . 0.0 110.215 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -79.21 -83.88 0.62 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.86 -34.76 0.71 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.291 -1.123 . . . . 0.0 110.341 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.404 ' O ' ' C ' ' A' ' 100' ' ' LYS . 8.5 t -70.44 -64.46 0.89 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.245 -0.909 . . . . 0.0 110.19 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 26.6 tttm -43.18 -31.61 0.61 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.268 -0.895 . . . . 0.0 110.301 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 83.2 t -74.64 -52.31 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.245 -0.91 . . . . 0.0 110.212 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.14 -27.4 45.16 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.281 -0.887 . . . . 0.0 110.159 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.14 46.53 5.0 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -120.5 67.42 13.66 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.279 -1.13 . . . . 0.0 110.148 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.44 169.42 21.77 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.997 1.525 . . . . 0.0 110.447 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -50.33 161.98 0.56 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 110.163 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.78 178.05 6.85 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.03 1.542 . . . . 0.0 110.423 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.1 p -102.18 135.84 43.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 110.166 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.13 -87.91 2.02 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 28.6 p -95.98 170.12 9.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.349 -1.089 . . . . 0.0 110.292 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.418 ' O ' HG12 ' A' ' 111' ' ' VAL . 33.8 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.214 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.568 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.568 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 46.0 Cg_endo -71.96 81.03 1.44 Allowed 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.027 1.541 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.66 116.87 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.315 -0.866 . . . . 0.0 110.332 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -64.64 143.19 58.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.877 . . . . 0.0 110.223 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.488 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 18.6 m -138.8 149.42 61.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 110.097 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -76.05 164.71 87.22 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.705 -2.206 . . . . 0.0 110.567 -0.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -172.48 156.66 25.62 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.01 154.54 18.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -1.123 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -147.59 147.21 29.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.229 -0.92 . . . . 0.0 110.278 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.34 117.56 34.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.922 . . . . 0.0 110.122 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -112.12 102.88 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.296 -0.878 . . . . 0.0 110.401 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 55.24 -101.73 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.82 51.31 0.82 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.29 143.55 21.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.269 -1.136 . . . . 0.0 110.102 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.87 123.87 43.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.173 -0.954 . . . . 0.0 110.161 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.6 t -109.99 140.55 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 110.326 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.0 mt -124.61 100.66 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.895 . . . . 0.0 110.183 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.616 HD22 ' CA ' ' A' ' 22' ' ' CYS . 20.3 mt -77.14 121.74 24.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.136 -0.977 . . . . 0.0 110.32 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.05 -141.45 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.229 -0.919 . . . . 0.0 110.02 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 21' ' ' ASP . 3.7 tt0 -66.09 133.51 50.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 110.118 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.524 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.4 t70 66.82 34.79 5.3 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.194 -0.941 . . . . 0.0 110.209 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.616 ' CA ' HD22 ' A' ' 18' ' ' LEU . 60.5 m 44.05 42.71 5.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.524 ' CD2' ' HB3' ' A' ' 21' ' ' ASP . 0.6 OUTLIER -86.85 144.19 27.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 110.143 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 6.2 tpt -69.76 112.61 6.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.949 . . . . 0.0 110.248 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -105.85 31.1 5.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 0.0 110.165 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -152.32 65.86 6.22 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.933 . . . . 0.0 110.116 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.54 -14.03 24.91 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.045 1.55 . . . . 0.0 110.399 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.99 -33.82 39.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.3 -0.875 . . . . 0.0 110.201 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 30' ' ' TRP . 9.9 m-20 -103.42 -85.92 0.45 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 110.129 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.469 ' HB3' ' O ' ' A' ' 29' ' ' ASP . 33.5 t90 58.98 146.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 110.297 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -163.5 179.43 7.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.236 -0.915 . . . . 0.0 110.171 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -68.69 -55.59 10.91 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 0.0 110.287 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -36.36 71.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.297 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.5 t -63.91 -61.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.192 -0.942 . . . . 0.0 110.317 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -46.97 -45.74 21.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 110.394 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -58.09 -45.41 87.25 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.233 -0.917 . . . . 0.0 110.459 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 72.0 t90 -58.13 -51.87 67.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.983 . . . . 0.0 110.38 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -54.39 -40.87 68.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.245 -0.909 . . . . 0.0 110.506 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.92 69.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.921 . . . . 0.0 110.564 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.442 ' CD ' ' OE2' ' A' ' 41' ' ' GLU . 1.3 tmm_? -73.66 -45.22 53.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 0.0 110.562 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.442 ' OE2' ' CD ' ' A' ' 40' ' ' ARG . 2.0 mp0 -66.81 -33.9 76.63 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 0.0 110.397 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.05 -68.13 0.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.348 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -80.89 -64.48 1.18 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 137.82 -7.4 3.56 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -51.36 117.82 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -1.19 . . . . 0.0 110.26 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -74.69 -33.16 62.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.163 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.74 144.17 43.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.865 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.6 mmm -85.95 129.78 34.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.288 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.711 HG23 ' H ' ' A' ' 52' ' ' HIS . 3.5 t -73.69 170.77 14.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.18 -0.95 . . . . 0.0 110.18 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 3.8 mt-10 -67.89 -23.43 65.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.255 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -74.49 -40.06 62.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.898 . . . . 0.0 110.339 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.711 ' H ' HG23 ' A' ' 49' ' ' THR . 2.5 m170 -59.84 -59.67 5.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -58.68 -30.24 67.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.281 -0.887 . . . . 0.0 110.243 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER -63.79 -65.63 0.65 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.908 . . . . 0.0 110.215 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.01 -29.03 63.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.276 -0.89 . . . . 0.0 110.362 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 52' ' ' HIS . 48.2 t -65.52 -39.82 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.279 -0.888 . . . . 0.0 110.148 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.73 -31.5 57.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 110.233 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.5 -49.33 71.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.293 -0.879 . . . . 0.0 110.15 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.04 -31.35 71.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 0.0 110.039 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -27.6 63.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.333 -0.854 . . . . 0.0 110.228 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.0 -45.81 90.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 0.0 110.298 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.5 -29.91 61.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -0.935 . . . . 0.0 110.307 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.672 ' NE1' ' HB1' ' A' ' 104' ' ' ALA . 88.6 t90 -66.02 -44.3 85.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.13 -44.13 83.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 110.228 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -64.19 -67.76 0.41 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.269 -0.894 . . . . 0.0 110.24 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -91.24 -63.34 1.27 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.33 44.13 0.62 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 34.3 p -139.39 -158.63 0.88 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -1.105 . . . . 0.0 110.187 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 4.9 m -139.41 101.87 7.38 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.0 110.192 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.87 172.27 16.21 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.107 1.582 . . . . 0.0 110.364 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' CG ' ' HD3' ' A' ' 73' ' ' LYS . 45.6 Cg_endo -72.52 -164.96 0.2 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.066 1.561 . . . . 0.0 110.368 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.44 ' O ' ' CG1' ' A' ' 72' ' ' ILE . 1.0 OUTLIER -116.12 44.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.21 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HD3' ' CG ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER -92.81 -66.79 0.9 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.254 -0.904 . . . . 0.0 110.259 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.7 mtp -60.04 -14.77 18.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.31 -0.869 . . . . 0.0 110.321 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.53 -58.21 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 110.229 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 m -62.7 -28.18 69.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.127 -0.983 . . . . 0.0 110.172 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.22 -28.12 69.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 110.165 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -106.68 -65.16 1.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 110.152 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 63.8 p -56.97 -35.09 68.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 0.0 110.219 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.7 79.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -75.04 122.88 24.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -1.137 . . . . 0.0 110.242 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.481 ' CB ' ' HE2' ' A' ' 85' ' ' LYS . 0.5 OUTLIER -53.67 136.26 39.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.306 -0.871 . . . . 0.0 110.217 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -62.01 -35.45 78.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.94 -36.03 77.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.481 ' HE2' ' CB ' ' A' ' 82' ' ' SER . 0.1 OUTLIER -58.4 -53.1 62.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 0.0 110.174 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.559 HG21 ' HG3' ' A' ' 94' ' ' PRO . 79.9 mt -65.9 -38.68 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.912 . . . . 0.0 110.131 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -56.18 -37.57 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.94 . . . . 0.0 109.946 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -48.2 25.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.431 HD22 ' CE1' ' A' ' 52' ' ' HIS . 22.6 mt -65.27 -11.72 44.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 110.121 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 0.1 OUTLIER -173.08 104.89 0.32 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 90' ' ' PHE . 45.2 Cg_endo -72.31 -25.6 18.36 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.056 1.556 . . . . 0.0 110.381 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.7 m -75.92 0.52 18.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 110.211 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.27 147.78 5.81 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 98' ' ' ALA . 46.9 Cg_endo -73.09 -10.39 24.41 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.035 1.545 . . . . 0.0 110.346 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -51.22 -84.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.348 -0.845 . . . . 0.0 110.231 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -76.72 -18.08 58.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 110.23 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -76.53 -67.1 1.73 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . -44.59 -38.09 4.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.272 -1.134 . . . . 0.0 110.124 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 54.7 m -69.88 -44.32 70.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.897 . . . . 0.0 110.211 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -54.61 -41.65 70.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 0.0 110.179 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.4 t -72.84 -37.24 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 110.21 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.5 70.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.336 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.72 50.19 1.85 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.672 ' HB1' ' NE1' ' A' ' 63' ' ' TRP . . . -175.55 81.96 0.3 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.251 -1.147 . . . . 0.0 110.252 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.41 -89.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.049 1.552 . . . . 0.0 110.482 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.404 ' HD3' ' HD2' ' A' ' 107' ' ' PRO . 0.7 OUTLIER -112.89 164.49 15.31 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.952 . . . . 0.0 110.201 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.404 ' HD2' ' HD3' ' A' ' 106' ' ' LYS . 46.5 Cg_endo -73.09 -168.92 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.987 1.519 . . . . 0.0 110.452 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.9 t -135.09 7.33 3.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.2 -0.937 . . . . 0.0 110.332 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -61.5 130.36 46.16 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.99 118.46 7.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.229 -179.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.5 121.61 7.25 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.925 1.487 . . . . 0.0 110.393 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.52 HG11 ' CD1' ' A' ' 18' ' ' LEU . 54.2 t -66.96 107.85 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 110.214 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -63.19 104.67 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.853 . . . . 0.0 110.176 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 93.8 m -94.5 142.76 25.23 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 110.168 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.0 Cg_endo -75.32 144.94 82.14 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.697 -2.21 . . . . 0.0 110.38 -0.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.94 165.11 30.6 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -115.8 144.59 43.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -1.111 . . . . 0.0 110.146 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -146.23 171.41 14.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.246 -0.909 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 1.2 mt-30 -133.45 122.57 23.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.897 . . . . 0.0 110.206 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 3.9 t -99.83 109.37 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.218 -0.927 . . . . 0.0 110.041 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 46.6 t0 56.33 -88.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.199 -0.938 . . . . 0.0 110.244 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.64 48.01 0.99 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 2.8 mttm -149.14 151.69 34.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.245 -1.15 . . . . 0.0 110.257 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 ttmm -112.53 111.28 22.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.28 -0.887 . . . . 0.0 110.288 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.1 t -104.56 140.18 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.294 -0.879 . . . . 0.0 110.204 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.7 107.87 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.904 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.749 HD22 ' C ' ' A' ' 22' ' ' CYS . 13.2 mt -83.65 124.59 30.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.25 -0.906 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 3.1 t70 -66.39 -170.63 0.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 0.0 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -38.23 69.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.308 -0.87 . . . . 0.0 110.256 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -96.33 39.79 1.14 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 110.175 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.749 ' C ' HD22 ' A' ' 18' ' ' LEU . 67.4 m 44.85 39.63 3.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 110.246 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.55 151.15 22.69 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 132.82 34.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 110.31 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -108.26 -8.66 15.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.24 -0.912 . . . . 0.0 110.114 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -139.66 60.49 16.28 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.42 ' CG ' ' HB3' ' A' ' 105' ' ' PRO . 45.7 Cg_endo -73.15 -1.73 11.0 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.03 1.542 . . . . 0.0 110.464 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.8 -31.28 62.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 110.164 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -106.09 36.54 2.54 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.244 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -61.19 144.04 54.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 0.0 110.181 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -152.14 175.59 12.43 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -61.49 -39.24 90.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.239 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 16.4 mttt -67.02 -31.79 72.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.222 -0.924 . . . . 0.0 110.202 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.447 ' O ' HD12 ' A' ' 38' ' ' LEU . 49.1 t -71.49 -58.6 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.206 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -52.98 -46.75 68.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.292 -0.88 . . . . 0.0 110.256 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -67.26 -33.12 74.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 110.188 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 33.7 t90 -61.72 -48.44 80.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.226 -0.921 . . . . 0.0 110.307 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.6 OUTLIER -67.45 -38.88 85.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.243 -0.911 . . . . 0.0 110.411 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.69 81.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.261 -0.899 . . . . 0.0 110.396 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.45 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 2.0 ttt-85 -71.63 -51.65 22.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 0.0 110.336 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -59.12 -26.84 65.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.177 -0.952 . . . . 0.0 110.427 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 1.5 mp -87.56 -72.08 0.54 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.127 -0.983 . . . . 0.0 110.356 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -42.7 20.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.239 -0.913 . . . . 0.0 110.384 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 118.12 21.11 4.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.438 ' N ' ' HA ' ' A' ' 40' ' ' ARG . 19.6 mt -79.63 105.6 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.317 -1.108 . . . . 0.0 110.188 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -67.21 -46.94 72.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.913 . . . . 0.0 110.063 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' MET . 11.5 tptp -118.71 109.45 16.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.887 . . . . 0.0 110.093 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' LYS . 4.6 tpt -42.8 150.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 110.271 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 52' ' ' HIS . 30.7 p -84.75 174.18 10.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 0.0 110.258 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.26 -40.87 64.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 110.302 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.442 ' CB ' HD11 ' A' ' 89' ' ' LEU . 67.2 mm-40 -68.61 -33.7 74.49 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.253 -0.904 . . . . 0.0 110.207 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.555 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -55.42 -49.67 71.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -0.887 . . . . 0.0 110.325 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.467 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 4.2 m95 -71.23 -26.93 63.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 110.33 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.3 mttm -62.54 -58.44 7.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 110.327 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -68.42 -50.48 52.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.369 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 52' ' ' HIS . 95.5 t -52.44 -33.61 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.415 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.46 -51.78 13.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 110.236 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.529 ' CZ ' HG22 ' A' ' 79' ' ' THR . 52.4 t80 -53.62 -31.53 47.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.71 -44.78 63.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 110.164 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -49.13 -35.62 16.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.17 -51.75 68.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -0.902 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.02 -41.88 98.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 110.217 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.428 ' O ' ' CD2' ' A' ' 63' ' ' TRP . 15.8 t90 -68.83 -12.51 61.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.264 -0.897 . . . . 0.0 110.221 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.52 -14.27 35.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.297 -0.877 . . . . 0.0 110.244 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.568 HG22 ' CD2' ' A' ' 66' ' ' PHE . 96.2 m -97.82 -46.37 5.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.913 . . . . 0.0 110.145 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.568 ' CD2' HG22 ' A' ' 65' ' ' THR . 60.9 m-85 -124.94 -8.86 7.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -0.896 . . . . 0.0 110.104 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 63' ' ' TRP . . . 65.83 45.44 88.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.19 147.57 40.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.5 t -117.32 103.13 51.81 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.28 152.69 50.34 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.971 1.511 . . . . 0.0 110.403 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.87 -90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.978 1.515 . . . . 0.0 110.346 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.629 HG12 HD11 ' A' ' 83' ' ' LEU . 1.0 OUTLIER -169.42 57.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -135.56 -68.3 0.52 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.028 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 5.7 ttm -67.84 -14.36 62.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 110.043 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.424 ' O ' ' OG1' ' A' ' 79' ' ' THR . 93.8 t -70.56 -42.68 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.882 . . . . 0.0 110.139 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -68.09 -27.11 66.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 110.088 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -72.14 -33.5 67.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.379 -0.826 . . . . 0.0 110.084 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -87.23 -63.64 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.308 -0.87 . . . . 0.0 110.119 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' CZ ' ' A' ' 58' ' ' TYR . 46.9 p -60.6 -42.34 96.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 110.13 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.38 -14.52 59.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -51.66 149.72 4.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -1.19 . . . . 0.0 110.179 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.0 p -71.96 143.11 49.36 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.629 HD11 HG12 ' A' ' 72' ' ' ILE . 29.0 tp -73.32 -29.28 62.58 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 110.306 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -59.59 -31.42 69.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.264 -0.898 . . . . 0.0 110.181 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HE2' ' NE2' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -65.3 -62.13 1.72 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.221 -0.925 . . . . 0.0 110.224 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 86' ' ' ILE . 2.5 mp -51.26 -45.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.355 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CE1' ' HA ' ' A' ' 92' ' ' SER . 1.5 t80 -60.53 -33.73 73.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.251 -0.906 . . . . 0.0 110.306 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.472 ' NE2' ' HE2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -76.71 -24.86 53.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.519 HD22 ' CG ' ' A' ' 52' ' ' HIS . 9.4 mt -76.13 -50.7 13.91 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.203 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 101' ' ' VAL . 74.1 m-85 -97.81 162.5 22.11 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 92' ' ' SER . 48.0 Cg_endo -74.92 76.7 3.29 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.115 1.587 . . . . 0.0 110.552 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.453 ' HA ' ' CE1' ' A' ' 87' ' ' TYR . 0.8 OUTLIER 41.61 83.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 163.14 70.89 0.02 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' CB ' HD13 ' A' ' 72' ' ' ILE . 46.7 Cg_endo -72.99 -21.27 20.97 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.003 1.528 . . . . 0.0 110.432 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.54 -81.44 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 110.226 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -66.34 -16.09 63.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.15 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -74.76 -70.84 1.2 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -51.35 -42.34 61.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.226 -1.161 . . . . 0.0 110.165 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.51 -48.41 81.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 110.216 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.22 -37.21 69.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.101 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.527 HG21 ' CE1' ' A' ' 90' ' ' PHE . 50.6 t -72.19 -31.96 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.13 -50.94 64.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.865 . . . . 0.0 110.213 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.03 43.41 1.78 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -95.08 116.78 66.67 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.224 -1.162 . . . . 0.0 110.079 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 106' ' ' LYS . 48.2 Cg_endo -73.1 -94.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.864 1.455 . . . . 0.0 110.456 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 105' ' ' PRO . 13.2 mmtp 40.32 65.32 4.05 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.184 -0.947 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.53 -38.44 3.38 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.028 1.541 . . . . 0.0 110.572 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.2 m -152.9 -80.7 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.81 99.72 0.23 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -83.1 -158.32 0.28 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -1.147 . . . . 0.0 110.255 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.126 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 120.742 0.306 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.29 135.04 21.91 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.003 1.528 . . . . 0.0 110.543 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 41' ' ' GLU . 71.1 t -80.08 87.16 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.108 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 109.58 19.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.224 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 26.0 p -102.18 157.36 33.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.236 -0.915 . . . . 0.0 110.243 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 47.7 Cg_endo -75.48 147.28 88.14 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.662 -2.224 . . . . 0.0 110.504 -0.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.03 174.86 46.88 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.72 144.38 44.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.325 -1.103 . . . . 0.0 110.148 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -145.09 165.94 26.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 110.201 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -116.26 137.94 51.72 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 77.7 t -133.84 118.64 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.948 . . . . 0.0 110.266 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 t0 46.34 52.33 10.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.891 . . . . 0.0 110.304 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.98 39.61 97.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.0 tttt -131.02 166.92 19.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.208 -1.172 . . . . 0.0 110.147 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.22 103.34 9.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 110.331 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.8 t -99.03 130.95 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 110.139 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 mp -111.73 115.96 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 0.0 110.243 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 22' ' ' CYS . 10.6 mt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 110.185 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.3 t0 -59.55 -172.36 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 110.404 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -64.25 -23.21 67.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.827 . . . . 0.0 110.298 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -108.26 35.17 3.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 0.0 110.261 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.604 ' HA ' HD22 ' A' ' 18' ' ' LEU . 1.4 m 52.42 42.96 31.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.232 -0.918 . . . . 0.0 110.263 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -111.49 111.08 21.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 110.263 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 18.1 mtp -45.12 144.34 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.285 -0.884 . . . . 0.0 110.256 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.36 13.46 15.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.193 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -145.79 59.71 5.91 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 110.141 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.78 -8.14 21.9 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 0.0 110.517 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -27.4 65.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.216 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 30' ' ' TRP . 5.9 m-20 -92.82 -74.36 0.52 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 0.0 110.257 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.425 ' O ' ' O ' ' A' ' 29' ' ' ASP . 68.9 t90 56.92 162.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.288 -0.882 . . . . 0.0 110.101 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.86 176.19 2.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -69.29 -51.22 39.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 110.206 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -32.96 74.74 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 110.231 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.73 -55.79 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.703 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -53.79 -47.3 70.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -67.53 -26.88 66.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.278 -0.889 . . . . 0.0 110.258 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 63.1 t90 -68.73 -54.49 15.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.291 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.535 HD23 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -62.93 -36.9 84.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.62 -37.26 86.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 110.294 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.09 -28.67 54.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.314 -0.866 . . . . 0.0 110.372 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 41' ' ' GLU . 7.3 mm-40 -76.95 -27.6 54.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.165 -0.96 . . . . 0.0 110.378 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.535 HD13 HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -96.53 -21.43 17.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.21 -0.931 . . . . 0.0 110.283 -179.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.415 ' HB3' HG13 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -127.29 -36.68 2.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.933 . . . . 0.0 110.324 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 96.96 21.93 19.32 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 43' ' ' GLU . 34.8 mt -59.03 97.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -1.161 . . . . 0.0 110.23 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -50.11 -43.77 51.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 109.984 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -136.32 115.09 12.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.858 . . . . 0.0 110.045 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -42.55 137.11 2.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.288 -0.883 . . . . 0.0 110.208 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.8 m -81.07 139.38 35.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 110.182 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -52.2 -24.8 7.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.186 -0.946 . . . . 0.0 110.229 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -75.98 -45.55 34.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.311 -0.868 . . . . 0.0 110.202 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.856 ' O ' HG23 ' A' ' 56' ' ' VAL . 22.6 m170 -51.8 -55.57 19.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.218 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.703 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 16.7 m95 -55.87 -29.24 59.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.255 -0.903 . . . . 0.0 110.251 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.56 -52.9 48.88 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.242 -0.911 . . . . 0.0 110.212 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -37.12 85.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.218 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 52' ' ' HIS . 11.9 t -64.63 -38.19 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.186 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -54.29 19.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.415 ' CE1' HG13 ' A' ' 75' ' ' VAL . 17.2 t80 -51.84 -41.11 61.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.171 -0.956 . . . . 0.0 110.225 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.52 -34.87 77.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.352 -0.842 . . . . 0.0 110.234 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 mtp-105 -60.44 -30.14 69.45 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -67.93 -45.94 72.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.0 110.276 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -37.87 89.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 0.0 110.254 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 67' ' ' GLY . 48.9 t90 -64.03 -48.15 77.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.233 -0.917 . . . . 0.0 110.193 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.03 -12.74 60.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.286 -0.884 . . . . 0.0 110.203 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 99.7 m -91.23 -22.33 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.97 -43.79 0.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 110.234 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 63' ' ' TRP . . . 103.07 43.03 1.97 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.8 t -154.3 158.89 40.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.219 -1.165 . . . . 0.0 110.25 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -97.0 116.6 66.11 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.23 -0.919 . . . . 0.0 110.286 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.47 ' HB2' ' HD2' ' A' ' 71' ' ' PRO . 45.9 Cg_endo -72.71 174.28 12.03 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.832 1.438 . . . . 0.0 110.425 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 45.5 Cg_endo -72.1 -159.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.947 1.499 . . . . 0.0 110.46 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 72' ' ' ILE . 7.9 tp -118.02 -1.4 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -0.865 . . . . 0.0 110.375 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -90.19 -44.67 9.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.227 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -23.74 63.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 58' ' ' TYR . 97.5 t -71.48 -41.93 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.304 -0.872 . . . . 0.0 110.317 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.488 ' O ' ' N ' ' A' ' 80' ' ' GLY . 6.8 m -62.24 -45.4 93.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -45.34 -47.67 13.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 0.0 110.372 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -69.66 -32.35 70.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.229 -0.92 . . . . 0.0 110.25 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 p -103.84 -74.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.221 -0.924 . . . . 0.0 110.306 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 76' ' ' THR . . . 128.85 -12.23 6.18 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 82' ' ' SER . 3.8 m-30 -43.24 97.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.221 -1.164 . . . . 0.0 110.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 80' ' ' GLY . 34.3 t -42.82 131.74 4.0 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.344 -0.847 . . . . 0.0 110.219 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.0 tp -51.61 -37.65 51.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.26 -0.9 . . . . 0.0 110.107 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.61 -40.55 72.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 110.061 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -64.11 -54.96 25.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 110.1 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.5 mt -51.64 -32.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.895 . . . . 0.0 110.083 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -74.99 -35.86 62.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 110.105 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.31 -26.22 62.76 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.333 -0.855 . . . . 0.0 110.054 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.28 -19.91 19.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.979 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.43 109.05 9.49 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.75 -39.69 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.982 1.517 . . . . 0.0 110.517 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -44.86 66.4 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.194 -0.942 . . . . 0.0 110.257 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 120.86 153.53 9.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.467 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -74.06 -162.41 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.96 1.505 . . . . 0.0 110.508 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 57.02 -89.58 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 110.511 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.406 ' N ' ' O ' ' A' ' 94' ' ' PRO . 36.3 m170 -66.6 -44.37 82.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.0 110.411 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -62.65 -66.93 2.31 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -41.67 -56.75 2.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.249 -1.148 . . . . 0.0 110.622 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 0.5 OUTLIER -50.44 -62.25 1.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.181 -0.949 . . . . 0.0 110.603 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -41.99 -49.61 4.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.216 -0.928 . . . . 0.0 110.526 -179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.26 -50.21 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.261 -0.899 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.44 -19.23 65.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.285 -0.884 . . . . 0.0 110.294 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.42 70.03 1.36 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -112.0 161.0 27.82 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.19 -1.182 . . . . 0.0 110.239 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.73 131.42 17.16 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.065 1.56 . . . . 0.0 110.425 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -82.33 140.47 45.33 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.196 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' O ' ' CB ' ' A' ' 108' ' ' THR . 46.3 Cg_endo -72.94 -161.14 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.942 1.496 . . . . 0.0 110.424 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.406 ' CB ' ' O ' ' A' ' 107' ' ' PRO . 0.5 OUTLIER 62.62 98.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.157 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.29 170.98 39.69 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.38 70.6 0.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -1.168 . . . . 0.0 110.241 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.163 179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.756 0.312 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.64 130.18 14.48 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.056 1.556 . . . . 0.0 110.515 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 41' ' ' GLU . 4.9 p -91.52 154.29 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 110.118 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.07 171.0 15.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 110.277 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' HD13 ' A' ' 18' ' ' LEU . 14.5 m -121.41 155.93 58.53 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.254 -0.904 . . . . 0.0 110.093 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.6 Cg_endo -76.19 158.01 97.87 Favored 'Cis proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.545 -2.273 . . . . 0.0 110.403 -0.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.84 151.27 15.56 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -102.84 143.56 32.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.291 -1.123 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -150.78 158.39 44.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.215 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -121.62 132.11 54.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 110.093 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.624 HG22 ' CD2' ' A' ' 37' ' ' TRP . 98.9 t -116.56 104.98 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.295 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 24.8 t0 55.14 -90.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -132.5 52.56 0.82 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.623 ' CD ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -153.15 152.51 31.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.256 -1.144 . . . . 0.0 110.224 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.32 133.34 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 110.27 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.665 HG22 HD21 ' A' ' 26' ' ' ASN . 72.9 t -132.41 111.19 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 0.0 110.158 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.766 HG23 ' O ' ' A' ' 17' ' ' ILE . 11.5 tt -107.55 96.66 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 0.0 110.281 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.573 HD13 ' SG ' ' A' ' 5' ' ' CYS . 76.4 mt -61.65 122.94 16.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.227 -0.921 . . . . 0.0 110.232 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.44 -152.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 0.0 110.218 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.15 -37.4 87.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' O ' ' C ' ' A' ' 22' ' ' CYS . 2.5 t0 -108.37 51.38 0.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.165 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 93.0 m 43.32 27.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 110.187 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.12 138.76 45.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 110.192 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.424 ' HG3' HD11 ' A' ' 38' ' ' LEU . 3.1 mtp -79.79 110.99 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 110.214 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.15 18.85 11.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.183 -0.948 . . . . 0.0 110.16 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.665 HD21 HG22 ' A' ' 16' ' ' VAL . 16.2 p-10 -135.12 52.34 7.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.5 Cg_endo -72.94 -22.64 19.53 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.999 1.526 . . . . 0.0 110.427 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 29' ' ' ASP . 0.6 OUTLIER -60.08 -18.0 43.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 110.225 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -127.2 36.92 4.34 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.897 . . . . 0.0 110.13 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.491 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 31.8 t90 -73.44 139.46 45.85 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 0.0 110.188 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.91 174.7 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.315 -0.866 . . . . 0.0 110.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 33' ' ' LYS . 25.4 pt-20 -66.42 -42.11 88.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.912 . . . . 0.0 110.165 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 32' ' ' GLU . 1.9 ttmm -67.85 -47.51 68.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 110.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.623 HG21 ' CD ' ' A' ' 14' ' ' LYS . 42.8 t -56.0 -54.41 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.251 -0.905 . . . . 0.0 110.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.491 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -56.8 -36.52 70.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 110.033 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 33' ' ' LYS . 1.0 OUTLIER -59.74 -44.73 93.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.934 . . . . 0.0 110.175 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.624 ' CD2' HG22 ' A' ' 11' ' ' VAL . 38.0 t90 -64.64 -38.43 90.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.184 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -58.16 -51.68 68.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 0.0 110.322 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.29 -27.24 66.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 0.0 110.223 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -64.43 -49.03 73.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 110.394 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.489 ' HB3' HG11 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -77.17 -28.19 53.97 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 0.0 110.413 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 42' ' ' LEU . 2.9 mm? -84.34 -3.72 58.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.229 -0.919 . . . . 0.0 110.364 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -155.3 -46.24 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 110.244 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 122.51 12.72 4.99 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 45' ' ' ILE . 9.6 mt -76.16 79.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.14 . . . . 0.0 110.148 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -50.21 60.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 110.263 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.81 131.31 55.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.906 . . . . 0.0 110.193 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 71.4 mmm -74.38 121.01 20.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 110.252 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 50' ' ' GLU . 0.7 OUTLIER -76.43 -157.17 0.08 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -0.89 . . . . 0.0 110.166 179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 49' ' ' THR . 7.5 mp0 -92.86 -27.86 16.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.188 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.29 -48.38 35.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.69 ' NE2' HD22 ' A' ' 89' ' ' LEU . 23.2 m80 -51.25 -46.5 62.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 110.267 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 2.9 m95 -72.15 -31.27 65.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 110.292 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -64.01 1.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.206 -0.934 . . . . 0.0 110.26 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.19 -43.43 98.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.243 -0.911 . . . . 0.0 110.265 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 52' ' ' HIS . 37.4 t -60.32 -27.01 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.257 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 5.0 tttt -76.64 -53.89 7.41 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.297 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.561 ' CD2' HG13 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -55.6 -34.01 64.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.951 . . . . 0.0 110.162 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.52 -53.1 60.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.172 -0.955 . . . . 0.0 110.089 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -52.53 -51.31 60.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.035 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.92 -41.82 46.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.51 ' CE2' ' HG3' ' A' ' 70' ' ' PRO . 4.9 t80 -65.74 -35.11 79.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.254 -0.903 . . . . 0.0 110.181 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.552 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 36.0 t90 -66.42 -22.24 66.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.296 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.76 -10.64 59.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.255 -0.903 . . . . 0.0 110.117 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.7 m -81.31 -49.13 11.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -152.0 -38.61 0.11 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.248 -0.907 . . . . 0.0 110.151 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.98 88.48 0.95 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -159.77 -178.5 7.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -1.171 . . . . 0.0 110.238 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.46 84.87 15.68 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.51 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 45.0 Cg_endo -72.44 125.92 11.13 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.395 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -74.57 91.54 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.897 1.472 . . . . 0.0 110.519 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.455 HG22 ' H ' ' A' ' 73' ' ' LYS . 8.4 mm 48.56 -132.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.0 109.917 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.455 ' H ' HG22 ' A' ' 72' ' ' ILE . 8.3 mttt 57.81 -97.49 0.07 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.052 -1.03 . . . . 0.0 110.36 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.55 -23.91 1.14 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.03 -1.044 . . . . 0.0 110.264 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.561 HG13 ' CD2' ' A' ' 58' ' ' TYR . 22.2 t -69.6 -47.18 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 110.301 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 73' ' ' LYS . 1.1 p -63.97 -34.86 78.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.22 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -43.99 -32.94 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 0.0 110.149 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.92 48.02 2.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 110.056 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 24.4 m -153.75 -70.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 110.26 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 107.54 87.35 1.92 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -153.16 104.55 2.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -1.131 . . . . 0.0 110.282 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.4 143.3 40.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 0.0 110.151 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.423 HD12 ' HA ' ' A' ' 83' ' ' LEU . 7.6 tp -60.56 -26.87 67.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.89 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.77 -41.48 74.08 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.307 -0.871 . . . . 0.0 110.45 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -65.84 -58.04 6.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.396 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.523 HG23 ' HG3' ' A' ' 94' ' ' PRO . 54.6 mt -46.29 -49.26 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.226 -0.921 . . . . 0.0 110.224 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -59.37 -41.39 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -65.17 -24.75 67.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.69 HD22 ' NE2' ' A' ' 52' ' ' HIS . 4.5 mt -79.48 -62.33 1.73 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.184 -0.947 . . . . 0.0 110.259 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 11.3 m-85 -85.08 170.81 12.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.901 . . . . 0.0 110.123 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 42.5 Cg_endo -74.54 -70.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.117 1.588 . . . . 0.0 110.571 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.87 56.52 0.67 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.044 -1.035 . . . . 0.0 110.033 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 76.52 143.07 1.4 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.523 ' HG3' HG23 ' A' ' 86' ' ' ILE . 45.5 Cg_endo -72.96 -90.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.954 1.502 . . . . 0.0 110.447 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . 53.91 -93.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 97' ' ' GLY . 8.7 m170 -69.63 -57.39 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.121 -0.987 . . . . 0.0 110.305 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 96' ' ' HIS . . . -43.65 -59.1 3.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 101' ' ' VAL . . . -47.48 -48.65 26.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -1.125 . . . . 0.0 110.451 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 99.7 m -53.78 -62.54 1.59 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.0 110.367 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 99' ' ' CYS . 15.0 mttp -44.16 -45.87 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.286 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 98' ' ' ALA . 54.4 t -53.76 -55.1 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.344 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.15 -22.74 66.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.227 -0.921 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 104' ' ' ALA . . . 114.07 -46.65 1.14 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 103' ' ' GLY . . . 42.15 72.35 1.14 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.354 -1.086 . . . . 0.0 110.276 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HG2' ' CZ2' ' A' ' 63' ' ' TRP . 45.7 Cg_endo -72.65 -168.88 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.974 1.512 . . . . 0.0 110.487 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -112.29 155.29 43.81 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.18 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.89 174.47 11.85 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.978 1.515 . . . . 0.0 110.432 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.1 m -128.37 109.49 11.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.0 110.212 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.64 -105.34 0.46 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.8 t -176.28 -61.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -1.149 . . . . 0.0 110.272 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.189 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.729 0.3 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.27 -60.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.071 1.564 . . . . 0.0 110.467 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 41' ' ' GLU . 5.7 t -138.09 4.3 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.405 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 3' ' ' VAL . 0.0 OUTLIER 63.33 114.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 110.397 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 79.2 m -137.14 151.71 72.32 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.315 -0.866 . . . . 0.0 110.04 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.6 Cg_endo -78.62 162.91 87.29 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.671 -2.22 . . . . 0.0 110.316 -0.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.26 173.11 45.19 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.555 ' O ' ' CD2' ' A' ' 9' ' ' TYR . 16.5 mt-10 -106.07 170.65 7.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -1.194 . . . . 0.0 110.035 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 8' ' ' GLU . 1.2 m-85 -169.52 171.21 7.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.216 -0.928 . . . . 0.0 110.344 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -132.6 137.97 47.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.355 -0.841 . . . . 0.0 110.118 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.583 HG22 ' CE2' ' A' ' 37' ' ' TRP . 75.8 t -117.71 106.88 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.276 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.7 t0 51.18 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.174 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -131.96 60.06 0.68 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -161.44 164.26 29.92 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.276 -1.132 . . . . 0.0 110.246 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.98 147.85 26.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 110.208 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.421 HG21 ' CG2' ' A' ' 11' ' ' VAL . 65.7 t -140.28 135.81 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.212 -0.93 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 17' ' ' ILE . 4.5 mp -127.33 100.24 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.216 -0.927 . . . . 0.0 110.177 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 18' ' ' LEU . 43.0 mt -73.36 131.78 42.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -83.85 -146.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.35 -0.844 . . . . 0.0 110.385 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -66.4 -48.54 69.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.343 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -98.67 39.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.2 -0.938 . . . . 0.0 109.95 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 55.7 m 56.56 31.99 20.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.377 -0.827 . . . . 0.0 110.026 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -75.94 155.09 35.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 110.209 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -98.61 113.66 25.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 110.14 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -88.26 16.03 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -128.98 64.74 71.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.275 -0.891 . . . . 0.0 110.22 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.63 -15.85 27.11 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.969 1.51 . . . . 0.0 110.357 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -15.96 62.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 110.217 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.9 OUTLIER -116.53 12.89 15.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -0.913 . . . . 0.0 110.324 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.687 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 24.8 t90 -63.77 147.87 50.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.264 -0.898 . . . . 0.0 110.215 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -174.27 -154.85 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -75.11 -33.3 61.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -0.912 . . . . 0.0 110.27 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -72.19 -39.87 68.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.312 -0.868 . . . . 0.0 110.274 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 38' ' ' LEU . 41.2 t -72.9 -36.93 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.871 . . . . 0.0 110.425 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -69.91 -50.46 42.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 0.0 110.381 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -60.76 -46.62 89.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.0 110.427 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.583 ' CE2' HG22 ' A' ' 11' ' ' VAL . 77.6 t90 -60.25 -54.63 43.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.191 -0.943 . . . . 0.0 110.509 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -50.94 -41.11 58.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 110.598 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.879 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -65.84 -37.06 85.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.0 110.562 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -35.58 74.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.206 -0.934 . . . . 0.0 110.631 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 3' ' ' VAL . 2.9 mm-40 -77.1 -30.05 55.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.156 -0.965 . . . . 0.0 110.383 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -75.98 0.29 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.229 -0.919 . . . . 0.0 110.279 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -85.3 -61.26 1.81 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 0.0 110.251 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 131.07 42.52 0.2 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.879 HD12 ' HB1' ' A' ' 39' ' ' ALA . 75.5 mt -78.88 99.86 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.302 -1.117 . . . . 0.0 110.214 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -59.59 -28.97 67.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -0.915 . . . . 0.0 110.117 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -144.07 118.46 9.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.328 -0.857 . . . . 0.0 110.145 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.419 ' HG3' ' NE1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -48.76 142.18 6.52 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.198 -0.939 . . . . 0.0 110.268 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.19 147.4 22.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.882 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HG3' ' N ' ' A' ' 51' ' ' GLU . 16.2 pt-20 -57.53 -36.85 72.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 110.213 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.482 ' N ' ' HG3' ' A' ' 50' ' ' GLU . 8.6 mm-40 -66.87 -34.62 78.19 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 110.241 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -69.09 -53.34 20.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 110.204 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.419 ' NE1' ' HG3' ' A' ' 48' ' ' MET . 5.0 m95 -58.28 -27.96 64.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.109 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 -56.81 5.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.042 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.71 -39.42 65.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.881 . . . . 0.0 110.056 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.7 t -69.46 -32.0 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 110.13 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -49.78 69.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.333 -0.855 . . . . 0.0 110.14 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -65.9 -37.25 85.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.244 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.86 75.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.266 -0.896 . . . . 0.0 110.314 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HA ' ' HB3' ' A' ' 63' ' ' TRP . 38.1 ttm-85 -60.08 -28.93 68.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.176 -0.953 . . . . 0.0 110.33 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 1.8 tt0 -56.77 -60.84 2.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.219 -0.926 . . . . 0.0 110.172 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -69.55 -26.57 64.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 110.198 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.498 ' HB3' ' HA ' ' A' ' 60' ' ' ARG . 32.5 t90 -65.94 -20.16 66.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 110.338 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -96.96 -0.46 47.43 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.221 -0.924 . . . . 0.0 110.282 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 m -108.34 -60.52 1.72 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.933 . . . . 0.0 110.306 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.4 ' O ' ' C ' ' A' ' 67' ' ' GLY . 4.8 m-85 -107.17 7.65 29.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.167 -0.958 . . . . 0.0 110.29 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 66' ' ' PHE . . . 45.91 69.83 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.23 147.31 25.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -1.138 . . . . 0.0 110.181 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 5.7 t -116.19 83.71 13.04 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 110.237 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.62 169.85 21.36 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.953 1.502 . . . . 0.0 110.355 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.02 -160.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.012 1.533 . . . . 0.0 110.511 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 72' ' ' ILE . 25.1 mm -102.75 40.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.265 -0.897 . . . . 0.0 110.187 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.78 -58.82 1.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.268 -0.895 . . . . 0.0 110.256 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.7 mmt -61.76 -28.85 69.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.35 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' O ' ' OG1' ' A' ' 79' ' ' THR . 6.8 t -71.43 -38.07 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.91 . . . . 0.0 110.218 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.579 HG23 ' H ' ' A' ' 81' ' ' PHE . 1.0 OUTLIER -63.79 -27.03 68.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.174 -0.954 . . . . 0.0 110.189 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.87 -29.92 13.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 0.0 110.237 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.68 46.63 2.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.255 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 24.5 m -148.29 -50.58 0.17 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.275 -0.891 . . . . 0.0 110.243 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.15 66.68 1.16 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.579 ' H ' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -127.35 143.93 51.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.21 -1.171 . . . . 0.0 110.154 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.95 130.59 54.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.256 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.9 -34.24 62.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.182 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 19.8 tt0 -58.01 -55.23 37.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.304 -0.873 . . . . 0.0 110.221 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.447 ' CE ' HD11 ' A' ' 89' ' ' LEU . 1.3 tptm -51.97 -52.16 52.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 110.167 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 94' ' ' PRO . 57.3 mt -54.94 -31.04 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.29 -0.881 . . . . 0.0 110.086 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -67.88 -51.16 51.39 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -0.871 . . . . 0.0 110.222 179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -30.57 68.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.216 -0.927 . . . . 0.0 110.154 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.447 HD11 ' CE ' ' A' ' 85' ' ' LYS . 13.8 mt -73.32 -66.73 0.65 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.244 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 102.29 51.17 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.226 -0.921 . . . . 0.0 110.32 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.07 94.76 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.918 1.483 . . . . 0.0 110.442 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 177.7 -37.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.227 -0.92 . . . . 0.0 110.286 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 130.21 131.85 3.37 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.487 ' HB2' HG13 ' A' ' 72' ' ' ILE . 46.9 Cg_endo -73.37 -162.89 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.937 1.493 . . . . 0.0 110.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 56.08 -90.42 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.298 -0.876 . . . . 0.0 110.3 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.47 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 57.1 m-70 -59.43 -33.85 71.76 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.384 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -69.62 -67.15 2.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.62 -52.3 4.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -1.135 . . . . 0.0 110.332 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.86 -46.91 81.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.201 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -51.79 -36.73 48.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 110.225 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.6 t -74.43 -36.24 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.203 -0.936 . . . . 0.0 110.237 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.61 -21.69 61.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 110.222 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.94 72.33 0.95 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' HA ' ' HD2' ' A' ' 105' ' ' PRO . . . -135.21 103.62 10.53 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.192 -1.181 . . . . 0.0 110.195 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.447 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 45.7 Cg_endo -72.79 113.93 3.89 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.009 1.531 . . . . 0.0 110.48 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -49.43 105.96 0.57 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.92 . . . . 0.0 110.146 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 105' ' ' PRO . 46.8 Cg_endo -72.66 151.95 52.83 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.08 1.568 . . . . 0.0 110.496 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 108' ' ' THR . 84.9 m -109.53 49.02 0.85 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.332 -0.855 . . . . 0.0 110.212 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 94.3 116.88 2.81 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.31 155.55 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -1.158 . . . . 0.0 110.221 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.177 179.95 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.85 98.35 0.98 Allowed 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.083 1.57 . . . . 0.0 110.408 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.9 m -69.94 155.57 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.227 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -128.92 157.78 40.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.493 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.7 m -116.63 146.41 37.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.075 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.5 174.21 53.98 Favored 'Cis proline' 0 C--N 1.313 -1.33 0 C-N-CA 121.752 -2.187 . . . . 0.0 110.357 -0.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' ILE . . . -176.34 173.03 46.0 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.532 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -150.82 138.35 19.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.304 -1.115 . . . . 0.0 110.041 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.532 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 51.6 m-85 -145.22 171.31 14.73 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.31 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -104.47 111.56 24.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 110.11 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ASP . 91.6 t -118.86 107.79 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.23 -0.919 . . . . 0.0 110.263 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' VAL . 11.0 t0 66.06 64.73 0.53 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.24 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 44.7 32.12 2.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 2.3 mttp -129.03 165.0 22.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -1.145 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -122.14 113.43 19.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 93.1 t -111.08 145.72 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 0.0 110.101 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 3.5 tt -137.53 109.61 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.264 -0.898 . . . . 0.0 110.223 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' HB3' ' HA ' ' A' ' 22' ' ' CYS . 56.4 mt -78.25 134.64 37.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.202 -0.936 . . . . 0.0 110.158 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 4.6 t0 -67.11 -167.97 0.06 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 110.226 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -17.92 65.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 110.197 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -114.26 38.14 3.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.292 -0.88 . . . . 0.0 110.238 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 18' ' ' LEU . 53.1 m 47.68 39.09 9.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -0.885 . . . . 0.0 110.151 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -97.1 155.55 16.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.187 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.24 90.68 8.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.3 -0.875 . . . . 0.0 110.275 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.421 ' NE2' HG12 ' A' ' 17' ' ' ILE . 9.5 pt20 -83.62 -4.21 58.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -0.907 . . . . 0.0 110.175 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.457 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 1.8 t30 -121.39 62.74 12.6 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 25' ' ' GLN . 45.8 Cg_endo -72.86 -16.27 26.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.015 1.534 . . . . 0.0 110.396 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' OE2' ' HA ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -64.22 -25.06 67.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -0.881 . . . . 0.0 110.262 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.69 0.37 30.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -0.929 . . . . 0.0 110.168 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 35' ' ' ALA . 42.7 t90 -46.38 148.19 0.99 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 0.0 110.147 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.0 -168.45 2.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.227 -0.921 . . . . 0.0 110.154 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.579 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 4.9 tt0 -74.93 -55.35 5.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.18 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -30.87 71.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 110.203 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.9 t -70.01 -50.04 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 0.0 110.24 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.576 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -59.89 -50.83 72.23 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.198 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -57.62 -57.73 11.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.197 -0.94 . . . . 0.0 110.281 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' O ' ' OE1' ' A' ' 41' ' ' GLU . 59.1 t90 -47.78 -36.85 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 110.281 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.64 -57.1 8.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 110.266 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.575 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -51.38 -28.49 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.306 -0.871 . . . . 0.0 110.189 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -62.67 1.33 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -0.892 . . . . 0.0 110.219 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' OE1' ' O ' ' A' ' 37' ' ' TRP . 2.9 mp0 -48.97 -37.0 18.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 110.318 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.456 HD13 ' HA ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -80.78 -75.33 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 110.315 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.4 -76.8 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.288 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.68 38.65 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.575 HD12 ' HB1' ' A' ' 39' ' ' ALA . 43.1 mt -79.73 104.4 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 110.034 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -78.8 -19.09 52.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.334 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -151.61 96.46 2.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 110.262 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.46 ' SD ' HG21 ' A' ' 45' ' ' ILE . 70.8 mmm -52.06 103.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.301 -0.874 . . . . 0.0 110.039 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 1.0 HG22 ' ND1' ' A' ' 52' ' ' HIS . 2.3 t -55.99 160.34 2.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -0.87 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -52.61 -36.63 56.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.202 -0.936 . . . . 0.0 110.281 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.97 -35.29 79.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 0.0 110.311 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 1.0 ' ND1' HG22 ' A' ' 49' ' ' THR . 22.4 m170 -65.16 -60.53 2.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.192 -0.943 . . . . 0.0 110.541 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.579 ' CZ2' ' HG3' ' A' ' 32' ' ' GLU . 5.4 m95 -57.02 -34.22 67.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.305 -0.872 . . . . 0.0 110.733 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -62.91 -60.1 3.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.163 -0.961 . . . . 0.0 110.464 -179.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 86' ' ' ILE . 1.9 tp -52.3 -39.16 60.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.187 -0.946 . . . . 0.0 110.247 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 52' ' ' HIS . 60.8 t -68.6 -30.88 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.236 -0.915 . . . . 0.0 110.185 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -49.8 64.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.257 -0.902 . . . . 0.0 110.11 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.587 ' CE2' HG23 ' A' ' 79' ' ' THR . 0.7 OUTLIER -66.86 -34.35 77.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.26 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -63.05 -32.38 73.74 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 110.25 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -66.13 -49.46 67.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.18 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -43.75 -46.18 7.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.195 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -73.95 -32.1 63.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.218 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.453 ' CG ' ' O ' ' A' ' 63' ' ' TRP . 78.7 t90 -81.63 8.75 9.03 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.195 -0.941 . . . . 0.0 110.141 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -113.36 -17.59 12.24 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.225 -0.922 . . . . 0.0 110.21 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.69 -46.02 3.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 110.082 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.79 -50.91 9.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 110.163 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.08 25.12 4.27 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 t -167.03 168.06 14.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -1.153 . . . . 0.0 110.109 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.439 ' O ' ' SG ' ' A' ' 69' ' ' CYS . 23.5 p -114.01 104.72 54.86 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.894 . . . . 0.0 110.173 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.18 172.02 16.41 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.015 1.534 . . . . 0.0 110.433 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.87 -169.83 0.54 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.0 110.414 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 72' ' ' ILE . 45.6 mm -97.54 63.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.225 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -107.26 -63.09 1.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 23.4 mtm -74.77 -19.36 60.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 110.168 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.74 -29.99 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.231 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.431 ' O ' ' HA2' ' A' ' 80' ' ' GLY . 84.0 m -59.32 -36.72 76.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.319 -0.863 . . . . 0.0 110.261 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.04 -28.19 54.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 110.358 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 -76.12 0.24 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.26 -0.9 . . . . 0.0 110.313 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.587 HG23 ' CE2' ' A' ' 58' ' ' TYR . 66.5 p -67.3 -51.16 56.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 110.279 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 76' ' ' THR . . . 106.75 9.07 31.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.96 108.21 2.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -1.156 . . . . 0.0 110.142 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.07 139.38 47.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -0.872 . . . . 0.0 110.253 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.4 tp -60.16 -27.86 67.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.1 -49.32 72.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 110.154 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -51.52 -55.25 20.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 110.12 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mt -54.82 -39.19 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 110.17 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -60.26 -36.84 78.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 110.218 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -75.31 -27.37 59.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.907 . . . . 0.0 110.194 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.566 HD22 ' NE2' ' A' ' 52' ' ' HIS . 14.9 mt -92.48 -5.36 52.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 0.0 110.299 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -156.43 99.61 2.09 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 110.199 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 90' ' ' PHE . 46.1 Cg_endo -73.25 -17.53 24.26 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.996 1.524 . . . . 0.0 110.459 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 71.9 m -67.47 -29.89 69.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.265 -0.897 . . . . 0.0 110.23 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.85 147.71 8.48 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.12 -1.79 11.08 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.051 1.553 . . . . 0.0 110.48 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.453 ' O ' ' SG ' ' A' ' 99' ' ' CYS . . . -79.65 -86.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.216 -0.928 . . . . 0.0 110.239 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -73.85 -5.42 40.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.363 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 101' ' ' VAL . . . -65.23 -94.4 0.03 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' A' ' 59' ' ' LEU . . . -42.69 -27.26 0.16 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.257 -1.143 . . . . 0.0 110.275 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 95' ' ' ALA . 56.0 m -65.63 -79.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.255 -0.903 . . . . 0.0 110.227 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 99' ' ' CYS . 0.0 OUTLIER -43.04 -40.25 3.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.365 -0.834 . . . . 0.0 110.289 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 97' ' ' GLY . 92.1 t -55.91 -48.72 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.153 -0.967 . . . . 0.0 110.247 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -65.39 -49.64 68.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 110.204 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' ' 105' ' ' PRO . . . 133.61 54.38 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.27 111.51 28.46 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.256 -1.143 . . . . 0.0 110.228 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 103' ' ' GLY . 45.7 Cg_endo -73.62 -58.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.033 1.543 . . . . 0.0 110.527 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -116.47 107.51 46.85 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 110.305 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.53 -171.88 0.94 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.057 1.556 . . . . 0.0 110.323 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.88 69.45 1.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 110.226 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.42 -74.81 0.07 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.6 t -82.63 -171.0 3.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.304 -1.115 . . . . 0.0 110.131 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.238 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.544 ' CB ' ' CD ' ' A' ' 2' ' ' PRO . 16.7 mtt . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 120.705 0.288 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 1' ' ' MET . 45.9 Cg_endo -72.36 -166.03 0.25 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.974 1.513 . . . . 0.0 110.421 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.534 HG11 ' CH2' ' A' ' 37' ' ' TRP . 5.0 m -104.22 173.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.155 -0.965 . . . . 0.0 110.255 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.33 107.92 3.66 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.324 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 26.3 p -88.13 158.73 49.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.94 . . . . 0.0 110.098 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.45 145.05 82.3 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 121.667 -2.222 . . . . 0.0 110.476 -0.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.08 174.93 46.91 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 125.96 54.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 110.123 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -129.99 156.18 44.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 110.31 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -113.29 134.78 54.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.216 -0.927 . . . . 0.0 110.04 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 14' ' ' LYS . 99.0 t -116.3 94.92 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.483 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 13' ' ' GLY . 1.1 m-20 48.29 94.95 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 0.0 110.542 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 12' ' ' ASP . . . 43.0 59.52 3.31 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 11' ' ' VAL . 1.3 mttt -166.6 153.2 8.88 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -1.138 . . . . 0.0 110.109 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -116.73 145.84 43.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 110.279 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.99 138.1 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 110.13 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 17' ' ' ILE . 50.8 mt -117.36 96.85 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.928 . . . . 0.0 110.367 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.646 HD22 ' HA ' ' A' ' 22' ' ' CYS . 16.4 mt -75.02 121.91 22.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 0.0 110.166 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.441 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -69.84 -171.08 0.37 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.322 -0.861 . . . . 0.0 110.239 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -62.47 -16.89 57.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 0.0 110.157 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.29 36.72 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.159 -0.963 . . . . 0.0 110.15 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.646 ' HA ' HD22 ' A' ' 18' ' ' LEU . 1.3 m 50.61 29.07 3.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.231 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -84.57 141.14 30.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.2 -0.937 . . . . 0.0 110.215 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.5 ttt -89.46 115.06 26.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 110.225 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -92.7 22.89 4.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 110.248 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -133.2 67.06 76.62 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 110.321 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.07 -13.7 26.09 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.027 1.54 . . . . 0.0 110.452 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -78.17 -10.81 59.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 0.0 110.192 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' TRP . 21.6 t70 -110.93 -5.12 14.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 110.225 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.455 ' CE3' ' N ' ' A' ' 31' ' ' ASP . 12.0 t90 -44.0 143.15 1.19 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.249 -0.907 . . . . 0.0 110.188 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' N ' ' CE3' ' A' ' 30' ' ' TRP . 18.6 m-20 -159.93 -163.43 1.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.474 ' HG3' ' CZ2' ' A' ' 53' ' ' TRP . 0.6 OUTLIER -74.52 -58.76 3.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.223 -0.923 . . . . 0.0 110.282 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -65.41 -31.03 71.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.217 -0.927 . . . . 0.0 110.188 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.5 t -66.99 -53.02 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 110.236 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.483 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -63.08 -53.83 47.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 110.344 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HG3' ' CG ' ' A' ' 48' ' ' MET . 2.7 tt0 -52.33 -36.23 52.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.268 -0.895 . . . . 0.0 110.32 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.534 ' CH2' HG11 ' A' ' 3' ' ' VAL . 28.1 t90 -70.08 -38.13 75.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.66 -51.54 66.84 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 0.0 110.281 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.709 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -68.65 -26.53 65.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.261 -0.899 . . . . 0.0 110.289 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.455 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -68.7 -44.61 73.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.503 -179.731 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.418 ' OE1' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -77.31 -36.93 53.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.144 -0.972 . . . . 0.0 110.797 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -58.56 2.62 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.0 110.677 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -16.63 55.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.188 -0.945 . . . . 0.0 110.472 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 85.48 14.64 67.88 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.709 HD12 ' HB1' ' A' ' 39' ' ' ALA . 8.0 mt -67.23 101.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.247 -1.149 . . . . 0.0 110.122 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -70.48 -13.87 62.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.318 -0.864 . . . . 0.0 110.235 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.8 tptt -168.32 120.21 0.82 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.508 ' CG ' ' HG3' ' A' ' 36' ' ' GLU . 31.5 mmm -67.74 131.68 46.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.29 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.0 p -78.68 -167.16 1.02 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 0.0 110.188 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -79.99 -52.61 7.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.193 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -56.61 -30.63 63.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.9 . . . . 0.0 110.124 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.437 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -57.54 -61.05 2.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.193 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.483 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 3.7 m95 -57.21 -33.7 67.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -0.869 . . . . 0.0 110.241 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 57' ' ' LYS . 4.2 tmtm? -58.2 -57.14 14.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.198 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tp -56.9 -50.88 71.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.288 -0.882 . . . . 0.0 110.198 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 52' ' ' HIS . 47.7 t -54.14 -29.04 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 110.229 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 54' ' ' LYS . 9.5 mmtt -73.44 -53.79 9.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 110.261 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.427 ' O ' ' HB2' ' A' ' 62' ' ' TYR . 3.1 t80 -51.3 -41.28 60.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.296 -0.878 . . . . 0.0 110.342 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.29 -49.53 77.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.306 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.98 -60.34 4.02 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.264 -0.897 . . . . 0.0 110.344 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.0 -27.01 4.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.29 -0.881 . . . . 0.0 110.361 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.8 -37.66 58.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.203 -0.936 . . . . 0.0 110.425 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.481 ' CZ2' ' HG2' ' A' ' 105' ' ' PRO . 41.9 t90 -65.05 -22.22 66.94 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.292 -0.88 . . . . 0.0 110.314 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -63.19 -59.06 5.25 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.211 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.7 m -75.89 -58.52 3.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.247 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -65.3 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.925 . . . . 0.0 110.209 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.23 18.94 3.66 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.537 HG23 ' HD3' ' A' ' 70' ' ' PRO . 8.8 t -141.22 174.22 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.148 . . . . 0.0 110.135 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 t -124.69 84.69 57.51 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.243 -0.911 . . . . 0.0 110.264 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD3' HG23 ' A' ' 68' ' ' THR . 46.2 Cg_endo -73.17 173.73 13.2 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.981 1.516 . . . . 0.0 110.366 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 70' ' ' PRO . 46.7 Cg_endo -73.09 160.44 45.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.002 1.528 . . . . 0.0 110.313 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 7.1 tt -79.03 -7.06 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.145 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -55.1 -62.81 1.42 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -63.74 -27.08 68.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.384 -0.822 . . . . 0.0 110.071 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.4 t -64.84 -34.22 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.875 . . . . 0.0 110.235 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -54.8 -27.65 43.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -0.893 . . . . 0.0 110.208 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -65.04 -39.4 93.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 110.151 179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -70.05 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 110.113 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.2 p -46.8 -39.09 11.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.874 . . . . 0.0 110.168 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.91 8.7 84.98 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -55.4 171.82 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.196 -1.179 . . . . 0.0 110.164 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.807 ' O ' HD12 ' A' ' 86' ' ' ILE . 15.8 m -113.94 147.23 38.9 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 13.0 tp -60.44 -27.9 67.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.43 -46.43 90.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 110.268 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 mtmt -63.67 -59.95 3.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.0 110.272 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.807 HD12 ' O ' ' A' ' 82' ' ' SER . 3.5 mt -47.01 -33.04 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.377 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -77.0 -36.32 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.222 -0.923 . . . . 0.0 110.378 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -68.63 -24.36 64.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.37 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.3 mt -90.22 -49.99 6.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.222 -0.924 . . . . 0.0 110.336 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -98.43 167.22 11.86 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.184 -0.948 . . . . 0.0 110.217 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.68 -89.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.998 1.525 . . . . 0.0 110.505 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 93' ' ' GLY . 42.7 t -104.68 85.77 2.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.194 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 61.3 139.96 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 46.4 Cg_endo -73.05 -90.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.061 1.558 . . . . 0.0 110.339 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 62.28 -132.94 0.54 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.934 . . . . 0.0 110.188 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 8.2 p-80 -42.28 -25.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.0 110.582 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.515 ' N ' ' CD2' ' A' ' 96' ' ' HIS . . . -66.63 -74.56 0.53 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.17 -48.1 4.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.317 -1.107 . . . . 0.0 110.498 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 9.4 t -57.01 -44.09 82.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.185 -0.947 . . . . 0.0 110.468 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -60.64 -58.22 9.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 110.373 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.0 t -46.76 -41.99 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.251 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.5 -53.29 59.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 0.0 110.201 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 84.52 52.23 3.61 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -88.83 120.82 70.13 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.209 -1.171 . . . . 0.0 110.172 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.481 ' HG2' ' CZ2' ' A' ' 63' ' ' TRP . 46.0 Cg_endo -72.33 140.29 33.42 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.875 1.46 . . . . 0.0 110.486 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.31 147.88 45.78 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.273 -0.892 . . . . 0.0 110.17 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.49 -59.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.992 1.522 . . . . 0.0 110.576 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 32.1 p -69.88 173.6 6.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 0.0 110.211 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.42 ' O ' ' SG ' ' A' ' 110' ' ' CYS . . . -171.99 117.31 0.67 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.42 ' SG ' ' O ' ' A' ' 109' ' ' GLY . 70.9 m -149.92 88.99 1.57 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.217 -1.167 . . . . 0.0 110.212 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 111' ' ' VAL . 21.5 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.152 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.8 0.333 . . . . 0.0 110.202 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' A' ' 1' ' ' MET . 46.1 Cg_endo -73.23 178.0 7.14 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.965 1.508 . . . . 0.0 110.377 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.524 HG21 ' HG3' ' A' ' 41' ' ' GLU . 13.2 t -69.1 125.91 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 110.131 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.02 133.68 55.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 110.157 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 62.3 m -103.09 150.38 37.81 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 110.176 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.4 Cg_endo -76.36 165.6 84.88 Favored 'Cis proline' 0 C--N 1.313 -1.317 0 C-N-CA 121.612 -2.245 . . . . 0.0 110.412 -0.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 154.91 20.26 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -111.33 152.56 27.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -1.144 . . . . 0.0 110.168 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -149.15 157.06 43.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.244 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.481 ' C ' HG23 ' A' ' 11' ' ' VAL . 1.1 tp60 -110.55 145.01 38.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 110.243 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.481 HG23 ' C ' ' A' ' 10' ' ' GLN . 22.7 t -148.79 110.57 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.217 -0.927 . . . . 0.0 110.023 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t0 58.51 -143.85 0.61 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.212 -0.93 . . . . 0.0 109.951 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.42 50.44 2.99 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.0 146.36 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.243 . . . . 0.0 110.319 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.98 143.18 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 110.098 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 17' ' ' ILE . 85.0 t -127.79 162.31 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.93 . . . . 0.0 110.351 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.476 HG12 ' N ' ' A' ' 18' ' ' LEU . 8.7 tt -148.96 164.37 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 110.115 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' ' 17' ' ' ILE . 16.6 mt -136.43 115.78 12.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.248 -0.908 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -57.74 -169.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.335 -0.853 . . . . 0.0 110.178 -179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.47 -20.71 66.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.212 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.32 38.85 2.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.5 m 48.46 42.57 18.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -96.52 145.13 25.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 110.147 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.431 ' SD ' HD12 ' A' ' 38' ' ' LEU . 2.1 mtp -82.81 105.43 13.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.235 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.33 19.42 13.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -129.51 71.81 82.04 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.69 -30.5 11.7 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 124.139 1.6 . . . . 0.0 110.418 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -67.09 -16.9 64.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.257 -0.902 . . . . 0.0 110.232 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.83 35.68 3.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.317 -0.864 . . . . 0.0 110.136 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -90.85 153.59 20.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.191 -0.943 . . . . 0.0 110.141 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -171.84 -168.08 0.55 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 0.0 110.204 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.497 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 2.5 mt-10 -72.12 -57.06 4.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 110.198 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.77 -29.99 67.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.283 -0.886 . . . . 0.0 110.199 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.34 -57.27 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.288 -0.882 . . . . 0.0 110.244 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -55.44 -38.74 69.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.309 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -52.23 63.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 0.0 110.23 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.444 ' CZ2' ' OE2' ' A' ' 41' ' ' GLU . 57.9 t90 -56.87 -33.13 66.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.0 110.236 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 38' ' ' LEU . 4.8 tt -69.57 -42.9 73.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.207 -0.933 . . . . 0.0 110.207 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.55 -31.43 72.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.217 -0.927 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -74.63 -44.07 52.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.154 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HG3' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -62.97 -36.93 85.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.317 -0.865 . . . . 0.0 110.145 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 mp -83.46 -67.75 0.77 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.913 . . . . 0.0 110.256 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.401 ' OE1' ' CD1' ' A' ' 45' ' ' ILE . 4.3 tt0 -80.44 -66.38 0.89 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 0.0 110.186 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.61 -13.9 2.0 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.401 ' CD1' ' OE1' ' A' ' 43' ' ' GLU . 33.7 mt -44.19 134.29 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.231 -1.158 . . . . 0.0 110.194 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -106.77 3.85 26.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 110.212 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -161.03 91.29 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 0.0 110.286 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.559 ' SD ' ' CZ2' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -44.95 123.85 4.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 52' ' ' HIS . 3.3 t -73.83 158.42 34.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 110.257 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.93 -34.47 55.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 110.15 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.24 -43.34 92.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.0 110.095 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.799 ' CE1' HD22 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -58.25 -56.66 19.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.287 -0.883 . . . . 0.0 110.224 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.651 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 6.6 m95 -59.29 -27.31 65.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.274 -0.891 . . . . 0.0 110.311 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 -67.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.188 -0.945 . . . . 0.0 110.283 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.1 tp -54.61 -32.44 58.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.287 -0.883 . . . . 0.0 110.152 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.0 t -68.72 -33.53 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 110.086 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.47 -42.43 68.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.275 -0.89 . . . . 0.0 110.136 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.37 -44.42 94.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 110.212 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.7 mt -58.15 -50.99 71.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.244 -0.91 . . . . 0.0 110.236 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -49.17 -50.05 39.66 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 110.381 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -52.78 -38.97 61.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 0.0 110.457 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -45.58 74.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 0.0 110.394 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 48.9 t90 -52.86 -46.52 67.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.212 -0.93 . . . . 0.0 110.334 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.16 -35.48 80.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.334 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.2 m -64.66 -33.99 77.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -142.11 -69.18 0.36 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.27 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.62 79.11 0.38 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.447 HG23 ' HD3' ' A' ' 70' ' ' PRO . 5.3 t -162.7 159.88 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.186 -1.185 . . . . 0.0 110.18 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.6 t -112.6 82.52 4.9 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 110.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HD3' HG23 ' A' ' 68' ' ' THR . 45.1 Cg_endo -73.42 160.25 44.99 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.045 1.55 . . . . 0.0 110.467 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -73.15 -89.62 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.095 1.576 . . . . 0.0 110.454 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 72' ' ' ILE . 0.7 OUTLIER -172.14 42.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.21 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.16 -64.83 1.05 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.274 -0.891 . . . . 0.0 110.15 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -40.22 95.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.265 -0.897 . . . . 0.0 110.188 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.455 ' O ' ' OG1' ' A' ' 79' ' ' THR . 20.8 t -52.63 -37.17 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m -66.19 -33.58 76.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 0.0 110.201 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -74.17 -33.1 63.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.59 -35.39 62.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.261 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 1.0 OUTLIER -107.44 -78.44 0.59 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 110.192 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.22 38.42 0.23 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -91.99 128.9 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -1.14 . . . . 0.0 110.234 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 84' ' ' GLU . 72.4 m -77.83 134.68 37.94 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.262 -0.898 . . . . 0.0 110.238 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 82' ' ' SER . 1.3 tp -42.8 -26.97 0.15 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.26 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -60.73 -53.3 59.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 110.34 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -47.92 79.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 110.297 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.64 -30.73 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -72.35 -48.08 44.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.201 -0.937 . . . . 0.0 110.263 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -38.5 80.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.174 -0.954 . . . . 0.0 110.127 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD22 ' CE1' ' A' ' 52' ' ' HIS . 8.1 mt -68.36 -65.58 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.905 . . . . 0.0 110.084 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.465 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 3.1 m-85 -82.25 173.7 7.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 110.152 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 90' ' ' PHE . 44.3 Cg_endo -73.65 -88.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.984 1.518 . . . . 0.0 110.447 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.6 p -155.86 80.1 1.0 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.189 -0.944 . . . . 0.0 110.272 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.56 82.85 0.04 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.07 -17.63 24.66 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.932 1.49 . . . . 0.0 110.432 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.77 -88.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -76.81 -2.26 32.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.941 . . . . 0.0 110.191 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -79.18 -70.41 1.33 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -50.81 -36.53 37.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -1.129 . . . . 0.0 110.188 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 5.2 m -70.26 -52.74 20.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.943 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.94 -33.25 36.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 110.173 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.446 HG21 ' HZ ' ' A' ' 90' ' ' PHE . 25.1 t -73.62 -45.23 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.196 -0.94 . . . . 0.0 110.092 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.98 -21.63 66.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.156 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 105' ' ' PRO . . . 82.74 53.9 3.41 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.55 107.85 29.74 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.205 -1.174 . . . . 0.0 110.135 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 103' ' ' GLY . 47.5 Cg_endo -74.21 0.81 7.99 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.019 1.536 . . . . 0.0 110.622 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.84 88.66 50.41 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.45 -46.81 0.33 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.042 1.548 . . . . 0.0 110.436 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 46.5 m -56.48 103.5 0.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.282 -0.886 . . . . 0.0 110.178 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.91 48.99 0.89 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -169.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.31 -1.112 . . . . 0.0 110.173 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.603 ' O ' HG12 ' A' ' 111' ' ' VAL . 45.0 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.251 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 120.788 0.328 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.67 -178.29 3.33 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.989 1.521 . . . . 0.0 110.417 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 9' ' ' TYR . 7.0 m -141.42 161.17 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.45 148.0 52.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.241 -0.912 . . . . 0.0 110.15 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 21.4 m -102.84 141.11 21.83 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.2 -0.938 . . . . 0.0 110.151 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.474 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.2 Cg_endo -75.36 159.21 97.94 Favored 'Cis proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.833 -2.153 . . . . 0.0 110.314 -0.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.77 136.34 3.01 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.448 ' OE2' HG12 ' A' ' 17' ' ' ILE . 12.4 tt0 -101.24 142.53 32.52 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.323 -1.104 . . . . 0.0 110.172 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CE2' HG12 ' A' ' 3' ' ' VAL . 25.5 m-85 -150.68 148.49 28.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.231 -0.918 . . . . 0.0 110.32 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -101.77 143.95 31.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.236 -0.915 . . . . 0.0 110.065 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' CG ' ' A' ' 14' ' ' LYS . 43.7 t -120.37 94.87 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.164 -0.96 . . . . 0.0 110.448 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.41 63.68 2.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 110.52 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.53 14.48 79.55 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.509 ' CG ' ' O ' ' A' ' 11' ' ' VAL . 16.1 mmtt -102.82 169.96 8.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.152 -1.205 . . . . 0.0 110.162 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.53 108.57 10.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 110.104 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.558 HG13 ' HB3' ' A' ' 24' ' ' MET . 55.2 t -116.73 145.07 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 110.26 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.448 HG12 ' OE2' ' A' ' 8' ' ' GLU . 3.6 mt -134.51 97.47 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.6 mt -71.79 110.15 6.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.294 -0.878 . . . . 0.0 110.273 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -68.46 -141.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.228 -0.92 . . . . 0.0 110.121 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -84.77 -2.71 58.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.304 -0.872 . . . . 0.0 110.145 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.42 38.01 4.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.271 -0.893 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.3 m 47.9 49.14 17.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -119.69 116.19 25.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.219 -0.926 . . . . 0.0 110.219 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.558 ' HB3' HG13 ' A' ' 16' ' ' VAL . 1.8 ptp -51.83 -21.75 3.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.319 -0.863 . . . . 0.0 110.296 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.63 29.81 5.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.012 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.62 75.97 36.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.322 -0.861 . . . . 0.0 110.175 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.84 -21.46 24.76 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.007 1.53 . . . . 0.0 110.408 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -38.34 73.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.318 -0.864 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.74 -2.77 57.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.169 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -61.93 125.6 24.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.149 -0.969 . . . . 0.0 110.277 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -137.3 -162.9 1.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 0.0 110.248 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.495 ' HA ' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -72.14 -62.43 1.44 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -0.965 . . . . 0.0 110.284 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -48.29 -49.28 34.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.9 t -56.31 -52.1 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.236 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -50.77 -36.19 35.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 32' ' ' GLU . 46.2 mt-10 -72.85 -36.61 67.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.215 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 57.0 t90 -60.49 -48.13 83.1 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.397 -0.815 . . . . 0.0 110.31 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 42' ' ' LEU . 8.1 mt -67.36 -51.21 54.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.301 -0.874 . . . . 0.0 110.32 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.488 ' HB1' HD12 ' A' ' 45' ' ' ILE . . . -53.75 -29.17 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.239 -0.913 . . . . 0.0 110.238 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER -77.07 -60.82 2.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 0.0 110.264 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.95 -35.35 6.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.268 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 ' O ' ' A' ' 38' ' ' LEU . 6.0 mp -80.16 -66.53 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -89.81 -47.62 7.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.237 -0.914 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 40' ' ' ARG . . . 119.47 13.69 6.16 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.488 HD12 ' HB1' ' A' ' 39' ' ' ALA . 63.2 mt -54.8 92.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -1.158 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 44' ' ' GLY . 3.5 mp0 -57.48 -35.79 70.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.263 -0.898 . . . . 0.0 110.216 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 146.1 46.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.186 -0.946 . . . . 0.0 110.208 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.508 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -85.07 134.74 34.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.325 -0.859 . . . . 0.0 110.208 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 46.3 p -93.36 -179.13 4.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.25 -0.906 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -79.42 -21.7 45.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 0.0 110.27 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -77.05 -36.25 56.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.256 -0.902 . . . . 0.0 110.319 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -71.09 -54.8 9.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.207 -0.933 . . . . 0.0 110.416 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.515 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 3.0 m95 -57.67 -33.22 68.11 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -67.33 -59.09 3.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 110.142 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.56 -35.77 31.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 110.154 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.4 t -69.89 -40.37 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.203 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -63.04 -35.44 80.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 0.0 110.237 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -75.2 -36.85 61.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.244 -0.91 . . . . 0.0 110.247 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.3 tp -60.2 -29.43 68.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.25 -0.907 . . . . 0.0 110.226 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.29 -59.64 3.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -0.924 . . . . 0.0 110.203 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -44.85 -45.94 10.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.915 . . . . 0.0 110.247 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -44.79 96.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 0.0 110.283 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 21.4 t90 -67.88 -14.5 63.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.329 -0.857 . . . . 0.0 110.287 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.17 -49.83 8.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 110.302 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -45.95 -49.09 16.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.195 -0.941 . . . . 0.0 110.208 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -134.65 -72.46 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 110.202 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.16 89.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.412 ' HB ' ' HD3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -158.04 174.86 14.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.199 -1.177 . . . . 0.0 110.014 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.409 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -153.58 57.52 1.95 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 110.274 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.412 ' HD3' ' HB ' ' A' ' 68' ' ' THR . 46.3 Cg_endo -73.02 171.79 16.82 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.975 1.513 . . . . 0.0 110.41 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.575 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . 45.9 Cg_endo -72.68 171.7 16.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.098 1.578 . . . . 0.0 110.498 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.798 HG21 ' CD1' ' A' ' 86' ' ' ILE . 3.5 tp -68.08 135.94 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.291 -0.881 . . . . 0.0 110.258 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -178.54 -57.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.851 . . . . 0.0 109.98 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -27.18 34.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.048 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 t -77.04 -27.52 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.277 -0.889 . . . . 0.0 110.206 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.1 m -54.95 -38.82 68.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 110.319 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.57 -36.97 16.69 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 0.0 110.396 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.432 ' HA ' ' OE1' ' A' ' 78' ' ' GLU . 13.5 mm-40 -87.98 -32.64 18.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.218 -0.926 . . . . 0.0 110.28 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -97.2 -74.91 0.56 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 0.0 110.218 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.01 36.88 1.09 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -92.64 88.31 6.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.188 -1.183 . . . . 0.0 110.228 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.4 m -49.29 136.07 16.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.165 -0.959 . . . . 0.0 110.227 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 72' ' ' ILE . 1.2 mp -44.16 -31.92 1.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 110.282 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.22 -53.8 48.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.275 -0.891 . . . . 0.0 110.249 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -48.55 81.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.798 ' CD1' HG21 ' A' ' 72' ' ' ILE . 79.2 mt -53.37 -29.4 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.242 -0.912 . . . . 0.0 110.151 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -77.02 -45.22 27.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 110.233 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -59.12 -33.56 71.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.216 -0.928 . . . . 0.0 110.267 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.7 mt -85.91 -63.89 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.25 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.446 ' HE2' HG21 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -101.26 106.48 45.54 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.86 -38.13 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.973 1.512 . . . . 0.0 110.476 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -49.3 -28.81 5.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.271 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.43 151.59 18.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.651 ' O ' ' HB3' ' A' ' 95' ' ' ALA . 45.7 Cg_endo -73.41 -170.33 0.64 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 124.017 1.535 . . . . 0.0 110.445 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 94' ' ' PRO . . . 66.85 -84.34 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.339 -0.851 . . . . 0.0 110.399 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HG3' ' A' ' 100' ' ' LYS . 0.9 OUTLIER -74.24 -34.05 63.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.03 -1.044 . . . . 0.0 110.379 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.2 -58.64 5.01 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.39 -44.93 72.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -1.161 . . . . 0.0 110.376 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 95' ' ' ALA . 5.4 t -61.18 -51.06 70.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 0.0 110.341 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 96' ' ' HIS . 0.7 OUTLIER -48.82 -50.09 36.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 110.285 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.446 HG21 ' HE2' ' A' ' 90' ' ' PHE . 52.1 t -64.15 -35.65 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 0.0 110.423 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.81 -27.64 69.02 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.258 -0.901 . . . . 0.0 110.294 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.71 36.24 29.79 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.12 126.9 55.49 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.281 -1.129 . . . . 0.0 110.177 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.78 131.32 15.69 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.888 1.468 . . . . 0.0 110.371 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -113.69 111.71 48.64 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.82 86.66 1.05 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.953 1.502 . . . . 0.0 110.391 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 108' ' ' THR . 9.8 t -55.65 117.63 3.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.885 . . . . 0.0 110.242 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.53 95.89 0.23 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -53.68 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.219 -1.165 . . . . 0.0 110.185 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.281 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.731 0.301 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.49 166.8 28.79 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.038 1.546 . . . . 0.0 110.478 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.619 HG11 ' CD1' ' A' ' 18' ' ' LEU . 48.3 t -107.24 -26.9 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.28 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.9 mttt 53.7 96.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.499 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 61.5 m -97.11 157.83 34.31 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 110.217 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.8 Cg_endo -75.5 170.8 70.85 Favored 'Cis proline' 0 C--N 1.312 -1.357 0 C-N-CA 121.672 -2.22 . . . . 0.0 110.387 -0.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . -177.02 150.66 10.42 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -106.43 137.26 44.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.338 -1.095 . . . . 0.0 110.301 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.482 ' CE2' HG13 ' A' ' 3' ' ' VAL . 73.0 m-85 -134.66 170.64 15.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.262 -0.898 . . . . 0.0 110.167 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.92 140.65 51.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 110.272 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 39.5 t -122.98 99.13 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -0.835 . . . . 0.0 110.036 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 11' ' ' VAL . 10.0 t0 55.89 -88.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.288 -0.882 . . . . 0.0 110.179 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -130.91 62.83 0.64 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.32 157.17 17.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -1.1 . . . . 0.0 110.241 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -114.88 133.91 55.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.8 t -126.93 124.9 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.914 . . . . 0.0 110.196 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.14 97.98 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.98 . . . . 0.0 110.311 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.619 ' CD1' HG11 ' A' ' 3' ' ' VAL . 20.5 mt -67.48 108.54 2.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 18' ' ' LEU . 34.3 t0 -49.62 -179.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.819 . . . . 0.0 110.102 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -62.58 -15.81 53.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.915 . . . . 0.0 110.223 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 20' ' ' GLU . 1.5 m-20 -117.07 41.99 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.0 m 48.2 49.91 16.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.231 -0.918 . . . . 0.0 110.218 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -109.65 161.45 15.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.272 -0.892 . . . . 0.0 110.254 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.424 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -89.73 108.85 19.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 110.233 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -83.82 4.57 28.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 110.162 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.505 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 4.3 m-20 -131.62 51.97 8.41 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.879 . . . . 0.0 110.208 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 26' ' ' ASN . 45.1 Cg_endo -72.56 -13.52 27.44 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.032 1.543 . . . . 0.0 110.474 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.86 -37.65 82.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 30' ' ' TRP . 0.9 OUTLIER -95.78 -70.79 0.7 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.264 -0.897 . . . . 0.0 110.213 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.577 ' CD2' ' N ' ' A' ' 31' ' ' ASP . 37.2 t90 55.78 163.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.155 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.577 ' N ' ' CD2' ' A' ' 30' ' ' TRP . 0.8 OUTLIER -172.86 -172.93 0.91 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.157 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -71.87 -41.33 68.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.274 -0.891 . . . . 0.0 110.114 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -70.06 -32.43 70.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.181 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.9 t -70.04 -51.23 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 110.142 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.62 44.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.07 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.24 -39.84 70.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.353 -0.842 . . . . 0.0 110.212 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.481 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 83.3 t90 -64.57 -31.79 73.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.296 -0.877 . . . . 0.0 110.184 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.409 HD11 ' HG2' ' A' ' 24' ' ' MET . 5.3 mt -70.79 -44.18 67.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 110.352 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.73 -30.36 67.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.88 . . . . 0.0 110.388 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -76.76 -36.04 57.33 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 37' ' ' TRP . 3.2 mm-40 -77.18 -27.02 53.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.554 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mp -98.2 -62.45 1.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.175 -0.953 . . . . 0.0 110.551 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.04 -78.12 0.17 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.158 -0.964 . . . . 0.0 110.285 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.99 51.48 0.04 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -112.88 107.8 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -1.105 . . . . 0.0 110.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -42.73 -43.36 3.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.311 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.42 143.11 28.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 110.242 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.29 125.33 22.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.311 -0.868 . . . . 0.0 110.208 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 49' ' ' THR . 19.0 p -70.76 160.84 31.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.224 -0.923 . . . . 0.0 110.226 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -54.08 -27.34 32.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.23 -0.919 . . . . 0.0 110.273 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -73.6 -41.4 62.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 110.394 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -61.83 -48.81 78.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 110.438 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 2.0 m95 -65.82 -31.94 73.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.41 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 50' ' ' GLU . 1.4 tttt -64.57 -66.37 0.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.343 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.521 HD11 HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -53.94 -49.98 67.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.326 -0.859 . . . . 0.0 110.307 -179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.786 HG21 HG11 ' A' ' 101' ' ' VAL . 34.3 t -55.33 -31.41 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.233 -0.917 . . . . 0.0 110.33 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -70.29 -46.64 63.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.211 -0.93 . . . . 0.0 110.192 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -60.2 -34.72 74.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.877 . . . . 0.0 110.378 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -43.3 86.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.223 -0.923 . . . . 0.0 110.453 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.25 -55.81 27.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 110.436 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -50.06 -27.38 5.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.947 . . . . 0.0 110.347 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.572 ' CG ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -76.8 -42.32 41.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.972 . . . . 0.0 110.391 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.569 ' CE3' ' O ' ' A' ' 63' ' ' TRP . 19.2 t90 -58.18 -20.31 40.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.304 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.54 -42.14 30.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.222 -0.923 . . . . 0.0 110.31 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -60.26 3.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.222 -0.924 . . . . 0.0 110.342 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -116.99 -33.78 4.62 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.907 . . . . 0.0 110.343 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 63' ' ' TRP . . . 93.01 71.59 1.17 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.3 t -166.09 -175.15 3.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.211 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.0 m -102.3 106.01 46.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.277 -0.89 . . . . 0.0 110.201 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.572 ' HG3' ' CG ' ' A' ' 62' ' ' TYR . 45.8 Cg_endo -72.94 144.92 39.21 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.052 1.553 . . . . 0.0 110.459 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.21 -178.28 3.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.091 1.574 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.2 mm -92.8 62.43 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 110.198 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.6 mtmm -130.89 -50.43 1.04 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.242 -0.911 . . . . 0.0 110.228 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 74' ' ' MET . 0.9 OUTLIER -67.23 -37.75 84.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.249 -0.907 . . . . 0.0 110.282 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.1 t -65.59 -55.76 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 84.0 m -52.87 -26.84 15.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.17 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -47.92 -41.46 24.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 110.379 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -136.98 32.7 2.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 0.0 110.351 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.893 HG22 ' CD1' ' A' ' 81' ' ' PHE . 46.2 m -123.77 -22.33 4.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.957 . . . . 0.0 110.288 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.79 20.13 78.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.893 ' CD1' HG22 ' A' ' 79' ' ' THR . 3.3 m-85 -96.55 172.68 7.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -1.144 . . . . 0.0 110.121 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.6 148.92 34.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 110.308 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 21.5 tp -58.65 -27.59 64.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.902 . . . . 0.0 110.222 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -62.56 -52.2 64.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.149 -0.969 . . . . 0.0 110.155 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.86 -33.21 68.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.337 -0.852 . . . . 0.0 110.077 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.521 HD11 HD11 ' A' ' 55' ' ' LEU . 50.4 mt -73.67 -29.01 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.865 . . . . 0.0 110.073 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.16 -35.76 66.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -40.8 50.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.05 -39.44 79.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.293 -0.879 . . . . 0.0 110.242 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.56 116.14 32.08 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.067 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.76 -7.82 20.61 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.878 1.462 . . . . 0.0 110.579 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 92' ' ' SER . 1.3 t -104.11 21.3 16.72 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.174 -0.954 . . . . 0.0 110.332 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 92' ' ' SER . . . 59.06 161.04 0.06 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 95' ' ' ALA . 47.6 Cg_endo -73.09 -16.68 25.29 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.977 1.514 . . . . 0.0 110.545 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.465 ' O ' ' O ' ' A' ' 94' ' ' PRO . . . -45.57 -95.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -77.2 -2.91 36.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 110.209 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -74.55 -91.96 0.16 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -43.1 -34.31 1.04 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.26 -1.141 . . . . 0.0 110.396 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.16 -62.37 1.66 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 110.454 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.02 -38.01 48.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.285 -0.884 . . . . 0.0 110.367 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.786 HG11 HG21 ' A' ' 56' ' ' VAL . 52.6 t -58.97 -59.08 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.938 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 56' ' ' VAL . . . -71.64 -7.07 45.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 110.305 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.79 79.45 1.01 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.11 90.63 13.62 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.246 -1.149 . . . . 0.0 110.201 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.442 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 46.1 Cg_endo -72.22 174.41 11.49 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.942 1.496 . . . . 0.0 110.443 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -141.83 107.82 5.91 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.266 -0.896 . . . . 0.0 110.357 -179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.61 118.83 5.77 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.954 1.502 . . . . 0.0 110.385 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.2 t -123.21 11.55 9.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 115.47 -162.69 12.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.403 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 30.1 p -98.49 17.91 17.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.243 -1.151 . . . . 0.0 110.202 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 110' ' ' CYS . 7.9 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.215 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.73 0.3 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.12 -33.0 7.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.061 1.558 . . . . 0.0 110.459 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG13 ' CD1' ' A' ' 18' ' ' LEU . 56.6 t -97.87 101.23 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.249 -0.907 . . . . 0.0 110.162 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 mptt -96.14 109.32 21.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.512 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 31.6 p -108.94 152.09 42.22 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.0 110.219 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 49.1 Cg_endo -75.57 161.59 94.13 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 121.644 -2.232 . . . . 0.0 110.548 -0.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.02 47.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -104.66 121.69 44.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.224 -1.163 . . . . 0.0 110.364 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -137.09 155.44 49.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.244 -0.91 . . . . 0.0 110.143 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -117.31 145.62 43.88 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.309 -0.87 . . . . 0.0 110.26 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.509 ' O ' ' N ' ' A' ' 13' ' ' GLY . 42.4 t -125.66 125.83 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.0 110.251 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.86 -91.01 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.295 -0.878 . . . . 0.0 110.362 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' VAL . . . -137.98 59.44 0.61 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.16 170.34 19.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -1.201 . . . . 0.0 110.225 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.02 136.21 54.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.216 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.603 HG13 ' HG2' ' A' ' 24' ' ' MET . 56.0 t -137.67 144.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.275 -0.891 . . . . 0.0 110.119 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.5 mt -112.29 105.85 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.172 -0.955 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.509 ' O ' ' CB ' ' A' ' 6' ' ' PRO . 11.8 mt -62.64 129.61 41.34 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.289 -0.882 . . . . 0.0 110.086 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.418 ' C ' ' HB3' ' A' ' 6' ' ' PRO . 6.9 t0 -84.5 -160.43 0.47 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.343 -0.848 . . . . 0.0 110.307 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.45 -13.05 60.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.0 110.254 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -107.59 26.27 10.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 5' ' ' CYS . 2.7 m 50.7 23.73 1.47 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.256 -0.902 . . . . 0.0 110.135 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' A' ' 24' ' ' MET . 68.3 t80 -109.44 155.86 20.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.866 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.603 ' HG2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -59.79 138.07 57.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 110.212 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.82 -20.38 31.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 0.0 110.183 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -124.8 71.7 60.9 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 110.058 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.29 -9.43 25.36 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.031 1.542 . . . . 0.0 110.48 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -46.63 -35.79 6.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -0.934 . . . . 0.0 110.104 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 30' ' ' TRP . 53.5 m-20 -93.48 -74.67 0.52 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.344 -0.847 . . . . 0.0 110.052 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.532 ' CE2' ' HB2' ' A' ' 35' ' ' ALA . 82.9 t90 52.15 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.31 -0.869 . . . . 0.0 110.285 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -105.54 -170.61 1.77 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -71.99 -57.44 4.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 110.342 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -54.83 -27.37 41.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.226 -0.921 . . . . 0.0 110.372 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.64 -48.77 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.275 -0.891 . . . . 0.0 110.334 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.671 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -60.11 -48.23 82.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.935 . . . . 0.0 110.383 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.76 -42.93 97.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -0.908 . . . . 0.0 110.428 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' CZ3' HG21 ' A' ' 11' ' ' VAL . 39.3 t90 -57.25 -47.66 80.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.311 -0.868 . . . . 0.0 110.506 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 13.1 mt -62.52 -43.24 99.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.16 -0.963 . . . . 0.0 110.493 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.78 -26.99 67.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.141 -0.975 . . . . 0.0 110.439 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.422 ' O ' ' HA2' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -77.2 -43.77 32.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.298 -0.876 . . . . 0.0 110.732 -179.625 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -74.46 -27.82 60.76 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.147 -0.97 . . . . 0.0 110.682 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -80.61 -47.5 14.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.97 . . . . 0.0 110.395 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -102.31 -48.37 4.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.943 . . . . 0.0 110.258 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 40' ' ' ARG . . . 121.13 12.15 5.93 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.13 106.3 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -1.132 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.1 -46.53 8.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.249 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -154.64 121.41 5.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.0 110.264 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.488 ' SD ' ' CG ' ' A' ' 52' ' ' HIS . 31.1 mmm -44.44 133.05 5.83 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.247 -0.908 . . . . 0.0 110.147 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.526 HG23 ' N ' ' A' ' 50' ' ' GLU . 5.9 t -74.46 -155.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 110.12 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.526 ' N ' HG23 ' A' ' 49' ' ' THR . 15.6 tt0 -87.63 -48.57 7.79 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.231 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -59.86 -26.67 66.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 110.289 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CG ' ' SD ' ' A' ' 48' ' ' MET . 0.1 OUTLIER -63.57 -55.92 20.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.325 -0.86 . . . . 0.0 110.441 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.671 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 2.5 m95 -61.6 -50.09 73.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -52.12 -45.94 65.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 0.0 110.309 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.559 ' CD1' ' CE2' ' A' ' 81' ' ' PHE . 0.3 OUTLIER -62.19 -60.75 3.13 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -0.943 . . . . 0.0 110.302 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.8 t -49.2 -27.56 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.0 110.259 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.6 ttpt -71.86 -48.65 44.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 110.191 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -59.06 -37.25 76.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 110.271 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -43.48 73.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.212 -0.93 . . . . 0.0 110.284 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -53.98 -46.59 71.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.922 . . . . 0.0 110.267 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.32 -39.78 10.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.227 -0.921 . . . . 0.0 110.432 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.13 -36.54 55.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 0.0 110.454 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 7.9 t90 -76.36 2.64 12.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.188 -0.945 . . . . 0.0 110.432 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -116.53 -4.92 11.71 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.195 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.6 m -107.09 -44.09 4.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 110.158 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -114.01 -43.15 3.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 110.252 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.45 54.07 0.85 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.491 ' O ' ' HD3' ' A' ' 70' ' ' PRO . 18.6 m -146.28 146.44 30.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -1.137 . . . . 0.0 110.114 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 42.2 t -104.85 95.65 9.35 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 0.0 110.184 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 68' ' ' THR . 47.4 Cg_endo -73.47 163.43 37.65 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.974 1.512 . . . . 0.0 110.484 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.4 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 45.2 Cg_endo -72.65 -89.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.96 1.505 . . . . 0.0 110.457 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.506 ' O ' ' CG1' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -178.46 62.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.945 . . . . 0.0 110.243 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -119.93 -54.17 2.14 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.306 -0.871 . . . . 0.0 110.18 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -25.42 63.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 110.243 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 28.5 t -72.31 -42.33 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.6 m -67.55 -29.73 69.18 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -0.918 . . . . 0.0 110.192 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -38.76 5.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.214 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -99.34 -76.23 0.55 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 110.212 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 78' ' ' GLU . 54.7 p -42.86 -45.25 4.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.905 . . . . 0.0 110.229 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.08 34.69 46.25 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.559 ' CE2' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -58.63 116.64 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -1.111 . . . . 0.0 110.254 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.56 129.0 38.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 110.196 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.3 tp -48.82 -37.1 18.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.952 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.7 -45.36 63.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 110.137 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.9 -40.4 92.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 110.18 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' A' ' 94' ' ' PRO . 24.7 mm -66.26 -27.03 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.3 -0.875 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -45.3 32.93 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -0.949 . . . . 0.0 110.317 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -53.21 46.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.192 -0.942 . . . . 0.0 110.178 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 19.4 mt -62.34 -45.27 93.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 110.181 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -130.07 84.83 59.17 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.233 -0.917 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.448 ' O ' ' CB ' ' A' ' 92' ' ' SER . 46.2 Cg_endo -73.47 86.7 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.971 1.511 . . . . 0.0 110.406 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER 172.7 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 147.87 127.65 1.72 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 46.9 Cg_endo -72.91 -18.0 24.85 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.755 1.397 . . . . 0.0 110.435 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.08 -79.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.215 -0.928 . . . . 0.0 110.235 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB2' ' A' ' 100' ' ' LYS . 2.8 m170 -75.61 -5.37 45.07 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.181 -0.949 . . . . 0.0 110.273 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.441 ' O ' HG23 ' A' ' 101' ' ' VAL . . . -78.23 -84.26 0.55 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.41 -29.18 0.25 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.314 -1.11 . . . . 0.0 110.53 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 104' ' ' ALA . 2.4 t -73.98 -49.28 25.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.095 -1.003 . . . . 0.0 110.409 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 17.4 ttmm -61.18 -35.19 76.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.218 -0.926 . . . . 0.0 110.407 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 97' ' ' GLY . 9.1 t -73.56 -42.27 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.37 -21.6 64.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.271 -0.893 . . . . 0.0 110.319 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.44 67.22 0.92 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.713 ' HB3' ' SG ' ' A' ' 99' ' ' CYS . . . -138.41 136.57 19.24 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.273 -1.133 . . . . 0.0 110.218 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.64 143.48 37.97 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.943 1.496 . . . . 0.0 110.436 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -48.09 140.33 9.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 110.192 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.76 161.36 44.05 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.075 1.566 . . . . 0.0 110.501 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.0 m -102.77 118.48 36.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.9 . . . . 0.0 110.22 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 114.9 172.64 17.48 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 16.8 p -137.35 173.96 11.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -1.154 . . . . 0.0 110.278 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.211 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 120.813 0.339 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.93 -168.25 0.4 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.067 1.562 . . . . 0.0 110.341 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.45 ' HB ' ' CZ ' ' A' ' 9' ' ' TYR . 7.8 m -141.38 170.43 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.196 -0.94 . . . . 0.0 110.161 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -124.31 109.55 13.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.0 110.209 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.501 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 71.8 m -84.43 150.46 57.22 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 0.0 110.091 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 50.3 Cg_endo -76.13 162.28 92.41 Favored 'Cis proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.632 -2.237 . . . . 0.0 110.486 -0.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.42 157.75 24.55 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -100.14 131.64 45.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.133 -1.216 . . . . 0.0 110.271 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.45 ' CZ ' ' HB ' ' A' ' 3' ' ' VAL . 66.3 m-85 -136.57 144.56 44.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.341 -0.849 . . . . 0.0 110.122 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 7.2 tt0 -112.65 126.95 55.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.114 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 60.5 t -108.65 94.54 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.231 -0.918 . . . . 0.0 110.378 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 14' ' ' LYS . 42.4 t0 60.52 71.47 0.57 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.238 -0.914 . . . . 0.0 110.639 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 58.9 14.36 23.21 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 12.7 mmtt -108.83 152.19 25.22 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.071 -1.252 . . . . 0.0 110.103 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -106.29 136.39 46.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.93 . . . . 0.0 110.27 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.2 t -140.41 117.53 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.981 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 26' ' ' ASN . 2.3 mp -100.4 115.92 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 110.542 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 18' ' ' LEU . 21.7 mt -95.09 116.71 29.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.301 -0.874 . . . . 0.0 109.989 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -94.97 -163.38 1.04 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.932 . . . . 0.0 110.317 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 19' ' ' ASP . 0.4 OUTLIER -42.42 126.03 3.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.845 . . . . 0.0 110.303 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER 64.13 39.29 7.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.933 . . . . 0.0 110.03 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 m 48.12 50.16 16.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 110.072 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.14 113.81 20.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.292 -0.88 . . . . 0.0 110.265 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . 0.811 ' SD ' HD11 ' A' ' 38' ' ' LEU . 4.4 tpt -50.8 145.8 6.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.166 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -143.2 18.14 1.91 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' HB2' HD12 ' A' ' 17' ' ' ILE . 20.8 t30 -125.2 59.97 26.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 0.0 110.27 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.96 -8.95 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.951 1.501 . . . . 0.0 110.374 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.3 -36.03 52.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.877 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.45 -77.83 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.326 -0.859 . . . . 0.0 110.267 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.499 ' CZ2' ' HA ' ' A' ' 102' ' ' ALA . 7.8 t90 61.16 107.76 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.309 -0.869 . . . . 0.0 110.231 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -124.52 -178.15 4.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.943 . . . . 0.0 110.25 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.62 -45.86 77.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.88 . . . . 0.0 110.266 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HD3' ' O ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -61.71 -35.57 78.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.27 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.1 t -65.92 -54.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -56.58 -40.89 76.02 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.294 -0.878 . . . . 0.0 110.322 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.87 -62.62 1.74 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 0.0 110.349 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 54.2 t90 -51.04 -30.59 15.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.925 . . . . 0.0 110.39 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.811 HD11 ' SD ' ' A' ' 24' ' ' MET . 2.2 mt -65.28 -52.26 55.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 110.369 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.08 -30.32 70.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.212 -0.93 . . . . 0.0 110.353 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.86 -29.32 61.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 0.0 110.379 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -76.99 -37.87 54.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.233 -0.917 . . . . 0.0 110.34 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 42' ' ' LEU . 10.2 tp -80.27 -58.78 2.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.94 . . . . 0.0 110.325 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -95.38 -84.18 0.34 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.179 -0.951 . . . . 0.0 110.161 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.63 39.06 0.02 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 45' ' ' ILE . 3.8 mt -79.7 88.32 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -45.06 -30.21 1.03 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 110.143 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 48' ' ' MET . 9.2 mttp -150.23 113.1 4.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.138 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.462 ' HA ' HG21 ' A' ' 45' ' ' ILE . 52.6 mmm -42.75 120.61 1.79 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.4 p -66.34 150.96 48.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.283 -0.885 . . . . 0.0 110.23 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -36.69 52.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.217 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -40.29 85.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 0.0 110.1 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -56.71 -56.19 24.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.167 -0.958 . . . . 0.0 109.964 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.1 m95 -59.76 -28.58 67.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 110.003 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -66.48 -41.7 88.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 0.0 109.94 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.788 ' O ' HD12 ' A' ' 59' ' ' LEU . 3.2 tp -68.55 -38.09 80.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.933 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.31 -39.67 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.339 -0.851 . . . . 0.0 110.041 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' TRP . 3.2 mtpp -64.91 -51.57 61.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.069 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.17 -41.14 78.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 110.114 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -64.39 -35.57 81.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.267 -0.896 . . . . 0.0 110.056 179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.2 mmm-85 -57.04 -36.28 70.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -0.904 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -67.24 -36.35 81.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.265 -0.897 . . . . 0.0 110.137 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -71.23 -30.74 66.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.0 110.213 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.418 ' HA ' ' OG1' ' A' ' 68' ' ' THR . 19.8 t90 -58.01 -27.31 63.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.275 -0.891 . . . . 0.0 110.138 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -95.65 29.67 2.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.213 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.04 -52.88 0.74 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -130.22 -78.72 0.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.168 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.21 25.12 0.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 69' ' ' CYS . 0.2 OUTLIER 58.46 -167.08 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.267 -1.137 . . . . 0.0 110.257 -179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 68' ' ' THR . 1.1 m 54.34 61.46 9.68 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 110.202 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.62 163.47 38.42 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.079 1.568 . . . . 0.0 110.48 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.3 -179.28 4.26 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.066 1.561 . . . . 0.0 110.376 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 72' ' ' ILE . 11.3 tp -88.45 28.43 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.212 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -126.96 -31.62 2.61 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.279 -0.888 . . . . 0.0 110.199 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -21.98 44.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 0.0 110.171 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' O ' ' HB ' ' A' ' 79' ' ' THR . 31.5 t -67.31 -53.79 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.7 t -72.2 -27.16 62.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.235 -0.916 . . . . 0.0 110.29 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.95 -37.57 1.92 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 0.0 110.196 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -142.05 53.86 1.47 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.23 -0.919 . . . . 0.0 110.223 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 75' ' ' VAL . 50.3 m -161.74 -37.32 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 0.0 110.158 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.3 33.92 18.7 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.64 124.43 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -1.126 . . . . 0.0 110.119 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.38 149.25 21.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -0.902 . . . . 0.0 110.258 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.5 tp -50.91 -27.04 6.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.297 -0.877 . . . . 0.0 110.159 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.97 -46.02 89.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -42.29 96.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 110.207 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.592 ' H ' HD12 ' A' ' 86' ' ' ILE . 3.2 mp -63.67 -28.67 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 110.265 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -77.01 -37.84 54.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.297 -0.877 . . . . 0.0 110.269 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.96 -26.26 59.46 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.272 -0.892 . . . . 0.0 110.257 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.67 -57.03 3.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 110.25 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -91.59 169.05 11.97 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.53 -55.4 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.097 1.578 . . . . 0.0 110.466 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.76 104.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.163 -0.961 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 118.69 77.2 0.55 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.511 ' HB3' ' CG2' ' A' ' 86' ' ' ILE . 45.7 Cg_endo -72.69 -10.85 25.56 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.022 1.538 . . . . 0.0 110.39 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.29 -77.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 0.0 110.214 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -74.96 -7.55 53.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 0.0 110.297 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.4 ' N ' ' CD2' ' A' ' 96' ' ' HIS . . . -76.29 -77.17 0.77 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -45.83 -35.09 4.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.174 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 39.5 m -68.1 -58.23 4.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -0.914 . . . . 0.0 110.27 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -50.21 -26.96 5.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -0.917 . . . . 0.0 110.3 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.3 t -77.04 -56.71 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.232 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . . . -61.4 -12.41 14.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.272 -0.893 . . . . 0.0 110.233 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 104' ' ' ALA . . . 85.75 80.13 1.15 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 103' ' ' GLY . . . -177.47 76.88 0.24 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.244 -1.151 . . . . 0.0 110.159 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.88 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.961 1.506 . . . . 0.0 110.475 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -164.7 70.57 1.5 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 0.0 110.264 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.34 163.69 37.15 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.111 1.585 . . . . 0.0 110.467 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.1 161.52 39.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 110.23 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 83.99 106.51 0.56 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.88 46.27 1.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -1.159 . . . . 0.0 110.271 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.195 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.797 0.332 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.8 158.81 49.66 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.025 1.54 . . . . 0.0 110.453 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.4 t -93.4 116.0 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.21 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 111.35 0.91 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 110.247 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.506 ' HA ' ' C ' ' A' ' 6' ' ' PRO . 99.1 m -105.24 148.33 36.06 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 110.16 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 5' ' ' CYS . 48.9 Cg_endo -75.98 177.89 37.38 Favored 'Cis proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.742 -2.191 . . . . 0.0 110.346 -0.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -175.89 146.75 8.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.519 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.8 tt0 -120.11 127.62 52.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.332 -1.099 . . . . 0.0 110.073 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 8' ' ' GLU . 29.2 m-85 -142.09 170.48 15.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 0.0 110.244 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -125.01 154.61 41.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.323 -0.861 . . . . 0.0 110.162 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 12' ' ' ASP . 44.3 t -131.37 101.62 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.903 . . . . 0.0 110.229 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER 42.61 90.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -0.92 . . . . 0.0 110.271 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.58 62.19 3.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.19 170.45 16.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -1.148 . . . . 0.0 110.196 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' C ' HG23 ' A' ' 16' ' ' VAL . 21.9 tttm -135.28 145.06 47.16 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.201 -0.937 . . . . 0.0 110.224 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.413 HG23 ' C ' ' A' ' 15' ' ' LYS . 78.4 t -148.05 113.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.154 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.3 mt -99.35 145.15 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.234 -0.917 . . . . 0.0 110.272 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' A' ' 22' ' ' CYS . 9.4 mt -123.82 108.83 12.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 110.095 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -55.72 -173.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.198 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 20' ' ' GLU . 51.0 tt0 -66.79 -15.37 63.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.889 . . . . 0.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.57 34.27 3.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 0.0 110.242 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.622 ' HA ' HD22 ' A' ' 18' ' ' LEU . 83.9 m 48.16 49.08 17.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.269 -0.895 . . . . 0.0 110.235 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.78 147.63 34.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 110.211 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.2 ttt -74.7 115.99 14.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 110.287 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -88.77 28.17 1.19 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 110.159 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -168.25 69.22 0.81 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.323 -0.861 . . . . 0.0 110.198 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.483 ' CG ' ' HB3' ' A' ' 105' ' ' PRO . 46.3 Cg_endo -72.71 -7.0 20.08 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.052 1.554 . . . . 0.0 110.488 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -78.0 -21.67 50.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 110.288 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -103.16 39.55 1.55 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 110.239 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.51 ' NE1' ' O ' ' A' ' 102' ' ' ALA . 83.8 t90 -71.79 137.14 47.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.111 -0.993 . . . . 0.0 110.129 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -144.84 -178.49 6.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.261 -0.9 . . . . 0.0 110.143 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.79 -62.29 1.47 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.248 -0.907 . . . . 0.0 110.289 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -54.49 -26.88 34.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.0 110.247 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.3 t -73.56 -56.76 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.254 -0.904 . . . . 0.0 110.292 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' HH2' ' A' ' 53' ' ' TRP . . . -52.55 -50.74 62.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -0.933 . . . . 0.0 110.449 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -61.07 -46.87 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.209 -0.932 . . . . 0.0 110.392 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 59.3 t90 -51.62 -47.12 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.188 -0.945 . . . . 0.0 110.392 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.86 -37.64 88.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.323 -0.861 . . . . 0.0 110.347 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.95 -39.4 81.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 110.284 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HG3' ' HB2' ' A' ' 46' ' ' GLN . 2.0 tmt_? -76.98 -37.17 55.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.318 -0.864 . . . . 0.0 110.376 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.82 -32.98 74.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 110.322 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 mt -87.3 -72.08 0.53 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 110.113 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -81.34 -60.76 2.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 110.243 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 46' ' ' GLN . . . 150.4 -19.05 1.04 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.9 mt -47.07 96.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -1.158 . . . . 0.0 110.243 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 40' ' ' ARG . 4.4 tm0? -89.29 -6.16 56.97 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 110.215 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -140.68 96.13 2.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 110.271 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.417 ' HE3' ' HB3' ' A' ' 52' ' ' HIS . 66.6 mmm -66.38 126.57 29.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 110.086 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 49' ' ' THR . 4.8 t -78.59 172.57 13.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.0 110.241 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -59.37 -35.3 73.64 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 110.246 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -64.45 -29.3 70.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 110.175 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.488 ' CE1' ' HB3' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -69.96 -65.64 0.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.269 -0.895 . . . . 0.0 110.247 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.503 ' HH2' ' HB3' ' A' ' 35' ' ' ALA . 4.7 m95 -49.62 -30.83 9.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 57' ' ' LYS . 2.2 tmtm? -67.97 -57.41 6.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.193 -0.942 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 14.2 tp -51.83 -49.41 62.9 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.295 -0.878 . . . . 0.0 110.17 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.02 -31.78 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 0.0 110.242 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -62.41 -49.49 75.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 110.218 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.529 ' C ' ' CD1' ' A' ' 58' ' ' TYR . 5.7 t80 -63.49 -45.73 89.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -53.11 -41.05 64.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -0.904 . . . . 0.0 110.232 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -40.71 71.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 110.271 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -58.36 -43.96 88.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.253 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.469 ' CZ ' ' HG3' ' A' ' 70' ' ' PRO . 0.2 OUTLIER -66.03 -39.37 90.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 110.162 -179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.46 ' CZ2' ' HD2' ' A' ' 105' ' ' PRO . 29.0 t90 -79.17 -11.61 59.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 0.0 110.174 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -95.89 -25.17 16.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 110.29 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.6 m -54.43 -30.62 53.09 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 110.233 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -163.0 -54.97 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -0.925 . . . . 0.0 110.268 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.9 73.27 0.01 OUTLIER Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 69' ' ' CYS . 6.7 m -155.56 -179.8 8.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -1.198 . . . . 0.0 110.198 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.634 ' H ' HG22 ' A' ' 68' ' ' THR . 49.1 t -157.15 81.59 3.26 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 0.0 110.319 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.469 ' HG3' ' CZ ' ' A' ' 62' ' ' TYR . 47.1 Cg_endo -73.26 171.47 17.58 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.989 1.52 . . . . 0.0 110.39 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.25 -159.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.958 1.504 . . . . 0.0 110.382 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 75' ' ' VAL . 3.9 tt -116.4 14.43 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -74.89 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.297 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.6 50.55 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.239 -0.913 . . . . 0.0 110.253 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 72' ' ' ILE . 91.5 t -77.13 -34.22 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.276 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 77' ' ' LYS . 17.0 m -68.2 -32.29 72.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.166 -0.959 . . . . 0.0 110.302 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 76' ' ' THR . 30.7 tttt -44.01 -27.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 110.295 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -107.71 -61.22 1.6 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.22 -0.925 . . . . 0.0 110.258 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -52.98 22.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 110.162 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.16 13.73 80.35 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.7 108.6 0.76 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.169 -1.194 . . . . 0.0 110.191 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.85 126.36 10.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.209 -0.932 . . . . 0.0 110.22 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.2 -30.33 11.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.271 -0.893 . . . . 0.0 110.147 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.58 -50.47 73.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.23 -0.919 . . . . 0.0 110.07 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -58.54 -50.37 74.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.248 -0.908 . . . . 0.0 110.005 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.408 ' CG2' ' HD3' ' A' ' 94' ' ' PRO . 54.7 mt -58.92 -26.99 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.023 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -39.7 64.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.427 -0.796 . . . . 0.0 110.117 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.08 -35.77 78.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.872 . . . . 0.0 110.093 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 80.7 mt -74.18 -59.27 2.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.185 -0.947 . . . . 0.0 110.067 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.89 118.67 17.71 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.285 -0.885 . . . . 0.0 110.101 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 92' ' ' SER . 45.1 Cg_endo -72.56 -177.81 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.85 1.447 . . . . 0.0 110.421 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 91' ' ' PRO . 30.0 m 55.64 19.61 3.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 110.145 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 64.57 149.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 96' ' ' HIS . 46.6 Cg_endo -73.06 -90.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.952 1.501 . . . . 0.0 110.426 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 94' ' ' PRO . . . 43.33 -93.28 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.153 -0.967 . . . . 0.0 110.337 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 94' ' ' PRO . 11.2 m170 -73.52 -56.2 5.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 0.0 110.352 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 98' ' ' ALA . . . -44.12 -56.92 5.09 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 97' ' ' GLY . . . -42.65 -44.58 4.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -1.108 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -65.23 -54.5 28.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 110.195 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HE3' ' O ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -42.83 -38.36 2.12 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.286 -0.884 . . . . 0.0 110.138 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 48.6 t -76.65 -41.67 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.246 -0.908 . . . . 0.0 110.233 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.51 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -53.31 -45.4 68.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.31 -0.869 . . . . 0.0 110.268 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 107.7 51.25 0.76 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.23 117.96 69.83 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.22 -1.165 . . . . 0.0 110.234 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.483 ' HB3' ' CG ' ' A' ' 27' ' ' PRO . 46.4 Cg_endo -72.73 -46.4 0.43 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.989 1.52 . . . . 0.0 110.436 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.9 120.39 41.89 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 110.194 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.53 98.08 1.01 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.902 1.474 . . . . 0.0 110.424 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 60.3 m -55.76 97.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.294 -0.879 . . . . 0.0 110.195 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.08 -47.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.0 63.97 0.24 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -1.1 . . . . 0.0 110.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.445 ' H ' HG12 ' A' ' 111' ' ' VAL . 3.2 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.174 179.952 . . . . . . . . 1 1 . 1 stop_ save_